2024-03-28T21:50:08Zhttp://repository.helmholtz-hzi.de/oai/requestoai:repository.helmholtz-hzi.de:10033/2006692019-08-30T11:30:31Zcom_10033_620656col_10033_620657
Xu, Kuiying
f13c3c7b48c7c8b05e9626b659ffcd87
500
Wetzel, Marie
f2124ab9cb1936935d94d9a025dc7053
500
W. Hartmann, Rolf
74e2f2a924952c72566cd52abb93572d
500
Marchais-Oberwinkler, Sandrine
8077578e04f781fbc378097c04d3ea68
500
2012-01-06T08:51:56Z
2012-01-06T08:51:56Z
2012-01-06T08:51:56Z
Synthesis and Biological Evaluation of Spiro-δ-lactones as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) 2011, 8 (5):406 Letters in Drug Design & Discovery
15701808
10.2174/157018011795514230
http://hdl.handle.net/10033/200669
Letters in Drug Design & Discovery
http://openurl.ingenta.com/content/xref?genre=article&issn=1570-1808&volume=8&issue=5&spage=406
Synthesis and Biological Evaluation of Spiro-δ-lactones as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2)
Article
2012-06-15T00:00:00Z
ORIGINAL
Ku et al_final.pdf
Ku et al_final.pdf
Original manuscript
application/pdf
447166
https://hzi.openrepository.com/bitstream/10033/200669/1/Ku%20et%20al_final.pdf
7b201b8171b647413587edb59a5c223b
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/200669/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/200669/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
11446
https://hzi.openrepository.com/bitstream/10033/200669/4/license_rdf
76bcf9fc488c2b315152bb267567cb40
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1783
https://hzi.openrepository.com/bitstream/10033/200669/5/license.txt
a473b78722aed6e21b452d1eab11bf75
MD5
5
false
THUMBNAIL
Ku et al_final.pdf.jpg
Ku et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
31080
https://hzi.openrepository.com/bitstream/10033/200669/8/Ku%20et%20al_final.pdf.jpg
f8195d5ce50512288a0798af9671d9d1
MD5
8
false
TEXT
Ku et al_final.pdf.txt
Ku et al_final.pdf.txt
Extracted Text
text/plain
83404
https://hzi.openrepository.com/bitstream/10033/200669/7/Ku%20et%20al_final.pdf.txt
1a756518ab8becc276092735606b78a2
MD5
7
false
10033/200669
oai:hzi.openrepository.com:10033/200669
2019-08-30 11:30:31.52
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2039492019-08-30T11:25:43Zcom_10033_620656col_10033_620657
Klein, Tobias
185be01aa59f77eff7bd922f0da77602
500
Henn, Claudia
73570f853c22dae62c667f0dd0692585
500
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany.
2012-01-20T13:41:17Z
2012-01-20T13:41:17Z
2011
Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validation. 2011, 6 (8):e22990 PLoS ONE
1932-6203
21857977
10.1371/journal.pone.0022990
http://hdl.handle.net/10033/203949
PloS one
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the reduction of estrone to estradiol, which is the most potent estrogen in humans. Inhibition of 17β-HSD1 and thereby reducing the intracellular estradiol concentration is thus a promising approach for the treatment of estrogen dependent diseases. In the past, several steroidal and non-steroidal inhibitors of 17β-HSD1 have been described but so far there is no cocrystal structure of the latter in complex with 17β-HSD1. However, a distinct knowledge of active site topologies and protein-ligand interactions is a prerequisite for structure-based drug design and optimization. An elegant strategy to enhance this knowledge is to compare inhibition values obtained for one compound toward ortholog proteins from various species, which are highly conserved in sequence and differ only in few residues. In this study the inhibitory potencies of selected members of different non-steroidal inhibitor classes toward marmoset 17β-HSD1 were determined and the data were compared with the values obtained for the human enzyme. A species specific inhibition profile was observed in the class of the (hydroxyphenyl)naphthols. Using a combination of computational methods, including homology modelling, molecular docking, MD simulation, and binding energy calculation, a reasonable model of the three-dimensional structure of marmoset 17β-HSD1 was developed and inhibition data were rationalized on the structural basis. In marmoset 17β-HSD1, residues 190 to 196 form a small α-helix, which induces conformational changes compared to the human enzyme. The docking poses suggest these conformational changes as determinants for species specificity and energy decomposition analysis highlighted the outstanding role of Asn152 as interaction partner for inhibitor binding. In summary, this strategy of comparing the biological activities of inhibitors toward highly conserved ortholog proteins might be an alternative to laborious x-ray or site-directed mutagenesis experiments in certain cases. Additionally, it facilitates inhibitor design and optimization by offering new information on protein-ligand interactions.
en
Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validation.
Article
2018-06-13T00:49:28Z
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the reduction of estrone to estradiol, which is the most potent estrogen in humans. Inhibition of 17β-HSD1 and thereby reducing the intracellular estradiol concentration is thus a promising approach for the treatment of estrogen dependent diseases. In the past, several steroidal and non-steroidal inhibitors of 17β-HSD1 have been described but so far there is no cocrystal structure of the latter in complex with 17β-HSD1. However, a distinct knowledge of active site topologies and protein-ligand interactions is a prerequisite for structure-based drug design and optimization. An elegant strategy to enhance this knowledge is to compare inhibition values obtained for one compound toward ortholog proteins from various species, which are highly conserved in sequence and differ only in few residues. In this study the inhibitory potencies of selected members of different non-steroidal inhibitor classes toward marmoset 17β-HSD1 were determined and the data were compared with the values obtained for the human enzyme. A species specific inhibition profile was observed in the class of the (hydroxyphenyl)naphthols. Using a combination of computational methods, including homology modelling, molecular docking, MD simulation, and binding energy calculation, a reasonable model of the three-dimensional structure of marmoset 17β-HSD1 was developed and inhibition data were rationalized on the structural basis. In marmoset 17β-HSD1, residues 190 to 196 form a small α-helix, which induces conformational changes compared to the human enzyme. The docking poses suggest these conformational changes as determinants for species specificity and energy decomposition analysis highlighted the outstanding role of Asn152 as interaction partner for inhibitor binding. In summary, this strategy of comparing the biological activities of inhibitors toward highly conserved ortholog proteins might be an alternative to laborious x-ray or site-directed mutagenesis experiments in certain cases. Additionally, it facilitates inhibitor design and optimization by offering new information on protein-ligand interactions.
ORIGINAL
KLein et al_final.pdf
KLein et al_final.pdf
Open Access publication
application/pdf
952401
https://hzi.openrepository.com/bitstream/10033/203949/1/KLein%20et%20al_final.pdf
849979037c0aa0eb2d39977806b61972
MD5
1
true
LICENSE
license.txt
license.txt
text/plain
1783
https://hzi.openrepository.com/bitstream/10033/203949/5/license.txt
dc80dbcc7033a1ce1cc038a7b7086906
MD5
5
false
THUMBNAIL
KLein et al_final.pdf.jpg
KLein et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
29927
https://hzi.openrepository.com/bitstream/10033/203949/12/KLein%20et%20al_final.pdf.jpg
cfb7fca0d830b4ed8127a7c08fe70734
MD5
12
false
TEXT
KLein et al_final.pdf.txt
KLein et al_final.pdf.txt
Extracted Text
text/plain
71934
https://hzi.openrepository.com/bitstream/10033/203949/11/KLein%20et%20al_final.pdf.txt
123e3bf385ccaac4070b023afbdcab98
MD5
11
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/203949/8/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
8
false
license_text
license_text
text/plain
0
https://hzi.openrepository.com/bitstream/10033/203949/9/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
9
false
license_rdf
license_rdf
text/plain
11453
https://hzi.openrepository.com/bitstream/10033/203949/10/license_rdf
2a244613036bb4c1dd83831dd93f76f0
MD5
10
false
10033/203949
oai:hzi.openrepository.com:10033/203949
2019-08-30 11:25:43.226
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2146512019-08-30T11:26:42Zcom_10033_620656col_10033_620657
Klein, Tobias
185be01aa59f77eff7bd922f0da77602
500
Henn, Claudia
73570f853c22dae62c667f0dd0692585
500
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany.
2012-03-07T15:35:23Z
2012-03-07T15:35:23Z
2011
Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validation. 2011, 6 (8):e22990 PLoS ONE
1932-6203
21857977
10.1371/journal.pone.0022990
http://hdl.handle.net/10033/214651
PloS one
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the reduction of estrone to estradiol, which is the most potent estrogen in humans. Inhibition of 17β-HSD1 and thereby reducing the intracellular estradiol concentration is thus a promising approach for the treatment of estrogen dependent diseases. In the past, several steroidal and non-steroidal inhibitors of 17β-HSD1 have been described but so far there is no cocrystal structure of the latter in complex with 17β-HSD1. However, a distinct knowledge of active site topologies and protein-ligand interactions is a prerequisite for structure-based drug design and optimization. An elegant strategy to enhance this knowledge is to compare inhibition values obtained for one compound toward ortholog proteins from various species, which are highly conserved in sequence and differ only in few residues. In this study the inhibitory potencies of selected members of different non-steroidal inhibitor classes toward marmoset 17β-HSD1 were determined and the data were compared with the values obtained for the human enzyme. A species specific inhibition profile was observed in the class of the (hydroxyphenyl)naphthols. Using a combination of computational methods, including homology modelling, molecular docking, MD simulation, and binding energy calculation, a reasonable model of the three-dimensional structure of marmoset 17β-HSD1 was developed and inhibition data were rationalized on the structural basis. In marmoset 17β-HSD1, residues 190 to 196 form a small α-helix, which induces conformational changes compared to the human enzyme. The docking poses suggest these conformational changes as determinants for species specificity and energy decomposition analysis highlighted the outstanding role of Asn152 as interaction partner for inhibitor binding. In summary, this strategy of comparing the biological activities of inhibitors toward highly conserved ortholog proteins might be an alternative to laborious x-ray or site-directed mutagenesis experiments in certain cases. Additionally, it facilitates inhibitor design and optimization by offering new information on protein-ligand interactions.
en
Amino Acid Sequence
Amino Acids
Animals
Binding Sites
Callithrix
Computer Simulation
Crystallography, X-Ray
Enzyme Inhibitors
Estradiol Dehydrogenases
Humans
Kinetics
Models, Molecular
Molecular Sequence Data
Molecular Structure
Protein Binding
Protein Structure, Tertiary
Sequence Homology, Amino Acid
Species Specificity
Structure-Activity Relationship
Substrate Specificity
Structural basis for species specific inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1): computational study and biological validation.
Article
2018-06-12T21:42:12Z
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the reduction of estrone to estradiol, which is the most potent estrogen in humans. Inhibition of 17β-HSD1 and thereby reducing the intracellular estradiol concentration is thus a promising approach for the treatment of estrogen dependent diseases. In the past, several steroidal and non-steroidal inhibitors of 17β-HSD1 have been described but so far there is no cocrystal structure of the latter in complex with 17β-HSD1. However, a distinct knowledge of active site topologies and protein-ligand interactions is a prerequisite for structure-based drug design and optimization. An elegant strategy to enhance this knowledge is to compare inhibition values obtained for one compound toward ortholog proteins from various species, which are highly conserved in sequence and differ only in few residues. In this study the inhibitory potencies of selected members of different non-steroidal inhibitor classes toward marmoset 17β-HSD1 were determined and the data were compared with the values obtained for the human enzyme. A species specific inhibition profile was observed in the class of the (hydroxyphenyl)naphthols. Using a combination of computational methods, including homology modelling, molecular docking, MD simulation, and binding energy calculation, a reasonable model of the three-dimensional structure of marmoset 17β-HSD1 was developed and inhibition data were rationalized on the structural basis. In marmoset 17β-HSD1, residues 190 to 196 form a small α-helix, which induces conformational changes compared to the human enzyme. The docking poses suggest these conformational changes as determinants for species specificity and energy decomposition analysis highlighted the outstanding role of Asn152 as interaction partner for inhibitor binding. In summary, this strategy of comparing the biological activities of inhibitors toward highly conserved ortholog proteins might be an alternative to laborious x-ray or site-directed mutagenesis experiments in certain cases. Additionally, it facilitates inhibitor design and optimization by offering new information on protein-ligand interactions.
ORIGINAL
KLein et al_final.pdf
KLein et al_final.pdf
open access publication
application/pdf
952406
https://hzi.openrepository.com/bitstream/10033/214651/1/KLein%20et%20al_final.pdf
e08d7520f121899ae40a2d527a75cfbb
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/214651/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
text/plain
0
https://hzi.openrepository.com/bitstream/10033/214651/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
text/plain
11453
https://hzi.openrepository.com/bitstream/10033/214651/4/license_rdf
2a244613036bb4c1dd83831dd93f76f0
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1783
https://hzi.openrepository.com/bitstream/10033/214651/5/license.txt
febb1c0aa8bf6b8ac46809e3a31e3ad4
MD5
5
false
TEXT
KLein et al_final.pdf.txt
KLein et al_final.pdf.txt
Extracted Text
text/plain
71935
https://hzi.openrepository.com/bitstream/10033/214651/8/KLein%20et%20al_final.pdf.txt
41cebb128024ecbdff988f7ccd1c7e3a
MD5
8
false
THUMBNAIL
KLein et al_final.pdf.jpg
KLein et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
30003
https://hzi.openrepository.com/bitstream/10033/214651/9/KLein%20et%20al_final.pdf.jpg
4c29d2ff3c745a07893f4f14608b26cb
MD5
9
false
10033/214651
oai:hzi.openrepository.com:10033/214651
2019-08-30 11:26:42.722
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2142382019-08-30T11:36:32Zcom_10033_620656col_10033_620657
Bihrer, Verena
92ac4dfee217650075bc10afdfb416bc
500
Friedrich-Rust, Mireen
f50a97ef297d6dfedc9bfb9fc4616c62
500
Kronenberger, Bernd
00042fa40d2e4daaf56e76aad6bb572a
500
Forestier, Nicole
c433d2dbcc1071fa6594ce46ccd692e2
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Shi, Ying
ecfd1b14997b5314aaaa41a948335ffd
500
Peveling-Oberhag, Jan
f579565dfcb1672bd5aac9725bb6ba92
500
Radeke, Heinfried H
974bd38b2b9694ef21072df622e2beea
500
Sarrazin, Christoph
fdd93ff071f4bbdd24040f82a6764bff
500
Herrmann, Eva
9608b96aa9de8c494912cc9e60562355
500
Zeuzem, Stefan
6d744694cd11d06e28229e8f415daa07
500
Waidmann, Oliver
f43b2269bc2756fcad532b3903970c71
500
Piiper, Albrecht
3399dbce6d1847de71ac96a5ec02d81a
500
Department of Medicine I, University of Frankfurt/M., Frankfurt, Germany.
2012-03-05T14:52:18Z
2012-03-05T14:52:18Z
2011-09
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. 2011, 106 (9):1663-9 Am. J. Gastroenterol.
1572-0241
21606975
10.1038/ajg.2011.161
http://hdl.handle.net/10033/214238
The American journal of gastroenterology
The liver contains large amounts of microRNA-122 (miR-122), whereas other tissues contain only marginal amounts of this miRNA. MicroRNAs have also been found to circulate in the blood in a cell-free form; their potential as readily accessible disease markers is currently evaluated. Here, we investigated if the serum levels of miR-122 might be useful as disease parameter in patients with chronic hepatitis C virus (HCV) infection.
en
Adult
Aged
Alanine Transaminase
Aspartate Aminotransferases
Bilirubin
Biological Markers
Female
Hepatitis C, Chronic
Humans
International Normalized Ratio
Liver
Male
MicroRNAs
Middle Aged
Necrosis
Serum Albumin
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Article
2012-03-15T00:00:00Z
The liver contains large amounts of microRNA-122 (miR-122), whereas other tissues contain only marginal amounts of this miRNA. MicroRNAs have also been found to circulate in the blood in a cell-free form; their potential as readily accessible disease markers is currently evaluated. Here, we investigated if the serum levels of miR-122 might be useful as disease parameter in patients with chronic hepatitis C virus (HCV) infection.
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/214238/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
text/plain
0
https://hzi.openrepository.com/bitstream/10033/214238/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
text/plain
11453
https://hzi.openrepository.com/bitstream/10033/214238/4/license_rdf
2a244613036bb4c1dd83831dd93f76f0
MD5
4
false
ORIGINAL
Bihrer et al_final.pdf
Bihrer et al_final.pdf
original manuscript
application/pdf
1752891
https://hzi.openrepository.com/bitstream/10033/214238/1/Bihrer%20et%20al_final.pdf
f272c69bfd101bf0b7b32abd2fa80510
MD5
1
true
LICENSE
license.txt
license.txt
text/plain
1783
https://hzi.openrepository.com/bitstream/10033/214238/5/license.txt
ecad430c71acbe2cd7c4b8439bff5358
MD5
5
false
THUMBNAIL
Bihrer et al_final.pdf.jpg
Bihrer et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
35931
https://hzi.openrepository.com/bitstream/10033/214238/8/Bihrer%20et%20al_final.pdf.jpg
2f1a93a3c4791566df2cb64b93e76b69
MD5
8
false
TEXT
Bihrer et al_final.pdf.txt
Bihrer et al_final.pdf.txt
Extracted Text
text/plain
28991
https://hzi.openrepository.com/bitstream/10033/214238/7/Bihrer%20et%20al_final.pdf.txt
8bbbc10c033a3226cc632cb7c629c263
MD5
7
false
10033/214238
oai:hzi.openrepository.com:10033/214238
2019-08-30 11:36:32.819
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2163012019-08-30T11:26:13Zcom_10033_620656col_10033_620657
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
Recanatini, Maurizio
dc841f4a4b53c4b02ccb209a8c5f2fd9
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University and Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C2.3, 66123 Saarbrücken, Germany.
2012-03-22T15:11:27Z
2012-03-22T15:11:27Z
2011-09
Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps. 2011, 25 (9):795-811 J. Comput. Aided Mol. Des.
1573-4951
21822722
10.1007/s10822-011-9464-7
http://hdl.handle.net/10033/216301
Journal of computer-aided molecular design
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the last step of the estrogen biosynthesis, namely the reduction of estrone to the biologically potent estradiol. As such it is a potentially attractive drug target for the treatment of estrogen-dependent diseases like breast cancer and endometriosis. 17β-HSD1 belongs to the bisubstrate enzymes and exists as an ensemble of conformations. These principally differ in the region of the βFαG'-loop, suggesting a prominent role in substrate and inhibitor binding. Although several classes of potent non-steroidal 17β-HSD1 inhibitors currently exist, their binding mode is still unclear. We aimed to elucidate the binding mode of bis(hydroxyphenyl)arenes, a highly potent class of 17β-HSD1 inhibitors, and to rank these compounds correctly with respect to their inhibitory potency, two essential aspects in drug design. Ensemble docking experiments resulted in a steroidal binding mode for the closed enzyme conformations and in an alternative mode for the opened and occluded conformers with the inhibitors placed below the NADPH interacting with it synergically via π-π stacking and H-bond formation. Both binding modes were investigated by MD simulations and MM-PBSA binding free energy estimations using as representative member for this class compound 1 (50 nM). Notably, only the alternative binding mode proved stable and was energetically more favorable, while when simulated in the steroidal binding mode compound 1 was displaced from the active site. In parallel, ab initio studies of small NADPH-inhibitor complexes were performed, which supported the importance of the synergistic interaction between inhibitors and cofactor.
en
Archived with thanks to Journal of computer-aided molecular design
17-Hydroxysteroid Dehydrogenases
Binding Sites
Drug Design
Enzyme Inhibitors
Humans
Molecular Dynamics Simulation
Protein Binding
Static Electricity
Thermodynamics
Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps.
Article
2018-06-12T16:56:15Z
17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyzes the last step of the estrogen biosynthesis, namely the reduction of estrone to the biologically potent estradiol. As such it is a potentially attractive drug target for the treatment of estrogen-dependent diseases like breast cancer and endometriosis. 17β-HSD1 belongs to the bisubstrate enzymes and exists as an ensemble of conformations. These principally differ in the region of the βFαG'-loop, suggesting a prominent role in substrate and inhibitor binding. Although several classes of potent non-steroidal 17β-HSD1 inhibitors currently exist, their binding mode is still unclear. We aimed to elucidate the binding mode of bis(hydroxyphenyl)arenes, a highly potent class of 17β-HSD1 inhibitors, and to rank these compounds correctly with respect to their inhibitory potency, two essential aspects in drug design. Ensemble docking experiments resulted in a steroidal binding mode for the closed enzyme conformations and in an alternative mode for the opened and occluded conformers with the inhibitors placed below the NADPH interacting with it synergically via π-π stacking and H-bond formation. Both binding modes were investigated by MD simulations and MM-PBSA binding free energy estimations using as representative member for this class compound 1 (50 nM). Notably, only the alternative binding mode proved stable and was energetically more favorable, while when simulated in the steroidal binding mode compound 1 was displaced from the active site. In parallel, ab initio studies of small NADPH-inhibitor complexes were performed, which supported the importance of the synergistic interaction between inhibitors and cofactor.
ORIGINAL
Negri_Recanatini_Hartmann_final.pdf
Negri_Recanatini_Hartmann_final.pdf
original manuscript
application/pdf
4637713
https://hzi.openrepository.com/bitstream/10033/216301/1/Negri_Recanatini_Hartmann_final.pdf
b4dbfa5cc61f635b175c535368578ba4
MD5
1
true
Negri_ SI.pdf
Negri_ SI.pdf
supporting information /figures
application/pdf
1264924
https://hzi.openrepository.com/bitstream/10033/216301/2/Negri_%20SI.pdf
d2d8a78b2fc6dc259cd979f8d46ca527
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/216301/3/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/216301/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/216301/5/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/216301/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Negri_ SI.pdf.txt
Negri_ SI.pdf.txt
Extracted Text
text/plain
13612
https://hzi.openrepository.com/bitstream/10033/216301/11/Negri_%20SI.pdf.txt
aea3934a8a3f5235feb0c41a8e7a0aa8
MD5
11
false
Negri_Recanatini_Hartmann_final.pdf.txt
Negri_Recanatini_Hartmann_final.pdf.txt
Extracted Text
text/plain
72544
https://hzi.openrepository.com/bitstream/10033/216301/12/Negri_Recanatini_Hartmann_final.pdf.txt
2192e5fd80debd8c09c26369f0ec3f9a
MD5
12
false
THUMBNAIL
Negri_Recanatini_Hartmann_final.pdf.jpg
Negri_Recanatini_Hartmann_final.pdf.jpg
Generated Thumbnail
image/jpeg
34231
https://hzi.openrepository.com/bitstream/10033/216301/14/Negri_Recanatini_Hartmann_final.pdf.jpg
6c5bfa8b50842da16a0d8fbb070abb3b
MD5
14
false
Negri_ SI.pdf.jpg
Negri_ SI.pdf.jpg
Generated Thumbnail
image/jpeg
26092
https://hzi.openrepository.com/bitstream/10033/216301/15/Negri_%20SI.pdf.jpg
4328841684f75b7d1accef3b19b4e8c6
MD5
15
false
10033/216301
oai:hzi.openrepository.com:10033/216301
2019-08-30 11:26:13.024
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2371532019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Bihrer, Verena
92ac4dfee217650075bc10afdfb416bc
500
Waidmann, Oliver
f43b2269bc2756fcad532b3903970c71
500
Friedrich-Rust, Mireen
f50a97ef297d6dfedc9bfb9fc4616c62
500
Forestier, Nicole
c433d2dbcc1071fa6594ce46ccd692e2
500
Susser, Simone
20ad369d8a985e61d8e8e03fe42a1dd8
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Welker, Martin
1ae55a2e408e4c290090ccf8bbd955ff
500
Shi, Ying
ecfd1b14997b5314aaaa41a948335ffd
500
Peveling-Oberhag, Jan
f579565dfcb1672bd5aac9725bb6ba92
500
Polta, Andreas
504a16010bc6f92195c80ef71f8662bc
500
von Wagner, Michael
9e75fe1a01fed1449871eb0ad630ea29
500
Radeke, Heinfried H
974bd38b2b9694ef21072df622e2beea
500
Sarrazin, Christoph
fdd93ff071f4bbdd24040f82a6764bff
500
Trojan, Jörg
c095bc2b0a82300cb74e7d6c3e47500f
500
Zeuzem, Stefan
6d744694cd11d06e28229e8f415daa07
500
Kronenberger, Bernd
00042fa40d2e4daaf56e76aad6bb572a
500
Piiper, Albrecht
3399dbce6d1847de71ac96a5ec02d81a
500
Department of Medicine I, University of Frankfurt/M., Frankfurt, Germany.
2012-08-03T12:25:14Z
2012-08-03T12:25:14Z
2011
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. 2011, 6 (10):e26971 PLoS ONE
1932-6203
22066022
10.1371/journal.pone.0026971
http://hdl.handle.net/10033/237153
PloS one
MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies, rendering it an interesting candidate as serum/plasma marker for malignancies. Here we correlated serum miR-21 levels with clinical parameters in patients with different stages of chronic hepatitis C virus infection (CHC) and CHC-associated HCC.
en
Archived with thanks to PloS one
Alanine Transaminase
Aspartate Aminotransferases
Bilirubin
Biological Markers
Carcinoma, Hepatocellular
Cohort Studies
Female
Hepatitis C, Chronic
Humans
Inflammation
Liver Neoplasms
Male
MicroRNAs
Middle Aged
Multivariate Analysis
Necrosis
Reproducibility of Results
Serum Albumin
gamma-Glutamyltransferase
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Article
2018-06-13T03:46:56Z
MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies, rendering it an interesting candidate as serum/plasma marker for malignancies. Here we correlated serum miR-21 levels with clinical parameters in patients with different stages of chronic hepatitis C virus infection (CHC) and CHC-associated HCC.
ORIGINAL
Bihrer et al_final.pdf
Bihrer et al_final.pdf
Open Access publication
application/pdf
441759
https://hzi.openrepository.com/bitstream/10033/237153/1/Bihrer%20et%20al_final.pdf
d0b82253192e70c74d053e7fde7a2014
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/237153/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/237153/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/237153/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/237153/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Bihrer et al_final.pdf.txt
Bihrer et al_final.pdf.txt
Extracted Text
text/plain
32843
https://hzi.openrepository.com/bitstream/10033/237153/8/Bihrer%20et%20al_final.pdf.txt
833386f66726352686104f3475abd0fc
MD5
8
false
THUMBNAIL
Bihrer et al_final.pdf.jpg
Bihrer et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
37702
https://hzi.openrepository.com/bitstream/10033/237153/9/Bihrer%20et%20al_final.pdf.jpg
17fcd57805d41303050e649b885180a5
MD5
9
false
10033/237153
oai:hzi.openrepository.com:10033/237153
2019-08-30 11:34:48.28
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2375552019-08-30T11:30:32Zcom_10033_620656col_10033_620657
Lu, Cenbin
5a0c4c8e74f17b1d3607bc0b7df2121d
500
Kirsch, Benjamin
8c673c51dcda680d6131094070a108db
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
de Jong, Johannes C
a1e7109c9f9524057415e109356e9f5c
500
Henn, Claudia
73570f853c22dae62c667f0dd0692585
500
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Müsken, Mathias
1204ff304c7364acca1cb3303dffeb45
500
Häussler, Susanne
d2527fb005be9775f94b5de7f3de1fbf
500
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz Institute for Pharmaceutical Research Saarland, Campus C2.3, 66123 Saarbrücken, Germany.
2012-08-07T13:35:08Z
2012-08-07T13:35:08Z
2012-03-23
Discovery of antagonists of PqsR, a key player in 2-alkyl-4-quinolone-dependent quorum sensing in Pseudomonas aeruginosa. 2012, 19 (3):381-90 Chem. Biol.
1879-1301
22444593
10.1016/j.chembiol.2012.01.015
http://hdl.handle.net/10033/237555
Chemistry & biology
The pqs quorum sensing communication system of Pseudomonas aeruginosa controls virulence factor production and is involved in biofilm formation, therefore playing an important role for pathogenicity. In order to attenuate P. aeruginosa pathogenicity, we followed a ligand-based drug design approach and synthesized a series of compounds targeting PqsR, the receptor of the pqs system. In vitro evaluation using a reporter gene assay in Escherichia coli led to the discovery of the first competitive PqsR antagonists, which are highly potent (K(d,app) of compound 20: 7 nM). These antagonists are able to reduce the production of the virulence factor pyocyanin in P. aeruginosa. Our finding offers insights into the ligand-receptor interaction of PqsR and provides a promising starting point for further drug design.
en
Archived with thanks to Chemistry & biology
4-Quinolones
Bacterial Proteins
Drug Design
Genes, Reporter
Kinetics
Pseudomonas aeruginosa
Pyocyanine
Quorum Sensing
Discovery of antagonists of PqsR, a key player in 2-alkyl-4-quinolone-dependent quorum sensing in Pseudomonas aeruginosa.
Article
2018-06-13T07:19:15Z
The pqs quorum sensing communication system of Pseudomonas aeruginosa controls virulence factor production and is involved in biofilm formation, therefore playing an important role for pathogenicity. In order to attenuate P. aeruginosa pathogenicity, we followed a ligand-based drug design approach and synthesized a series of compounds targeting PqsR, the receptor of the pqs system. In vitro evaluation using a reporter gene assay in Escherichia coli led to the discovery of the first competitive PqsR antagonists, which are highly potent (K(d,app) of compound 20: 7 nM). These antagonists are able to reduce the production of the virulence factor pyocyanin in P. aeruginosa. Our finding offers insights into the ligand-receptor interaction of PqsR and provides a promising starting point for further drug design.
ORIGINAL
Lu et al_final.pdf
Lu et al_final.pdf
original manuscript
application/pdf
351529
https://hzi.openrepository.com/bitstream/10033/237555/1/Lu%20et%20al_final.pdf
5995b0151906a415d1cf78afbb62ec44
MD5
1
true
Supplemental Information.pdf
Supplemental Information.pdf
supplemental materials and figures
application/pdf
903672
https://hzi.openrepository.com/bitstream/10033/237555/2/Supplemental%20Information.pdf
6c2ab05ea8f612891b96a34ed83117e0
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/237555/3/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/237555/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/237555/5/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/237555/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Supplemental Information.pdf.txt
Supplemental Information.pdf.txt
Extracted Text
text/plain
45592
https://hzi.openrepository.com/bitstream/10033/237555/11/Supplemental%20Information.pdf.txt
a8170b12cf476e31156995ecf3abc703
MD5
11
false
Lu et al_final.pdf.txt
Lu et al_final.pdf.txt
Extracted Text
text/plain
55843
https://hzi.openrepository.com/bitstream/10033/237555/12/Lu%20et%20al_final.pdf.txt
1f67148c1ba4c0f0633a6d89e8b2bdab
MD5
12
false
THUMBNAIL
Lu et al_final.pdf.jpg
Lu et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32919
https://hzi.openrepository.com/bitstream/10033/237555/14/Lu%20et%20al_final.pdf.jpg
c09461be8ea829f4ab12de7ae96e6cff
MD5
14
false
Supplemental Information.pdf.jpg
Supplemental Information.pdf.jpg
Generated Thumbnail
image/jpeg
45933
https://hzi.openrepository.com/bitstream/10033/237555/15/Supplemental%20Information.pdf.jpg
16c1340dac357fb0696a23f3f8b9fec9
MD5
15
false
elsevier-thumbnail.png
application/octet-stream
136748
https://hzi.openrepository.com/bitstream/10033/237555/16/elsevier-thumbnail.png
eea677e67b3be2c125a3ecf2b7aa658d
MD5
16
false
10033/237555
oai:hzi.openrepository.com:10033/237555
2019-08-30 11:30:32.132
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2462112019-08-30T11:25:11Zcom_10033_620656col_10033_620657
Bansal, Ranju
47c80019390c231f0f47557ed41dfdad
500
Guleria, Sheetal
9fc8a5638b1966f93d2c13665ec02f49
500
Thota, Sridhar
83b1e9db462bd72bed8e3323fceb5dbb
500
Bodhankar, Subhash L
7f0878b1f7172f11d51a61f0163e71cf
500
Patwardhan, Moreshwar R
d1fcfd4112fbec66d69d17a896f9102c
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Harvey, Alan L
3fee20d306aca383fb413fa12c25609e
500
University Institute of Pharmaceutical Sciences, Sector-14, Panjab University, Chandigarh 160014, India. ranju29in@yahoo.co.in
2012-09-28T08:27:23Z
2012-09-28T08:27:23Z
2012-05
Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties. 2012, 77 (6):621-9 Steroids
1878-5867
22366075
10.1016/j.steroids.2012.02.005
http://hdl.handle.net/10033/246211
Steroids
As a part of our investigations into the structural-activity relationship studies of a novel class of medicinally active 16-substituted steroids, several new 16-imidazolyl substituted steroidal derivatives have been synthesized and pharmacologically evaluated in the current study. The new steroidal analogues 5, 6, 8, 9, 11 and 12 exhibited moderate cytotoxic effects in sixty cancer cell lines derived from nine cancers types. The imidazolyl substituted steroidal derivatives 6 (DPJ-RG-1241) and 7 (RB-401) were obtained as the powerful inhibitors of aromatase with IC50=0.18 μM and IC50=0.168 μM, respectively, approximately 1.2 and 1.4 times more potent in comparison to standard drug exemestane. The bis-quaternary steroids 13 and 14 displayed potent skeletal muscle relaxant properties. An affinity constant of 0.007 μM was observed for compound 14 on frog rectus abdominis muscle preparation and 13 displayed a very high anticholinesterase activity K(i)=25 nM, approximately 115-fold higher in comparison to standard drug galanthamine (K(i)=2.9 μM).
en
Archived with thanks to Steroids
Antineoplastic Agents
Aromatase Inhibitors
Cell Line, Tumor
Cell Proliferation
Chemistry Techniques, Synthetic
Drug Design
Humans
Imidazoles
Inhibitory Concentration 50
Steroids
Design, synthesis and evaluation of novel 16-imidazolyl substituted steroidal derivatives possessing potent diversified pharmacological properties.
Article
2018-06-13T04:24:17Z
As a part of our investigations into the structural-activity relationship studies of a novel class of medicinally active 16-substituted steroids, several new 16-imidazolyl substituted steroidal derivatives have been synthesized and pharmacologically evaluated in the current study. The new steroidal analogues 5, 6, 8, 9, 11 and 12 exhibited moderate cytotoxic effects in sixty cancer cell lines derived from nine cancers types. The imidazolyl substituted steroidal derivatives 6 (DPJ-RG-1241) and 7 (RB-401) were obtained as the powerful inhibitors of aromatase with IC50=0.18 μM and IC50=0.168 μM, respectively, approximately 1.2 and 1.4 times more potent in comparison to standard drug exemestane. The bis-quaternary steroids 13 and 14 displayed potent skeletal muscle relaxant properties. An affinity constant of 0.007 μM was observed for compound 14 on frog rectus abdominis muscle preparation and 13 displayed a very high anticholinesterase activity K(i)=25 nM, approximately 115-fold higher in comparison to standard drug galanthamine (K(i)=2.9 μM).
ORIGINAL
Bansal et al_final.pdf
Bansal et al_final.pdf
original manuscript
application/pdf
377043
https://hzi.openrepository.com/bitstream/10033/246211/1/Bansal%20et%20al_final.pdf
e5c269b1421829a80a32d50d142ff508
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/246211/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/246211/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/246211/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/246211/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Bansal et al_final.pdf.txt
Bansal et al_final.pdf.txt
Extracted Text
text/plain
49633
https://hzi.openrepository.com/bitstream/10033/246211/8/Bansal%20et%20al_final.pdf.txt
6fc0ed00dcb4ff12f3a22d876780589c
MD5
8
false
THUMBNAIL
Bansal et al_final.pdf.jpg
Bansal et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32861
https://hzi.openrepository.com/bitstream/10033/246211/9/Bansal%20et%20al_final.pdf.jpg
d73dde6a5c3a8c04d6e29bc5bc6d4e03
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
139346
https://hzi.openrepository.com/bitstream/10033/246211/10/elsevier-thumbnail.png
80e2afacb5d5f26cd7f24e89acccc7bc
MD5
10
false
10033/246211
oai:hzi.openrepository.com:10033/246211
2019-08-30 11:25:11.216
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/2493562019-08-30T11:27:46Zcom_10033_620656col_10033_620657
Spadaro, Alessandro
e86c76b3cc5d2afa07aab4b240e176a2
500
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
Marchais-Oberwinkler, Sandrine
8077578e04f781fbc378097c04d3ea68
500
Bey, Emmanuel
c1860f95b4228d8d5faa91e3ac6f29e4
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany.
2012-10-18T11:35:47Z
2012-10-18T11:35:47Z
2012
Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1). 2012, 7 (1):e29252 PLoS ONE
1932-6203
22242164
10.1371/journal.pone.0029252
http://hdl.handle.net/10033/249356
PloS one
17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the development and progession of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17β-HSD1, which catalyses the reduction of the weak estrogen estrone (E1) to E2, is often overexpressed in breast cancer and endometriotic tissues. An inhibition of 17β-HSD1 could selectively reduce the local E2-level thus allowing for a novel, targeted approach in the treatment of EDD. Continuing our search for new nonsteroidal 17β-HSD1 inhibitors, a novel pharmacophore model was derived from crystallographic data and used for the virtual screening of a small library of compounds. Subsequent experimental verification of the virtual hits led to the identification of the moderately active compound 5. Rigidification and further structure modifications resulted in the discovery of a novel class of 17β-HSD1 inhibitors bearing a benzothiazole-scaffold linked to a phenyl ring via keto- or amide-bridge. Their putative binding modes were investigated by correlating their biological data with features of the pharmacophore model. The most active keto-derivative 6 shows IC₅₀-values in the nanomolar range for the transformation of E1 to E2 by 17β-HSD1, reasonable selectivity against 17β-HSD2 but pronounced affinity to the estrogen receptors (ERs). On the other hand, the best amide-derivative 21 shows only medium 17β-HSD1 inhibitory activity at the target enzyme as well as fair selectivity against 17β-HSD2 and ERs. The compounds 6 and 21 can be regarded as first benzothiazole-type 17β-HSD1 inhibitors for the development of potential therapeutics.
en
Archived with thanks to PloS one
17-Hydroxysteroid Dehydrogenases
Cell Line, Tumor
Crystallization
Enzyme Inhibitors
Estrogen Receptor alpha
Estrogen Receptor beta
Estrogens, Non-Steroidal
Humans
Ligands
Models, Molecular
Structure-Activity Relationship
Thiazoles
Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1).
Article
2018-06-13T19:35:16Z
17β-estradiol (E2), the most potent estrogen in humans, known to be involved in the development and progession of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17β-HSD1, which catalyses the reduction of the weak estrogen estrone (E1) to E2, is often overexpressed in breast cancer and endometriotic tissues. An inhibition of 17β-HSD1 could selectively reduce the local E2-level thus allowing for a novel, targeted approach in the treatment of EDD. Continuing our search for new nonsteroidal 17β-HSD1 inhibitors, a novel pharmacophore model was derived from crystallographic data and used for the virtual screening of a small library of compounds. Subsequent experimental verification of the virtual hits led to the identification of the moderately active compound 5. Rigidification and further structure modifications resulted in the discovery of a novel class of 17β-HSD1 inhibitors bearing a benzothiazole-scaffold linked to a phenyl ring via keto- or amide-bridge. Their putative binding modes were investigated by correlating their biological data with features of the pharmacophore model. The most active keto-derivative 6 shows IC₅₀-values in the nanomolar range for the transformation of E1 to E2 by 17β-HSD1, reasonable selectivity against 17β-HSD2 but pronounced affinity to the estrogen receptors (ERs). On the other hand, the best amide-derivative 21 shows only medium 17β-HSD1 inhibitory activity at the target enzyme as well as fair selectivity against 17β-HSD2 and ERs. The compounds 6 and 21 can be regarded as first benzothiazole-type 17β-HSD1 inhibitors for the development of potential therapeutics.
ORIGINAL
spadaro et al_final.pdf
spadaro et al_final.pdf
Open Access publication
application/pdf
1020459
https://hzi.openrepository.com/bitstream/10033/249356/1/spadaro%20et%20al_final.pdf
86e3a4883ba064c5f4c01f38ec643a3a
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/249356/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/249356/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/249356/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/249356/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
spadaro et al_final.pdf.txt
spadaro et al_final.pdf.txt
Extracted Text
text/plain
63960
https://hzi.openrepository.com/bitstream/10033/249356/8/spadaro%20et%20al_final.pdf.txt
31cb2c4618deb470e5cf7446b21c3702
MD5
8
false
THUMBNAIL
spadaro et al_final.pdf.jpg
spadaro et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
27938
https://hzi.openrepository.com/bitstream/10033/249356/9/spadaro%20et%20al_final.pdf.jpg
378b97087fadab5763a1ad0f1a86e6db
MD5
9
false
10033/249356
oai:hzi.openrepository.com:10033/249356
2019-08-30 11:27:46.671
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2667122019-08-30T11:30:32Zcom_10033_620656col_10033_620657
Bansal, Ranju
47c80019390c231f0f47557ed41dfdad
500
Thota, Sridhar
83b1e9db462bd72bed8e3323fceb5dbb
500
Karkra, Nalin
8c434d6b8b0b964348c6719879b062a3
500
Minu, Maninder
1e0331f33dff9a87e6fd3e96cbd4a29f
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
University Institute of Pharmaceutical Sciences, Sector-14, Panjab University, Chandigarh 160 014, India. ranju29in@yahoo.co.in
2013-01-23T15:18:03Z
2013-01-23T15:18:03Z
2012-12
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids. 2012, 45:36-40 Bioorg. Chem.
1090-2120
23064126
10.1016/j.bioorg.2012.08.005
http://hdl.handle.net/10033/266712
Bioorganic chemistry
A new series of 16E-arylidene androstene derivatives has been synthesized and evaluated for aromatase inhibitory activity. The impact of various aryl substituents at 16 position of the steroid skeleton on aromatase inhibitory activity has been observed. The 16E-arylidenosteroids 6, 10 and 11 exhibited significant inhibition of the aromatase enzyme. 16-(4-Pyridylmethylene)-4-androstene-3,17-dione (6, IC(50): 5.2 μM) and 16-(benzo-[1,3]dioxol-5-ylmethylene)androsta-1,4-diene-3,17-dione (11, IC(50): 6.4 μM) were found to be approximately five times more potent in comparison to aminoglutethimide.
en
Archived with thanks to Bioorganic chemistry
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids.
Article
2018-06-12T23:42:13Z
A new series of 16E-arylidene androstene derivatives has been synthesized and evaluated for aromatase inhibitory activity. The impact of various aryl substituents at 16 position of the steroid skeleton on aromatase inhibitory activity has been observed. The 16E-arylidenosteroids 6, 10 and 11 exhibited significant inhibition of the aromatase enzyme. 16-(4-Pyridylmethylene)-4-androstene-3,17-dione (6, IC(50): 5.2 μM) and 16-(benzo-[1,3]dioxol-5-ylmethylene)androsta-1,4-diene-3,17-dione (11, IC(50): 6.4 μM) were found to be approximately five times more potent in comparison to aminoglutethimide.
ORIGINAL
Bansal et al_final.pdf
Bansal et al_final.pdf
original manuscript
application/pdf
439532
https://hzi.openrepository.com/bitstream/10033/266712/1/Bansal%20et%20al_final.pdf
395d8f88dd015202e8934d192ef2060a
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/266712/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/266712/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/266712/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/266712/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Bansal et al_final.pdf.txt
Bansal et al_final.pdf.txt
Extracted Text
text/plain
25847
https://hzi.openrepository.com/bitstream/10033/266712/8/Bansal%20et%20al_final.pdf.txt
c637ea8ed750e9573fb8f893a805ec08
MD5
8
false
THUMBNAIL
Bansal et al_final.pdf.jpg
Bansal et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
30748
https://hzi.openrepository.com/bitstream/10033/266712/9/Bansal%20et%20al_final.pdf.jpg
cfe9046bba1b80788f4101c4870936bc
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
145280
https://hzi.openrepository.com/bitstream/10033/266712/10/elsevier-thumbnail.png
41d356e7ca2fe88d7cc8be29ff02e686
MD5
10
false
10033/266712
oai:hzi.openrepository.com:10033/266712
2019-08-30 11:30:32.031
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2699122019-08-30T11:28:24Zcom_10033_620656col_10033_620657
Yin, Lina
1c5597cce0b9b3daed8ff22aa291ee6c
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University & Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany.
2013-02-21T08:04:32Z
2013-02-21T08:04:32Z
2012
3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2. 2012, 7 (11):e48048 PLoS ONE
1932-6203
23133610
10.1371/journal.pone.0048048
http://hdl.handle.net/10033/269912
PloS one
Aldosterone synthase (CYP11B2) is a promising therapeutic target for the treatment of cardiovascular diseases related to abnormally high aldosterone levels. On the basis of our previously identified lead compounds I-III, a series of 3-pyridinyl substituted aliphatic cycles were designed, synthesized and tested as CYP11B2 inhibitors. Aromaticity abolishment of the core was successfully applied to overcome the undesired CYP1A2 inhibition. This study resulted in a series of potent and selective CYP11B2 inhibitors, with compound 12 (IC(50) = 21 nM, SF = 50) as the most promising one, which shows no inhibition toward CYP1A2 at 2 µM. The design conception demonstrated in this study can be helpful in the optimization of CYP inhibitor drugs regarding CYP1A2 selectivity.
en
Archived with thanks to PloS one
3-Pyridyl substituted aliphatic cycles as CYP11B2 inhibitors: aromaticity abolishment of the core significantly increased selectivity over CYP1A2.
Article
2018-06-12T17:49:31Z
Aldosterone synthase (CYP11B2) is a promising therapeutic target for the treatment of cardiovascular diseases related to abnormally high aldosterone levels. On the basis of our previously identified lead compounds I-III, a series of 3-pyridinyl substituted aliphatic cycles were designed, synthesized and tested as CYP11B2 inhibitors. Aromaticity abolishment of the core was successfully applied to overcome the undesired CYP1A2 inhibition. This study resulted in a series of potent and selective CYP11B2 inhibitors, with compound 12 (IC(50) = 21 nM, SF = 50) as the most promising one, which shows no inhibition toward CYP1A2 at 2 µM. The design conception demonstrated in this study can be helpful in the optimization of CYP inhibitor drugs regarding CYP1A2 selectivity.
ORIGINAL
yin et al_final.pdf
yin et al_final.pdf
Open Access publication
application/pdf
604453
https://hzi.openrepository.com/bitstream/10033/269912/1/yin%20et%20al_final.pdf
ca6ed1929da2f1ac69c3bad60437ec1c
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/269912/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/269912/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/269912/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/269912/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
yin et al_final.pdf.txt
yin et al_final.pdf.txt
Extracted Text
text/plain
60463
https://hzi.openrepository.com/bitstream/10033/269912/8/yin%20et%20al_final.pdf.txt
ea0bd824b63fcf7c981ee47318f26733
MD5
8
false
THUMBNAIL
yin et al_final.pdf.jpg
yin et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
27892
https://hzi.openrepository.com/bitstream/10033/269912/9/yin%20et%20al_final.pdf.jpg
250c05d3bfeebaef5e78d83b193c9d9a
MD5
9
false
10033/269912
oai:hzi.openrepository.com:10033/269912
2019-08-30 11:28:24.035
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2971952019-08-30T11:29:47Zcom_10033_620656col_10033_620657
Yin, Lina
1c5597cce0b9b3daed8ff22aa291ee6c
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University & Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C2-3, Saarbrücken D-66123, Germany. q.hu@mx.uni-saarland.de.
2013-08-01T09:32:52Z
2013-08-01T09:32:52Z
2013
Recent progress in pharmaceutical therapies for castration-resistant prostate cancer. 2013, 14 (7):13958-78 Int J Mol Sci
1422-0067
23880851
10.3390/ijms140713958
http://hdl.handle.net/10033/297195
International journal of molecular sciences
Since 2010, six drugs have been approved for the treatment of castration-resistant prostate cancer, i.e., CYP17 inhibitor Abiraterone, androgen receptor antagonist Enzalutamide, cytotoxic agent Cabazitaxel, vaccine Sipuleucel-T, antibody Denosumab against receptor activator of nuclear factor kappa B ligand and radiopharmaceutical Alpharadin. All these drugs demonstrate improvement on overall survival, expect for Denosumab, which increases the bone mineral density of patients under androgen deprivation therapy and prolongs bone-metastasis-free survival. Besides further CYP17 inhibitors (Orteronel, Galeterone, VT-464 and CFG920), androgen receptor antagonists (ARN-509, ODM-201, AZD-3514 and EZN-4176) and vaccine Prostvac, more drug candidates with various mechanisms or new indications of launched drugs are currently under evaluation in different stages of clinical trials, including various kinase inhibitors and platinum complexes. Some novel strategies have also been proposed aimed at further potentiation of antitumor effects or reduction of side effects and complications related to treatments. Under these flourishing circumstances, more investigations should be performed on the optimal combination or the sequence of treatments needed to delay or reverse possible resistance and thus maximize the clinical benefits for the patients.
en
Archived with thanks to International journal of molecular sciences
Recent progress in pharmaceutical therapies for castration-resistant prostate cancer.
Article
2018-06-13T15:16:32Z
Since 2010, six drugs have been approved for the treatment of castration-resistant prostate cancer, i.e., CYP17 inhibitor Abiraterone, androgen receptor antagonist Enzalutamide, cytotoxic agent Cabazitaxel, vaccine Sipuleucel-T, antibody Denosumab against receptor activator of nuclear factor kappa B ligand and radiopharmaceutical Alpharadin. All these drugs demonstrate improvement on overall survival, expect for Denosumab, which increases the bone mineral density of patients under androgen deprivation therapy and prolongs bone-metastasis-free survival. Besides further CYP17 inhibitors (Orteronel, Galeterone, VT-464 and CFG920), androgen receptor antagonists (ARN-509, ODM-201, AZD-3514 and EZN-4176) and vaccine Prostvac, more drug candidates with various mechanisms or new indications of launched drugs are currently under evaluation in different stages of clinical trials, including various kinase inhibitors and platinum complexes. Some novel strategies have also been proposed aimed at further potentiation of antitumor effects or reduction of side effects and complications related to treatments. Under these flourishing circumstances, more investigations should be performed on the optimal combination or the sequence of treatments needed to delay or reverse possible resistance and thus maximize the clinical benefits for the patients.
ORIGINAL
Yin et al_final.pdf
Yin et al_final.pdf
Open Access publication
application/pdf
367465
https://hzi.openrepository.com/bitstream/10033/297195/1/Yin%20et%20al_final.pdf
0564c8d448b994cd1e7417ba19b98cf6
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/297195/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/297195/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/297195/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/297195/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Yin et al_final.pdf.txt
Yin et al_final.pdf.txt
Extracted Text
text/plain
63904
https://hzi.openrepository.com/bitstream/10033/297195/8/Yin%20et%20al_final.pdf.txt
400befa2fb7ef4a8632de12685687798
MD5
8
false
THUMBNAIL
Yin et al_final.pdf.jpg
Yin et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
27897
https://hzi.openrepository.com/bitstream/10033/297195/9/Yin%20et%20al_final.pdf.jpg
0396106bd8fd9b4843a2b65db55ee012
MD5
9
false
10033/297195
oai:hzi.openrepository.com:10033/297195
2019-08-30 11:29:47.229
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2982522019-08-30T11:28:51Zcom_10033_620656col_10033_620657
Krug, Sebastian J
6af3d040b71f3e203cf06449926fdbe7
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany.
2013-08-14T14:20:01Z
2013-08-14T14:20:01Z
2013-03
Hits identified in library screening demonstrate selective CYP17A1 lyase inhibition. 2013, 134:75-9 J. Steroid Biochem. Mol. Biol.
1879-1220
23142656
10.1016/j.jsbmb.2012.10.019
http://hdl.handle.net/10033/298252
The Journal of steroid biochemistry and molecular biology
A screening of structurally different steroid hormone synthesis inhibitors was performed in order to find a starting point for the development of a new inhibitor of the bifunctional steroidogenic enzyme CYP17A1. Emphasis was placed on determination of selectivity between the two catalytic steps, namely 17α-hydroxylase and C(17,20)-lyase. For that purpose a new inhibition assay has been developed. Hits identified within this novel assay demonstrated selective inhibition of CYP17A1 lyase activity, and thus mark the basis for the development of selective C(17,20)-lyase inhibitors for the treatment of prostate cancer.
en
Archived with thanks to The Journal of steroid biochemistry and molecular biology
Enzyme Inhibitors
Humans
Inhibitory Concentration 50
Male
Prostatic Neoplasms
Small Molecule Libraries
Steroid 17-alpha-Hydroxylase
Hits identified in library screening demonstrate selective CYP17A1 lyase inhibition.
Article
2018-06-12T23:39:19Z
A screening of structurally different steroid hormone synthesis inhibitors was performed in order to find a starting point for the development of a new inhibitor of the bifunctional steroidogenic enzyme CYP17A1. Emphasis was placed on determination of selectivity between the two catalytic steps, namely 17α-hydroxylase and C(17,20)-lyase. For that purpose a new inhibition assay has been developed. Hits identified within this novel assay demonstrated selective inhibition of CYP17A1 lyase activity, and thus mark the basis for the development of selective C(17,20)-lyase inhibitors for the treatment of prostate cancer.
ORIGINAL
Krug, Hu and Hartmann_final.pdf
Krug, Hu and Hartmann_final.pdf
original manuscript
application/pdf
327619
https://hzi.openrepository.com/bitstream/10033/298252/1/Krug%2c%20Hu%20and%20Hartmann_final.pdf
4a6a3c24ff7d23bde2127b266a5be51f
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/298252/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/298252/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/298252/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/298252/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Krug, Hu and Hartmann_final.pdf.txt
Krug, Hu and Hartmann_final.pdf.txt
Extracted Text
text/plain
23413
https://hzi.openrepository.com/bitstream/10033/298252/8/Krug%2c%20Hu%20and%20Hartmann_final.pdf.txt
78dba3da85d50a371c49f80e1c8ee829
MD5
8
false
THUMBNAIL
Krug, Hu and Hartmann_final.pdf.jpg
Krug, Hu and Hartmann_final.pdf.jpg
Generated Thumbnail
image/jpeg
28235
https://hzi.openrepository.com/bitstream/10033/298252/9/Krug%2c%20Hu%20and%20Hartmann_final.pdf.jpg
d1d0d1c76fd7e3d46dfaee23561dad60
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
126541
https://hzi.openrepository.com/bitstream/10033/298252/10/elsevier-thumbnail.png
132bcea248587bd1ee49ed873cc9a61b
MD5
10
false
10033/298252
oai:hzi.openrepository.com:10033/298252
2019-08-30 11:28:51.392
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2983752019-08-30T11:26:42Zcom_10033_620656col_10033_620657
Berényi, Agnes
eb71e920414758b777c42f0268ca7562
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
Marchais-Oberwinkler, Sandrine
8077578e04f781fbc378097c04d3ea68
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Minorics, Renáta
f86d8cea675b1cd78c24e174bdec2fff
500
Ocsovszki, Imre
9fa9261c12577f579c7e927bbb94f384
500
Falkay, George
e0e502b22872f64153a779eab5f1749c
500
Zupkó, István
e4a03645edd77ee7dc4ca8db8af7b500
500
Department of Pharmacodynamics and Biopharmacy, University of Szeged , Szeged , Hungary.
2013-08-15T09:51:45Z
2013-08-15T09:51:45Z
2013-08
Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitro. 2013, 28 (4):695-703 J Enzyme Inhib Med Chem
1475-6374
22471733
10.3109/14756366.2012.672414
http://hdl.handle.net/10033/298375
Journal of enzyme inhibition and medicinal chemistry
Inhibition of the local formation of estrogens seems to be an attractive strategy for pharmacological intervention in hormone-dependent disorders. The direct antiproliferative properties of ten nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors were investigated on human cancer cell lines of gynecological origin. The mechanism of the antiproliferative action was approximated by cell cycle analysis, fluorescent microscopy, BrdU assay, determination of caspase-3 activity and quantification of the expression of cell cycle regulators at mRNA level. Treatment of HeLa cells with some of the compounds resulted in a concentration-dependent inhibition of the G1-S transition and an increase in the apoptotic population. The most effective agents increased the expression of tumor suppressors p21 and p53, while CDK2 and Rb were down-regulated. The reported anticancer actions of the tested compounds are independent of the 17β-HSD1-inhibiting capacity. These results indicate that it is possible to combine direct antiproliferative activity and 17β-HSD1 inhibition resulting in novel agents with dual mode of action.
en
Archived with thanks to Journal of enzyme inhibition and medicinal chemistry
Direct antiproliferative effect of nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors in vitro.
Article
2014-08-15T00:00:00Z
Inhibition of the local formation of estrogens seems to be an attractive strategy for pharmacological intervention in hormone-dependent disorders. The direct antiproliferative properties of ten nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors were investigated on human cancer cell lines of gynecological origin. The mechanism of the antiproliferative action was approximated by cell cycle analysis, fluorescent microscopy, BrdU assay, determination of caspase-3 activity and quantification of the expression of cell cycle regulators at mRNA level. Treatment of HeLa cells with some of the compounds resulted in a concentration-dependent inhibition of the G1-S transition and an increase in the apoptotic population. The most effective agents increased the expression of tumor suppressors p21 and p53, while CDK2 and Rb were down-regulated. The reported anticancer actions of the tested compounds are independent of the 17β-HSD1-inhibiting capacity. These results indicate that it is possible to combine direct antiproliferative activity and 17β-HSD1 inhibition resulting in novel agents with dual mode of action.
ORIGINAL
Berenyi et al_final.pdf
Berenyi et al_final.pdf
original manuscript
application/pdf
1906763
https://hzi.openrepository.com/bitstream/10033/298375/1/Berenyi%20et%20al_final.pdf
68fafff0d55b52cc62e59840881a1696
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/298375/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/298375/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/298375/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/298375/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Berenyi et al_final.pdf.txt
Berenyi et al_final.pdf.txt
Extracted Text
text/plain
43022
https://hzi.openrepository.com/bitstream/10033/298375/8/Berenyi%20et%20al_final.pdf.txt
7efd133fc2d55905764621c41c0d67a4
MD5
8
false
THUMBNAIL
Berenyi et al_final.pdf.jpg
Berenyi et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
33613
https://hzi.openrepository.com/bitstream/10033/298375/9/Berenyi%20et%20al_final.pdf.jpg
4dfbaa61b8b4ba3e0db65252e1eba2e2
MD5
9
false
10033/298375
oai:hzi.openrepository.com:10033/298375
2019-08-30 11:26:42.639
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2992512019-08-30T11:26:06Zcom_10033_620656col_10033_620657
Hamed, Mostafa M.
a18cd3e66f5a3c72694ed00510628437
500
Abou El Ella, Dalal A.
a4bf73146897bce2f801a0c1aabce26d
500
Keeton, Adam B.
4adc51b538faffd43d60e370db88ceb9
500
Piazza, Gary A.
98011c614bf13c4f563d217ae2712d0b
500
Engel, Matthias
3ec141dda82defecef97cd49b8a79de5
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Abadi, Ashraf H.
3cd751b9b524caba7e3c64366d434549
500
2013-08-20T12:39:00Z
2013-08-20T12:39:00Z
2013-08-20
Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: influence of the position 4 substituent 2013, 4 (8):1202 MedChemComm
2040-2503
2040-2511
10.1039/c3md00118k
http://hdl.handle.net/10033/299251
MedChemComm
http://xlink.rsc.org/?DOI=c3md00118k
Archived with thanks to MedChemComm
Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: influence of the position 4 substituent
Article
2018-06-12T17:30:28Z
ORIGINAL
Hamed et al_final.pdf
Hamed et al_final.pdf
allowed publisher's PDF
application/pdf
349967
https://hzi.openrepository.com/bitstream/10033/299251/1/Hamed%20et%20al_final.pdf
361de501a8fd3f9f87fef0fe76677a9c
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/299251/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/299251/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/299251/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/299251/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Hamed et al_final.pdf.txt
Hamed et al_final.pdf.txt
Extracted Text
text/plain
25525
https://hzi.openrepository.com/bitstream/10033/299251/8/Hamed%20et%20al_final.pdf.txt
23e556e932f9ced1eda6d2f8f55964ef
MD5
8
false
THUMBNAIL
Hamed et al_final.pdf.jpg
Hamed et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
35166
https://hzi.openrepository.com/bitstream/10033/299251/9/Hamed%20et%20al_final.pdf.jpg
1cc65e149ea50a7aa65f4e727a4e4239
MD5
9
false
10033/299251
oai:hzi.openrepository.com:10033/299251
2019-08-30 11:26:06.665
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/2995042019-08-30T11:32:16Zcom_10033_620656col_10033_620657
Perspicace, Enrico
45ea5b9b93888712a62e1bf810f54fc7
500
Marchais-Oberwinkler, Sandrine
8077578e04f781fbc378097c04d3ea68
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C23, D-66123 Saarbrücken, Germany.
2013-08-22T12:14:57Z
2013-08-22T12:14:57Z
2013
Synthesis and biological evaluation of thieno[3,2-d]- pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones: conformationally restricted 17b-hydroxysteroid dehydrogenase type 2 (17b-HSD2) inhibitors. 2013, 18 (4):4487-509 Molecules
1420-3049
23591928
10.3390/molecules18044487
http://hdl.handle.net/10033/299504
Molecules (Basel, Switzerland)
In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones was designed and synthesized with the goal of improving the biological activity as 17b-hydroxysteroid dehydrogenase type 2 inhibitors of the corresponding amidothiophene derivatives. Two moderately active compounds were discovered and this allowed the identification of the biologically active open conformer as well as the extension of the enzyme binding site characterisation.
en
Archived with thanks to Molecules (Basel, Switzerland)
Synthesis and biological evaluation of thieno[3,2-d]- pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones: conformationally restricted 17b-hydroxysteroid dehydrogenase type 2 (17b-HSD2) inhibitors.
Article
2018-06-13T03:44:10Z
In this study, a series of conformationally restricted thieno[3,2-d]pyrimidinones, thieno[3,2-d]pyrimidines and quinazolinones was designed and synthesized with the goal of improving the biological activity as 17b-hydroxysteroid dehydrogenase type 2 inhibitors of the corresponding amidothiophene derivatives. Two moderately active compounds were discovered and this allowed the identification of the biologically active open conformer as well as the extension of the enzyme binding site characterisation.
ORIGINAL
Perspicace, Marchais-Oberwinkler and Hartmann_final.pdf
Perspicace, Marchais-Oberwinkler and Hartmann_final.pdf
Open Access publication
application/pdf
528168
https://hzi.openrepository.com/bitstream/10033/299504/1/Perspicace%2c%20Marchais-Oberwinkler%20and%20Hartmann_final.pdf
ef0375757c85d39242eab02f856280c2
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/299504/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/299504/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/299504/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/299504/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Perspicace, Marchais-Oberwinkler and Hartmann_final.pdf.txt
Perspicace, Marchais-Oberwinkler and Hartmann_final.pdf.txt
Extracted Text
text/plain
62754
https://hzi.openrepository.com/bitstream/10033/299504/8/Perspicace%2c%20Marchais-Oberwinkler%20and%20Hartmann_final.pdf.txt
e1cdb373457cffa1a74415d3c43c2095
MD5
8
false
THUMBNAIL
Perspicace, Marchais-Oberwinkler and Hartmann_final.pdf.jpg
Perspicace, Marchais-Oberwinkler and Hartmann_final.pdf.jpg
Generated Thumbnail
image/jpeg
34496
https://hzi.openrepository.com/bitstream/10033/299504/9/Perspicace%2c%20Marchais-Oberwinkler%20and%20Hartmann_final.pdf.jpg
0432ec63e2ef1b983d95d364fa2ae7f9
MD5
9
false
10033/299504
oai:hzi.openrepository.com:10033/299504
2019-08-30 11:32:16.928
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3037382019-08-30T11:28:51Zcom_10033_620656col_10033_620657
Köberle, Verena
c8f5d5cbbbab794f18aa31d180d30f95
500
Pleli, Thomas
27e7dd45a0feeab4238d76370dbb3728
500
Schmithals, Christian
c22ecd6f07d061cb7c400ba9a162f66d
500
Augusto Alonso, Eduardo
e599c5a59b1791c939b6d79cb4a3652f
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Bönig, Halvard
6fd9a535fa9d3838d48d071b4d3cc431
500
Peveling-Oberhag, Jan
f579565dfcb1672bd5aac9725bb6ba92
500
Biondi, Ricardo M
d7a8b3b45435312847b785cb2ba2a8e6
500
Zeuzem, Stefan
6d744694cd11d06e28229e8f415daa07
500
Kronenberger, Bernd
00042fa40d2e4daaf56e76aad6bb572a
500
Waidmann, Oliver
f43b2269bc2756fcad532b3903970c71
500
Piiper, Albrecht
3399dbce6d1847de71ac96a5ec02d81a
500
Department of Medicine I, University Hospital Frankfurt, Frankfurt, Germany.
2013-10-21T14:39:02Z
2013-10-21T14:39:02Z
2013
Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers. 2013, 8 (9):e75184 PLoS ONE
1932-6203
24073250
10.1371/journal.pone.0075184
http://hdl.handle.net/10033/303738
PloS one
MicroRNAs circulating in the blood, stabilized by complexation with proteins and/or additionally by encapsulation in lipid vesicles, are currently being evaluated as biomarkers. The consequences of their differential association with lipids/vesicles for their stability and use as biomarkers are largely unexplored and are subject of the present study.
en
Archived with thanks to PloS one
Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers.
Article
2018-06-12T23:04:31Z
MicroRNAs circulating in the blood, stabilized by complexation with proteins and/or additionally by encapsulation in lipid vesicles, are currently being evaluated as biomarkers. The consequences of their differential association with lipids/vesicles for their stability and use as biomarkers are largely unexplored and are subject of the present study.
ORIGINAL
Köberle et al_final.pdf
Köberle et al_final.pdf
Open Access publication
application/pdf
1625608
https://hzi.openrepository.com/bitstream/10033/303738/1/K%c3%b6berle%20et%20al_final.pdf
9a82ce7c5c12d789c9bee942e0e53284
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/303738/2/license_url
c0b3e2a72fe5e4b72fa5798bb22cd3a3
MD5
2
false
license_text
license_text
application/octet-stream
21991
https://hzi.openrepository.com/bitstream/10033/303738/3/license_text
b4eca20ce36d53f0d7292a7ee1205054
MD5
3
false
license_rdf
license_rdf
application/octet-stream
24332
https://hzi.openrepository.com/bitstream/10033/303738/4/license_rdf
306824103cdab5a2460a7737d9c97e69
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/303738/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Köberle et al_final.pdf.txt
Köberle et al_final.pdf.txt
Extracted Text
text/plain
36684
https://hzi.openrepository.com/bitstream/10033/303738/8/K%c3%b6berle%20et%20al_final.pdf.txt
68f2a874a0973bef2116310dd345f62b
MD5
8
false
THUMBNAIL
Köberle et al_final.pdf.jpg
Köberle et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32592
https://hzi.openrepository.com/bitstream/10033/303738/9/K%c3%b6berle%20et%20al_final.pdf.jpg
28339918e6d79ac8f1dd50d0029c593b
MD5
9
false
10033/303738
oai:hzi.openrepository.com:10033/303738
2019-08-30 11:28:51.314
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3063732019-08-30T11:33:57Zcom_10033_620656col_10033_620657
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Campus C2.3, D-66123 Saarbrücken, Germany. Electronic address: christine.maurer@helmholtz-hzi.de.
2013-12-05T12:46:06Z
2013-12-05T12:46:06Z
2013-12
Development and validation of a UHPLC-MS/MS procedure for quantification of the Pseudomonas Quinolone Signal in bacterial culture after acetylation for characterization of new quorum sensing inhibitors. 2013, 86:127-34 J Pharm Biomed Anal
1873-264X
24001903
10.1016/j.jpba.2013.07.047
http://hdl.handle.net/10033/306373
Journal of pharmaceutical and biomedical analysis
The appearance of antibiotic resistance requires novel therapeutic strategies. One approach is to selectively attenuate bacterial pathogenicity by interfering with bacterial cell-to-cell communication known as quorum sensing. The PQS quorum sensing system of Pseudomonas aeruginosa employs as signal molecule the Pseudomonas Quinolone Signal (PQS; 2-heptyl-3-hydroxy-4-(1H)-quinolone), a key contributor to virulence and biofilm formation. Thus, interference with PQS production is considered as promising approach for the development of novel anti-infectives. Therefore, in this study, we developed and validated an ultra-high performance liquid chromatographic-tandem mass spectrometric approach for reliable quantification of PQS in P. aeruginosa cultures for activity determination of new quorum sensing inhibitors. The poor chromatographic properties of PQS reported by others could be overcome by fast microwave-assisted acetylation. The validation procedure including matrix effects, recovery, process efficiency, selectivity, carry-over, accuracy and precision, stability of the processed sample, and limit of quantification demonstrated that the method fulfilled all requirements of common validation guidelines. Its applicability was successfully proven in routine testing. In addition, two-point calibration was shown to be applicable for fast and reliable PQS quantification saving time and resources. In summary, the described method provides a powerful tool for the discovery of new quorum sensing inhibitors as potential anti-infectives and illustrated the usefulness of chemical derivatization, acetylation, in liquid chromatography-mass spectrometry analysis.
en
Archived with thanks to Journal of pharmaceutical and biomedical analysis
Development and validation of a UHPLC-MS/MS procedure for quantification of the Pseudomonas Quinolone Signal in bacterial culture after acetylation for characterization of new quorum sensing inhibitors.
Article
2018-06-12T22:42:29Z
The appearance of antibiotic resistance requires novel therapeutic strategies. One approach is to selectively attenuate bacterial pathogenicity by interfering with bacterial cell-to-cell communication known as quorum sensing. The PQS quorum sensing system of Pseudomonas aeruginosa employs as signal molecule the Pseudomonas Quinolone Signal (PQS; 2-heptyl-3-hydroxy-4-(1H)-quinolone), a key contributor to virulence and biofilm formation. Thus, interference with PQS production is considered as promising approach for the development of novel anti-infectives. Therefore, in this study, we developed and validated an ultra-high performance liquid chromatographic-tandem mass spectrometric approach for reliable quantification of PQS in P. aeruginosa cultures for activity determination of new quorum sensing inhibitors. The poor chromatographic properties of PQS reported by others could be overcome by fast microwave-assisted acetylation. The validation procedure including matrix effects, recovery, process efficiency, selectivity, carry-over, accuracy and precision, stability of the processed sample, and limit of quantification demonstrated that the method fulfilled all requirements of common validation guidelines. Its applicability was successfully proven in routine testing. In addition, two-point calibration was shown to be applicable for fast and reliable PQS quantification saving time and resources. In summary, the described method provides a powerful tool for the discovery of new quorum sensing inhibitors as potential anti-infectives and illustrated the usefulness of chemical derivatization, acetylation, in liquid chromatography-mass spectrometry analysis.
ORIGINAL
Maurer, Steinbach and Hartmann_final.pdf
Maurer, Steinbach and Hartmann_final.pdf
original manuscript
application/pdf
302835
https://hzi.openrepository.com/bitstream/10033/306373/1/Maurer%2c%20Steinbach%20and%20Hartmann_final.pdf
aad24b37a892f1002fc96e8d44f2e051
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/306373/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
20637
https://hzi.openrepository.com/bitstream/10033/306373/3/license_text
3502e4e55cdd12598f770edf56010391
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/306373/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/306373/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Maurer, Steinbach and Hartmann_final.pdf.txt
Maurer, Steinbach and Hartmann_final.pdf.txt
Extracted Text
text/plain
43838
https://hzi.openrepository.com/bitstream/10033/306373/8/Maurer%2c%20Steinbach%20and%20Hartmann_final.pdf.txt
7a401a05313863985ce52dbb9ceb258e
MD5
8
false
THUMBNAIL
Maurer, Steinbach and Hartmann_final.pdf.jpg
Maurer, Steinbach and Hartmann_final.pdf.jpg
Generated Thumbnail
image/jpeg
34324
https://hzi.openrepository.com/bitstream/10033/306373/9/Maurer%2c%20Steinbach%20and%20Hartmann_final.pdf.jpg
58c63cf40603374a09f10037718c7d0c
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
130685
https://hzi.openrepository.com/bitstream/10033/306373/10/elsevier-thumbnail.png
90a1432e912a22dc80860241c8706aa3
MD5
10
false
10033/306373
oai:hzi.openrepository.com:10033/306373
2019-08-30 11:33:57.277
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3114212019-08-30T11:26:42Zcom_10033_620656col_10033_620657
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Weidel, Elisabeth
6839ba8cfbc9408b9e94d895e029828f
500
Henn, Claudia
73570f853c22dae62c667f0dd0692585
500
Brengel, Christian
dc4fc696a5fe75d5a07912d4d04b28af
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
2014-01-16T14:53:04Z
2014-01-16T14:53:04Z
2013
Molecular basis of HHQ biosynthesis: molecular dynamics simulations, enzyme kinetic and surface plasmon resonance studies. 2013, 6 (1):10 BMC Biophys
2046-1682
23916145
10.1186/2046-1682-6-10
http://hdl.handle.net/10033/311421
BMC biophysics
PQS (PseudomonasQuinolone Signal) and its precursor HHQ are signal molecules of the P. aeruginosa quorum sensing system. They explicate their role in mammalian pathogenicity by binding to the receptor PqsR that induces virulence factor production and biofilm formation. The enzyme PqsD catalyses the biosynthesis of HHQ.
en
Archived with thanks to BMC biophysics
Molecular basis of HHQ biosynthesis: molecular dynamics simulations, enzyme kinetic and surface plasmon resonance studies.
Article
2018-06-12T23:48:53Z
PQS (PseudomonasQuinolone Signal) and its precursor HHQ are signal molecules of the P. aeruginosa quorum sensing system. They explicate their role in mammalian pathogenicity by binding to the receptor PqsR that induces virulence factor production and biofilm formation. The enzyme PqsD catalyses the biosynthesis of HHQ.
ORIGINAL
Steinbach et al_final.pdf
Steinbach et al_final.pdf
Open Access publication
application/pdf
1697159
https://hzi.openrepository.com/bitstream/10033/311421/1/Steinbach%20et%20al_final.pdf
22886568d59a18803b5a403ceadf2198
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/311421/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
21011
https://hzi.openrepository.com/bitstream/10033/311421/3/license_text
d1f59b8c1de3c261e71f917b82f73499
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/311421/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/311421/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Steinbach et al_final.pdf.txt
Steinbach et al_final.pdf.txt
Extracted Text
text/plain
64507
https://hzi.openrepository.com/bitstream/10033/311421/8/Steinbach%20et%20al_final.pdf.txt
3d5f38d9c424088cef234e7d25970b21
MD5
8
false
THUMBNAIL
Steinbach et al_final.pdf.jpg
Steinbach et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
30861
https://hzi.openrepository.com/bitstream/10033/311421/9/Steinbach%20et%20al_final.pdf.jpg
1fc3e663764bb478189cca6dc1a7bcb4
MD5
9
false
10033/311421
oai:hzi.openrepository.com:10033/311421
2019-08-30 11:26:42.702
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3116762019-08-30T11:26:42Zcom_10033_620656col_10033_620657
Elgaher, Walid A. M.
50d60f9096bcb4902c03095ad4b3c7fc
500
Fruth, Martina
46b0fa794808411c2735c5f474c86cd6
500
Groh, Matthias
77153195b19ba7b5a79c4fcbbf4a9263
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C2.3, Saarland University, 66123 Saarbrücken, Germany
2014-01-22T14:47:34Z
2014-01-22T14:47:34Z
2014-01-22
Expanding the scaffold for bacterial RNA polymerase inhibitors: design, synthesis and structure–activity relationships of ureido-heterocyclic-carboxylic acids 2014, 4 (5):2177 RSC Advances
2046-2069
10.1039/c3ra45820b
http://hdl.handle.net/10033/311676
RSC Advances
http://xlink.rsc.org/?DOI=c3ra45820b
Archived with thanks to RSC Advances
Expanding the scaffold for bacterial RNA polymerase inhibitors: design, synthesis and structure–activity relationships of ureido-heterocyclic-carboxylic acids
Article
2014-10-24T00:00:00Z
ORIGINAL
Elgaher et al_final.pdf
Elgaher et al_final.pdf
allowed publisher's PDF
application/pdf
5813380
https://hzi.openrepository.com/bitstream/10033/311676/1/Elgaher%20et%20al_final.pdf
1737401644c947c037e1f4b0b1dc8ef5
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/311676/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
21011
https://hzi.openrepository.com/bitstream/10033/311676/3/license_text
d1f59b8c1de3c261e71f917b82f73499
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/311676/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/311676/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Elgaher et al_final.pdf.txt
Elgaher et al_final.pdf.txt
Extracted Text
text/plain
382
https://hzi.openrepository.com/bitstream/10033/311676/8/Elgaher%20et%20al_final.pdf.txt
e1ecdda979e650de64246997b8f4bce5
MD5
8
false
THUMBNAIL
Elgaher et al_final.pdf.jpg
Elgaher et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
33647
https://hzi.openrepository.com/bitstream/10033/311676/9/Elgaher%20et%20al_final.pdf.jpg
43d375c09de24f9504428ab9fe27e586
MD5
9
false
10033/311676
oai:hzi.openrepository.com:10033/311676
2019-08-30 11:26:42.375
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3119292019-08-30T11:33:01Zcom_10033_620656col_10033_620657
Grombein, Cornelia M.
91ea3267bdc8ff1724982f8dd0203634
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Heim, Ralf
dc9f29f37760c5ed2bca46fa0809ff38
500
Huch, Volker
b587303d42ad78853c3d3ee72a07bc4e
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Helmholtz-Institut für Pharmazeutische Forschung Saarland
2014-01-27T13:53:31Z
2014-01-27T13:53:31Z
2014-01-27
Unexpected results of a SNAr-reaction. A novel synthetic approach to 1-arylthio-2-naphthols 2013, 54 (48):6615 Tetrahedron Letters
404039
10.1016/j.tetlet.2013.09.111
http://hdl.handle.net/10033/311929
Tetrahedron Letters
http://linkinghub.elsevier.com/retrieve/pii/S0040403913016766
Archived with thanks to Tetrahedron Letters
Unexpected results of a SNAr-reaction. A novel synthetic approach to 1-arylthio-2-naphthols
Article
2018-06-12T22:30:42Z
ORIGINAL
Grombein et al_final.pdf
Grombein et al_final.pdf
original manuscript
application/pdf
494044
https://hzi.openrepository.com/bitstream/10033/311929/1/Grombein%20et%20al_final.pdf
75b98762c25b626c47229e40586e23f6
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/311929/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
21192
https://hzi.openrepository.com/bitstream/10033/311929/3/license_text
ab390a06b47b3eee2acf42ead4071997
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/311929/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/311929/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Grombein et al_final.pdf.txt
Grombein et al_final.pdf.txt
Extracted Text
text/plain
12411
https://hzi.openrepository.com/bitstream/10033/311929/8/Grombein%20et%20al_final.pdf.txt
115eb85377a7d9ba4d62c07e23452218
MD5
8
false
THUMBNAIL
Grombein et al_final.pdf.jpg
Grombein et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
28373
https://hzi.openrepository.com/bitstream/10033/311929/9/Grombein%20et%20al_final.pdf.jpg
931359015480c2aa4e6086d421b9ce86
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
129043
https://hzi.openrepository.com/bitstream/10033/311929/10/elsevier-thumbnail.png
b5169158acb1b9ec6c7dd55902a5b29d
MD5
10
false
10033/311929
oai:hzi.openrepository.com:10033/311929
2019-08-30 11:33:01.448
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3167182019-08-30T11:33:57Zcom_10033_620656col_10033_620657
Lu, Cenbin
5a0c4c8e74f17b1d3607bc0b7df2121d
500
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Kirsch, Benjamin
8c673c51dcda680d6131094070a108db
500
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Division of Drug design and optimization. Helmholtz-Institute for Pharmaceutical Research Saarland & Pharmaceutical and Medicinal Chemistry, Saarland University.
2014-05-12T09:42:12Z
2014-05-12T09:42:12Z
2014-01-20
Overcoming the unexpected functional inversion of a PqsR antagonist in Pseudomonas aeruginosa: an in vivo potent antivirulence agent targeting pqs quorum sensing. 2014, 53 (4):1109-12 Angew. Chem. Int. Ed. Engl.
1521-3773
24338917
10.1002/anie.201307547
http://hdl.handle.net/10033/316718
Angewandte Chemie (International ed. in English)
The virulence regulator PqsR of Pseudomonas aeruginosa is considered as an attractive target for attenuating the bacterial pathogenicity without eliciting resistance. However, despite efforts and desires, no promising PqsR antagonist has been discovered thus far. Now, a surprising functionality change of a highly affine PqsR antagonist in P. aeruginosa is revealed, which is mediated by a bacterial signal molecule synthase and responsible for low cellular potency. Blockade of the susceptible position led to the discovery of the first antivirulence compound that is potent in vivo and targets PqsR, thus providing a proof of concept for this novel antivirulence therapy.
en
Archived with thanks to Angewandte Chemie (International ed. in English)
Overcoming the unexpected functional inversion of a PqsR antagonist in Pseudomonas aeruginosa: an in vivo potent antivirulence agent targeting pqs quorum sensing.
Article
2015-01-15T00:00:00Z
The virulence regulator PqsR of Pseudomonas aeruginosa is considered as an attractive target for attenuating the bacterial pathogenicity without eliciting resistance. However, despite efforts and desires, no promising PqsR antagonist has been discovered thus far. Now, a surprising functionality change of a highly affine PqsR antagonist in P. aeruginosa is revealed, which is mediated by a bacterial signal molecule synthase and responsible for low cellular potency. Blockade of the susceptible position led to the discovery of the first antivirulence compound that is potent in vivo and targets PqsR, thus providing a proof of concept for this novel antivirulence therapy.
ORIGINAL
Lu et al_final.pdf
Lu et al_final.pdf
original manuscript
application/pdf
464051
https://hzi.openrepository.com/bitstream/10033/316718/1/Lu%20et%20al_final.pdf
50780d508b7c1c56cbe3fbaa3500eff5
MD5
1
true
Lu_Supporting Information.pdf
Lu_Supporting Information.pdf
supporting information Lu et al.
application/pdf
484311
https://hzi.openrepository.com/bitstream/10033/316718/2/Lu_Supporting%20Information.pdf
bcb929856ef747387bc43a40efbd4445
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/316718/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
21798
https://hzi.openrepository.com/bitstream/10033/316718/4/license_text
54220ed38777a85ed971f5b7600cee2b
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/316718/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/316718/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Lu et al_final.pdf.txt
Lu et al_final.pdf.txt
Extracted Text
text/plain
18923
https://hzi.openrepository.com/bitstream/10033/316718/11/Lu%20et%20al_final.pdf.txt
42dafc6c412c67cbbe05b8e2736e0578
MD5
11
false
Lu_Supporting Information.pdf.txt
Lu_Supporting Information.pdf.txt
Extracted Text
text/plain
20338
https://hzi.openrepository.com/bitstream/10033/316718/12/Lu_Supporting%20Information.pdf.txt
ed77a47767ac80862a36a5f11286cfdd
MD5
12
false
THUMBNAIL
Lu et al_final.pdf.jpg
Lu et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
23443
https://hzi.openrepository.com/bitstream/10033/316718/15/Lu%20et%20al_final.pdf.jpg
fdd82404e30e45f8ba16227d06c36c4b
MD5
15
false
Lu_Supporting Information.pdf.jpg
Lu_Supporting Information.pdf.jpg
Generated Thumbnail
image/jpeg
36262
https://hzi.openrepository.com/bitstream/10033/316718/16/Lu_Supporting%20Information.pdf.jpg
9b44b40ea8c5bfe6185867a2c578480e
MD5
16
false
10033/316718
oai:hzi.openrepository.com:10033/316718
2019-08-30 11:33:57.29
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3227012019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Hinsberger, Stefan
702ae58059e1a16c46f91747912528ba
500
de Jong, Johannes C
a1e7109c9f9524057415e109356e9f5c
500
Groh, Matthias
77153195b19ba7b5a79c4fcbbf4a9263
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
2014-07-09T14:37:21Z
2014-07-09T14:37:21Z
2014-04-09
Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections. 2014, 76:343-51 Eur J Med Chem
1768-3254
24589489
10.1016/j.ejmech.2014.02.014
http://hdl.handle.net/10033/322701
European journal of medicinal chemistry
Targeting PqsD is a promising novel approach to disrupt bacterial cell-to-cell-communication in Pseudomonas aeruginosa. In search of selective PqsD inhibitors, two series of benzamidobenzoic acids - one published as RNAP inhibitors and the other as PqsD inhibitors - were investigated for inhibitory activity toward the respective other enzyme. Additionally, novel derivatives were synthesized and biologically evaluated. By this means, the structural features needed for benzamidobenzoic acids to be potent and, most notably, selective PqsD inhibitors were identified. The most interesting compound of this study was the 3-Cl substituted compound 5 which strongly inhibits PqsD (IC₅₀ 6.2 μM) while exhibiting no inhibition of RNAP.
en
Archived with thanks to European journal of medicinal chemistry
Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections.
Article
2018-06-12T20:01:54Z
Targeting PqsD is a promising novel approach to disrupt bacterial cell-to-cell-communication in Pseudomonas aeruginosa. In search of selective PqsD inhibitors, two series of benzamidobenzoic acids - one published as RNAP inhibitors and the other as PqsD inhibitors - were investigated for inhibitory activity toward the respective other enzyme. Additionally, novel derivatives were synthesized and biologically evaluated. By this means, the structural features needed for benzamidobenzoic acids to be potent and, most notably, selective PqsD inhibitors were identified. The most interesting compound of this study was the 3-Cl substituted compound 5 which strongly inhibits PqsD (IC₅₀ 6.2 μM) while exhibiting no inhibition of RNAP.
ORIGINAL
Hinsberger et al_final.pdf
Hinsberger et al_final.pdf
original manuscript
application/pdf
339308
https://hzi.openrepository.com/bitstream/10033/322701/1/Hinsberger%20et%20al_final.pdf
54b0d9a87c8fb6b79518fd41828da67c
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/322701/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22424
https://hzi.openrepository.com/bitstream/10033/322701/3/license_text
9d4aa3148f8600b6240582f6981c8f65
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/322701/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/322701/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Hinsberger et al_final.pdf.txt
Hinsberger et al_final.pdf.txt
Extracted Text
text/plain
46520
https://hzi.openrepository.com/bitstream/10033/322701/8/Hinsberger%20et%20al_final.pdf.txt
9d031a0c56079fb75b1506c9ce1cae70
MD5
8
false
THUMBNAIL
Hinsberger et al_final.pdf.jpg
Hinsberger et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
30009
https://hzi.openrepository.com/bitstream/10033/322701/9/Hinsberger%20et%20al_final.pdf.jpg
129bb86cecf202b67a05ecffc7258223
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
116955
https://hzi.openrepository.com/bitstream/10033/322701/10/elsevier-thumbnail.png
ca02b35c9c05d43b15f200e57b9bd9f9
MD5
10
false
10033/322701
oai:hzi.openrepository.com:10033/322701
2019-08-30 11:34:48.487
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/3249672019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Abdelsamie, Ahmed S
b7451f5abfd51938e22a95fd4f3cec99
500
Bey, Emmanuel
c1860f95b4228d8d5faa91e3ac6f29e4
500
Hanke, Nina
82f6bb1daf0318f7c0084876c1f53264
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
2014-08-19T09:52:53Z
2014-08-19T09:52:53Z
2014-07-23
Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker. 2014, 82:394-406 Eur J Med Chem
1768-3254
24929290
10.1016/j.ejmech.2014.05.074
http://hdl.handle.net/10033/324967
European journal of medicinal chemistry
Estradiol is the most potent estrogen in humans. It is known to be involved in the development and proliferation of estrogen dependent diseases such as breast cancer and endometriosis. The last step of its biosynthesis is catalyzed by 17β-hydroxysteroid dehydrogenase type 1 (17β- HSD1) which consequently is a promising target for the treatment of these diseases. Recently, we reported on bicyclic substituted hydroxyphenylmethanones as potent inhibitors of 17β-HSD1. The present study focuses on rational structural modifications in this compound class with the aim of gaining more insight into its structure-activity relationship (SAR). (4-Hydroxyphenyl)-(5-(3-hydroxyphenylsulfanyl)-thiophen-2-yl)methanone (25) was discovered as a member of a novel potent class of human 17β-HSD1 inhibitors. Computational methods were used to elucidate its interactions with the target protein. The compound showed activity also towards the murine 17β-HSD1 enzyme and thus is a starting point for the design of compounds suitable for evaluation in an animal disease model.
en
Archived with thanks to European journal of medicinal chemistry
Inhibition of 17β-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker.
Article
2018-06-13T09:09:56Z
Estradiol is the most potent estrogen in humans. It is known to be involved in the development and proliferation of estrogen dependent diseases such as breast cancer and endometriosis. The last step of its biosynthesis is catalyzed by 17β-hydroxysteroid dehydrogenase type 1 (17β- HSD1) which consequently is a promising target for the treatment of these diseases. Recently, we reported on bicyclic substituted hydroxyphenylmethanones as potent inhibitors of 17β-HSD1. The present study focuses on rational structural modifications in this compound class with the aim of gaining more insight into its structure-activity relationship (SAR). (4-Hydroxyphenyl)-(5-(3-hydroxyphenylsulfanyl)-thiophen-2-yl)methanone (25) was discovered as a member of a novel potent class of human 17β-HSD1 inhibitors. Computational methods were used to elucidate its interactions with the target protein. The compound showed activity also towards the murine 17β-HSD1 enzyme and thus is a starting point for the design of compounds suitable for evaluation in an animal disease model.
ORIGINAL
Abdelsamie et al_final.pdf
Abdelsamie et al_final.pdf
original manuscript
application/pdf
840278
https://hzi.openrepository.com/bitstream/10033/324967/1/Abdelsamie%20et%20al_final.pdf
73307348a613818f94124e9a3a939d64
MD5
1
true
Abdelsamie_Support.pdf
Abdelsamie_Support.pdf
supporting information
application/pdf
5608381
https://hzi.openrepository.com/bitstream/10033/324967/2/Abdelsamie_Support.pdf
32877178633f45f1268ae90df9dbbbc7
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/324967/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
22424
https://hzi.openrepository.com/bitstream/10033/324967/4/license_text
9d4aa3148f8600b6240582f6981c8f65
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/324967/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/324967/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Abdelsamie et al_final.pdf.txt
Abdelsamie et al_final.pdf.txt
Extracted Text
text/plain
62544
https://hzi.openrepository.com/bitstream/10033/324967/11/Abdelsamie%20et%20al_final.pdf.txt
3b43c0046eaae16ba55f06de27cae24d
MD5
11
false
Abdelsamie_Support.pdf.txt
Abdelsamie_Support.pdf.txt
Extracted Text
text/plain
21875
https://hzi.openrepository.com/bitstream/10033/324967/12/Abdelsamie_Support.pdf.txt
15f37aeba515a598b80f2a6c7f413b47
MD5
12
false
THUMBNAIL
Abdelsamie et al_final.pdf.jpg
Abdelsamie et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32706
https://hzi.openrepository.com/bitstream/10033/324967/17/Abdelsamie%20et%20al_final.pdf.jpg
8f000c49ed82c3523664b4402ce0772c
MD5
17
false
Abdelsamie_Support.pdf.jpg
Abdelsamie_Support.pdf.jpg
Generated Thumbnail
image/jpeg
35665
https://hzi.openrepository.com/bitstream/10033/324967/18/Abdelsamie_Support.pdf.jpg
2a0e6abeee1f9a0e1e03d7ef94ef45d0
MD5
18
false
elsevier-thumbnail.png
application/octet-stream
124566
https://hzi.openrepository.com/bitstream/10033/324967/19/elsevier-thumbnail.png
498c12d1f7ebcd89dd723f8de89791b0
MD5
19
false
10033/324967
oai:hzi.openrepository.com:10033/324967
2019-08-30 11:34:48.313
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/3250052019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Lu, Cenbin
5a0c4c8e74f17b1d3607bc0b7df2121d
500
Kirsch, Benjamin
8c673c51dcda680d6131094070a108db
500
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
de Jong, Johannes C
a1e7109c9f9524057415e109356e9f5c
500
Braunshausen, Andrea
3cb924713878d5b818959940ca66d9f9
500
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz-Institut für Pharmazeutische Forschung Saarland Campus, Geb. C2.3 Universität des Saarlandes, D-66123 Saarbrücken, Germany.
2014-08-20T09:16:05Z
2014-08-20T09:16:05Z
2014-05-22
Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships. 2014, 79:173-83 Eur J Med Chem
1768-3254
24735643
10.1016/j.ejmech.2014.04.016
http://hdl.handle.net/10033/325005
European journal of medicinal chemistry
Increasing antibiotic resistance urgently requires novel therapeutic options to combat bacterial infections. The anti-virulence therapy selectively intervening with pathogenicity without affecting bacterial viability is such a strategy to overcome resistance. We consider the virulence regulator PqsR as an attractive target in the human pathogen Pseudomonas aeruginosa, and recently discovered the first PqsR antagonists, which, however, suffered from poor aqueous solubility. In this work, the antagonists were structurally modified to become more soluble, and their structure-activity as well as structure-property relationships were studied. A novel promising compound with improved solubility and enhanced anti-virulence activity was discovered (IC50: 3.8 μM, pyocyanin). Our findings emphasize the crucial role of substituents at the 3-position and the carbonyl group at the 4-position for ligand-receptor interactions, and illuminate the way for further optimization of PqsR antagonists as anti-virulence agents.
en
Archived with thanks to European journal of medicinal chemistry
Optimization of anti-virulence PqsR antagonists regarding aqueous solubility and biological properties resulting in new insights in structure-activity relationships.
Article
2018-06-13T01:37:35Z
Increasing antibiotic resistance urgently requires novel therapeutic options to combat bacterial infections. The anti-virulence therapy selectively intervening with pathogenicity without affecting bacterial viability is such a strategy to overcome resistance. We consider the virulence regulator PqsR as an attractive target in the human pathogen Pseudomonas aeruginosa, and recently discovered the first PqsR antagonists, which, however, suffered from poor aqueous solubility. In this work, the antagonists were structurally modified to become more soluble, and their structure-activity as well as structure-property relationships were studied. A novel promising compound with improved solubility and enhanced anti-virulence activity was discovered (IC50: 3.8 μM, pyocyanin). Our findings emphasize the crucial role of substituents at the 3-position and the carbonyl group at the 4-position for ligand-receptor interactions, and illuminate the way for further optimization of PqsR antagonists as anti-virulence agents.
ORIGINAL
Lu et al_final.pdf
Lu et al_final.pdf
original manuscript
application/pdf
358397
https://hzi.openrepository.com/bitstream/10033/325005/1/Lu%20et%20al_final.pdf
dab32eff55358fbe4049172a83673927
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/325005/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22424
https://hzi.openrepository.com/bitstream/10033/325005/3/license_text
9d4aa3148f8600b6240582f6981c8f65
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/325005/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/325005/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Lu et al_final.pdf.txt
Lu et al_final.pdf.txt
Extracted Text
text/plain
56282
https://hzi.openrepository.com/bitstream/10033/325005/8/Lu%20et%20al_final.pdf.txt
93fcc303511201394d38c332f2599f97
MD5
8
false
THUMBNAIL
Lu et al_final.pdf.jpg
Lu et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
34309
https://hzi.openrepository.com/bitstream/10033/325005/9/Lu%20et%20al_final.pdf.jpg
c0f4694c9dcbaa7a82567ed1fbff57a1
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
127969
https://hzi.openrepository.com/bitstream/10033/325005/10/elsevier-thumbnail.png
86378ac1c2fcc8e65671ecd1f649a53e
MD5
10
false
10033/325005
oai:hzi.openrepository.com:10033/325005
2019-08-30 11:34:48.423
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3260692019-08-30T11:36:32Zcom_10033_620656col_10033_620658
Wohlschlager, Therese
99fe8a12cf30b6f803e78bf0259a3504
500
Butschi, Alex
d318c7005f2d3b3bd8a7e0246e58c7ad
500
Grassi, Paola
b8f0e58e9cec810e790af50e68e6ca05
500
Sutov, Grigorij
54be7a1aa7ec906ed0d38c7e6649b505
500
Gauss, Robert
cf759f25412b8540dfd36d4d06af36a7
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Schmieder, Stefanie S
6cb4031e8a62b919ee32047a03bd1171
500
Knobel, Martin
16f535eaab055c9072eaf40bc659c967
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
Dell, Anne
12faa79193e45d9e96248af5b2447cce
500
Haslam, Stuart M
45dd34e89df61101fb71c9d63295a15b
500
Hengartner, Michael O
d28fe8be0b6526b75a7c6f73231952e4
500
Aebi, Markus
5c52c7df390042fd44526ec434863497
500
Künzler, Markus
3a9da4fff2b338b85cb9efa2a54263f9
500
2014-09-12T09:43:18Z
2014-09-12T09:43:18Z
2014-07-08
Methylated glycans as conserved targets of animal and fungal innate defense. 2014, 111 (27):E2787-96 Proc. Natl. Acad. Sci. U.S.A.
1091-6490
24879441
10.1073/pnas.1401176111
http://hdl.handle.net/10033/326069
Proceedings of the National Academy of Sciences of the United States of America
Effector proteins of innate immune systems recognize specific non-self epitopes. Tectonins are a family of β-propeller lectins conserved from bacteria to mammals that have been shown to bind bacterial lipopolysaccharide (LPS). We present experimental evidence that two Tectonins of fungal and animal origin have a specificity for O-methylated glycans. We show that Tectonin 2 of the mushroom Laccaria bicolor (Lb-Tec2) agglutinates Gram-negative bacteria and exerts toxicity toward the model nematode Caenorhabditis elegans, suggesting a role in fungal defense against bacteria and nematodes. Biochemical and genetic analysis of these interactions revealed that both bacterial agglutination and nematotoxicity of Lb-Tec2 depend on the recognition of methylated glycans, namely O-methylated mannose and fucose residues, as part of bacterial LPS and nematode cell-surface glycans. In addition, a C. elegans gene, termed samt-1, coding for a candidate membrane transport protein for the presumptive donor substrate of glycan methylation, S-adenosyl-methionine, from the cytoplasm to the Golgi was identified. Intriguingly, limulus lectin L6, a structurally related antibacterial protein of the Japanese horseshoe crab Tachypleus tridentatus, showed properties identical to the mushroom lectin. These results suggest that O-methylated glycans constitute a conserved target of the fungal and animal innate immune system. The broad phylogenetic distribution of O-methylated glycans increases the spectrum of potential antagonists recognized by Tectonins, rendering this conserved protein family a universal defense armor.
en
Archived with thanks to Proceedings of the National Academy of Sciences of the United States of America
Methylated glycans as conserved targets of animal and fungal innate defense.
Article
2018-06-13T04:02:01Z
Effector proteins of innate immune systems recognize specific non-self epitopes. Tectonins are a family of β-propeller lectins conserved from bacteria to mammals that have been shown to bind bacterial lipopolysaccharide (LPS). We present experimental evidence that two Tectonins of fungal and animal origin have a specificity for O-methylated glycans. We show that Tectonin 2 of the mushroom Laccaria bicolor (Lb-Tec2) agglutinates Gram-negative bacteria and exerts toxicity toward the model nematode Caenorhabditis elegans, suggesting a role in fungal defense against bacteria and nematodes. Biochemical and genetic analysis of these interactions revealed that both bacterial agglutination and nematotoxicity of Lb-Tec2 depend on the recognition of methylated glycans, namely O-methylated mannose and fucose residues, as part of bacterial LPS and nematode cell-surface glycans. In addition, a C. elegans gene, termed samt-1, coding for a candidate membrane transport protein for the presumptive donor substrate of glycan methylation, S-adenosyl-methionine, from the cytoplasm to the Golgi was identified. Intriguingly, limulus lectin L6, a structurally related antibacterial protein of the Japanese horseshoe crab Tachypleus tridentatus, showed properties identical to the mushroom lectin. These results suggest that O-methylated glycans constitute a conserved target of the fungal and animal innate immune system. The broad phylogenetic distribution of O-methylated glycans increases the spectrum of potential antagonists recognized by Tectonins, rendering this conserved protein family a universal defense armor.
ORIGINAL
Wohlschlager et al_final.pdf
Wohlschlager et al_final.pdf
original manuscript
application/pdf
16010432
https://hzi.openrepository.com/bitstream/10033/326069/1/Wohlschlager%20et%20al_final.pdf
55708c245b2be94d728d76afc9cc6b4e
MD5
1
true
Wohlschlager_SupportingInformation_rerevised.pdf
Wohlschlager_SupportingInformation_rerevised.pdf
Supporting information
application/pdf
2323367
https://hzi.openrepository.com/bitstream/10033/326069/2/Wohlschlager_SupportingInformation_rerevised.pdf
f8dac7cd35f72018eb1d6d9392a53b4e
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/326069/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
22605
https://hzi.openrepository.com/bitstream/10033/326069/4/license_text
0d804ae578d831f4967f509ae1b0641e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/326069/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/326069/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Wohlschlager et al_final.pdf.txt
Wohlschlager et al_final.pdf.txt
Extracted Text
text/plain
67831
https://hzi.openrepository.com/bitstream/10033/326069/11/Wohlschlager%20et%20al_final.pdf.txt
b254d259eb2e6b3c026cae6815408fb9
MD5
11
false
Wohlschlager_SupportingInformation_rerevised.pdf.txt
Wohlschlager_SupportingInformation_rerevised.pdf.txt
Extracted Text
text/plain
32874
https://hzi.openrepository.com/bitstream/10033/326069/12/Wohlschlager_SupportingInformation_rerevised.pdf.txt
d2a0cdf06c87675f144844713a751175
MD5
12
false
THUMBNAIL
Wohlschlager et al_final.pdf.jpg
Wohlschlager et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
36230
https://hzi.openrepository.com/bitstream/10033/326069/15/Wohlschlager%20et%20al_final.pdf.jpg
ed083ff5ef4e3116c9591a5b90dea71a
MD5
15
false
Wohlschlager_SupportingInformation_rerevised.pdf.jpg
Wohlschlager_SupportingInformation_rerevised.pdf.jpg
Generated Thumbnail
image/jpeg
73255
https://hzi.openrepository.com/bitstream/10033/326069/16/Wohlschlager_SupportingInformation_rerevised.pdf.jpg
96df5c7e9ab80425af040651954e9292
MD5
16
false
10033/326069
oai:hzi.openrepository.com:10033/326069
2019-08-30 11:36:32.727
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3261742019-08-30T11:27:16Zcom_10033_620656col_10033_620657
Zhu, Weixing
12a5ecca252734b6d9e6f884506401a5
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Groh, Matthias
77153195b19ba7b5a79c4fcbbf4a9263
500
Fountain, Michelle
831c169bf5e3fc6d6bf0d0607a24a3c7
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
2014-09-16T12:41:07Z
2014-09-16T12:41:07Z
2014-07
New insights into the bacterial RNA polymerase inhibitor CBR703 as a starting point for optimization as an anti-infective agent. 2014, 58 (7):4242-5 Antimicrob. Agents Chemother.
1098-6596
24820077
10.1128/AAC.02600-14
http://hdl.handle.net/10033/326174
Antimicrobial agents and chemotherapy
CBR703 was reported to inhibit bacterial RNA polymerase (RNAP) and biofilm formation, considering it to be a good candidate for further optimization. While synthesized derivatives of CBR703 did not result in more-active RNAP inhibitors, we observed promising antibacterial activities. These again correlated with a significant cytotoxicity toward mammalian cells. Furthermore, we suspect the promising effects on biofilm formation to be artifacts. Consequently, this class of compounds can be considered unattractive as antibacterial agents.
en
Archived with thanks to Antimicrobial agents and chemotherapy
New insights into the bacterial RNA polymerase inhibitor CBR703 as a starting point for optimization as an anti-infective agent.
Article
2018-06-12T22:50:31Z
CBR703 was reported to inhibit bacterial RNA polymerase (RNAP) and biofilm formation, considering it to be a good candidate for further optimization. While synthesized derivatives of CBR703 did not result in more-active RNAP inhibitors, we observed promising antibacterial activities. These again correlated with a significant cytotoxicity toward mammalian cells. Furthermore, we suspect the promising effects on biofilm formation to be artifacts. Consequently, this class of compounds can be considered unattractive as antibacterial agents.
ORIGINAL
Zhu et al_final.pdf
Zhu et al_final.pdf
submitted manuscript
application/pdf
397583
https://hzi.openrepository.com/bitstream/10033/326174/1/Zhu%20et%20al_final.pdf
f3c0c7875ff22678f5176aaa59a13e48
MD5
1
true
Weixing Zhu revision SI.pdf
Weixing Zhu revision SI.pdf
supplemental information and figures
application/pdf
1051818
https://hzi.openrepository.com/bitstream/10033/326174/2/Weixing%20Zhu%20revision%20SI.pdf
d0e21bc2107493c3d930821d9ef37196
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/326174/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
22605
https://hzi.openrepository.com/bitstream/10033/326174/4/license_text
0d804ae578d831f4967f509ae1b0641e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/326174/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/326174/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Zhu et al_final.pdf.txt
Zhu et al_final.pdf.txt
Extracted Text
text/plain
18674
https://hzi.openrepository.com/bitstream/10033/326174/11/Zhu%20et%20al_final.pdf.txt
be8319f8a1d11fa044f203f694dcfdd5
MD5
11
false
Weixing Zhu revision SI.pdf.txt
Weixing Zhu revision SI.pdf.txt
Extracted Text
text/plain
51782
https://hzi.openrepository.com/bitstream/10033/326174/12/Weixing%20Zhu%20revision%20SI.pdf.txt
ff28fccd94ba7f05e745f9d590116329
MD5
12
false
THUMBNAIL
Zhu et al_final.pdf.jpg
Zhu et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
31702
https://hzi.openrepository.com/bitstream/10033/326174/15/Zhu%20et%20al_final.pdf.jpg
fea5453ba96800c382dda23901d3653b
MD5
15
false
Weixing Zhu revision SI.pdf.jpg
Weixing Zhu revision SI.pdf.jpg
Generated Thumbnail
image/jpeg
79676
https://hzi.openrepository.com/bitstream/10033/326174/16/Weixing%20Zhu%20revision%20SI.pdf.jpg
bbdcfb6f3ac94dc3baf3c30f0f9d00f6
MD5
16
false
10033/326174
oai:hzi.openrepository.com:10033/326174
2019-08-30 11:27:16.348
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3365532019-08-30T11:36:05Zcom_10033_620656col_10033_620658
Butschi, Alex
d318c7005f2d3b3bd8a7e0246e58c7ad
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
Wälti, Martin A
f9d351c92f03b43c1c9411dfcec3cc0d
500
Olieric, Vincent
8f92a359c6460e08501e8eb8c3184c80
500
Paschinger, Katharina
27fb9c88f677a6374c143218a24563e5
500
Nöbauer, Katharina
7e6c6edbc39b802162e9f47ada79c755
500
Guo, Xiaoqiang
13f3b2742fe6e097086e4e871f9c841a
500
Seeberger, Peter H
48de6337a930b17b536796c5c81080e9
500
Wilson, Iain B H
e67599e65e427b7b88b4cf0ed8936e49
500
Aebi, Markus
5c52c7df390042fd44526ec434863497
500
Hengartner, Michael O
d28fe8be0b6526b75a7c6f73231952e4
500
Künzler, Markus
3a9da4fff2b338b85cb9efa2a54263f9
500
Institute of Molecular Biology, University of Zürich, Zürich, Switzerland.
2014-12-03T10:32:51Z
2014-12-03T10:32:51Z
2010-01
Caenorhabditis elegans N-glycan core beta-galactoside confers sensitivity towards nematotoxic fungal galectin CGL2. 2010, 6 (1):e1000717 PLoS Pathog.
1553-7374
20062796
10.1371/journal.ppat.1000717
http://hdl.handle.net/10033/336553
PLoS pathogens
The physiological role of fungal galectins has remained elusive. Here, we show that feeding of a mushroom galectin, Coprinopsis cinerea CGL2, to Caenorhabditis elegans inhibited development and reproduction and ultimately resulted in killing of this nematode. The lack of toxicity of a carbohydrate-binding defective CGL2 variant and the resistance of a C. elegans mutant defective in GDP-fucose biosynthesis suggested that CGL2-mediated nematotoxicity depends on the interaction between the galectin and a fucose-containing glycoconjugate. A screen for CGL2-resistant worm mutants identified this glycoconjugate as a Galbeta1,4Fucalpha1,6 modification of C. elegans N-glycan cores. Analysis of N-glycan structures in wild type and CGL2-resistant nematodes confirmed this finding and allowed the identification of a novel putative glycosyltransferase required for the biosynthesis of this glycoepitope. The X-ray crystal structure of a complex between CGL2 and the Galbeta1,4Fucalpha1,6GlcNAc trisaccharide at 1.5 A resolution revealed the biophysical basis for this interaction. Our results suggest that fungal galectins play a role in the defense of fungi against predators by binding to specific glycoconjugates of these organisms.
en
Agaricales
Amino Acid Sequence
Animals
Caenorhabditis elegans
Caenorhabditis elegans Proteins
Fungal Proteins
Galactosides
Galectin 2
Molecular Sequence Data
Nematode Infections
Protein Structure, Quaternary
Structure-Activity Relationship
Caenorhabditis elegans N-glycan core beta-galactoside confers sensitivity towards nematotoxic fungal galectin CGL2.
Article
2018-06-13T03:47:23Z
The physiological role of fungal galectins has remained elusive. Here, we show that feeding of a mushroom galectin, Coprinopsis cinerea CGL2, to Caenorhabditis elegans inhibited development and reproduction and ultimately resulted in killing of this nematode. The lack of toxicity of a carbohydrate-binding defective CGL2 variant and the resistance of a C. elegans mutant defective in GDP-fucose biosynthesis suggested that CGL2-mediated nematotoxicity depends on the interaction between the galectin and a fucose-containing glycoconjugate. A screen for CGL2-resistant worm mutants identified this glycoconjugate as a Galbeta1,4Fucalpha1,6 modification of C. elegans N-glycan cores. Analysis of N-glycan structures in wild type and CGL2-resistant nematodes confirmed this finding and allowed the identification of a novel putative glycosyltransferase required for the biosynthesis of this glycoepitope. The X-ray crystal structure of a complex between CGL2 and the Galbeta1,4Fucalpha1,6GlcNAc trisaccharide at 1.5 A resolution revealed the biophysical basis for this interaction. Our results suggest that fungal galectins play a role in the defense of fungi against predators by binding to specific glycoconjugates of these organisms.
ORIGINAL
Butschi et al_final.pdf
Butschi et al_final.pdf
Open Access publication
application/pdf
1288615
https://hzi.openrepository.com/bitstream/10033/336553/1/Butschi%20et%20al_final.pdf
9ad0892615365c7d8008f0cf8f81dfec
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/336553/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22790
https://hzi.openrepository.com/bitstream/10033/336553/3/license_text
5583a4be1f6dbb777e1501f0e06a0664
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/336553/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/336553/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Butschi et al_final.pdf.txt
Butschi et al_final.pdf.txt
Extracted Text
text/plain
86021
https://hzi.openrepository.com/bitstream/10033/336553/8/Butschi%20et%20al_final.pdf.txt
34e909b76b129c4414f9d96deb536311
MD5
8
false
THUMBNAIL
Butschi et al_final.pdf.jpg
Butschi et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
34046
https://hzi.openrepository.com/bitstream/10033/336553/9/Butschi%20et%20al_final.pdf.jpg
02eb0998d255afffed4782676172c45e
MD5
9
false
10033/336553
oai:hzi.openrepository.com:10033/336553
2019-08-30 11:36:05.435
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3365872019-08-30T11:36:32Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Exner, Thomas E
1ea6a7bd1f771fc28d109b7925519d61
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C 2.3, D-66123, Saarbrücken, Germany; Department of Chemistry and Graduate School Chemical Biology, University of Konstanz, D-78457, Konstanz, Germany.
2014-12-04T10:46:13Z
2014-12-04T10:46:13Z
2014
A Biophysical Study with Carbohydrate Derivatives Explains the Molecular Basis of Monosaccharide Selectivity of the Pseudomonas aeruginosa Lectin LecB. 2014, 9 (11):e112822 PLoS ONE
1932-6203
25415418
10.1371/journal.pone.0112822
http://hdl.handle.net/10033/336587
PloS one
The rise of resistances against antibiotics in bacteria is a major threat for public health and demands the development of novel antibacterial therapies. Infections with Pseudomonas aeruginosa are a severe problem for hospitalized patients and for patients suffering from cystic fibrosis. These bacteria can form biofilms and thereby increase their resistance towards antibiotics. The bacterial lectin LecB was shown to be necessary for biofilm formation and the inhibition with its carbohydrate ligands resulted in reduced amounts of biofilm. The natural ligands for LecB are glycosides of d-mannose and l-fucose, the latter displaying an unusual strong affinity. Interestingly, although mannosides are much weaker ligands for LecB, they do form an additional hydrogen bond with the protein in the crystal structure. To analyze the individual contributions of the methyl group in fucosides and the hydroxymethyl group in mannosides to the binding, we designed and synthesized derivatives of these saccharides. We report glycomimetic inhibitors that dissect the individual interactions of their saccharide precursors with LecB and give insight into the biophysics of binding by LecB. Furthermore, theoretical calculations supported by experimental thermodynamic data suggest a perturbed hydrogen bonding network for mannose derivatives as molecular basis for the selectivity of LecB for fucosides. Knowledge gained on the mode of interaction of LecB with its ligands at ambient conditions will be useful for future drug design.
en
A Biophysical Study with Carbohydrate Derivatives Explains the Molecular Basis of Monosaccharide Selectivity of the Pseudomonas aeruginosa Lectin LecB.
Article
2018-06-13T20:04:59Z
The rise of resistances against antibiotics in bacteria is a major threat for public health and demands the development of novel antibacterial therapies. Infections with Pseudomonas aeruginosa are a severe problem for hospitalized patients and for patients suffering from cystic fibrosis. These bacteria can form biofilms and thereby increase their resistance towards antibiotics. The bacterial lectin LecB was shown to be necessary for biofilm formation and the inhibition with its carbohydrate ligands resulted in reduced amounts of biofilm. The natural ligands for LecB are glycosides of d-mannose and l-fucose, the latter displaying an unusual strong affinity. Interestingly, although mannosides are much weaker ligands for LecB, they do form an additional hydrogen bond with the protein in the crystal structure. To analyze the individual contributions of the methyl group in fucosides and the hydroxymethyl group in mannosides to the binding, we designed and synthesized derivatives of these saccharides. We report glycomimetic inhibitors that dissect the individual interactions of their saccharide precursors with LecB and give insight into the biophysics of binding by LecB. Furthermore, theoretical calculations supported by experimental thermodynamic data suggest a perturbed hydrogen bonding network for mannose derivatives as molecular basis for the selectivity of LecB for fucosides. Knowledge gained on the mode of interaction of LecB with its ligands at ambient conditions will be useful for future drug design.
ORIGINAL
Sommer et al_final.pdf
Sommer et al_final.pdf
Open Access publication
application/pdf
1409332
https://hzi.openrepository.com/bitstream/10033/336587/1/Sommer%20et%20al_final.pdf
54cef0b1916830f52ea542b2e8303787
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/336587/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22790
https://hzi.openrepository.com/bitstream/10033/336587/3/license_text
5583a4be1f6dbb777e1501f0e06a0664
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/336587/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/336587/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Sommer et al_final.pdf.txt
Sommer et al_final.pdf.txt
Extracted Text
text/plain
62237
https://hzi.openrepository.com/bitstream/10033/336587/8/Sommer%20et%20al_final.pdf.txt
0dd6f26029dc6491edce6dc50489fb21
MD5
8
false
THUMBNAIL
Sommer et al_final.pdf.jpg
Sommer et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
29831
https://hzi.openrepository.com/bitstream/10033/336587/9/Sommer%20et%20al_final.pdf.jpg
23398645b0674e4d4b4bd757d68348e5
MD5
9
false
10033/336587
oai:hzi.openrepository.com:10033/336587
2019-08-30 11:36:32.831
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3367002019-08-30T11:36:32Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Joachim, Ines
e3e184873e8376884d46e8a942d2d271
500
Wagner, Stefanie
935803ea3ccfe8267a16e098ea9a33bc
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
University of Konstanz, Department of Chemistry and Zukunftskolleg, Universitätsstrasse 10, D-78457 Konstanz.
2014-12-05T09:59:07Z
2014-12-05T09:59:07Z
2013
New approaches to control infections: anti-biofilm strategies against gram-negative bacteria. 2013, 67 (4):286-90 Chimia (Aarau)
0009-4293
23967708
http://hdl.handle.net/10033/336700
Chimia
Hospital-acquired bacterial infections, especially with Gram-negative pathogens, present a major threat due to the rapid spread of antibiotic-resistant strains. Targeting mechanisms of bacterial virulence has recently appeared as a promising new therapeutic paradigm. Biofilm formation is a bacterial lifestyle, which offers a survival advantage through its protective matrix against host immune defense and antibiotic treatment. Interfering with biogenesis of adhesive organelles, bacterial communication or carbohydrate-mediated adhesion as anti-biofilm strategies are reviewed.
en
Anti-Bacterial Agents
Biofilms
Cross Infection
Gram-Negative Bacteria
Gram-Negative Bacterial Infections
Humans
New approaches to control infections: anti-biofilm strategies against gram-negative bacteria.
Article
2018-06-13T21:23:47Z
Hospital-acquired bacterial infections, especially with Gram-negative pathogens, present a major threat due to the rapid spread of antibiotic-resistant strains. Targeting mechanisms of bacterial virulence has recently appeared as a promising new therapeutic paradigm. Biofilm formation is a bacterial lifestyle, which offers a survival advantage through its protective matrix against host immune defense and antibiotic treatment. Interfering with biogenesis of adhesive organelles, bacterial communication or carbohydrate-mediated adhesion as anti-biofilm strategies are reviewed.
ORIGINAL
Sommer et al_2013final.pdf
Sommer et al_2013final.pdf
allowed publisher's PDF
application/pdf
448347
https://hzi.openrepository.com/bitstream/10033/336700/1/Sommer%20et%20al_2013final.pdf
6b7e7698b378156e028ecd42da49fcd1
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/336700/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22790
https://hzi.openrepository.com/bitstream/10033/336700/3/license_text
5583a4be1f6dbb777e1501f0e06a0664
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/336700/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/336700/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Sommer et al_2013final.pdf.txt
Sommer et al_2013final.pdf.txt
Extracted Text
text/plain
32697
https://hzi.openrepository.com/bitstream/10033/336700/8/Sommer%20et%20al_2013final.pdf.txt
70381bc5d0f44265244134843aa6fcce
MD5
8
false
THUMBNAIL
Sommer et al_2013final.pdf.jpg
Sommer et al_2013final.pdf.jpg
Generated Thumbnail
image/jpeg
30841
https://hzi.openrepository.com/bitstream/10033/336700/9/Sommer%20et%20al_2013final.pdf.jpg
6f4df80d0947319ab3ce589ce7bee10f
MD5
9
false
10033/336700
oai:hzi.openrepository.com:10033/336700
2019-08-30 11:36:32.914
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3366982019-08-30T11:27:43Zcom_10033_620656col_10033_620658
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
Ernst, Beat
e130fa4686bf62ca5c871d2181ccfb28
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C 2.3, D-66123, Saarbrücken, Germany
2014-12-05T09:45:07Z
2014-12-05T09:45:07Z
2014-12-05
Mimetics of Sialyl Lewis<SUP>x</SUP>: The Pre-Organization of the Carboxylic Acid is Essential for Binding to Selectins 2007, 61 (4):194 CHIMIA International Journal for Chemistry
00094293
00000000
10.2533/chimia.2007.194
http://hdl.handle.net/10033/336698
CHIMIA International Journal for Chemistry
http://openurl.ingenta.com/content/xref?genre=article&issn=0009-4293&volume=61&issue=4&spage=194
Mimetics of Sialyl Lewis<SUP>x</SUP>: The Pre-Organization of the Carboxylic Acid is Essential for Binding to Selectins
Meetings and Proceedings
2018-06-12T17:47:00Z
ORIGINAL
Titz and Ernst_final.pdf
Titz and Ernst_final.pdf
allowed publisher's PDF
application/pdf
444674
https://hzi.openrepository.com/bitstream/10033/336698/1/Titz%20and%20Ernst_final.pdf
550f499ff2795ccc915bfed05a1fa616
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/336698/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22790
https://hzi.openrepository.com/bitstream/10033/336698/3/license_text
5583a4be1f6dbb777e1501f0e06a0664
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/336698/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/336698/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Titz and Ernst_final.pdf.txt
Titz and Ernst_final.pdf.txt
Extracted Text
text/plain
308
https://hzi.openrepository.com/bitstream/10033/336698/8/Titz%20and%20Ernst_final.pdf.txt
901cd12c9b51bebbb0ad583f3ed00fed
MD5
8
false
THUMBNAIL
Titz and Ernst_final.pdf.jpg
Titz and Ernst_final.pdf.jpg
Generated Thumbnail
image/jpeg
30309
https://hzi.openrepository.com/bitstream/10033/336698/9/Titz%20and%20Ernst_final.pdf.jpg
4d7c79e30a5e41793c4d291b847cd363
MD5
9
false
10033/336698
oai:hzi.openrepository.com:10033/336698
2019-08-30 11:27:43.723
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3445702019-08-30T11:30:58Zcom_10033_620656col_10033_620657
Stefanachi, Angela
422bf54102f5e912915ca9a7f6909574
500
Hanke, Nina
82f6bb1daf0318f7c0084876c1f53264
500
Pisani, Leonardo
4d2035436fade99826d4a158e3008f6e
500
Leonetti, Francesco
c4ae9ccced4fdfe5451c35d1eed9fcb9
500
Nicolotti, Orazio
2b09cf681aedcda2c29d499ffad96a7e
500
Catto, Marco
f4b782534cd8167fedfd105a60f6faba
500
Cellamare, Saverio
64c22710e0aec8f137e3b5f2085d756c
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Carotti, Angelo
b3355f694f7d93c1823a3b97863fb61b
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), PO Box 15 11 50, D-66041 Saarbrücken, Germany.
2015-02-18T13:39:43Z
2015-02-18T13:39:43Z
2015-01-07
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase. 2015, 89:106-14 Eur J Med Chem
1768-3254
25462231
10.1016/j.ejmech.2014.10.021
http://hdl.handle.net/10033/344570
European journal of medicinal chemistry
Diseases triggered by an abnormally high level of cortisol (hypercortisolism), such as the Cushing's and metabolic syndromes, could be successfully tackled by inhibitors of CYP11B1, a steroidal cytochrome P450 enzyme that catalyzes the last hydroxylation step of the cortisol biosynthesis. Structural optimization of 7-(benzyloxy)-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one 2, a selective aromatase inhibitor, afforded the 4-(1H-imidazol-1-ylmethyl)-7-{[3-(trifluoromethoxy)benzyl]oxy}-2H-chromen-2-one 7, with improved inhibitory potency at human CYP11B1 (IC50 = 5 nM) and an enhanced selectivity over human CYP11B2 (SIB = 25) compared to lead compound 2 (IC50 = 72 nM, SIB = 4.0) and metyrapone (IC50 = 15 nM, SIB = 4.8), a non-selective drug used in the therapy of the Cushing's syndrome. Structure-activity relationship studies allowed the design and optimization of a novel series of potent and selective compounds, that can be regarded as open analogues of 2H-chromen-2-one derivatives. Compound 23, 2-(1H-imidazol-1-yl)-1-(4-{[3(trifluoromethoxy)benzyl]oxy}phenyl) ethanone, was the most interesting inhibitor of the series displaying a high potency at CYP11B1 (IC50 = 15 nM), increased selectivities over CYP11B2 (SIB = 33), CYP19 (SIB = 390) and CYP17 (5% inhibition at 2.5 μM concentration).
en
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase.
Article
2018-06-13T05:42:39Z
Diseases triggered by an abnormally high level of cortisol (hypercortisolism), such as the Cushing's and metabolic syndromes, could be successfully tackled by inhibitors of CYP11B1, a steroidal cytochrome P450 enzyme that catalyzes the last hydroxylation step of the cortisol biosynthesis. Structural optimization of 7-(benzyloxy)-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one 2, a selective aromatase inhibitor, afforded the 4-(1H-imidazol-1-ylmethyl)-7-{[3-(trifluoromethoxy)benzyl]oxy}-2H-chromen-2-one 7, with improved inhibitory potency at human CYP11B1 (IC50 = 5 nM) and an enhanced selectivity over human CYP11B2 (SIB = 25) compared to lead compound 2 (IC50 = 72 nM, SIB = 4.0) and metyrapone (IC50 = 15 nM, SIB = 4.8), a non-selective drug used in the therapy of the Cushing's syndrome. Structure-activity relationship studies allowed the design and optimization of a novel series of potent and selective compounds, that can be regarded as open analogues of 2H-chromen-2-one derivatives. Compound 23, 2-(1H-imidazol-1-yl)-1-(4-{[3(trifluoromethoxy)benzyl]oxy}phenyl) ethanone, was the most interesting inhibitor of the series displaying a high potency at CYP11B1 (IC50 = 15 nM), increased selectivities over CYP11B2 (SIB = 33), CYP19 (SIB = 390) and CYP17 (5% inhibition at 2.5 μM concentration).
ORIGINAL
Stefanachi et al_final.pdf
Stefanachi et al_final.pdf
original manuscript
application/pdf
840310
https://hzi.openrepository.com/bitstream/10033/344570/1/Stefanachi%20et%20al_final.pdf
b28eecc7a40aa7fbf11c7793d21b3fd7
MD5
1
true
Table 1 Stefanachi EJMC 2015.pdf
Table 1 Stefanachi EJMC 2015.pdf
Table 1
application/pdf
58987
https://hzi.openrepository.com/bitstream/10033/344570/2/Table%201%20Stefanachi%20EJMC%202015.pdf
5c7313c0b704a538436ecf834514e9e4
MD5
2
false
Table 2 Stefanachi EJMC 2015.pdf
Table 2 Stefanachi EJMC 2015.pdf
Table 2
application/pdf
108411
https://hzi.openrepository.com/bitstream/10033/344570/3/Table%202%20Stefanachi%20EJMC%202015.pdf
730e6aa80134776bb411a11734c773d1
MD5
3
false
Table 3 Stefanachi EJMC 2015.pdf
Table 3 Stefanachi EJMC 2015.pdf
Table 3
application/pdf
55371
https://hzi.openrepository.com/bitstream/10033/344570/4/Table%203%20Stefanachi%20EJMC%202015.pdf
4d684735969f468d9e0f65b4e70f8c72
MD5
4
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/344570/5/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
5
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/344570/6/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
6
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/344570/7/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
7
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/344570/8/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
8
false
TEXT
Stefanachi et al_final.pdf.txt
Stefanachi et al_final.pdf.txt
Extracted Text
text/plain
40327
https://hzi.openrepository.com/bitstream/10033/344570/17/Stefanachi%20et%20al_final.pdf.txt
d4166f1f4697d6d31703834cb86790a9
MD5
17
false
Table 1 Stefanachi EJMC 2015.pdf.txt
Table 1 Stefanachi EJMC 2015.pdf.txt
Extracted Text
text/plain
522
https://hzi.openrepository.com/bitstream/10033/344570/18/Table%201%20Stefanachi%20EJMC%202015.pdf.txt
75f9976e0b6e9894c46cf22513bec181
MD5
18
false
Table 2 Stefanachi EJMC 2015.pdf.txt
Table 2 Stefanachi EJMC 2015.pdf.txt
Extracted Text
text/plain
1959
https://hzi.openrepository.com/bitstream/10033/344570/19/Table%202%20Stefanachi%20EJMC%202015.pdf.txt
1ddcc97525fec54e12a5bcebb22892be
MD5
19
false
Table 3 Stefanachi EJMC 2015.pdf.txt
Table 3 Stefanachi EJMC 2015.pdf.txt
Extracted Text
text/plain
911
https://hzi.openrepository.com/bitstream/10033/344570/20/Table%203%20Stefanachi%20EJMC%202015.pdf.txt
4daec46470f85ad7691dd90011d025c4
MD5
20
false
THUMBNAIL
Stefanachi et al_final.pdf.jpg
Stefanachi et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
36736
https://hzi.openrepository.com/bitstream/10033/344570/25/Stefanachi%20et%20al_final.pdf.jpg
6450a46108aa1cea468a749ec274e2df
MD5
25
false
Table 1 Stefanachi EJMC 2015.pdf.jpg
Table 1 Stefanachi EJMC 2015.pdf.jpg
Generated Thumbnail
image/jpeg
22949
https://hzi.openrepository.com/bitstream/10033/344570/26/Table%201%20Stefanachi%20EJMC%202015.pdf.jpg
7294f604a2881e20c917c9c811982ab1
MD5
26
false
Table 2 Stefanachi EJMC 2015.pdf.jpg
Table 2 Stefanachi EJMC 2015.pdf.jpg
Generated Thumbnail
image/jpeg
54066
https://hzi.openrepository.com/bitstream/10033/344570/27/Table%202%20Stefanachi%20EJMC%202015.pdf.jpg
397c47db86a73ed15c07789715b45a0a
MD5
27
false
Table 3 Stefanachi EJMC 2015.pdf.jpg
Table 3 Stefanachi EJMC 2015.pdf.jpg
Generated Thumbnail
image/jpeg
35406
https://hzi.openrepository.com/bitstream/10033/344570/28/Table%203%20Stefanachi%20EJMC%202015.pdf.jpg
7c0f9493a4c6fb5364f8b00f5ecd842e
MD5
28
false
elsevier-thumbnail.png
application/octet-stream
129270
https://hzi.openrepository.com/bitstream/10033/344570/29/elsevier-thumbnail.png
7656a4c515ac9890d0d8403810b967b3
MD5
29
false
10033/344570
oai:hzi.openrepository.com:10033/344570
2019-08-30 11:30:58.46
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3445742019-08-30T11:30:58Zcom_10033_620656col_10033_620657
Allegretta, Giuseppe
7c3de38445707166591b1ef19f318cea
500
Weidel, Elisabeth
6839ba8cfbc9408b9e94d895e029828f
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), PO Box 15 11 50, D-66041 Saarbrücken, Germany.
2015-02-18T13:48:22Z
2015-02-18T13:48:22Z
2015-01-27
Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD. 2015, 90:351-9 Eur J Med Chem
1768-3254
25437621
10.1016/j.ejmech.2014.11.055
http://hdl.handle.net/10033/344574
European journal of medicinal chemistry
A new strategy for treating Pseudomonas aeruginosa infections could be disrupting the Pseudomonas Quinolone Signal (PQS) quorum sensing (QS) system. The goal is to impair communication among the cells and, hence, reduce the expression of virulence factors and the formation of biofilms. PqsD is an essential enzyme for the synthesis of PQS and shares some features with chalcone synthase (CHS2), an enzyme expressed in Medicago sativa. Both proteins are quite similar concerning the size of the active site, the catalytic residues and the electrostatic surface potential at the entrance of the substrate tunnel. Hence, we evaluated selected substrates of the vegetable enzyme as potential inhibitors of the bacterial protein. This similarity-guided approach led to the identification of a new class of PqsD inhibitors having a catechol structure as an essential feature for activity, a saturated linker with two or more carbons and an ester moiety bearing bulky substituents. The developed compounds showed PqsD inhibition with IC50 values in the single-digit micromolar range. The binding mode of these compounds was investigated by Surface Plasmon Resonance (SPR) experiments revealing that their interaction with the protein is not influenced by the presence of the anthranilic acid bound to active site cysteine. Importantly, some compounds reduced the signal molecule production in cellulo.
en
Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD.
Article
2018-06-12T16:54:45Z
A new strategy for treating Pseudomonas aeruginosa infections could be disrupting the Pseudomonas Quinolone Signal (PQS) quorum sensing (QS) system. The goal is to impair communication among the cells and, hence, reduce the expression of virulence factors and the formation of biofilms. PqsD is an essential enzyme for the synthesis of PQS and shares some features with chalcone synthase (CHS2), an enzyme expressed in Medicago sativa. Both proteins are quite similar concerning the size of the active site, the catalytic residues and the electrostatic surface potential at the entrance of the substrate tunnel. Hence, we evaluated selected substrates of the vegetable enzyme as potential inhibitors of the bacterial protein. This similarity-guided approach led to the identification of a new class of PqsD inhibitors having a catechol structure as an essential feature for activity, a saturated linker with two or more carbons and an ester moiety bearing bulky substituents. The developed compounds showed PqsD inhibition with IC50 values in the single-digit micromolar range. The binding mode of these compounds was investigated by Surface Plasmon Resonance (SPR) experiments revealing that their interaction with the protein is not influenced by the presence of the anthranilic acid bound to active site cysteine. Importantly, some compounds reduced the signal molecule production in cellulo.
ORIGINAL
Allegretta et al_final.pdf
Allegretta et al_final.pdf
original manuscript
application/pdf
681414
https://hzi.openrepository.com/bitstream/10033/344574/1/Allegretta%20et%20al_final.pdf
13644808a4b5ac627caca0ec9b21e9e5
MD5
1
true
GA_SuppInfo.pdf
GA_SuppInfo.pdf
supporting information
application/pdf
1929800
https://hzi.openrepository.com/bitstream/10033/344574/2/GA_SuppInfo.pdf
5ae2773d609e45ae0b976751f5f26f76
MD5
2
false
GA_Table1.pdf
GA_Table1.pdf
Table 1
application/pdf
202916
https://hzi.openrepository.com/bitstream/10033/344574/3/GA_Table1.pdf
150a5056e8e7fac703e20e700a1ed7f3
MD5
3
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/344574/4/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
4
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/344574/5/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
5
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/344574/6/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
6
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/344574/7/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
7
false
TEXT
Allegretta et al_final.pdf.txt
Allegretta et al_final.pdf.txt
Extracted Text
text/plain
49453
https://hzi.openrepository.com/bitstream/10033/344574/14/Allegretta%20et%20al_final.pdf.txt
f820828089c9e9685a9c496c55b79781
MD5
14
false
GA_SuppInfo.pdf.txt
GA_SuppInfo.pdf.txt
Extracted Text
text/plain
26779
https://hzi.openrepository.com/bitstream/10033/344574/15/GA_SuppInfo.pdf.txt
735c9371864d9e5b859b93ceabf1f307
MD5
15
false
GA_Table1.pdf.txt
GA_Table1.pdf.txt
Extracted Text
text/plain
1081
https://hzi.openrepository.com/bitstream/10033/344574/16/GA_Table1.pdf.txt
b3abab76ea03e0391f6a063b1d96a721
MD5
16
false
THUMBNAIL
Allegretta et al_final.pdf.jpg
Allegretta et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
28579
https://hzi.openrepository.com/bitstream/10033/344574/20/Allegretta%20et%20al_final.pdf.jpg
23f42c1616cb58f5eac8808f0172ada6
MD5
20
false
GA_SuppInfo.pdf.jpg
GA_SuppInfo.pdf.jpg
Generated Thumbnail
image/jpeg
28349
https://hzi.openrepository.com/bitstream/10033/344574/21/GA_SuppInfo.pdf.jpg
c7aa0a084dce20c3d7ad8ae9fda048e6
MD5
21
false
GA_Table1.pdf.jpg
GA_Table1.pdf.jpg
Generated Thumbnail
image/jpeg
41381
https://hzi.openrepository.com/bitstream/10033/344574/22/GA_Table1.pdf.jpg
9a2e424d9ed5e29852c8143384e4720e
MD5
22
false
elsevier-thumbnail.png
application/octet-stream
126965
https://hzi.openrepository.com/bitstream/10033/344574/23/elsevier-thumbnail.png
21b6eee7e88c8cb6d7ae32c8be119680
MD5
23
false
10033/344574
oai:hzi.openrepository.com:10033/344574
2019-08-30 11:30:58.491
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3452912019-08-30T11:31:23Zcom_10033_620656col_10033_620657
Grombein, Cornelia M
cfe338b92d4c0550ee717c118176d131
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Heim, Ralf
dc9f29f37760c5ed2bca46fa0809ff38
500
Rau, Sabrina
8667de75eecd5184bbe8480bca2981e8
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University, Campus C23, D-66123 Saarbrücken, Germany.
2015-02-25T10:38:26Z
2015-02-25T10:38:26Z
2015-01-07
1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors. 2015, 89:597-605 Eur J Med Chem
1768-3254
25462268
10.1016/j.ejmech.2014.10.027
http://hdl.handle.net/10033/345291
European journal of medicinal chemistry
1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols and related compounds were synthesized and evaluated for inhibition of aldosterone synthase (CYP11B2), a potential target for cardiovascular diseases associated with elevated plasma aldosterone levels like congestive heart failure and myocardial fibrosis. Introduction of substituents at the phenylsulfinyl moiety and changes of the substitution pattern at the naphthalene core were examined. Potent compounds were further examined for selectivity versus other important steroidogenic CYP enzymes, i.e. the highly homologous 11β-hydroxylase (CYP11B1), CYP17 and CYP19. The most potent compound (IC50 = 14 nM) discovered was the meta-trifluoromethoxy derivative 11, which also exhibited excellent selectivity toward CYP11B1 (SF = 415), and showed no inhibition of CYP17 and CYP19.
en
1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.
Article
2018-06-13T09:14:54Z
1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols and related compounds were synthesized and evaluated for inhibition of aldosterone synthase (CYP11B2), a potential target for cardiovascular diseases associated with elevated plasma aldosterone levels like congestive heart failure and myocardial fibrosis. Introduction of substituents at the phenylsulfinyl moiety and changes of the substitution pattern at the naphthalene core were examined. Potent compounds were further examined for selectivity versus other important steroidogenic CYP enzymes, i.e. the highly homologous 11β-hydroxylase (CYP11B1), CYP17 and CYP19. The most potent compound (IC50 = 14 nM) discovered was the meta-trifluoromethoxy derivative 11, which also exhibited excellent selectivity toward CYP11B1 (SF = 415), and showed no inhibition of CYP17 and CYP19.
ORIGINAL
Crombein et al_final.pdf
Crombein et al_final.pdf
original manuscript
application/pdf
558993
https://hzi.openrepository.com/bitstream/10033/345291/1/Crombein%20et%20al_final.pdf
bd73086703ded9c1520fcc61a535116b
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/345291/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/345291/3/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/345291/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/345291/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Crombein et al_final.pdf.txt
Crombein et al_final.pdf.txt
Extracted Text
text/plain
53937
https://hzi.openrepository.com/bitstream/10033/345291/8/Crombein%20et%20al_final.pdf.txt
d4cbdf991e3baeea85c9b391d677ad77
MD5
8
false
THUMBNAIL
Crombein et al_final.pdf.jpg
Crombein et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
31088
https://hzi.openrepository.com/bitstream/10033/345291/9/Crombein%20et%20al_final.pdf.jpg
583f6848e8a645f9a72a1955e26965ee
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
125877
https://hzi.openrepository.com/bitstream/10033/345291/10/elsevier-thumbnail.png
1efe803e53549df59231581132004122
MD5
10
false
10033/345291
oai:hzi.openrepository.com:10033/345291
2019-08-30 11:31:23.633
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3458232019-08-30T11:37:44Zcom_10033_620656col_10033_620657
Weidel, Elisabeth
6839ba8cfbc9408b9e94d895e029828f
500
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Hinsberger, Stefan
702ae58059e1a16c46f91747912528ba
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
2015-03-02T13:39:14Z
2015-03-02T13:39:14Z
2014
Composing compound libraries for hit discovery--rationality-driven preselection or random choice by structural diversity? 2014, 6 (18):2057-72 Future Med Chem
1756-8927
25531968
10.4155/fmc.14.142
http://hdl.handle.net/10033/345823
Future medicinal chemistry
In order to identify new scaffolds for drug discovery, surface plasmon resonance is frequently used to screen structurally diverse libraries. Usually, hit rates are low and identification processes are time consuming. Hence, approaches which improve hit rates and, thus, reduce the library size are required.
en
Composing compound libraries for hit discovery--rationality-driven preselection or random choice by structural diversity?
Article
2018-06-13T09:07:56Z
In order to identify new scaffolds for drug discovery, surface plasmon resonance is frequently used to screen structurally diverse libraries. Usually, hit rates are low and identification processes are time consuming. Hence, approaches which improve hit rates and, thus, reduce the library size are required.
ORIGINAL
Weidel et al_final.pdf
Weidel et al_final.pdf
original manuscript
application/pdf
331505
https://hzi.openrepository.com/bitstream/10033/345823/1/Weidel%20et%20al_final.pdf
d18d10aa3a507f230e58264a860b6662
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/345823/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/345823/3/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/345823/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/345823/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Weidel et al_final.pdf.txt
Weidel et al_final.pdf.txt
Extracted Text
text/plain
57586
https://hzi.openrepository.com/bitstream/10033/345823/8/Weidel%20et%20al_final.pdf.txt
4809aa5bb1671d621d94e7db4cdba406
MD5
8
false
THUMBNAIL
Weidel et al_final.pdf.jpg
Weidel et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
30857
https://hzi.openrepository.com/bitstream/10033/345823/9/Weidel%20et%20al_final.pdf.jpg
ebb6b7f109778950f9045496ef984a4a
MD5
9
false
10033/345823
oai:hzi.openrepository.com:10033/345823
2019-08-30 11:37:44.802
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3461342019-08-30T11:31:23Zcom_10033_620656col_10033_620657
Gargano, Emanuele M
a782b330ff21c4d90c06e04f7aa8e465
500
Perspicace, Enrico
45ea5b9b93888712a62e1bf810f54fc7
500
Hanke, Nina
82f6bb1daf0318f7c0084876c1f53264
500
Carotti, Angelo
b3355f694f7d93c1823a3b97863fb61b
500
Marchais-Oberwinkler, Sandrine
8077578e04f781fbc378097c04d3ea68
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany.
2015-03-04T10:43:11Z
2015-03-04T10:43:11Z
2014-11-24
Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors. 2014, 87:203-19 Eur J Med Chem
1768-3254
25259513
10.1016/j.ejmech.2014.09.061
http://hdl.handle.net/10033/346134
European journal of medicinal chemistry
17β-HSD2 is a promising new target for the treatment of osteoporosis. In this paper, a rational strategy to overcome the metabolic liability in the 2,5-thiophene amide class of 17β-HSD2 inhibitors is described, and the biological activity of the new inhibitors. Applying different strategies, as lowering the cLogP or modifying the structures of the molecules, compounds 27, 31 and 35 with strongly improved metabolic stability were obtained. For understanding biotransformation in the 2,5-thiophene amide class the main metabolic pathways of three properly selected compounds were elucidated.
en
Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors.
Article
2018-06-13T00:28:29Z
17β-HSD2 is a promising new target for the treatment of osteoporosis. In this paper, a rational strategy to overcome the metabolic liability in the 2,5-thiophene amide class of 17β-HSD2 inhibitors is described, and the biological activity of the new inhibitors. Applying different strategies, as lowering the cLogP or modifying the structures of the molecules, compounds 27, 31 and 35 with strongly improved metabolic stability were obtained. For understanding biotransformation in the 2,5-thiophene amide class the main metabolic pathways of three properly selected compounds were elucidated.
ORIGINAL
Gargano et al with_figures.pdf
Gargano et al with_figures.pdf
original manuscript with figures
application/pdf
915818
https://hzi.openrepository.com/bitstream/10033/346134/1/Gargano%20et%20al%20with_figures.pdf
9444718bcd4f6f319780492696108c41
MD5
1
true
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/346134/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/346134/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/346134/3/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/346134/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
TEXT
Gargano et al with_figures.pdf.txt
Gargano et al with_figures.pdf.txt
Extracted Text
text/plain
64346
https://hzi.openrepository.com/bitstream/10033/346134/8/Gargano%20et%20al%20with_figures.pdf.txt
a11fbac11dce80d52a51587f5c201983
MD5
8
false
THUMBNAIL
Gargano et al with_figures.pdf.jpg
Gargano et al with_figures.pdf.jpg
Generated Thumbnail
image/jpeg
35138
https://hzi.openrepository.com/bitstream/10033/346134/9/Gargano%20et%20al%20with_figures.pdf.jpg
90eb5dafdc13b7fd29e95d4662dc3ff7
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
120680
https://hzi.openrepository.com/bitstream/10033/346134/10/elsevier-thumbnail.png
22c06f26849d6a32608d1cad1e1ac007
MD5
10
false
10033/346134
oai:hzi.openrepository.com:10033/346134
2019-08-30 11:31:23.692
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3466022019-08-30T11:27:46Zcom_10033_620656col_10033_620657
Beber, T C
b12391eeaee8bb37b5bd568990a0fd77
500
Andrade, D F
3f24fbefbe99869e513968ba3d24266c
500
Kann, B
7ce778bf803304af5ab9a4424cf9d164
500
Fontana, M C
469f8be0bea74e431e9e98880366bddd
500
Coradini, K
1e3037674b108bb0bea47271e94133b4
500
Windbergs, M
612f40e98fa0852c985aeaeedf2ff25d
500
Beck, R C R
57a81c88f3530f1a2056ac00b06b7c6d
500
Helmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.
2015-03-13T14:53:24Z
2015-03-13T14:53:24Z
2014-11
Submicron polymeric particles prepared by vibrational spray-drying: Semisolid formulation and skin penetration/permeation studies. 2014, 88 (3):602-13 Eur J Pharm Biopharm
1873-3441
25078859
10.1016/j.ejpb.2014.07.008
http://hdl.handle.net/10033/346602
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V
Topical glucocorticoids (TG) such as dexamethasone (DEX) have been used for decades for the treatment of skin diseases. However, TG present well-documented side effects and their delivery to the skin is often insufficient. Therefore, many efforts have been undergone to improve the amount of drug delivered to the skin and to reduce side effects at the same time. In this work, the feasibility of DEX-submicron polymeric particles (SP) prepared by vibrational spray-drying as an approach to overcome the challenges associated with the topical administration of this drug class was evaluated. DEX was homogeneously dispersed in the SP matrix, according to confocal Raman microscopy analysis. Drug-loaded SP were incorporated into the oil phase of oil-in-water emulsions (creams). The formulation containing polymeric submicron particles (C-SP) showed controlled drug release kinetics and a significant drug accumulation in skin compared to formulations containing non-polymeric particles or free drug. DEX accumulation in the stratum corneum was evaluated by tape stripping and a depot effect over time was observed for C-SP, while the formulation containing the free drug showed a decrease over time. Similarly, C-SP presented higher drug retention in epidermis and dermis in skin penetration studies performed on pig skin in Franz diffusion cells, while drug permeation into the receptor compartment was negligible. It was demonstrated, for the first time, the advantageous application of submicron polymeric particles obtained by vibrational spray-drying in semisolid formulations for cutaneous administration to overcome challenges related to the therapy with TG such as DEX.
en
Submicron polymeric particles prepared by vibrational spray-drying: Semisolid formulation and skin penetration/permeation studies.
Article
2018-06-13T04:00:57Z
Topical glucocorticoids (TG) such as dexamethasone (DEX) have been used for decades for the treatment of skin diseases. However, TG present well-documented side effects and their delivery to the skin is often insufficient. Therefore, many efforts have been undergone to improve the amount of drug delivered to the skin and to reduce side effects at the same time. In this work, the feasibility of DEX-submicron polymeric particles (SP) prepared by vibrational spray-drying as an approach to overcome the challenges associated with the topical administration of this drug class was evaluated. DEX was homogeneously dispersed in the SP matrix, according to confocal Raman microscopy analysis. Drug-loaded SP were incorporated into the oil phase of oil-in-water emulsions (creams). The formulation containing polymeric submicron particles (C-SP) showed controlled drug release kinetics and a significant drug accumulation in skin compared to formulations containing non-polymeric particles or free drug. DEX accumulation in the stratum corneum was evaluated by tape stripping and a depot effect over time was observed for C-SP, while the formulation containing the free drug showed a decrease over time. Similarly, C-SP presented higher drug retention in epidermis and dermis in skin penetration studies performed on pig skin in Franz diffusion cells, while drug permeation into the receptor compartment was negligible. It was demonstrated, for the first time, the advantageous application of submicron polymeric particles obtained by vibrational spray-drying in semisolid formulations for cutaneous administration to overcome challenges related to the therapy with TG such as DEX.
ORIGINAL
Beber et al_final.pdf
Beber et al_final.pdf
original manuscript
application/pdf
362240
https://hzi.openrepository.com/bitstream/10033/346602/1/Beber%20et%20al_final.pdf
54b9abe562484bb90d4f89b8b34550a9
MD5
1
true
tables 1 to 4.pdf
tables 1 to 4.pdf
tables 1 to 4
application/pdf
114273
https://hzi.openrepository.com/bitstream/10033/346602/2/tables%201%20to%204.pdf
bbb7886f3a075b73ee2ef175318c879b
MD5
2
false
tables 5 to 7.pdf
tables 5 to 7.pdf
tables 5 to 7
application/pdf
139573
https://hzi.openrepository.com/bitstream/10033/346602/3/tables%205%20to%207.pdf
237d82c4b6406597efa22d6d80575461
MD5
3
false
FIG1.tif
FIG1.tif
figure 1
image/tiff
1022198
https://hzi.openrepository.com/bitstream/10033/346602/4/FIG1.tif
431093f45a881321861797e8a0cfe69d
MD5
4
false
FIG2.TIF
FIG2.TIF
figure 2
image/tiff
113450
https://hzi.openrepository.com/bitstream/10033/346602/5/FIG2.TIF
5cb90c3138ad127257d6d05ccf68096a
MD5
5
false
FIG3.tif
FIG3.tif
figure 3
image/tiff
4491904
https://hzi.openrepository.com/bitstream/10033/346602/6/FIG3.tif
5f1ca5dfe7375397ff1973f657a160be
MD5
6
false
FIG4.tif
FIG4.tif
figure 4
image/tiff
253908
https://hzi.openrepository.com/bitstream/10033/346602/7/FIG4.tif
919308fcf5f96eca99e0fa049460e61f
MD5
7
false
FIG5.tif
FIG5.tif
figure 5
image/tiff
453562
https://hzi.openrepository.com/bitstream/10033/346602/8/FIG5.tif
6bf43c2dc0b5b74c0432a03ffe281a06
MD5
8
false
FIG6.tif
FIG6.tif
figure 6
image/tiff
1013622
https://hzi.openrepository.com/bitstream/10033/346602/9/FIG6.tif
db9e3481147af454804cf87907c41163
MD5
9
false
FIG7.tif
FIG7.tif
figure 7
image/tiff
750474
https://hzi.openrepository.com/bitstream/10033/346602/10/FIG7.tif
a93cf68e38b21fb572f3d1f627cdca46
MD5
10
false
FIG8.tif
FIG8.tif
figure 8
image/tiff
397924
https://hzi.openrepository.com/bitstream/10033/346602/11/FIG8.tif
3b8f90ea08911686a23d455f99e8d393
MD5
11
false
FIG9.tif
FIG9.tif
figure 9
image/tiff
755930
https://hzi.openrepository.com/bitstream/10033/346602/12/FIG9.tif
2fdc86eff0684386eeb3d9701c10e6a9
MD5
12
false
FIG10.tif
FIG10.tif
figure 10
image/tiff
967114
https://hzi.openrepository.com/bitstream/10033/346602/13/FIG10.tif
9005ac04a6a5d9d7b3e344e489b5c586
MD5
13
false
FIG11.tif
FIG11.tif
figure 11
image/tiff
796680
https://hzi.openrepository.com/bitstream/10033/346602/14/FIG11.tif
2319640d6d79cb84f1d39c2917b73762
MD5
14
false
FIG12.TIF
FIG12.TIF
figure 12
image/tiff
839566
https://hzi.openrepository.com/bitstream/10033/346602/15/FIG12.TIF
1ebd8603f30f4509e4fd00d10adb9a4b
MD5
15
false
FIG13.tif
FIG13.tif
figure 13
image/tiff
359868
https://hzi.openrepository.com/bitstream/10033/346602/16/FIG13.tif
4db97f733560506fb3090178591c6dca
MD5
16
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/346602/17/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
17
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/346602/18/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
18
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/346602/19/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
19
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/346602/20/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
20
false
TEXT
Beber et al_final.pdf.txt
Beber et al_final.pdf.txt
Extracted Text
text/plain
73223
https://hzi.openrepository.com/bitstream/10033/346602/40/Beber%20et%20al_final.pdf.txt
a5d00418e00099c291a67cd7058039c6
MD5
40
false
tables 1 to 4.pdf.txt
tables 1 to 4.pdf.txt
Extracted Text
text/plain
1746
https://hzi.openrepository.com/bitstream/10033/346602/41/tables%201%20to%204.pdf.txt
949dbd32a9502063f8e3f5f6ad599e3d
MD5
41
false
tables 5 to 7.pdf.txt
tables 5 to 7.pdf.txt
Extracted Text
text/plain
1248
https://hzi.openrepository.com/bitstream/10033/346602/42/tables%205%20to%207.pdf.txt
1f438859ceb3dc602eb3f7fbd07ce14d
MD5
42
false
THUMBNAIL
FIG1.tif.jpg
FIG1.tif.jpg
Generated Thumbnail
image/jpeg
4940
https://hzi.openrepository.com/bitstream/10033/346602/46/FIG1.tif.jpg
fd37433bfd37e3428e6a1078f62ea5a5
MD5
46
false
FIG2.TIF.jpg
FIG2.TIF.jpg
Generated Thumbnail
image/jpeg
3627
https://hzi.openrepository.com/bitstream/10033/346602/47/FIG2.TIF.jpg
26ad8b2ab441f4d310e2061e6d563da0
MD5
47
false
FIG3.tif.jpg
FIG3.tif.jpg
Generated Thumbnail
image/jpeg
6662
https://hzi.openrepository.com/bitstream/10033/346602/48/FIG3.tif.jpg
645cd2bac30eb14cdeb053d547263bdb
MD5
48
false
FIG4.tif.jpg
FIG4.tif.jpg
Generated Thumbnail
image/jpeg
3182
https://hzi.openrepository.com/bitstream/10033/346602/49/FIG4.tif.jpg
7bd777378f5bba5cc963e53efc3b398e
MD5
49
false
FIG5.tif.jpg
FIG5.tif.jpg
Generated Thumbnail
image/jpeg
4997
https://hzi.openrepository.com/bitstream/10033/346602/50/FIG5.tif.jpg
e698b15176b0d0e673b020f3f9225a93
MD5
50
false
FIG6.tif.jpg
FIG6.tif.jpg
Generated Thumbnail
image/jpeg
7002
https://hzi.openrepository.com/bitstream/10033/346602/51/FIG6.tif.jpg
c89b18efc366e435d0985013a147bf83
MD5
51
false
FIG7.tif.jpg
FIG7.tif.jpg
Generated Thumbnail
image/jpeg
7266
https://hzi.openrepository.com/bitstream/10033/346602/52/FIG7.tif.jpg
b90c35a14c22fd1b989024e5331ef473
MD5
52
false
FIG8.tif.jpg
FIG8.tif.jpg
Generated Thumbnail
image/jpeg
4638
https://hzi.openrepository.com/bitstream/10033/346602/53/FIG8.tif.jpg
2508a3b2b26b26208c70e53d2728c40d
MD5
53
false
FIG9.tif.jpg
FIG9.tif.jpg
Generated Thumbnail
image/jpeg
7068
https://hzi.openrepository.com/bitstream/10033/346602/54/FIG9.tif.jpg
db56d5fdb930e8fc1873cfc419883d87
MD5
54
false
FIG10.tif.jpg
FIG10.tif.jpg
Generated Thumbnail
image/jpeg
6383
https://hzi.openrepository.com/bitstream/10033/346602/55/FIG10.tif.jpg
bfb470c3315a7f7efb52f816966c0d59
MD5
55
false
FIG11.tif.jpg
FIG11.tif.jpg
Generated Thumbnail
image/jpeg
6280
https://hzi.openrepository.com/bitstream/10033/346602/56/FIG11.tif.jpg
2fcb81d232f8b7fd5a10b478fc6d8e75
MD5
56
false
FIG12.TIF.jpg
FIG12.TIF.jpg
Generated Thumbnail
image/jpeg
6155
https://hzi.openrepository.com/bitstream/10033/346602/57/FIG12.TIF.jpg
e146b0e54518088da2bea81ae3c75238
MD5
57
false
FIG13.tif.jpg
FIG13.tif.jpg
Generated Thumbnail
image/jpeg
3381
https://hzi.openrepository.com/bitstream/10033/346602/58/FIG13.tif.jpg
943da3d8519336ba3ab851be1fb6b371
MD5
58
false
Beber et al_final.pdf.jpg
Beber et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
34006
https://hzi.openrepository.com/bitstream/10033/346602/65/Beber%20et%20al_final.pdf.jpg
70ce61f442770a677d10067b28713e24
MD5
65
false
tables 1 to 4.pdf.jpg
tables 1 to 4.pdf.jpg
Generated Thumbnail
image/jpeg
22914
https://hzi.openrepository.com/bitstream/10033/346602/66/tables%201%20to%204.pdf.jpg
2b0d60a30ace7eebae376df72885ec01
MD5
66
false
tables 5 to 7.pdf.jpg
tables 5 to 7.pdf.jpg
Generated Thumbnail
image/jpeg
18631
https://hzi.openrepository.com/bitstream/10033/346602/67/tables%205%20to%207.pdf.jpg
2d72f81904d55eb3a2a7993be2a4a158
MD5
67
false
elsevier-thumbnail.png
application/octet-stream
127048
https://hzi.openrepository.com/bitstream/10033/346602/68/elsevier-thumbnail.png
680ef940ef2f7aa24916e3b9ec292354
MD5
68
false
10033/346602
oai:hzi.openrepository.com:10033/346602
2019-08-30 11:27:46.595
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3469152019-08-30T11:28:23Zcom_10033_620656col_10033_620657
Grombein, Cornelia M
cfe338b92d4c0550ee717c118176d131
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Rau, Sabrina
8667de75eecd5184bbe8480bca2981e8
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Campus C2 3, D-66123 Saarbrücken, Germany.
2015-03-19T15:21:26Z
2015-03-19T15:21:26Z
2015-01-27
Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase. 2015, 90:788-96 Eur J Med Chem
1768-3254
25528333
10.1016/j.ejmech.2014.12.022
http://hdl.handle.net/10033/346915
European journal of medicinal chemistry
Aldosterone synthase (CYP11B2) catalyzes the conversion of 11-deoxycorticosterone to aldosterone via corticosterone and 18-hydroxycorticosterone. CYP11B2 is regarded as a new target for several cardiovascular diseases which are associated with chronically elevated aldosterone levels such as hypertension, congestive heart failure and myocardial fibrosis. In this paper, we optimized heterocycle substituted 3,4-dihydropyridin-2(1H)-ones as CYP11B inhibitors by systematic introduction of heteroatoms and by bioisosteric exchange of the lactame moiety by a sultame moiety. The most promising compounds regarding inhibition of human CYP11B2 and selectivity versus human enzymes CYP11B1, CYP17, and CYP19 were tested for inhibition of rat CYP11B2. Thus, we discovered compounds 4 and 9 which show potent inhibition of hCYP11B2 (IC50 < 1 nM) and the corresponding rat enzyme (4: 64%, 9: 51% inhibition, at 2 μM).
en
Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase.
Article
2018-06-12T17:22:57Z
Aldosterone synthase (CYP11B2) catalyzes the conversion of 11-deoxycorticosterone to aldosterone via corticosterone and 18-hydroxycorticosterone. CYP11B2 is regarded as a new target for several cardiovascular diseases which are associated with chronically elevated aldosterone levels such as hypertension, congestive heart failure and myocardial fibrosis. In this paper, we optimized heterocycle substituted 3,4-dihydropyridin-2(1H)-ones as CYP11B inhibitors by systematic introduction of heteroatoms and by bioisosteric exchange of the lactame moiety by a sultame moiety. The most promising compounds regarding inhibition of human CYP11B2 and selectivity versus human enzymes CYP11B1, CYP17, and CYP19 were tested for inhibition of rat CYP11B2. Thus, we discovered compounds 4 and 9 which show potent inhibition of hCYP11B2 (IC50 < 1 nM) and the corresponding rat enzyme (4: 64%, 9: 51% inhibition, at 2 μM).
ORIGINAL
Grombein et al_final.pdf
Grombein et al_final.pdf
original manuscrípt
application/pdf
354386
https://hzi.openrepository.com/bitstream/10033/346915/1/Grombein%20et%20al_final.pdf
20b1745bfe7aebd1c2051aa5786471fb
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/346915/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/346915/3/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/346915/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/346915/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Grombein et al_final.pdf.txt
Grombein et al_final.pdf.txt
Extracted Text
text/plain
55158
https://hzi.openrepository.com/bitstream/10033/346915/8/Grombein%20et%20al_final.pdf.txt
fb630023e3a36462bef2553d80965f59
MD5
8
false
THUMBNAIL
Grombein et al_final.pdf.jpg
Grombein et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
29301
https://hzi.openrepository.com/bitstream/10033/346915/9/Grombein%20et%20al_final.pdf.jpg
f487abd3b9d97b761a21ef8a00530d8f
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
126687
https://hzi.openrepository.com/bitstream/10033/346915/10/elsevier-thumbnail.png
c82a95ef1c13bb58e9a07149f20e0dff
MD5
10
false
10033/346915
oai:hzi.openrepository.com:10033/346915
2019-08-30 11:28:23.711
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/3470622019-08-30T11:26:13Zcom_10033_620656col_10033_620657
Laggai, Stephan
c228d60fa22610a9012031d57042e2b8
500
Kessler, Sonja M
d5122b0536926c98fa2fac9b02611d46
500
Boettcher, Stefan
d5f134223e3e83b55ec2be0b391fca72
500
Lebrun, Valérie
bb33f4d581bf79660f7602237e1e7e4d
500
Gemperlein, Katja
e8ff1c6487cc0298c39a523cfe7b344f
500
Lederer, Eva
48f7152cc2602e7bfc5c7288d631001e
500
Leclercq, Isabelle A
e323edc2d8966b67e76c1a152f9fee6c
500
Mueller, Rolf
06ad2113c5addd9b3e6da4fbb43c6121
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Haybaeck, Johannes
babf1677bb614412c92de481b95b8a57
500
Kiemer, Alexandra K
6e260d6c067d0655fe452062e8c840ba
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany.
2015-03-24T12:10:17Z
2015-03-24T12:10:17Z
2014-04-22
The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis. 2014, 55 (6):1087-1097 J. Lipid Res.
0022-2275
24755648
10.1194/jlr.M045500
http://hdl.handle.net/10033/347062
Journal of lipid research
Liver-specific overexpression of the insulin-like growth factor 2 (IGF2) mRNA binding protein p62/IGF2BP2-2 induces a fatty liver, which highly expresses IGF2. Because IGF2 expression is elevated in patients with steatohepatitis, the aim of our study was to elucidate the role and interconnection of p62 and IGF2 in lipid metabolism. Expression of p62 and IGF2 highly correlated in human liver disease. p62 induced an elevated ratio of C18:C16 and increased fatty acid elongase 6 (ELOVL6) protein, the enzyme catalyzing the elongation of C16 to C18 fatty acids and promoting nonalcoholic steatohepatitis in mice and humans. The p62 overexpression induced the activation of the ELOVL6 transcriptional activator sterol regulatory element binding transcription factor 1 (SREBF1). Recombinant IGF2 induced the nuclear translocation of SREBF1 and a neutralizing IGF2 antibody reduced ELOVL6 and mature SREBF1 protein levels. Concordantly, p62 and IGF2 correlated with ELOVL6 in human livers. Decreased palmitoyl-CoA levels, as found in p62 transgenic livers, can explain the lipogenic action of ELOVL6. Accordingly, p62 represents an inducer of hepatic C18 fatty acid production via a SREBF1-dependent induction of ELOVL6. These findings underline the detrimental role of p62 in liver disease.
ENG
The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.
Article
2015-06-15T00:00:00Z
Liver-specific overexpression of the insulin-like growth factor 2 (IGF2) mRNA binding protein p62/IGF2BP2-2 induces a fatty liver, which highly expresses IGF2. Because IGF2 expression is elevated in patients with steatohepatitis, the aim of our study was to elucidate the role and interconnection of p62 and IGF2 in lipid metabolism. Expression of p62 and IGF2 highly correlated in human liver disease. p62 induced an elevated ratio of C18:C16 and increased fatty acid elongase 6 (ELOVL6) protein, the enzyme catalyzing the elongation of C16 to C18 fatty acids and promoting nonalcoholic steatohepatitis in mice and humans. The p62 overexpression induced the activation of the ELOVL6 transcriptional activator sterol regulatory element binding transcription factor 1 (SREBF1). Recombinant IGF2 induced the nuclear translocation of SREBF1 and a neutralizing IGF2 antibody reduced ELOVL6 and mature SREBF1 protein levels. Concordantly, p62 and IGF2 correlated with ELOVL6 in human livers. Decreased palmitoyl-CoA levels, as found in p62 transgenic livers, can explain the lipogenic action of ELOVL6. Accordingly, p62 represents an inducer of hepatic C18 fatty acid production via a SREBF1-dependent induction of ELOVL6. These findings underline the detrimental role of p62 in liver disease.
ORIGINAL
Laggai et al_final.pdf
Laggai et al_final.pdf
original manuscript
application/pdf
443670
https://hzi.openrepository.com/bitstream/10033/347062/1/Laggai%20et%20al_final.pdf
671cf8de14f712f02f9ad0888d4eef5e
MD5
1
true
jlr_elovl6_figures.pdf
jlr_elovl6_figures.pdf
figures
application/pdf
3352069
https://hzi.openrepository.com/bitstream/10033/347062/2/jlr_elovl6_figures.pdf
52f87dc3d605097c86f6a1e9b6a4809f
MD5
2
false
supplemental data_Elovl6_JLR.pdf
supplemental data_Elovl6_JLR.pdf
supplemental data
application/pdf
371852
https://hzi.openrepository.com/bitstream/10033/347062/3/supplemental%20data_Elovl6_JLR.pdf
2c6f6c47146ed1f0dcc44494787406cb
MD5
3
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/347062/4/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
4
false
license_text
license_text
application/octet-stream
22864
https://hzi.openrepository.com/bitstream/10033/347062/5/license_text
8e37d7b9d509ac90b985587e2924ad4f
MD5
5
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/347062/6/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
6
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/347062/7/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
7
false
TEXT
Laggai et al_final.pdf.txt
Laggai et al_final.pdf.txt
Extracted Text
text/plain
55876
https://hzi.openrepository.com/bitstream/10033/347062/14/Laggai%20et%20al_final.pdf.txt
7b3ac9d40d73ffbd2e33b0b6f22e0a94
MD5
14
false
jlr_elovl6_figures.pdf.txt
jlr_elovl6_figures.pdf.txt
Extracted Text
text/plain
2840
https://hzi.openrepository.com/bitstream/10033/347062/15/jlr_elovl6_figures.pdf.txt
15fdfcd223970f778c2e04681c918779
MD5
15
false
supplemental data_Elovl6_JLR.pdf.txt
supplemental data_Elovl6_JLR.pdf.txt
Extracted Text
text/plain
4047
https://hzi.openrepository.com/bitstream/10033/347062/16/supplemental%20data_Elovl6_JLR.pdf.txt
fd2691617130822e44f952c6237a79f3
MD5
16
false
THUMBNAIL
Laggai et al_final.pdf.jpg
Laggai et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
33514
https://hzi.openrepository.com/bitstream/10033/347062/20/Laggai%20et%20al_final.pdf.jpg
5bf619680c78389c9a14e28c1d26702d
MD5
20
false
jlr_elovl6_figures.pdf.jpg
jlr_elovl6_figures.pdf.jpg
Generated Thumbnail
image/jpeg
119727
https://hzi.openrepository.com/bitstream/10033/347062/21/jlr_elovl6_figures.pdf.jpg
7fecfb4f4fb809071b626aa698270373
MD5
21
false
supplemental data_Elovl6_JLR.pdf.jpg
supplemental data_Elovl6_JLR.pdf.jpg
Generated Thumbnail
image/jpeg
16057
https://hzi.openrepository.com/bitstream/10033/347062/22/supplemental%20data_Elovl6_JLR.pdf.jpg
c29df1974fc18c7454b90be3e6ae9fa5
MD5
22
false
10033/347062
oai:hzi.openrepository.com:10033/347062
2019-08-30 11:26:13.06
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/5562022019-08-30T11:28:51Zcom_10033_620656col_10033_620657
Sahner, J Henning
b7f58a38e61a17c640584238557dda03
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Kamal, Ahmed
24b7cdd5e0b700d33a4958511eec9658
500
Weidel, Elisabeth
6839ba8cfbc9408b9e94d895e029828f
500
Groh, Matthias
77153195b19ba7b5a79c4fcbbf4a9263
500
Börger, Carsten
44582b1f9da955b2ee0e6776f6190853
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University & Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Department of Drug Design and Optimization, Campus C2 3, 66123 Saarbrücken, Germany.
2015-06-03T12:40:11Z
2015-06-03T12:40:11Z
2015-05-26
Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa. 2015, 96:14-21 Eur J Med Chem
1768-3254
25874327
10.1016/j.ejmech.2015.04.007
http://hdl.handle.net/10033/556202
European journal of medicinal chemistry
Pseudomonas aeruginosa employs a quorum sensing (QS) communication system that makes use of small diffusible molecules. Among other effects, the QS system coordinates the formation of biofilm which decisively contributes to difficulties in the therapy of Pseudomonas infections. The present work deals with the structure-activity exploration of ureidothiophene-2-carboxylic acids as inhibitors of PqsD, a key enzyme in the biosynthetic pathway of signal molecules in the Pseudomonas QS system. We describe an improvement of the inhibitory activity by successfully combining features from two different PqsD inhibitor classes. Furthermore the functional groups, which are responsible for the inhibitory potency, were identified. Moreover, the inability of the new inhibitors, to prevent signal molecule formation in whole cell assays, is discussed.
en
Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa.
Article
2018-06-12T21:49:49Z
Pseudomonas aeruginosa employs a quorum sensing (QS) communication system that makes use of small diffusible molecules. Among other effects, the QS system coordinates the formation of biofilm which decisively contributes to difficulties in the therapy of Pseudomonas infections. The present work deals with the structure-activity exploration of ureidothiophene-2-carboxylic acids as inhibitors of PqsD, a key enzyme in the biosynthetic pathway of signal molecules in the Pseudomonas QS system. We describe an improvement of the inhibitory activity by successfully combining features from two different PqsD inhibitor classes. Furthermore the functional groups, which are responsible for the inhibitory potency, were identified. Moreover, the inability of the new inhibitors, to prevent signal molecule formation in whole cell assays, is discussed.
ORIGINAL
Sahner et al_final.pdf
Sahner et al_final.pdf
original manuscript
application/pdf
296526
https://hzi.openrepository.com/bitstream/10033/556202/1/Sahner%20et%20al_final.pdf
e856170402857a8d71410a6a262fecf3
MD5
1
true
Highlights.pdf
Highlights.pdf
highlights according to authors
application/pdf
50551
https://hzi.openrepository.com/bitstream/10033/556202/2/Highlights.pdf
caae53b4dd6692a0504c893786017fbf
MD5
2
false
Supplementary Data revision.pdf
Supplementary Data revision.pdf
supplementary data
application/pdf
1871447
https://hzi.openrepository.com/bitstream/10033/556202/3/Supplementary%20Data%20revision.pdf
c8999d164bd2bf1c6049dc4d375905b3
MD5
3
false
Tables 1 to 3.pdf
Tables 1 to 3.pdf
Tables 1 to 3
application/pdf
19960
https://hzi.openrepository.com/bitstream/10033/556202/4/Tables%201%20to%203.pdf
fd1d2004dfc6bdd9611a40ef0b710c45
MD5
4
false
Scheme 1.tif
Scheme 1.tif
Scheme 1
image/tiff
222618
https://hzi.openrepository.com/bitstream/10033/556202/5/Scheme%201.tif
3c825af478cb95bdd0b7a41c32e6ec31
MD5
5
false
Scheme 2.tif
Scheme 2.tif
Scheme 2
image/tiff
227610
https://hzi.openrepository.com/bitstream/10033/556202/6/Scheme%202.tif
fbf00a4aa232f3e00b2f198268f0601e
MD5
6
false
Figure_1_300dpi.tif
Figure_1_300dpi.tif
figure 1
image/tiff
2389724
https://hzi.openrepository.com/bitstream/10033/556202/7/Figure_1_300dpi.tif
e98e9c4a162a4f5d372120a18a16c21c
MD5
7
false
Figure_2_300dpi.tif
Figure_2_300dpi.tif
figure 2
image/tiff
4282982
https://hzi.openrepository.com/bitstream/10033/556202/8/Figure_2_300dpi.tif
d85839d2fdde6d28949debd6ef3fd11d
MD5
8
false
Figure_3_300dpi.tif
Figure_3_300dpi.tif
figure 3
image/tiff
4589446
https://hzi.openrepository.com/bitstream/10033/556202/9/Figure_3_300dpi.tif
57caab17129324768f8858213bf555c3
MD5
9
false
Figure_4_300dpi.tif
Figure_4_300dpi.tif
figure 4
image/tiff
6603116
https://hzi.openrepository.com/bitstream/10033/556202/10/Figure_4_300dpi.tif
70e7f1bcfb9f830243794e020e8efec0
MD5
10
false
Figure_5_300dpi.tif
Figure_5_300dpi.tif
figure 5
image/tiff
3369648
https://hzi.openrepository.com/bitstream/10033/556202/11/Figure_5_300dpi.tif
7162376f1941bccf350246b9c9304ba7
MD5
11
false
Chart 1.tif
Chart 1.tif
chart 1
image/tiff
76843
https://hzi.openrepository.com/bitstream/10033/556202/12/Chart%201.tif
dca4bc23db86f86949a24ceca2917301
MD5
12
false
Chart 2.tif
Chart 2.tif
chart 2
image/tiff
33726
https://hzi.openrepository.com/bitstream/10033/556202/13/Chart%202.tif
7994fb998095fb98bcc8472b14f56c20
MD5
13
false
Chart 3.tif
Chart 3.tif
chart3
image/tiff
88378
https://hzi.openrepository.com/bitstream/10033/556202/14/Chart%203.tif
12c738c4cd596bb86a19d38c3e6ce70c
MD5
14
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/556202/18/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
18
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/556202/15/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
15
false
license_text
license_text
application/octet-stream
18964
https://hzi.openrepository.com/bitstream/10033/556202/16/license_text
0dd3c0c7ff4c5df08684f0758cba7900
MD5
16
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/556202/17/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
17
false
TEXT
Sahner et al_final.pdf.txt
Sahner et al_final.pdf.txt
Extracted Text
text/plain
37173
https://hzi.openrepository.com/bitstream/10033/556202/37/Sahner%20et%20al_final.pdf.txt
5380d6c9f53e2246dfd0bb85f9c283ac
MD5
37
false
Highlights.pdf.txt
Highlights.pdf.txt
Extracted Text
text/plain
219
https://hzi.openrepository.com/bitstream/10033/556202/38/Highlights.pdf.txt
cc702550d1461e5de987685ae57cd10f
MD5
38
false
Supplementary Data revision.pdf.txt
Supplementary Data revision.pdf.txt
Extracted Text
text/plain
16051
https://hzi.openrepository.com/bitstream/10033/556202/39/Supplementary%20Data%20revision.pdf.txt
04fff77bb77cce313bdacc25e5030480
MD5
39
false
Tables 1 to 3.pdf.txt
Tables 1 to 3.pdf.txt
Extracted Text
text/plain
897
https://hzi.openrepository.com/bitstream/10033/556202/40/Tables%201%20to%203.pdf.txt
f831d46cb61753c4d358a9455be2bc32
MD5
40
false
THUMBNAIL
Scheme 1.tif.jpg
Scheme 1.tif.jpg
Generated Thumbnail
image/jpeg
4302
https://hzi.openrepository.com/bitstream/10033/556202/45/Scheme%201.tif.jpg
de1f32459a1581a1376b51e015e930d1
MD5
45
false
Scheme 2.tif.jpg
Scheme 2.tif.jpg
Generated Thumbnail
image/jpeg
3698
https://hzi.openrepository.com/bitstream/10033/556202/46/Scheme%202.tif.jpg
8e8811894d0a67170b45f83372dc4a15
MD5
46
false
Figure_1_300dpi.tif.jpg
Figure_1_300dpi.tif.jpg
Generated Thumbnail
image/jpeg
5552
https://hzi.openrepository.com/bitstream/10033/556202/47/Figure_1_300dpi.tif.jpg
8c42f8d0721cd431379fd2ee071704ee
MD5
47
false
Figure_2_300dpi.tif.jpg
Figure_2_300dpi.tif.jpg
Generated Thumbnail
image/jpeg
15875
https://hzi.openrepository.com/bitstream/10033/556202/48/Figure_2_300dpi.tif.jpg
8a13b8df0d3ae9e0419e255208336f3f
MD5
48
false
Figure_3_300dpi.tif.jpg
Figure_3_300dpi.tif.jpg
Generated Thumbnail
image/jpeg
2975
https://hzi.openrepository.com/bitstream/10033/556202/49/Figure_3_300dpi.tif.jpg
7ac4b9fac97e0e3e95ffd77ce7fad597
MD5
49
false
Figure_4_300dpi.tif.jpg
Figure_4_300dpi.tif.jpg
Generated Thumbnail
image/jpeg
4706
https://hzi.openrepository.com/bitstream/10033/556202/50/Figure_4_300dpi.tif.jpg
579e7b050a68df3b23f6dfaf225706c0
MD5
50
false
Figure_5_300dpi.tif.jpg
Figure_5_300dpi.tif.jpg
Generated Thumbnail
image/jpeg
9986
https://hzi.openrepository.com/bitstream/10033/556202/51/Figure_5_300dpi.tif.jpg
7a2392054134187a57fefaec3a400a28
MD5
51
false
Chart 1.tif.jpg
Chart 1.tif.jpg
Generated Thumbnail
image/jpeg
2333
https://hzi.openrepository.com/bitstream/10033/556202/52/Chart%201.tif.jpg
174a994e7b330ef10876a5694bc74988
MD5
52
false
Chart 2.tif.jpg
Chart 2.tif.jpg
Generated Thumbnail
image/jpeg
2668
https://hzi.openrepository.com/bitstream/10033/556202/53/Chart%202.tif.jpg
b59c04fac87c249f2ac95767b9d787d4
MD5
53
false
Chart 3.tif.jpg
Chart 3.tif.jpg
Generated Thumbnail
image/jpeg
1719
https://hzi.openrepository.com/bitstream/10033/556202/54/Chart%203.tif.jpg
a4ac37642f882e2ab5562de23fe34361
MD5
54
false
Sahner et al_final.pdf.jpg
Sahner et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32902
https://hzi.openrepository.com/bitstream/10033/556202/63/Sahner%20et%20al_final.pdf.jpg
9d781df9bd0c40a2b9a25ecbb5f39fc8
MD5
63
false
Highlights.pdf.jpg
Highlights.pdf.jpg
Generated Thumbnail
image/jpeg
9004
https://hzi.openrepository.com/bitstream/10033/556202/64/Highlights.pdf.jpg
c2a1ec2d96aa436813f1772d9fbe5634
MD5
64
false
Supplementary Data revision.pdf.jpg
Supplementary Data revision.pdf.jpg
Generated Thumbnail
image/jpeg
35851
https://hzi.openrepository.com/bitstream/10033/556202/65/Supplementary%20Data%20revision.pdf.jpg
1ad2b9f8710d4258e6588ee57580d4e6
MD5
65
false
Tables 1 to 3.pdf.jpg
Tables 1 to 3.pdf.jpg
Generated Thumbnail
image/jpeg
19828
https://hzi.openrepository.com/bitstream/10033/556202/66/Tables%201%20to%203.pdf.jpg
306ea13e24f4338d9592fd13ba82609d
MD5
66
false
elsevier-thumbnail.png
application/octet-stream
56862
https://hzi.openrepository.com/bitstream/10033/556202/67/elsevier-thumbnail.png
184477d76df78e7a16021c7619853573
MD5
67
false
10033/556202
oai:hzi.openrepository.com:10033/556202
2019-08-30 11:28:51.4
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5562032019-08-30T11:28:51Zcom_10033_620656col_10033_620657
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Kunde, Jessica
21df16ecc67b91a17847147f4bc40da7
500
Hanke, Nina
82f6bb1daf0318f7c0084876c1f53264
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany.
2015-06-03T12:52:31Z
2015-06-03T12:52:31Z
2015-05-26
Identification of 4-(4-nitro-2-phenethoxyphenyl)pyridine as a promising new lead for discovering inhibitors of both human and rat 11β-Hydroxylase. 2015, 96:139-50 Eur J Med Chem
1768-3254
25874338
10.1016/j.ejmech.2015.04.013
http://hdl.handle.net/10033/556203
European journal of medicinal chemistry
The inhibition of 11β-hydroxylase is a promising strategy for the treatment of Cushing's syndrome, in particular for the recurrent and subclinical cases. To achieve proof of concept in rats, efforts were paid to identify novel lead compounds inhibiting both human and rat CYP11B1. Modifications on a potent promiscuous inhibitor of hCYP11B1, hCYP11B2 and hCYP19 (compound IV) that exhibited moderate rCYP11B1 inhibition led to compound 8 as a new promising lead compound. Significant improvements compared to starting point IV were achieved regarding inhibitory potency against both human and rat CYP11B1 (IC50 values of 2 and 163 nM, respectively) as well as selectivity over hCYP19 (IC50 = 1900 nM). Accordingly, compound 8 was around 7- and 28-fold more potent than metyrapone regarding the inhibition of human and rat CYP11B1 and exhibited a comparable selectivity over hCYP11B2 (SF of 3.5 vs 4.9). With further optimizations on this new lead compound 8, drug candidates with satisfying profiles are expected to be discovered.
en
Identification of 4-(4-nitro-2-phenethoxyphenyl)pyridine as a promising new lead for discovering inhibitors of both human and rat 11β-Hydroxylase.
Article
2018-06-13T00:51:48Z
The inhibition of 11β-hydroxylase is a promising strategy for the treatment of Cushing's syndrome, in particular for the recurrent and subclinical cases. To achieve proof of concept in rats, efforts were paid to identify novel lead compounds inhibiting both human and rat CYP11B1. Modifications on a potent promiscuous inhibitor of hCYP11B1, hCYP11B2 and hCYP19 (compound IV) that exhibited moderate rCYP11B1 inhibition led to compound 8 as a new promising lead compound. Significant improvements compared to starting point IV were achieved regarding inhibitory potency against both human and rat CYP11B1 (IC50 values of 2 and 163 nM, respectively) as well as selectivity over hCYP19 (IC50 = 1900 nM). Accordingly, compound 8 was around 7- and 28-fold more potent than metyrapone regarding the inhibition of human and rat CYP11B1 and exhibited a comparable selectivity over hCYP11B2 (SF of 3.5 vs 4.9). With further optimizations on this new lead compound 8, drug candidates with satisfying profiles are expected to be discovered.
ORIGINAL
Hu et al_final.pdf
Hu et al_final.pdf
original manuscript
application/pdf
2952857
https://hzi.openrepository.com/bitstream/10033/556203/1/Hu%20et%20al_final.pdf
8d920ef9a40c8305e269d8e4538d18d2
MD5
1
true
Supplementary Data revision.pdf
Supplementary Data revision.pdf
supplemental data
application/pdf
1871447
https://hzi.openrepository.com/bitstream/10033/556203/2/Supplementary%20Data%20revision.pdf
c8999d164bd2bf1c6049dc4d375905b3
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/556203/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
18964
https://hzi.openrepository.com/bitstream/10033/556203/4/license_text
0dd3c0c7ff4c5df08684f0758cba7900
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/556203/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/556203/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Hu et al_final.pdf.txt
Hu et al_final.pdf.txt
Extracted Text
text/plain
76984
https://hzi.openrepository.com/bitstream/10033/556203/11/Hu%20et%20al_final.pdf.txt
dfa2ebfa032d64e9c48f73050323f8c9
MD5
11
false
Supplementary Data revision.pdf.txt
Supplementary Data revision.pdf.txt
Extracted Text
text/plain
16051
https://hzi.openrepository.com/bitstream/10033/556203/12/Supplementary%20Data%20revision.pdf.txt
04fff77bb77cce313bdacc25e5030480
MD5
12
false
THUMBNAIL
Hu et al_final.pdf.jpg
Hu et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
31049
https://hzi.openrepository.com/bitstream/10033/556203/15/Hu%20et%20al_final.pdf.jpg
e29b11f86f1112e8cb2dfb324ec03e02
MD5
15
false
Supplementary Data revision.pdf.jpg
Supplementary Data revision.pdf.jpg
Generated Thumbnail
image/jpeg
35851
https://hzi.openrepository.com/bitstream/10033/556203/16/Supplementary%20Data%20revision.pdf.jpg
1ad2b9f8710d4258e6588ee57580d4e6
MD5
16
false
elsevier-thumbnail.png
application/octet-stream
58429
https://hzi.openrepository.com/bitstream/10033/556203/17/elsevier-thumbnail.png
b91704bd20e4975f9c10807ba568bc41
MD5
17
false
10033/556203
oai:hzi.openrepository.com:10033/556203
2019-08-30 11:28:51.492
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5567812019-08-30T11:29:17Zcom_10033_620656col_10033_620658
Hofmann, Anna
2d98082aad6b27b0e2462ce70825eb6b
500
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Stifel, Julia
a7b739d9ef788aea9fb58ac5ba2b17be
500
Göttker-Schnetmann, Inigo
213ead32f2e564e1aef7e108c640ad68
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
hemical Biology of Carbohydrates, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), D-66123 Saarbrücken, Germany.
2015-06-11T14:17:27Z
2015-06-11T14:17:27Z
2015-05-05
Synthesis of mannoheptose derivatives and their evaluation as inhibitors of the lectin LecB from the opportunistic pathogen Pseudomonas aeruginosa. 2015, 412:34-42 Carbohydr. Res.
1873-426X
26004349
10.1016/j.carres.2015.04.010
http://hdl.handle.net/10033/556781
Carbohydrate research
Biofilm formation and chronic infections with Pseudomonas aeruginosa depend on lectins produced by the bacterium. The bacterial C-type lectin LecB binds to the two monosaccharides l-fucose and d-mannose and conjugates thereof. Previously, d-mannose derivatives with amide and sulfonamide substituents at C6 were reported as potent inhibitors of the bacterial lectin LecB and LecB-mediated bacterial surface adhesion. Because d-mannose establishes a hydrogen bond via its 6-OH group with Ser23 of LecB in the crystal structure and may be beneficial for binding affinity, we extended d-mannose and synthesized mannoheptoses bearing the free 6-OH group as well as amido and sulfonamido-substituents at C7. Two series of diastereomeric mannoheptoses were synthesized and the stereochemistry was determined by X-ray crystallography. The potency of the mannoheptoses as LecB inhibitors was assessed in a competitive binding assay. The data reveal a diastereoselectivity of LecB for (6S)-mannoheptose derivatives with increased activity over methyl α-d-mannoside.
ENG
Synthesis of mannoheptose derivatives and their evaluation as inhibitors of the lectin LecB from the opportunistic pathogen Pseudomonas aeruginosa.
Article
2016-08-15T00:00:00Z
Biofilm formation and chronic infections with Pseudomonas aeruginosa depend on lectins produced by the bacterium. The bacterial C-type lectin LecB binds to the two monosaccharides l-fucose and d-mannose and conjugates thereof. Previously, d-mannose derivatives with amide and sulfonamide substituents at C6 were reported as potent inhibitors of the bacterial lectin LecB and LecB-mediated bacterial surface adhesion. Because d-mannose establishes a hydrogen bond via its 6-OH group with Ser23 of LecB in the crystal structure and may be beneficial for binding affinity, we extended d-mannose and synthesized mannoheptoses bearing the free 6-OH group as well as amido and sulfonamido-substituents at C7. Two series of diastereomeric mannoheptoses were synthesized and the stereochemistry was determined by X-ray crystallography. The potency of the mannoheptoses as LecB inhibitors was assessed in a competitive binding assay. The data reveal a diastereoselectivity of LecB for (6S)-mannoheptose derivatives with increased activity over methyl α-d-mannoside.
ORIGINAL
Hofmann et al_final.pdf
Hofmann et al_final.pdf
original manuscript
application/pdf
860392
https://hzi.openrepository.com/bitstream/10033/556781/1/Hofmann%20et%20al_final.pdf
3fe1658d5cbc374769e0aa1819663aec
MD5
1
true
Revision-SI.pdf
Revision-SI.pdf
supplemental information
application/pdf
4307459
https://hzi.openrepository.com/bitstream/10033/556781/2/Revision-SI.pdf
2930d74689f43b28524c448215e8506d
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/556781/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/556781/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/556781/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/556781/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Hofmann et al_final.pdf.txt
Hofmann et al_final.pdf.txt
Extracted Text
text/plain
51528
https://hzi.openrepository.com/bitstream/10033/556781/11/Hofmann%20et%20al_final.pdf.txt
b95f1f48c3b2e28436877247ff2202a3
MD5
11
false
Revision-SI.pdf.txt
Revision-SI.pdf.txt
Extracted Text
text/plain
3253
https://hzi.openrepository.com/bitstream/10033/556781/12/Revision-SI.pdf.txt
29ffa8d39baf7f9de601fa8067e8664d
MD5
12
false
THUMBNAIL
Hofmann et al_final.pdf.jpg
Hofmann et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32384
https://hzi.openrepository.com/bitstream/10033/556781/15/Hofmann%20et%20al_final.pdf.jpg
3b3dfbd3b468641faf2ef256e33b8d9f
MD5
15
false
Revision-SI.pdf.jpg
Revision-SI.pdf.jpg
Generated Thumbnail
image/jpeg
27338
https://hzi.openrepository.com/bitstream/10033/556781/16/Revision-SI.pdf.jpg
7ddbd59b4ac66a8cddd236006db9b692
MD5
16
false
elsevier-thumbnail.png
application/octet-stream
120165
https://hzi.openrepository.com/bitstream/10033/556781/17/elsevier-thumbnail.png
71ce1597fb21c2293538c9771057f612
MD5
17
false
10033/556781
oai:hzi.openrepository.com:10033/556781
2019-08-30 11:29:17.452
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5610552019-08-30T11:35:39Zcom_10033_620656col_10033_620657
Zielonka, Stefan
147ce198439d89a72cedec64c5424535
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Könning, Doreen
6f537485003509929c083debb4bd4655
500
Grzeschik, Julius
898ef13fcc0aaa56b04e030dec15e69e
500
Krah, Simon
6cf47b3d9a8214619aebf13398033b3a
500
Becker, Stefan
3ce33b119656cf91f4002d7b81831889
500
Dickgießer, Stephan
a96a23a5668d5f32dd6627a9b86c7744
500
Kolmar, Harald
99594f33693a836f3064a4ab58294d07
600
http://orcid.org/0000-0002-8210-1993
2Helmholtz-Institute for Pharmaceutical Research Saarland, Saarland University, Campus C2.3, 66123 Saarbrücken, Germany.
2015-07-27T09:50:38Z
2015-07-27T09:50:38Z
2015-08
The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope. 2015, 17 (4):386-92 Mar. Biotechnol.
1436-2236
26003538
10.1007/s10126-015-9642-z
http://hdl.handle.net/10033/561055
Marine biotechnology (New York, N.Y.)
In this present study, we engineered hypervariable loop 2 (HV2) of the IgNAR variable domain in a way that it solely facilitates antigen binding, potentially functioning as an autonomous paratope. For this, the surface-exposed loop corresponding to HV2 was diversified and antigen-specific variable domain of IgNAR antibody (vNAR) molecules were isolated by library screening using yeast surface display (YSD) as platform technology. An epithelial cell adhesion molecule (EpCAM)-specific vNAR was used as starting material, and nine residues in HV2 were randomized. Target-specific clones comprising a new HV2-mediated paratope were isolated against cluster of differentiation 3ε (CD3ε) and human Fcγ while retaining high affinity for EpCAM. Essentially, we demonstrate that a new paratope comprising moderate affinities against a given target molecule can be engineered into the vNAR scaffold that acts independent of the original antigen-binding site, composed of complementarity-determining region 3 (CDR3) and CDR1.
en
The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope.
Article
2016-08-02T00:00:00Z
In this present study, we engineered hypervariable loop 2 (HV2) of the IgNAR variable domain in a way that it solely facilitates antigen binding, potentially functioning as an autonomous paratope. For this, the surface-exposed loop corresponding to HV2 was diversified and antigen-specific variable domain of IgNAR antibody (vNAR) molecules were isolated by library screening using yeast surface display (YSD) as platform technology. An epithelial cell adhesion molecule (EpCAM)-specific vNAR was used as starting material, and nine residues in HV2 were randomized. Target-specific clones comprising a new HV2-mediated paratope were isolated against cluster of differentiation 3ε (CD3ε) and human Fcγ while retaining high affinity for EpCAM. Essentially, we demonstrate that a new paratope comprising moderate affinities against a given target molecule can be engineered into the vNAR scaffold that acts independent of the original antigen-binding site, composed of complementarity-determining region 3 (CDR3) and CDR1.
ORIGINAL
Zielonka et al_final.pdf
Zielonka et al_final.pdf
original manuscript
application/pdf
975208
https://hzi.openrepository.com/bitstream/10033/561055/1/Zielonka%20et%20al_final.pdf
efebc13f7fff5e9bbf8740e43ecaf32d
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/561055/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
21595
https://hzi.openrepository.com/bitstream/10033/561055/3/license_text
4024d768533e835cd7a5251ed22f1588
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/561055/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/561055/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Zielonka et al_final.pdf.txt
Zielonka et al_final.pdf.txt
Extracted Text
text/plain
30115
https://hzi.openrepository.com/bitstream/10033/561055/8/Zielonka%20et%20al_final.pdf.txt
47a9832da5b8a793bc46929d945f46d8
MD5
8
false
THUMBNAIL
Zielonka et al_final.pdf.jpg
Zielonka et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
32731
https://hzi.openrepository.com/bitstream/10033/561055/9/Zielonka%20et%20al_final.pdf.jpg
576933255ee65d4b2055f91eae525d6a
MD5
9
false
10033/561055
oai:hzi.openrepository.com:10033/561055
2019-08-30 11:35:39.546
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5759332019-08-30T11:33:30Zcom_10033_620656col_10033_620657
Müller, Stefan
8fe94f635ff49943d7a85e6cbea3a062
500
Rachid, Shwan
9340504052d52d1ea68f19c92fa3f042
500
Hoffmann, Thomas
81d6eda3d2406b5c5e00e3cd11fe8b0a
500
Surup, Frank
380780c50a64ac61d2e3dc56ff14d50e
500
Volz, Carsten
e8b23b910d325e5e91a028a1b34f39d1
500
Zaburannyi, Nestor
fb1e115bcccef96c43ede7c62ac64c77
500
Müller, Rolf
38d0f8dc80ae572919b57a1e4d8baf29
500
Helmholtz Institute for Pharmaceutical Research Saarland,Saarbru¨ cken, Saarland 66123, Germany.
2015-08-25T13:54:50Z
2015-08-25T13:54:50Z
2014-07-17
Biosynthesis of crocacin involves an unusual hydrolytic release domain showing similarity to condensation domains. 2014, 21 (7):855-65 Chem. Biol.
1879-1301
24981773
10.1016/j.chembiol.2014.05.012
http://hdl.handle.net/10033/575933
Chemistry & biology
The crocacins are potent antifungal and cytotoxic natural compounds from myxobacteria of the genus Chondromyces. Although total synthesis approaches have been reported, the molecular and biochemical basis guiding the formation of the linear crocacin scaffold has remained unknown. Along with the identification and functional analysis of the crocacin biosynthetic gene cluster from Chondromyces crocatus Cm c5, we here present the identification and biochemical characterization of an unusual chain termination domain homologous to condensation domains responsible for hydrolytic release of the product from the assembly line. In particular, gene inactivation studies and in vitro experiments using the heterologously produced domain CroK-C2 confirm this surprising role giving rise to the linear carboxylic acid. Additionally, we determined the kinetic parameters of CroK-C2 by monitoring hydrolytic cleavage of the substrate mimic N-acetylcysteaminyl-crocacin B using an innovative high-performance liquid chromatography mass spectrometry-based assay.
en
Biological Products
Genetic Engineering
Hydrolysis
Models, Biological
Molecular Sequence Data
Multigene Family
Myxococcales
Peptide Synthases
Polyenes
Protein Structure, Tertiary
Biosynthesis of crocacin involves an unusual hydrolytic release domain showing similarity to condensation domains.
Article
2018-06-12T17:30:50Z
The crocacins are potent antifungal and cytotoxic natural compounds from myxobacteria of the genus Chondromyces. Although total synthesis approaches have been reported, the molecular and biochemical basis guiding the formation of the linear crocacin scaffold has remained unknown. Along with the identification and functional analysis of the crocacin biosynthetic gene cluster from Chondromyces crocatus Cm c5, we here present the identification and biochemical characterization of an unusual chain termination domain homologous to condensation domains responsible for hydrolytic release of the product from the assembly line. In particular, gene inactivation studies and in vitro experiments using the heterologously produced domain CroK-C2 confirm this surprising role giving rise to the linear carboxylic acid. Additionally, we determined the kinetic parameters of CroK-C2 by monitoring hydrolytic cleavage of the substrate mimic N-acetylcysteaminyl-crocacin B using an innovative high-performance liquid chromatography mass spectrometry-based assay.
ORIGINAL
Müller et al_final.pdf
Müller et al_final.pdf
Open Access article
application/pdf
1474624
https://hzi.openrepository.com/bitstream/10033/575933/1/M%c3%bcller%20et%20al_final.pdf
d7673ace4fbc2ddde19940535d9e8ee9
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/575933/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
21597
https://hzi.openrepository.com/bitstream/10033/575933/3/license_text
54dd59d40230fe99c6f8f5992623f9e2
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/575933/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/575933/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Müller et al_final.pdf.txt
Müller et al_final.pdf.txt
Extracted Text
text/plain
64438
https://hzi.openrepository.com/bitstream/10033/575933/8/M%c3%bcller%20et%20al_final.pdf.txt
a8e2fd6af659ede28ecaa5349c2c9b1d
MD5
8
false
THUMBNAIL
Müller et al_final.pdf.jpg
Müller et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
28733
https://hzi.openrepository.com/bitstream/10033/575933/9/M%c3%bcller%20et%20al_final.pdf.jpg
a384c43e204dc842829bfb251aba6536
MD5
9
false
elsevier-thumbnail.png
application/octet-stream
135096
https://hzi.openrepository.com/bitstream/10033/575933/10/elsevier-thumbnail.png
6ccc06d9b5a4232fb49b932d0e2b546b
MD5
10
false
10033/575933
oai:hzi.openrepository.com:10033/575933
2019-08-30 11:33:30.104
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6209482019-08-30T11:36:32Zcom_10033_620656col_10033_620657
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Weidel, Elisabeth
6839ba8cfbc9408b9e94d895e029828f
500
Henn, Claudia
73570f853c22dae62c667f0dd0692585
500
Brengel, Christian
dc4fc696a5fe75d5a07912d4d04b28af
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Negri, Matthias
207b95ad6d8ba2303f68ea34dc6fd052
500
2017-06-15T08:44:04Z
2017-06-15T08:44:04Z
2013-08-01
2015-09-04T08:24:33Z
BMC Biophysics. 2013 Aug 01;6(1):10
http://dx.doi.org/10.1186/2046-1682-6-10
http://hdl.handle.net/10033/620948
Abstract Background PQS (P seudomonas Quinolone Signal) and its precursor HHQ are signal molecules of the P. aeruginosa quorum sensing system. They explicate their role in mammalian pathogenicity by binding to the receptor PqsR that induces virulence factor production and biofilm formation. The enzyme PqsD catalyses the biosynthesis of HHQ. Results Enzyme kinetic analysis and surface plasmon resonance (SPR) biosensor experiments were used to determine mechanism and substrate order of the biosynthesis. Comparative analysis led to the identification of domains involved in functionality of PqsD. A kinetic cycle was set up and molecular dynamics (MD) simulations were used to study the molecular bases of the kinetics of PqsD. Trajectory analysis, pocket volume measurements, binding energy estimations and decompositions ensured insights into the binding mode of the substrates anthraniloyl-CoA and β-ketodecanoic acid. Conclusions Enzyme kinetics and SPR experiments hint at a ping-pong mechanism for PqsD with ACoA as first substrate. Trajectory analysis of different PqsD complexes evidenced ligand-dependent induced-fit motions affecting the modified ACoA funnel access to the exposure of a secondary channel. A tunnel-network is formed in which Ser317 plays an important role by binding to both substrates. Mutagenesis experiments resulting in the inactive S317F mutant confirmed the importance of this residue. Two binding modes for β-ketodecanoic acid were identified with distinct catalytic mechanism preferences.
Molecular basis of HHQ biosynthesis: molecular dynamics simulations, enzyme kinetic and surface plasmon resonance studies
Journal Article
en
Steinbach et al.; licensee BioMed Central Ltd.
2018-06-13T05:30:52Z
Abstract
Background
PQS (P
seudomonas
Quinolone Signal) and its precursor HHQ are signal molecules of the P. aeruginosa quorum sensing system. They explicate their role in mammalian pathogenicity by binding to the receptor PqsR that induces virulence factor production and biofilm formation. The enzyme PqsD catalyses the biosynthesis of HHQ.
Results
Enzyme kinetic analysis and surface plasmon resonance (SPR) biosensor experiments were used to determine mechanism and substrate order of the biosynthesis. Comparative analysis led to the identification of domains involved in functionality of PqsD. A kinetic cycle was set up and molecular dynamics (MD) simulations were used to study the molecular bases of the kinetics of PqsD. Trajectory analysis, pocket volume measurements, binding energy estimations and decompositions ensured insights into the binding mode of the substrates anthraniloyl-CoA and β-ketodecanoic acid.
Conclusions
Enzyme kinetics and SPR experiments hint at a ping-pong mechanism for PqsD with ACoA as first substrate. Trajectory analysis of different PqsD complexes evidenced ligand-dependent induced-fit motions affecting the modified ACoA funnel access to the exposure of a secondary channel. A tunnel-network is formed in which Ser317 plays an important role by binding to both substrates. Mutagenesis experiments resulting in the inactive S317F mutant confirmed the importance of this residue. Two binding modes for β-ketodecanoic acid were identified with distinct catalytic mechanism preferences.
ORIGINAL
13628_2012_Article_53.pdf
application/pdf
1082406
https://hzi.openrepository.com/bitstream/10033/620948/1/13628_2012_Article_53.pdf
70b75664343ceeb24871958716835f56
MD5
1
true
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/620948/2/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
2
false
SWORD
art_1070821020502236341.zip
SWORD deposit package
application/octet-stream
993147
https://hzi.openrepository.com/bitstream/10033/620948/3/art_1070821020502236341.zip
f3407d3a012de83c6320d01ac4d9a78a
MD5
3
false
TEXT
13628_2012_Article_53.pdf.txt
13628_2012_Article_53.pdf.txt
Extracted Text
text/plain
64333
https://hzi.openrepository.com/bitstream/10033/620948/4/13628_2012_Article_53.pdf.txt
7447236b7caa4bc597f7aef673e72ec0
MD5
4
false
THUMBNAIL
13628_2012_Article_53.pdf.jpg
13628_2012_Article_53.pdf.jpg
Generated Thumbnail
image/jpeg
114876
https://hzi.openrepository.com/bitstream/10033/620948/5/13628_2012_Article_53.pdf.jpg
565c16770fb82508fd4a58b32cf331a9
MD5
5
false
10033/620948
oai:hzi.openrepository.com:10033/620948
2019-08-30 11:36:32.73
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/5774382019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Adam, Oliver
fc6e5cf2b030ecc449bfd9f79f85b8ca
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
Hanke, Nina
82f6bb1daf0318f7c0084876c1f53264
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Klemmer, Birgit
9d48ac1a487717e9733a8322d204efc9
500
Böhm, Michael
a7f5ba0a7a9173ceecd71630fdc785d8
500
Laufs, Ulrich
01a04ad48ebbb09d05a85df15ef1495d
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany.
2015-09-17T15:17:44Z
2015-09-17T15:17:44Z
2015-08
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice. 2015, 85:140-50 J. Mol. Cell. Cardiol.
1095-8584
26047574
10.1016/j.yjmcc.2015.05.019
http://hdl.handle.net/10033/577438
Journal of molecular and cellular cardiology
Loop diuretics are used for fluid control in patients with heart failure. Furosemide and torasemide may exert differential effects on myocardial fibrosis. Here, we studied the effects of torasemide and furosemide on atrial fibrosis and remodeling during atrial fibrillation. In primary neonatal cardiac fibroblasts, torasemide (50μM, 24h) but not furosemide (50μM, 24h) reduced the expression of connective tissue growth factor (CTGF; 65±6%) and the pro-fibrotic miR-21 (44±23%), as well as the expression of lysyl oxidase (LOX; 57±8%), a regulator of collagen crosslinking. Mineralocorticoid receptor (MR) expression and activity were not altered. Torasemide but not furosemide inhibited human aldosterone synthase (CYP11B2) activity in transfected lung fibroblasts (V79MZ cells) by 75±1.8%. The selective CYP11B2 inhibitor SL242 mimicked the torasemide effects. Mice with cardiac overexpression of Rac1 GTPase (RacET), which develop atrial fibrosis and spontaneous AF with aging, were treated long-term (8months) with torasemide (10mg/kg/day), furosemide (40mg/kg/day) or vehicle. Treatment with torasemide but not furosemide prevented atrial fibrosis in RacET as well as the up-regulation of CTGF, LOX, and miR-2, whereas MR expression and activity remained unaffected. These effects correlated with a reduced prevalence of atrial fibrillation (33% RacET+Tora vs. 80% RacET). Torasemide but not furosemide inhibits CYP11B2 activity and reduces the expression of CTGF, LOX, and miR-21. These effects are associated with prevention of atrial fibrosis and a reduced prevalence of atrial fibrillation in mice.
en
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
Article
2016-08-15T00:00:00Z
Loop diuretics are used for fluid control in patients with heart failure. Furosemide and torasemide may exert differential effects on myocardial fibrosis. Here, we studied the effects of torasemide and furosemide on atrial fibrosis and remodeling during atrial fibrillation. In primary neonatal cardiac fibroblasts, torasemide (50μM, 24h) but not furosemide (50μM, 24h) reduced the expression of connective tissue growth factor (CTGF; 65±6%) and the pro-fibrotic miR-21 (44±23%), as well as the expression of lysyl oxidase (LOX; 57±8%), a regulator of collagen crosslinking. Mineralocorticoid receptor (MR) expression and activity were not altered. Torasemide but not furosemide inhibited human aldosterone synthase (CYP11B2) activity in transfected lung fibroblasts (V79MZ cells) by 75±1.8%. The selective CYP11B2 inhibitor SL242 mimicked the torasemide effects. Mice with cardiac overexpression of Rac1 GTPase (RacET), which develop atrial fibrosis and spontaneous AF with aging, were treated long-term (8months) with torasemide (10mg/kg/day), furosemide (40mg/kg/day) or vehicle. Treatment with torasemide but not furosemide prevented atrial fibrosis in RacET as well as the up-regulation of CTGF, LOX, and miR-2, whereas MR expression and activity remained unaffected. These effects correlated with a reduced prevalence of atrial fibrillation (33% RacET+Tora vs. 80% RacET). Torasemide but not furosemide inhibits CYP11B2 activity and reduces the expression of CTGF, LOX, and miR-21. These effects are associated with prevention of atrial fibrosis and a reduced prevalence of atrial fibrillation in mice.
ORIGINAL
Adams et al_final.pdf
Adams et al_final.pdf
original manuscript
application/pdf
990116
https://hzi.openrepository.com/bitstream/10033/577438/1/Adams%20et%20al_final.pdf
8cdf9c2e91368ecd3360d0e5fdc1bb35
MD5
1
true
Supplement Figure.pdf
Supplement Figure.pdf
supplemental figures
application/pdf
102266
https://hzi.openrepository.com/bitstream/10033/577438/2/Supplement%20Figure.pdf
e1eca8d06882f6742a5a4d25cfafaaa3
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/577438/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
21597
https://hzi.openrepository.com/bitstream/10033/577438/4/license_text
54dd59d40230fe99c6f8f5992623f9e2
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/577438/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/577438/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Adams et al_final.pdf.txt
Adams et al_final.pdf.txt
Extracted Text
text/plain
53331
https://hzi.openrepository.com/bitstream/10033/577438/11/Adams%20et%20al_final.pdf.txt
db525cd0ef8c4cc7d4a07ce9c9d3f233
MD5
11
false
Supplement Figure.pdf.txt
Supplement Figure.pdf.txt
Extracted Text
text/plain
850
https://hzi.openrepository.com/bitstream/10033/577438/12/Supplement%20Figure.pdf.txt
e62cdc9985c161502df6c7b172bfeb2c
MD5
12
false
THUMBNAIL
Adams et al_final.pdf.jpg
Adams et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
31848
https://hzi.openrepository.com/bitstream/10033/577438/15/Adams%20et%20al_final.pdf.jpg
9365ce27a08c12d72109790c5928e3ab
MD5
15
false
Supplement Figure.pdf.jpg
Supplement Figure.pdf.jpg
Generated Thumbnail
image/jpeg
52071
https://hzi.openrepository.com/bitstream/10033/577438/16/Supplement%20Figure.pdf.jpg
e964b92e3698f11f68042402b8dc98e4
MD5
16
false
elsevier-thumbnail.png
application/octet-stream
59983
https://hzi.openrepository.com/bitstream/10033/577438/17/elsevier-thumbnail.png
90494fe37575e48d7171f0b5d0ebb69c
MD5
17
false
10033/577438
oai:hzi.openrepository.com:10033/577438
2019-08-30 11:34:48.256
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/5796122019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Abdelsamie, Ahmed S
b7451f5abfd51938e22a95fd4f3cec99
500
Bey, Emmanuel
c1860f95b4228d8d5faa91e3ac6f29e4
500
Gargano, Emanuele M
a782b330ff21c4d90c06e04f7aa8e465
500
van Koppen, Chris J
db7e7de5298174dba408322916cfa9dd
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus C23, D-66123 Saarbrücken, Germany.
2015-10-14T08:24:30Z
2015-10-14T08:24:30Z
2015-10-20
Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme. 2015, 103:56-68 Eur J Med Chem
1768-3254
26322835
10.1016/j.ejmech.2015.08.030
http://hdl.handle.net/10033/579612
European journal of medicinal chemistry
17β-Estradiol (E2), the most potent human estrogen, is known to be involved in the etiology of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyses the last step of E2 biosynthesis and is thus a promising target for the treatment of EDD. The previously described bicyclic substituted hydroxyphenylmethanones (BSHs) display high inhibitory potency towards human 17β-HSD1, but marginal activity towards rodent 17β-HSD1, precluding a proof of principle study in an animal endometriosis model. The aim of this work was to perform structural optimizations in the BSHs class to enhance inhibitory activity against rodent (mouse and rat) 17β-HSD1 while maintaining activity against the human enzyme. The introduction of fluorine atoms on the benzoyl moiety resulted in compounds with the desired properties. Molecular docking and homology modeling were applied to elucidate the binding mode and interspecies differences in activity. Compound 33 is the most potent inhibitor of both human and rat 17β-HSD1 up to date (IC50 = 2 nM and 97 nM, respectively).
en
Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme.
Article
2016-11-01T00:00:00Z
17β-Estradiol (E2), the most potent human estrogen, is known to be involved in the etiology of estrogen-dependent diseases (EDD) like breast cancer and endometriosis. 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) catalyses the last step of E2 biosynthesis and is thus a promising target for the treatment of EDD. The previously described bicyclic substituted hydroxyphenylmethanones (BSHs) display high inhibitory potency towards human 17β-HSD1, but marginal activity towards rodent 17β-HSD1, precluding a proof of principle study in an animal endometriosis model. The aim of this work was to perform structural optimizations in the BSHs class to enhance inhibitory activity against rodent (mouse and rat) 17β-HSD1 while maintaining activity against the human enzyme. The introduction of fluorine atoms on the benzoyl moiety resulted in compounds with the desired properties. Molecular docking and homology modeling were applied to elucidate the binding mode and interspecies differences in activity. Compound 33 is the most potent inhibitor of both human and rat 17β-HSD1 up to date (IC50 = 2 nM and 97 nM, respectively).
ORIGINAL
Abdelsamie et al_final.pdf
Abdelsamie et al_final.pdf
original manuscript
application/pdf
980195
https://hzi.openrepository.com/bitstream/10033/579612/1/Abdelsamie%20et%20al_final.pdf
a70ae1678bd5dfa0da436a469ed52d89
MD5
1
true
SuppInfoR1_210715.pdf
SuppInfoR1_210715.pdf
supplemental information
application/pdf
3109356
https://hzi.openrepository.com/bitstream/10033/579612/2/SuppInfoR1_210715.pdf
e7b4d732dd0e1c447fbcdd4862440ce5
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/579612/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
21597
https://hzi.openrepository.com/bitstream/10033/579612/4/license_text
54dd59d40230fe99c6f8f5992623f9e2
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/579612/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/579612/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Abdelsamie et al_final.pdf.txt
Abdelsamie et al_final.pdf.txt
Extracted Text
text/plain
64829
https://hzi.openrepository.com/bitstream/10033/579612/11/Abdelsamie%20et%20al_final.pdf.txt
2aaf2074ef0b4017baec040dcbad3d46
MD5
11
false
SuppInfoR1_210715.pdf.txt
SuppInfoR1_210715.pdf.txt
Extracted Text
text/plain
54004
https://hzi.openrepository.com/bitstream/10033/579612/12/SuppInfoR1_210715.pdf.txt
6738b42f5e9674c6389adc81de4febc6
MD5
12
false
THUMBNAIL
Abdelsamie et al_final.pdf.jpg
Abdelsamie et al_final.pdf.jpg
Generated Thumbnail
image/jpeg
33113
https://hzi.openrepository.com/bitstream/10033/579612/15/Abdelsamie%20et%20al_final.pdf.jpg
9ac44615fac9182f831a862ab52e2693
MD5
15
false
SuppInfoR1_210715.pdf.jpg
SuppInfoR1_210715.pdf.jpg
Generated Thumbnail
image/jpeg
44974
https://hzi.openrepository.com/bitstream/10033/579612/16/SuppInfoR1_210715.pdf.jpg
21e3a831ecca4cc182633651d91f8395
MD5
16
false
elsevier-thumbnail.png
application/octet-stream
58648
https://hzi.openrepository.com/bitstream/10033/579612/17/elsevier-thumbnail.png
8226db4fe242a4759e709ff796b9690f
MD5
17
false
10033/579612
oai:hzi.openrepository.com:10033/579612
2019-08-30 11:34:48.514
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5931012019-08-30T11:34:17Zcom_10033_620656col_10033_620657
Thomann, Andreas
e515af4963c71ff3693be682e3be68b3
500
Eberhard, Jens
6e47660391fa40a4bc204e4a5244339a
500
Allegretta, Giuseppe
7c3de38445707166591b1ef19f318cea
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Hartmann, Rolf
0894006c4568c1a0a48e1c9ec4eed888
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany.
Helmholtz-Institute for Pharmaceutical Research Saarland, Saarland University
Helmholtz-Institute for Pharmaceutical Research Saarland, Saarland University
Helmholtz-Institute for Pharmaceutical Research Saarland, Saarland University
Helmholtz-Institute for Pharmaceutical Research Saarland, Saarland University
Helmholtz-Institute for Pharmaceutical Research Saarland, Saarland University
2016-01-08T15:36:42Z
2016-01-08T15:36:42Z
2015-10-21
Mild and Catalyst-Free Microwave-Assisted Synthesis of 4,6-Disubstituted 2-Methylthiopyrimidines – Exploiting Tetrazole as an Efficient Leaving Group 2015, 26 (18):2606 Synlett
0936-5214
1437-2096
10.1055/s-0035-1560577
http://hdl.handle.net/10033/593101
Synlett
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0035-1560577
Mild and Catalyst-Free Microwave-Assisted Synthesis of 4,6-Disubstituted 2-Methylthiopyrimidines – Exploiting Tetrazole as an Efficient Leaving Group
Article
2016-11-15T00:00:00Z
ORIGINAL
Thomann_etal_revision#2_manuscript_17_08_2015.pdf
Thomann_etal_revision#2_manuscript_17_08_2015.pdf
submitted manuscript
application/pdf
1112620
https://hzi.openrepository.com/bitstream/10033/593101/1/Thomann_etal_revision%232_manuscript_17_08_2015.pdf
26924b7384f77605e7ad3162a82b09eb
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/593101/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/593101/3/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/593101/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/593101/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Thomann_etal_revision#2_manuscript_17_08_2015.pdf.txt
Thomann_etal_revision#2_manuscript_17_08_2015.pdf.txt
Extracted Text
text/plain
50092
https://hzi.openrepository.com/bitstream/10033/593101/6/Thomann_etal_revision%232_manuscript_17_08_2015.pdf.txt
a8e82dcd3178c6d07dc137eed7cace64
MD5
6
false
THUMBNAIL
Thomann_etal_revision#2_manuscript_17_08_2015.pdf.jpg
Thomann_etal_revision#2_manuscript_17_08_2015.pdf.jpg
Generated Thumbnail
image/jpeg
91679
https://hzi.openrepository.com/bitstream/10033/593101/7/Thomann_etal_revision%232_manuscript_17_08_2015.pdf.jpg
9b918881b9ea0eb29d24be65e7ad30a1
MD5
7
false
10033/593101
oai:hzi.openrepository.com:10033/593101
2019-08-30 11:34:17.738
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5940532019-08-30T11:33:01Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Varrot, Annabelle
9f34f205cce62dce96f9cfa8be8d240f
500
Wagner, Stefanie
935803ea3ccfe8267a16e098ea9a33bc
500
Audfray, Aymeric
1edb28f079b53ed00b3746d26b2cc012
500
Prestel, Andreas
59a42e1f111ed5b81ec68a6aebbf5ab7
500
Möller, Heiko M.
ae0abbefbaaf65ff83c29de4c2f3d3ec
500
Imberty, Anne
6e3e5ebf482abdb8033b0c4c8cfa10db
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany.
Chemical Biology of Carbohydrates; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Universitätsstrasse 10 66123 Saarbrücken Germany
Chemical Biology of Carbohydrates; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Universitätsstrasse 10 66123 Saarbrücken Germany
Centre de Recherche sur les Macromolécules Végétales (CERMAV-UPR5301); CNRS and Université Grenoble Alpes, BP53; 38041 Grenoble cedex 9 France
Chemical Biology of Carbohydrates; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Universitätsstrasse 10 66123 Saarbrücken Germany
Centre de Recherche sur les Macromolécules Végétales (CERMAV-UPR5301); CNRS and Université Grenoble Alpes, BP53; 38041 Grenoble cedex 9 France
Department of Chemistry and Graduate School Chemical Biology; University of Konstanz; 78457 Konstanz Germany
Department of Chemistry and Graduate School Chemical Biology; University of Konstanz; 78457 Konstanz Germany
Centre de Recherche sur les Macromolécules Végétales (CERMAV-UPR5301); CNRS and Université Grenoble Alpes, BP53; 38041 Grenoble cedex 9 France
Chemical Biology of Carbohydrates; Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Universitätsstrasse 10 66123 Saarbrücken Germany
2016-01-19T14:44:13Z
2016-01-19T14:44:13Z
2015-12
Cinnamide Derivatives of d -Mannose as Inhibitors of the Bacterial Virulence Factor LecB from Pseudomonas aeruginosa 2015, 4 (6):756 ChemistryOpen
21911363
10.1002/open.201500162
http://hdl.handle.net/10033/594053
ChemistryOpen
http://doi.wiley.com/10.1002/open.201500162
Cinnamide Derivatives of d -Mannose as Inhibitors of the Bacterial Virulence Factor LecB from Pseudomonas aeruginosa
Article
2018-06-13T04:24:26Z
ORIGINAL
Sommer et al.pdf
Sommer et al.pdf
Open Access publication
application/pdf
2152006
https://hzi.openrepository.com/bitstream/10033/594053/1/Sommer%20et%20al.pdf
d26d63088d4e0a97be22c85d99c896ed
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/594053/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/594053/3/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/594053/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/594053/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Sommer et al.pdf.txt
Sommer et al.pdf.txt
Extracted Text
text/plain
54893
https://hzi.openrepository.com/bitstream/10033/594053/6/Sommer%20et%20al.pdf.txt
b4ea36ee4a3047d4eab2733a41cfbed6
MD5
6
false
THUMBNAIL
Sommer et al.pdf.jpg
Sommer et al.pdf.jpg
Generated Thumbnail
image/jpeg
146613
https://hzi.openrepository.com/bitstream/10033/594053/7/Sommer%20et%20al.pdf.jpg
09a1934c7d446dcb7bcf35ee140871b1
MD5
7
false
10033/594053
oai:hzi.openrepository.com:10033/594053
2019-08-30 11:33:01.31
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5957132019-08-30T11:37:23Zcom_10033_620656col_10033_620657
Reuter, Kerstin
ddc040e77c69e2378eb10e4788f74cb5
500
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Helms, Volkhard
8ed0801e76fb23b34d99f53049a7aefa
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany.
2016-02-05T14:20:00Z
2016-02-05T14:20:00Z
2016
Interfering with Bacterial Quorum Sensing. 2016, 8:1-15 Perspect Medicin Chem
1177-391X
26819549
10.4137/PMC.S13209
http://hdl.handle.net/10033/595713
Perspectives in medicinal chemistry
Quorum sensing (QS) describes the exchange of chemical signals in bacterial populations to adjust the bacterial phenotypes according to the density of bacterial cells. This serves to express phenotypes that are advantageous for the group and ensure bacterial survival. To do so, bacterial cells synthesize autoinducer (AI) molecules, release them to the environment, and take them up. Thereby, the AI concentration reflects the cell density. When the AI concentration exceeds a critical threshold in the cells, the AI may activate the expression of virulence-associated genes or of luminescent proteins. It has been argued that targeting the QS system puts less selective pressure on these pathogens and should avoid the development of resistant bacteria. Therefore, the molecular components of QS systems have been suggested as promising targets for developing new anti-infective compounds. Here, we review the QS systems of selected gram-negative and gram-positive bacteria, namely, Vibrio fischeri, Pseudomonas aeruginosa, and Staphylococcus aureus, and discuss various antivirulence strategies based on blocking different components of the QS machinery.
en
Interfering with Bacterial Quorum Sensing.
Article
2018-06-13T01:32:19Z
Quorum sensing (QS) describes the exchange of chemical signals in bacterial populations to adjust the bacterial phenotypes according to the density of bacterial cells. This serves to express phenotypes that are advantageous for the group and ensure bacterial survival. To do so, bacterial cells synthesize autoinducer (AI) molecules, release them to the environment, and take them up. Thereby, the AI concentration reflects the cell density. When the AI concentration exceeds a critical threshold in the cells, the AI may activate the expression of virulence-associated genes or of luminescent proteins. It has been argued that targeting the QS system puts less selective pressure on these pathogens and should avoid the development of resistant bacteria. Therefore, the molecular components of QS systems have been suggested as promising targets for developing new anti-infective compounds. Here, we review the QS systems of selected gram-negative and gram-positive bacteria, namely, Vibrio fischeri, Pseudomonas aeruginosa, and Staphylococcus aureus, and discuss various antivirulence strategies based on blocking different components of the QS machinery.
ORIGINAL
Reuter et al.pdf
Reuter et al.pdf
Open Access article
application/pdf
2153189
https://hzi.openrepository.com/bitstream/10033/595713/1/Reuter%20et%20al.pdf
686078a15c84d658f03da4f16474ff49
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/595713/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/595713/3/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/595713/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/595713/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Reuter et al.pdf.txt
Reuter et al.pdf.txt
Extracted Text
text/plain
75320
https://hzi.openrepository.com/bitstream/10033/595713/6/Reuter%20et%20al.pdf.txt
f3d21cd4f8ce65b0269d57392873431b
MD5
6
false
THUMBNAIL
Reuter et al.pdf.jpg
Reuter et al.pdf.jpg
Generated Thumbnail
image/jpeg
148678
https://hzi.openrepository.com/bitstream/10033/595713/7/Reuter%20et%20al.pdf.jpg
7475ae7460388cd9ff90bf48eb7bce1a
MD5
7
false
10033/595713
oai:hzi.openrepository.com:10033/595713
2019-08-30 11:37:23.974
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/5966492019-08-30T11:37:24Zcom_10033_620656col_10033_620657
Thomann, Andreas
e515af4963c71ff3693be682e3be68b3
500
Huch, Volker
b587303d42ad78853c3d3ee72a07bc4e
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS);Saarland University, Building A4.1, 66123 Saarbruecken, Germany.
2016-02-18T15:35:30Z
2016-02-18T15:35:30Z
2015-12-01
Crystal structure of 4-methyl-sulfanyl-2-(2H-tetra-zol-2-yl)pyrimidine. 2015, 71 (Pt 12):o1051-2 Acta Crystallogr E Crystallogr Commun
2056-9890
26870493
10.1107/S2056989015023634
http://hdl.handle.net/10033/596649
Acta crystallographica. Section E, Crystallographic communications
The title compound, C6H6N6S, crystallized with two independent mol-ecules (A and B) in the asymmetric unit. The conformation of the two mol-ecules differs slightly. While the tetra-zole ring is inclined to the pyrim-idene ring by 5.48 (7) and 4.24 (7)° in mol-ecules A and B, respectively, the N-C-S-C torsion angles of the thio-methyl groups differ by ca 180°. In the crystal, the A and B mol-ecules are linked via a C-H⋯N hydrogen bond. They stack along the b-axis direction forming columns within which there are weak π-π inter-actions present [shortest inter-centroid distance = 3.6933 (13) Å].
en
Crystal structure of 4-methyl-sulfanyl-2-(2H-tetra-zol-2-yl)pyrimidine.
Article
2018-06-12T21:24:38Z
The title compound, C6H6N6S, crystallized with two independent mol-ecules (A and B) in the asymmetric unit. The conformation of the two mol-ecules differs slightly. While the tetra-zole ring is inclined to the pyrim-idene ring by 5.48 (7) and 4.24 (7)° in mol-ecules A and B, respectively, the N-C-S-C torsion angles of the thio-methyl groups differ by ca 180°. In the crystal, the A and B mol-ecules are linked via a C-H⋯N hydrogen bond. They stack along the b-axis direction forming columns within which there are weak π-π inter-actions present [shortest inter-centroid distance = 3.6933 (13) Å].
ORIGINAL
Thomann et al.pdf
Thomann et al.pdf
Open Access publication
application/pdf
422353
https://hzi.openrepository.com/bitstream/10033/596649/1/Thomann%20et%20al.pdf
5c19a7cfdb0ad227fa33d9c4824c6b37
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/596649/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/596649/3/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/596649/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/596649/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Thomann et al.pdf.txt
Thomann et al.pdf.txt
Extracted Text
text/plain
16818
https://hzi.openrepository.com/bitstream/10033/596649/6/Thomann%20et%20al.pdf.txt
4ac20ac35ad7adbf05eb85d0755031d9
MD5
6
false
THUMBNAIL
Thomann et al.pdf.jpg
Thomann et al.pdf.jpg
Generated Thumbnail
image/jpeg
79756
https://hzi.openrepository.com/bitstream/10033/596649/7/Thomann%20et%20al.pdf.jpg
23bcecf73129740485f2324464a72100
MD5
7
false
10033/596649
oai:hzi.openrepository.com:10033/596649
2019-08-30 11:37:24.126
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6043822019-08-30T11:35:39Zcom_10033_620656col_10033_620657
Krah, Simon
6cf47b3d9a8214619aebf13398033b3a
500
Schröter, Christian
d57b5b77843f572353fe6f682ee4beba
500
Zielonka, Stefan
147ce198439d89a72cedec64c5424535
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Valldorf, Bernhard
420d9dc5aa206cc9f00f8b2e45785407
500
Kolmar, Harald
5989991fb885a1d13b170f2afce3dcce
500
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarland University, Campus C2.3, D-66123 Saarbrücken, Germany.
2016-04-04T14:22:16Z
2016-04-04T14:22:16Z
2016-02
Single-domain antibodies for biomedical applications. 2016, 38 (1):21-8 Immunopharmacol Immunotoxicol
1532-2513
26551147
10.3109/08923973.2015.1102934
http://hdl.handle.net/10033/604382
Immunopharmacology and immunotoxicology
Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.
en
Single-domain antibodies for biomedical applications.
Article
2017-01-05T00:00:00Z
Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.
ORIGINAL
Krah et al.pdf
Krah et al.pdf
original manuscript
application/pdf
630736
https://hzi.openrepository.com/bitstream/10033/604382/1/Krah%20et%20al.pdf
2a5da95162faa44c59772cae66353fcc
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/604382/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/604382/3/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
3
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/604382/4/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/604382/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Krah et al.pdf.txt
Krah et al.pdf.txt
Extracted Text
text/plain
56011
https://hzi.openrepository.com/bitstream/10033/604382/6/Krah%20et%20al.pdf.txt
ac23bcb04e74ea044072a3d735a39d71
MD5
6
false
THUMBNAIL
Krah et al.pdf.jpg
Krah et al.pdf.jpg
Generated Thumbnail
image/jpeg
45858
https://hzi.openrepository.com/bitstream/10033/604382/7/Krah%20et%20al.pdf.jpg
53b00774d0143941c40dc7d08ea41bf6
MD5
7
false
10033/604382
oai:hzi.openrepository.com:10033/604382
2019-08-30 11:35:39.685
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6112232019-08-30T11:33:29Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Wagner, Stefanie
935803ea3ccfe8267a16e098ea9a33bc
500
Varrot, Annabelle
9f34f205cce62dce96f9cfa8be8d240f
500
Nycholat, Corwin M.
687d8af703487871a7a3786031eea5fd
500
Khaledi, Ariane
a8a9ff385e89aa57a31be3ed27dd8b21
500
Häussler, Susanne
0472b1124bdc0b2ac7989888c4e6aaf9
600
http://orcid.org/0000-0001-6141-9102
Paulson, James C.
5b2b404cf16ee4b51c70b179c5d7b315
500
Imberty, Anne
6e3e5ebf482abdb8033b0c4c8cfa10db
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
2016-05-31T08:39:04Z
2016-05-31T08:39:04Z
2016
The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery 2016 Chem. Sci.
2041-6520
2041-6539
10.1039/C6SC00696E
http://hdl.handle.net/10033/611223
Chem. Sci.
http://xlink.rsc.org/?DOI=C6SC00696E
The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery
Article
2018-06-12T16:46:00Z
ORIGINAL
Sommer et al.pdf
Sommer et al.pdf
Open Access publication
application/pdf
2649803
https://hzi.openrepository.com/bitstream/10033/611223/1/Sommer%20et%20al.pdf
df17d7a4dae4d010b6f89bc86f7587a0
MD5
1
true
Sommer_supp.pdf
Sommer_supp.pdf
supplemental material
application/pdf
2277328
https://hzi.openrepository.com/bitstream/10033/611223/2/Sommer_supp.pdf
543d008dfe16e5e7f998f3ee9d624060
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/611223/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/611223/4/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/611223/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/611223/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
THUMBNAIL
Sommer et al.pdf.jpg
Sommer et al.pdf.jpg
Generated Thumbnail
image/jpeg
106223
https://hzi.openrepository.com/bitstream/10033/611223/13/Sommer%20et%20al.pdf.jpg
0bf0055950a66af84bf28cfbcc7e9d8c
MD5
13
false
Sommer_supp.pdf.jpg
Sommer_supp.pdf.jpg
Generated Thumbnail
image/jpeg
37738
https://hzi.openrepository.com/bitstream/10033/611223/14/Sommer_supp.pdf.jpg
67c6f94eb5af56c129c40eb09f55bc8f
MD5
14
false
TEXT
Sommer_supp.pdf.txt
Sommer_supp.pdf.txt
Extracted Text
text/plain
36344
https://hzi.openrepository.com/bitstream/10033/611223/8/Sommer_supp.pdf.txt
d414db75fb211da96d0e9e146f15c805
MD5
8
false
Sommer et al.pdf.txt
Sommer et al.pdf.txt
Extracted Text
text/plain
47172
https://hzi.openrepository.com/bitstream/10033/611223/10/Sommer%20et%20al.pdf.txt
92a2d6b22e844fb3977cca3f3268e5a9
MD5
10
false
10033/611223
oai:hzi.openrepository.com:10033/611223
2019-08-30 11:33:29.68
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6112272019-08-30T11:32:59Zcom_10033_620656col_10033_620657
Barthold, S.
884a1c193d7cea845838269c3a7a5881
500
Kletting, S.
e07472a6197e0b6adc975091cd3f0ed4
500
Taffner, J.
76fe95d5cd7d66dd83a29050f05a269e
500
de Souza Carvalho-Wodarz, C.
f53ddba0b1061cae03cdde917113bd01
500
Lepeltier, E.
f837a913df356c1f5c227ce01f0e8d5e
500
Loretz, B.
4c4ee98eeebc322413fe24a77d9d6154
500
Lehr, Claus Michael
a7797d2b7084a203efc9093a497cd9c8
600
http://orcid.org/0000-0002-5864-8462
Helmholtz-Institut für pharmaceutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2016-05-31T12:16:24Z
2016-05-31T12:16:24Z
2016
Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins 2016, 4 (13):2377 J. Mater. Chem. B
2050-750X
2050-7518
10.1039/C6TB00178E
http://hdl.handle.net/10033/611227
J. Mater. Chem. B
http://xlink.rsc.org/?DOI=C6TB00178E
Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins
Article
2018-06-12T17:28:50Z
ORIGINAL
Barthold et al.pdf
Barthold et al.pdf
Open Access article
application/pdf
3027113
https://hzi.openrepository.com/bitstream/10033/611227/1/Barthold%20et%20al.pdf
46cdbdf2ed1dc63fddec24750ad811d9
MD5
1
true
Barthold_supp.pdf
Barthold_supp.pdf
supplemenatal material
application/pdf
443484
https://hzi.openrepository.com/bitstream/10033/611227/2/Barthold_supp.pdf
f2ff4782025e969de65ef1d37e8c3e32
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/611227/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/611227/4/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/611227/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/611227/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Barthold et al.pdf.txt
Barthold et al.pdf.txt
Extracted Text
text/plain
55838
https://hzi.openrepository.com/bitstream/10033/611227/7/Barthold%20et%20al.pdf.txt
edce3dbebad078beb17af246b4665d34
MD5
7
false
Barthold_supp.pdf.txt
Barthold_supp.pdf.txt
Extracted Text
text/plain
2662
https://hzi.openrepository.com/bitstream/10033/611227/9/Barthold_supp.pdf.txt
5a2703aff280a7a0b2721e95a20d5759
MD5
9
false
THUMBNAIL
Barthold et al.pdf.jpg
Barthold et al.pdf.jpg
Generated Thumbnail
image/jpeg
110547
https://hzi.openrepository.com/bitstream/10033/611227/11/Barthold%20et%20al.pdf.jpg
44fc3d9c87081012d11d4944b63650e7
MD5
11
false
Barthold_supp.pdf.jpg
Barthold_supp.pdf.jpg
Generated Thumbnail
image/jpeg
43662
https://hzi.openrepository.com/bitstream/10033/611227/12/Barthold_supp.pdf.jpg
ee7c5a04655fab66676d89cc6bb9393a
MD5
12
false
10033/611227
oai:hzi.openrepository.com:10033/611227
2019-08-30 11:32:59.964
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6112592019-08-30T11:33:25Zcom_10033_620656col_10033_620658
Beshr, Ghamdan
bd56df65fbfa89ea13c42f39acb82f8f
500
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Siebert, David Chan Bodin
f38dddeefd38b60cf54348929fc0284b
500
Hofmann, Anna
2d98082aad6b27b0e2462ce70825eb6b
500
Imberty, Anne
6e3e5ebf482abdb8033b0c4c8cfa10db
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
2016-05-31T14:35:19Z
2016-05-31T14:35:19Z
2016
Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors 2016, 7 (3):519 Med. Chem. Commun.
2040-2503
2040-2511
10.1039/C5MD00557D
http://hdl.handle.net/10033/611259
Med. Chem. Commun.
http://xlink.rsc.org/?DOI=C5MD00557D
Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors
Article
2017-01-15T00:00:00Z
ORIGINAL
Beshr et al.pdf
Beshr et al.pdf
original manuscript
application/pdf
1442713
https://hzi.openrepository.com/bitstream/10033/611259/1/Beshr%20et%20al.pdf
fa88b3fc9cb9475a59f5b382a2e2fd34
MD5
1
true
S_info.pdf
S_info.pdf
supporting information
application/pdf
1945792
https://hzi.openrepository.com/bitstream/10033/611259/2/S_info.pdf
ca13f62da52e90d012ab6ed94126784c
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/611259/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
22333
https://hzi.openrepository.com/bitstream/10033/611259/4/license_text
33af6f23fea3b848a02227818b46d2ee
MD5
4
false
license_rdf
license_rdf
application/octet-stream
23748
https://hzi.openrepository.com/bitstream/10033/611259/5/license_rdf
b92763cfc0af52c7c868455edfaf3266
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/611259/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Beshr et al.pdf.txt
Beshr et al.pdf.txt
Extracted Text
text/plain
54907
https://hzi.openrepository.com/bitstream/10033/611259/7/Beshr%20et%20al.pdf.txt
7b9c8bf039879651492246d0fbf0b29c
MD5
7
false
S_info.pdf.txt
S_info.pdf.txt
Extracted Text
text/plain
2615
https://hzi.openrepository.com/bitstream/10033/611259/9/S_info.pdf.txt
9a601e0bf325bfc7f46c9c2212105632
MD5
9
false
THUMBNAIL
Beshr et al.pdf.jpg
Beshr et al.pdf.jpg
Generated Thumbnail
image/jpeg
43006
https://hzi.openrepository.com/bitstream/10033/611259/11/Beshr%20et%20al.pdf.jpg
638d5b3cf1a4369ec06ed9a84b88737b
MD5
11
false
S_info.pdf.jpg
S_info.pdf.jpg
Generated Thumbnail
image/jpeg
44240
https://hzi.openrepository.com/bitstream/10033/611259/12/S_info.pdf.jpg
e4732df96848f4f77ab3ab7bbddbe657
MD5
12
false
10033/611259
oai:hzi.openrepository.com:10033/611259
2019-08-30 11:33:25.329
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6156132019-08-30T11:30:58Zcom_10033_620656col_10033_620657
Gargano, Emanuele M
a782b330ff21c4d90c06e04f7aa8e465
500
Allegretta, Giuseppe
7c3de38445707166591b1ef19f318cea
500
Perspicace, Enrico
45ea5b9b93888712a62e1bf810f54fc7
500
Carotti, Angelo
b3355f694f7d93c1823a3b97863fb61b
500
Van Koppen, Chris
da55b9e98e78dce1f6bf05a83e461b20
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
Marchais-Oberwinkler, Sandrine
8077578e04f781fbc378097c04d3ea68
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS),Saarland 9 University, 66123 Saarbrücken, Germany.
2016-07-06T09:39:32Z
2016-07-06T09:39:32Z
2015
17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog. 2015, 10 (7):e0134754 PLoS ONE
1932-6203
26230928
10.1371/journal.pone.0134754
http://hdl.handle.net/10033/615613
PloS one
Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparative h17β-HSD2 and m17β-HSD2 SAR study are described. 17a is the first compound to show strong inhibition of both h17β-HSD2 and m17β-HSD2, intracellular activity, metabolic stability, selectivity toward h17β-HSD1, m17β-HSD1 and estrogen receptors α and β as well as appropriate physicochemical properties for oral bioavailability. These properties make it eligible for pre-clinical animal studies, prior to human studies.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Animals
Cell Line, Tumor
Enzyme Inhibitors
Estradiol Dehydrogenases
Humans
Mice
Structure-Activity Relationship
17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting Both the Human Enzyme and Its Murine Ortholog.
Article
2018-06-13T19:42:16Z
Design and synthesis of a new class of inhibitors for the treatment of osteoporosis and its comparative h17β-HSD2 and m17β-HSD2 SAR study are described. 17a is the first compound to show strong inhibition of both h17β-HSD2 and m17β-HSD2, intracellular activity, metabolic stability, selectivity toward h17β-HSD1, m17β-HSD1 and estrogen receptors α and β as well as appropriate physicochemical properties for oral bioavailability. These properties make it eligible for pre-clinical animal studies, prior to human studies.
ORIGINAL
Gargano et al.PDF
Gargano et al.PDF
Open Access publication
application/pdf
328348
https://hzi.openrepository.com/bitstream/10033/615613/1/Gargano%20et%20al.PDF
98790fdc131ce8f06000145a8dad6684
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/615613/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/615613/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/615613/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/615613/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Gargano et al.PDF.txt
Gargano et al.PDF.txt
Extracted Text
text/plain
70924
https://hzi.openrepository.com/bitstream/10033/615613/6/Gargano%20et%20al.PDF.txt
a2aae3981964990ac423a93c62ce8d84
MD5
6
false
THUMBNAIL
Gargano et al.PDF.jpg
Gargano et al.PDF.jpg
Generated Thumbnail
image/jpeg
96990
https://hzi.openrepository.com/bitstream/10033/615613/7/Gargano%20et%20al.PDF.jpg
002b568b114b98534b5642762c0cc938
MD5
7
false
10033/615613
oai:hzi.openrepository.com:10033/615613
2019-08-30 11:30:58.399
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6159092019-08-30T11:30:58Zcom_10033_620656col_10033_620657
Elgaher, Walid A M
0a7859e1a980acffd44f260e6d2f659b
500
Sharma, Kamal K
a90dca530fe54076dd2d78d04074e6fe
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Saladini, Francesco
884dc5cb6512f54288e12a874746e4f8
500
Pires, Manuel
9743062133262b6988ded48362759c7e
500
Real, Eleonore
7233ff512b50a6634b8c48283d217a95
500
Mély, Yves
d32870282c05a2140b566c001056dcd6
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.
2016-07-11T14:26:33Z
2016-07-11T14:26:33Z
2016-07-07
Discovery and Structure-Based Optimization of 2-Ureidothiophene-3-carboxylic Acids as Dual Bacterial RNA Polymerase and Viral Reverse Transcriptase Inhibitors. 2016: J. Med. Chem.
1520-4804
27339173
10.1021/acs.jmedchem.6b00730
http://hdl.handle.net/10033/615909
Journal of medicinal chemistry
We are concerned with the development of novel anti-infectives with dual antibacterial and antiretroviral activities for MRSA/HIV-1 co-infection. To achieve this goal, we exploited for the first time the mechanistic function similarity between the bacterial RNA polymerase (RNAP) "switch region" and the viral non-nucleoside reverse transcriptase inhibitor (NNRTI) binding site. Starting from our previously discovered RNAP inhibitors, we managed to develop potent RT inhibitors effective against several resistant HIV-1 strains with maintained or enhanced RNAP inhibitory properties following a structure-based design approach. A quantitative structure-activity relationship (QSAR) analysis revealed distinct molecular features necessary for RT inhibition. Furthermore, mode of action (MoA) studies revealed that these compounds inhibit RT noncompetitively, through a new mechanism via closing of the RT clamp. In addition, the novel RNAP/RT inhibitors are characterized by a potent antibacterial activity against S. aureus and in cellulo antiretroviral activity against NNRTI-resistant strains. In HeLa and HEK 293 cells, the compounds showed only marginal cytotoxicity.
ENG
http://creativecommons.org/licenses/by-nc-sa/4.0/
Discovery and Structure-Based Optimization of 2-Ureidothiophene-3-carboxylic Acids as Dual Bacterial RNA Polymerase and Viral Reverse Transcriptase Inhibitors.
Article
2017-07-15T00:00:00Z
We are concerned with the development of novel anti-infectives with dual antibacterial and antiretroviral activities for MRSA/HIV-1 co-infection. To achieve this goal, we exploited for the first time the mechanistic function similarity between the bacterial RNA polymerase (RNAP) "switch region" and the viral non-nucleoside reverse transcriptase inhibitor (NNRTI) binding site. Starting from our previously discovered RNAP inhibitors, we managed to develop potent RT inhibitors effective against several resistant HIV-1 strains with maintained or enhanced RNAP inhibitory properties following a structure-based design approach. A quantitative structure-activity relationship (QSAR) analysis revealed distinct molecular features necessary for RT inhibition. Furthermore, mode of action (MoA) studies revealed that these compounds inhibit RT noncompetitively, through a new mechanism via closing of the RT clamp. In addition, the novel RNAP/RT inhibitors are characterized by a potent antibacterial activity against S. aureus and in cellulo antiretroviral activity against NNRTI-resistant strains. In HeLa and HEK 293 cells, the compounds showed only marginal cytotoxicity.
ORIGINAL
Elgaher et al.pdf
Elgaher et al.pdf
original manuscript
application/pdf
930463
https://hzi.openrepository.com/bitstream/10033/615909/1/Elgaher%20et%20al.pdf
6bf4ea2424a3e06afc2249026548d683
MD5
1
true
Supporting info.pdf
Supporting info.pdf
supporting information
application/pdf
2190700
https://hzi.openrepository.com/bitstream/10033/615909/2/Supporting%20info.pdf
c49ba3dd0256c014e13ac330c8303840
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/615909/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/615909/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/615909/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/615909/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Elgaher et al.pdf.txt
Elgaher et al.pdf.txt
Extracted Text
text/plain
62121
https://hzi.openrepository.com/bitstream/10033/615909/7/Elgaher%20et%20al.pdf.txt
d25bc66e3d4457c1a2baaf948f836add
MD5
7
false
Supporting info.pdf.txt
Supporting info.pdf.txt
Extracted Text
text/plain
12889
https://hzi.openrepository.com/bitstream/10033/615909/9/Supporting%20info.pdf.txt
952e76664bfdef0d8f97478670976d88
MD5
9
false
THUMBNAIL
Elgaher et al.pdf.jpg
Elgaher et al.pdf.jpg
Generated Thumbnail
image/jpeg
55814
https://hzi.openrepository.com/bitstream/10033/615909/11/Elgaher%20et%20al.pdf.jpg
862251800c309bc71bcded6a315a318a
MD5
11
false
Supporting info.pdf.jpg
Supporting info.pdf.jpg
Generated Thumbnail
image/jpeg
34995
https://hzi.openrepository.com/bitstream/10033/615909/12/Supporting%20info.pdf.jpg
b694aebf13b3e095ddb784d5496590ea
MD5
12
false
10033/615909
oai:hzi.openrepository.com:10033/615909
2019-08-30 11:30:58.621
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6185992019-08-30T11:35:39Zcom_10033_620656col_10033_620657
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Fruth, Martina
46b0fa794808411c2735c5f474c86cd6
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Avrutina, Olga
afbca2d8c5faf1b3d0c8664562bb2323
500
Hoßmann, Jörn
13017518dd07fc58640855c7e54b564e
500
Nadmid, Suvd
4773cc488b1b581970198834dd17edb6
500
Gorges, Jan
f1ac2c530eb86532c587b82ac8d06c67
500
Herrmann, Jennifer
fa0fef1bcbd5fcc22c343dc565ab4710
500
Kazmaier, Uli
718decfa86a7dd95ba4c1a6cd3bf8ebb
500
Dersch, Petra
500f0a5abfe1d165918adfd28d1a4df3
600
http://orcid.org/0000-0001-8177-3280
Müller, Rolf
38d0f8dc80ae572919b57a1e4d8baf29
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
German Centre for Infection Research (DZIF), PartnerSite Hannover-Braunschweig, 30625 Hannover, Germany.
2016-08-19T12:59:04Z
2016-08-19T12:59:04Z
2016-06
Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologies. 2016, 8 (9):931-47 Future Med Chem
1756-8927
27253623
10.4155/fmc-2016-0033
http://hdl.handle.net/10033/618599
Future medicinal chemistry
CsrA is a global post-transcriptional regulator protein affecting mRNA translation and/or stability. Widespread among bacteria, it is essential for their full virulence and thus represents a promising anti-infective drug target. Therefore, we aimed at the discovery of CsrA-RNA interaction inhibitors. Results & methodology: We followed two strategies: a screening of small molecules (A) and an RNA ligand-based approach (B). Using surface plasmon resonance-based binding and fluorescence polarization-based competition assays, (A) yielded seven small-molecule inhibitors, among them MM14 (IC50 of 4 µM). (B) resulted in RNA-based inhibitor GGARNA (IC50 of 113 µM).
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologies.
Article
2017-06-15T00:00:00Z
CsrA is a global post-transcriptional regulator protein affecting mRNA translation and/or stability. Widespread among bacteria, it is essential for their full virulence and thus represents a promising anti-infective drug target. Therefore, we aimed at the discovery of CsrA-RNA interaction inhibitors. Results & methodology: We followed two strategies: a screening of small molecules (A) and an RNA ligand-based approach (B). Using surface plasmon resonance-based binding and fluorescence polarization-based competition assays, (A) yielded seven small-molecule inhibitors, among them MM14 (IC50 of 4 µM). (B) resulted in RNA-based inhibitor GGARNA (IC50 of 113 µM).
ORIGINAL
Maurer et al.pdf
Maurer et al.pdf
original manuscript
application/pdf
1209197
https://hzi.openrepository.com/bitstream/10033/618599/1/Maurer%20et%20al.pdf
7ad0a9c073ff81bd1e3559cfe76e19bb
MD5
1
true
Maurer_supp info.pdf
Maurer_supp info.pdf
supplementary materials
application/pdf
1586997
https://hzi.openrepository.com/bitstream/10033/618599/2/Maurer_supp%20info.pdf
ef7dce60d67b2e2d08eb20179eec040c
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/618599/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/618599/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/618599/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/618599/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Maurer et al.pdf.txt
Maurer et al.pdf.txt
Extracted Text
text/plain
67832
https://hzi.openrepository.com/bitstream/10033/618599/7/Maurer%20et%20al.pdf.txt
ddadeabf251ce16c344445bf53f19162
MD5
7
false
Maurer_supp info.pdf.txt
Maurer_supp info.pdf.txt
Extracted Text
text/plain
24539
https://hzi.openrepository.com/bitstream/10033/618599/9/Maurer_supp%20info.pdf.txt
3c897e20aea1c0a4ed0ca25ed05d4b4d
MD5
9
false
THUMBNAIL
Maurer et al.pdf.jpg
Maurer et al.pdf.jpg
Generated Thumbnail
image/jpeg
57520
https://hzi.openrepository.com/bitstream/10033/618599/11/Maurer%20et%20al.pdf.jpg
0d44650d45516b5340e5c9ab76feca17
MD5
11
false
Maurer_supp info.pdf.jpg
Maurer_supp info.pdf.jpg
Generated Thumbnail
image/jpeg
59055
https://hzi.openrepository.com/bitstream/10033/618599/12/Maurer_supp%20info.pdf.jpg
029eb877c072a0cfa37bbe2ba979f95b
MD5
12
false
10033/618599
oai:hzi.openrepository.com:10033/618599
2019-08-30 11:35:39.636
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6205942019-08-30T11:34:48Zcom_10033_620656col_10033_620657
Thomann, Andreas
e515af4963c71ff3693be682e3be68b3
500
Brengel, Christian
dc4fc696a5fe75d5a07912d4d04b28af
500
Börger, Carsten
44582b1f9da955b2ee0e6776f6190853
500
Kail, Dagmar
9b4ebcf40c4275f3a471d45ef2d350ad
500
Steinbach, Anke
6444633e605cbf33469e9021f95820c0
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS),Saarland Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2016-11-25T11:41:20Z
2016-11-25T11:41:20Z
2016-11-21
Structure-Activity Relationships of 2-Sufonylpyrimidines as Quorum-Sensing Inhibitors to Tackle Biofilm Formation and eDNA Release of Pseudomonas aeruginosa. 2016, 11 (22):2522-2533 ChemMedChem
1860-7187
27731921
10.1002/cmdc.201600419
http://hdl.handle.net/10033/620594
ChemMedChem
Drug-resistant Pseudomonas aeruginosa (PA) strains are on the rise, making treatment with current antibiotics ineffective. Hence, circumventing resistance or restoring the activity of antibiotics by novel approaches is of high demand. Targeting the Pseudomonas quinolone signal quorum sensing (PQS-QS) system is an intriguing strategy to abolish PA pathogenicity without affecting the viability of the pathogen. Herein we report the structure-activity relationships of 2-sulfonylpyrimidines, which were previously identified as dual-target inhibitors of the PQS receptor PqsR and the PQS synthase PqsD. The SAR elucidation was guided by a combined approach using ligand efficiency and ligand lipophilicity efficiency to select the most promising compounds. In addition, the most effective inhibitors were rationally modified by the guidance of QSAR using Hansch analyses. Finally, these inhibitors showed the capacity to decrease biofilm mass and extracellular DNA, which are important determinants for antibiotic resistance.
ENG
http://creativecommons.org/licenses/by-nc-sa/4.0/
Structure-Activity Relationships of 2-Sufonylpyrimidines as Quorum-Sensing Inhibitors to Tackle Biofilm Formation and eDNA Release of Pseudomonas aeruginosa.
Article
2017-10-12T00:00:00Z
Drug-resistant Pseudomonas aeruginosa (PA) strains are on the rise, making treatment with current antibiotics ineffective. Hence, circumventing resistance or restoring the activity of antibiotics by novel approaches is of high demand. Targeting the Pseudomonas quinolone signal quorum sensing (PQS-QS) system is an intriguing strategy to abolish PA pathogenicity without affecting the viability of the pathogen. Herein we report the structure-activity relationships of 2-sulfonylpyrimidines, which were previously identified as dual-target inhibitors of the PQS receptor PqsR and the PQS synthase PqsD. The SAR elucidation was guided by a combined approach using ligand efficiency and ligand lipophilicity efficiency to select the most promising compounds. In addition, the most effective inhibitors were rationally modified by the guidance of QSAR using Hansch analyses. Finally, these inhibitors showed the capacity to decrease biofilm mass and extracellular DNA, which are important determinants for antibiotic resistance.
ORIGINAL
Manuscript 10-28-15.pdf
Manuscript 10-28-15.pdf
submitted manuscript
application/pdf
4543823
https://hzi.openrepository.com/bitstream/10033/620594/1/Manuscript%2010-28-15.pdf
dcac7d2805bfbfe359faf92fb58d0636
MD5
1
true
Supp 10-28-15.pdf
Supp 10-28-15.pdf
Supplemental material
application/pdf
2643416
https://hzi.openrepository.com/bitstream/10033/620594/2/Supp%2010-28-15.pdf
4be802bac9f82d9d8ef157ab3fafd99b
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/620594/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620594/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620594/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/620594/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Manuscript 10-28-15.pdf.txt
Manuscript 10-28-15.pdf.txt
Extracted Text
text/plain
59766
https://hzi.openrepository.com/bitstream/10033/620594/7/Manuscript%2010-28-15.pdf.txt
ec9cc6d4130c70ea5d6cd2655f731c6b
MD5
7
false
Supp 10-28-15.pdf.txt
Supp 10-28-15.pdf.txt
Extracted Text
text/plain
17148
https://hzi.openrepository.com/bitstream/10033/620594/9/Supp%2010-28-15.pdf.txt
d29568c9099eaaf5e9b902f7bf6c3c39
MD5
9
false
THUMBNAIL
Manuscript 10-28-15.pdf.jpg
Manuscript 10-28-15.pdf.jpg
Generated Thumbnail
image/jpeg
43215
https://hzi.openrepository.com/bitstream/10033/620594/11/Manuscript%2010-28-15.pdf.jpg
3efe8979cb659cd534eb248252ef4819
MD5
11
false
Supp 10-28-15.pdf.jpg
Supp 10-28-15.pdf.jpg
Generated Thumbnail
image/jpeg
68838
https://hzi.openrepository.com/bitstream/10033/620594/12/Supp%2010-28-15.pdf.jpg
08b9bebbe2279d5b16be3ee1edb38aba
MD5
12
false
10033/620594
oai:hzi.openrepository.com:10033/620594
2019-08-30 11:34:48.309
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6208052019-08-30T11:36:32Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Varrot, Annabelle
9f34f205cce62dce96f9cfa8be8d240f
500
Imberty, Anne
6e3e5ebf482abdb8033b0c4c8cfa10db
500
Künzler, Markus
3a9da4fff2b338b85cb9efa2a54263f9
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS),Saarland Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-02-03T11:38:00Z
2017-02-03T11:38:00Z
2016
O-Alkylated heavy atom carbohydrate probes for protein X-ray crystallography: Studies towards the synthesis of methyl 2-O-methyl-L-selenofucopyranoside. 2016, 12:2828-2833 Beilstein J Org Chem
28144356
10.3762/bjoc.12.282
http://hdl.handle.net/10033/620805
Beilstein journal of organic chemistry
Selenoglycosides are used as reactive glycosyl donors in the syntheses of oligosaccharides. In addition, such heavy atom analogs of natural glycosides are useful tools for structure determination of their lectin receptors using X-ray crystallography. Some lectins, e.g., members of the tectonin family, only bind to carbohydrate epitopes with O-alkylated ring hydroxy groups. In this context, we report the first synthesis of an O-methylated selenoglycoside, specifically methyl 2-O-methyl-L-selenofucopyranoside, a ligand of the lectin tectonin-2 from the mushroom Laccaria bicolor. The synthetic route required a strategic revision and further optimization due to the intrinsic lability of alkyl selenoglycosides, in particular for the labile fucose. Here, we describe a successful synthetic access to methyl 2-O-methyl-L-selenofucopyranoside in 9 linear steps and 26% overall yield starting from allyl L-fucopyranoside.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
O-Alkylated heavy atom carbohydrate probes for protein X-ray crystallography: Studies towards the synthesis of methyl 2-O-methyl-L-selenofucopyranoside.
Article
2018-06-12T22:56:38Z
Selenoglycosides are used as reactive glycosyl donors in the syntheses of oligosaccharides. In addition, such heavy atom analogs of natural glycosides are useful tools for structure determination of their lectin receptors using X-ray crystallography. Some lectins, e.g., members of the tectonin family, only bind to carbohydrate epitopes with O-alkylated ring hydroxy groups. In this context, we report the first synthesis of an O-methylated selenoglycoside, specifically methyl 2-O-methyl-L-selenofucopyranoside, a ligand of the lectin tectonin-2 from the mushroom Laccaria bicolor. The synthetic route required a strategic revision and further optimization due to the intrinsic lability of alkyl selenoglycosides, in particular for the labile fucose. Here, we describe a successful synthetic access to methyl 2-O-methyl-L-selenofucopyranoside in 9 linear steps and 26% overall yield starting from allyl L-fucopyranoside.
ORIGINAL
Sommer et al.pdf
Sommer et al.pdf
Open Access article
application/pdf
299351
https://hzi.openrepository.com/bitstream/10033/620805/1/Sommer%20et%20al.pdf
29d6795c57847d15e1be2dd768156d28
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/620805/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620805/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620805/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/620805/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Sommer et al.pdf.txt
Sommer et al.pdf.txt
Extracted Text
text/plain
26071
https://hzi.openrepository.com/bitstream/10033/620805/6/Sommer%20et%20al.pdf.txt
d333c377e5d5af8638366942ef881d36
MD5
6
false
THUMBNAIL
Sommer et al.pdf.jpg
Sommer et al.pdf.jpg
Generated Thumbnail
image/jpeg
62490
https://hzi.openrepository.com/bitstream/10033/620805/7/Sommer%20et%20al.pdf.jpg
47674924808f383efc02d71c38470a4e
MD5
7
false
10033/620805
oai:hzi.openrepository.com:10033/620805
2019-08-30 11:36:32.997
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6209172019-08-30T11:29:47Zcom_10033_620656col_10033_620657
Fazli, Mustafa
aa8c47c2935abb83934d0bd54d456275
500
Rybtke, Morten
193fbe3c1e83f0bfc8e030b07a949a4d
500
Steiner, Elisabeth
2eb7eb722b238194bdaae1668932d07d
500
Weidel, Elisabeth
6839ba8cfbc9408b9e94d895e029828f
500
Berthelsen, Jens
1cf38a816e9ee50b52a7969497c3ed05
500
Groizeleau, Julie
c2ab9b252c2bbf330e7e16dca16cea40
500
Bin, Wu
cddffa85a4ca1d9a3ba7068709c136bc
500
Zhi, Boo Zhao
a14d64dd51eed403d95b2fcaccaa42d1
500
Yaming, Zhang
fdc581496c7415f96a1f495fb2d3aad1
500
Kaever, Volkhard
c2c4019ccc1ba8201e6889532568e2e9
500
Givskov, Michael
163c965f237a78cc9248197c169600ba
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Eberl, Leo
d70055c701219454a96b8f175870af35
500
Tolker-Nielsen, Tim
3415ff027daf0903919e70733d37a593
600
http://orcid.org/0000-0002-9751-474X
Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-05-12T14:47:05Z
2017-05-12T14:47:05Z
2017-04-16
Regulation of Burkholderia cenocepacia biofilm formation by RpoN and the c-di-GMP effector BerB. 2017 Microbiologyopen
2045-8827
28419759
10.1002/mbo3.480
http://hdl.handle.net/10033/620917
MicrobiologyOpen
Knowledge about the molecular mechanisms that are involved in the regulation of biofilm formation is essential for the development of biofilm-control measures. It is well established that the nucleotide second messenger cyclic diguanosine monophosphate (c-di-GMP) is a positive regulator of biofilm formation in many bacteria, but more knowledge about c-di-GMP effectors is needed. We provide evidence that c-di-GMP, the alternative sigma factor RpoN (σ54), and the enhancer-binding protein BerB play a role in biofilm formation of Burkholderia cenocepacia by regulating the production of a biofilm-stabilizing exopolysaccharide. Our findings suggest that BerB binds c-di-GMP, and activates RpoN-dependent transcription of the berA gene coding for a c-di-GMP-responsive transcriptional regulator. An increased level of the BerA protein in turn induces the production of biofilm-stabilizing exopolysaccharide in response to high c-di-GMP levels. Our findings imply that the production of biofilm exopolysaccharide in B. cenocepacia is regulated through a cascade involving two consecutive transcription events that are both activated by c-di-GMP. This type of regulation may allow tight control of the expenditure of cellular resources.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Regulation of Burkholderia cenocepacia biofilm formation by RpoN and the c-di-GMP effector BerB.
Article
2018-06-12T23:13:31Z
Knowledge about the molecular mechanisms that are involved in the regulation of biofilm formation is essential for the development of biofilm-control measures. It is well established that the nucleotide second messenger cyclic diguanosine monophosphate (c-di-GMP) is a positive regulator of biofilm formation in many bacteria, but more knowledge about c-di-GMP effectors is needed. We provide evidence that c-di-GMP, the alternative sigma factor RpoN (σ54), and the enhancer-binding protein BerB play a role in biofilm formation of Burkholderia cenocepacia by regulating the production of a biofilm-stabilizing exopolysaccharide. Our findings suggest that BerB binds c-di-GMP, and activates RpoN-dependent transcription of the berA gene coding for a c-di-GMP-responsive transcriptional regulator. An increased level of the BerA protein in turn induces the production of biofilm-stabilizing exopolysaccharide in response to high c-di-GMP levels. Our findings imply that the production of biofilm exopolysaccharide in B. cenocepacia is regulated through a cascade involving two consecutive transcription events that are both activated by c-di-GMP. This type of regulation may allow tight control of the expenditure of cellular resources.
ORIGINAL
Fazli et al.pdf
Fazli et al.pdf
Open Access article
application/pdf
1160946
https://hzi.openrepository.com/bitstream/10033/620917/1/Fazli%20et%20al.pdf
10323d29f420c18bdc7d114671bb7655
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/620917/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620917/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620917/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/620917/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Fazli et al.pdf.txt
Fazli et al.pdf.txt
Extracted Text
text/plain
65524
https://hzi.openrepository.com/bitstream/10033/620917/6/Fazli%20et%20al.pdf.txt
3049b7f9591557020712c8035b9d8bf5
MD5
6
false
THUMBNAIL
Fazli et al.pdf.jpg
Fazli et al.pdf.jpg
Generated Thumbnail
image/jpeg
120333
https://hzi.openrepository.com/bitstream/10033/620917/7/Fazli%20et%20al.pdf.jpg
9cb8b1e8c3768ce2de2b054216b25200
MD5
7
false
10033/620917
oai:hzi.openrepository.com:10033/620917
2019-08-30 11:29:47.238
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/6209342019-08-30T11:33:57Zcom_10033_620656col_10033_620658
Torge, Afra
f47a76f1b21753e907419c2b891612fd
500
Wagner, Stefanie
935803ea3ccfe8267a16e098ea9a33bc
500
Chaves, Paula S
00b51e8b8b0544fed686d2d5bb836576
500
Oliveira, Edilene G
dea084c711c4f79e0b20e900cbf69ecd
500
Guterres, Silvia S
17e75f62199c7160466c6a431f32eae0
500
Pohlmann, Adriana R
e16c1ca732ed31574566522dec8a02c3
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
Schneider, Marc
993f7dd6db902d444eca4004f4281ba2
600
http://orcid.org/0000-0002-9260-7357
Beck, Ruy C R
ab77a720bfc973ddeede49bfa3439184
500
Helmholtz Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-06-06T14:47:00Z
2017-06-06T14:47:00Z
2017-05-10
Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis. 2017, 527 (1-2):92-102 Int J Pharm
1873-3476
28499793
10.1016/j.ijpharm.2017.05.013
http://hdl.handle.net/10033/620934
International journal of pharmaceutics
Treatment of bacterial airway infections is essential for cystic fibrosis therapy. However, effectiveness of antibacterial treatment is limited as bacteria inside the mucus are protected from antibiotics and immune response. To overcome this biological barrier, ciprofloxacin was loaded into lipid-core nanocapsules (LNC) for high mucus permeability, sustained release and antibacterial activity. Ciprofloxacin-loaded LNC with a mean size of 180nm showed a by 50% increased drug permeation through mucus. In bacterial growth assays, the drug in the LNC had similar minimum inhibitory concentrations as the free drug in P. aeruginosa and S. aureus. Interestingly, formation of biofilm-like aggregates, which were observed for S. aureus treated with free ciprofloxacin, was avoided by exposure to LNC. With the combined advantages over the non-encapsulated drug, ciprofloxacin-loaded LNC represent a promising drug delivery system with the prospect of an improved antibiotic therapy in cystic fibrosis.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis.
Article
2018-07-15T00:00:00Z
Treatment of bacterial airway infections is essential for cystic fibrosis therapy. However, effectiveness of antibacterial treatment is limited as bacteria inside the mucus are protected from antibiotics and immune response. To overcome this biological barrier, ciprofloxacin was loaded into lipid-core nanocapsules (LNC) for high mucus permeability, sustained release and antibacterial activity. Ciprofloxacin-loaded LNC with a mean size of 180nm showed a by 50% increased drug permeation through mucus. In bacterial growth assays, the drug in the LNC had similar minimum inhibitory concentrations as the free drug in P. aeruginosa and S. aureus. Interestingly, formation of biofilm-like aggregates, which were observed for S. aureus treated with free ciprofloxacin, was avoided by exposure to LNC. With the combined advantages over the non-encapsulated drug, ciprofloxacin-loaded LNC represent a promising drug delivery system with the prospect of an improved antibiotic therapy in cystic fibrosis.
ORIGINAL
Torge et al.pdf
Torge et al.pdf
original manuscript
application/pdf
32633494
https://hzi.openrepository.com/bitstream/10033/620934/1/Torge%20et%20al.pdf
ea20a37811cd5e42ffbf48147ca4d59b
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/620934/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620934/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620934/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/620934/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Torge et al.pdf.txt
Torge et al.pdf.txt
Extracted Text
text/plain
65309
https://hzi.openrepository.com/bitstream/10033/620934/6/Torge%20et%20al.pdf.txt
3fa0424fca8cbc739fa27a517dfe4857
MD5
6
false
THUMBNAIL
Torge et al.pdf.jpg
Torge et al.pdf.jpg
Generated Thumbnail
image/jpeg
45357
https://hzi.openrepository.com/bitstream/10033/620934/7/Torge%20et%20al.pdf.jpg
7c4c70acd89b5bd89c66468198a2712c
MD5
7
false
elsevier-thumbnail.png
application/octet-stream
54168
https://hzi.openrepository.com/bitstream/10033/620934/8/elsevier-thumbnail.png
0e8819c9d2ba71c80d44decad1c7a5eb
MD5
8
false
10033/620934
oai:hzi.openrepository.com:10033/620934
2019-08-30 11:33:57.352
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6209652019-08-30T11:34:22Zcom_10033_620656col_10033_620657
Allegretta, Giuseppe
7c3de38445707166591b1ef19f318cea
500
Maurer, Christine K
12a5217ca7d73a38490461cbb6cd9974
500
Eberhard, Jens
6e47660391fa40a4bc204e4a5244339a
500
Maura, Damien
2aa04936bb3132aa8c93c2933cf6486c
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Rahme, Laurence
8efec3f6d381b47f0b4e04320cff022a
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS),Saarland 9 University, 66123 Saarbrücken, Germany.
2017-06-21T08:51:17Z
2017-06-21T08:51:17Z
2017
In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor Treatment. 2017, 8:924 Front Microbiol
28596760
10.3389/fmicb.2017.00924
http://hdl.handle.net/10033/620965
Frontiers in microbiology
Pseudomonas aeruginosa is a Gram-negative bacterium, which causes opportunistic infections in immuno-compromised individuals. Due to its multiple resistances toward antibiotics, the development of new drugs is required. Interfering with Quorum Sensing (QS), a cell-to-cell communication system, has shown to be highly efficient in reducing P. aeruginosa pathogenicity. One of its QS systems employs Pseudomonas Quinolone Signal (PQS) and 4-hydroxy-2-heptylquinoline (HHQ) as signal molecules. Both activate the transcriptional regulator MvfR (Multiple Virulence Factor Regulator), also called PqsR, driving the production of QS molecules as well as toxins and biofilm formation. The aim of this work was to elucidate the effects of QS inhibitors (QSIs), such as MvfR antagonists and PqsBC inhibitors, on the biosynthesis of the MvfR-regulated small molecules 2'-aminoacetophenone (2-AA), dihydroxyquinoline (DHQ), HHQ, PQS, and 4-hydroxy-2-heptylquinoline-N-oxide (HQNO). The employed synthetic MvfR antagonist fully inhibited pqs small molecule formation showing expected sigmoidal dose-response curves for 2-AA, HQNO, HHQ and PQS. Surprisingly, DHQ levels were enhanced at lower antagonist concentrations followed by a full suppression at higher QSI amounts. This particular bi-phasic profile hinted at the accumulation of a biosynthetic intermediate resulting in the observed overproduction of the shunt product DHQ. Additionally, investigations on PqsBC inhibitors showed a reduction of MvfR natural ligands, while increased 2-AA, DHQ and HQNO levels compared to the untreated cells were detected. Moreover, PqsBC inhibitors did not show any significant effect in PA14 pqsC mutant demonstrating their target selectivity. As 2-AA is important for antibacterial tolerance, the QSIs were evaluated in their capability to attenuate persistence. Indeed, persister cells were reduced along with 2-AA inhibition resulting from MvfR antagonism, but not from PqsBC inhibition. In conclusion, antagonizing MvfR using a dosage capable of fully suppressing this QS system will lead to a favorable therapeutic outcome as DHQ overproduction is avoided and bacterial persistence is reduced.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor Treatment.
Article
2018-06-13T01:16:46Z
Pseudomonas aeruginosa is a Gram-negative bacterium, which causes opportunistic infections in immuno-compromised individuals. Due to its multiple resistances toward antibiotics, the development of new drugs is required. Interfering with Quorum Sensing (QS), a cell-to-cell communication system, has shown to be highly efficient in reducing P. aeruginosa pathogenicity. One of its QS systems employs Pseudomonas Quinolone Signal (PQS) and 4-hydroxy-2-heptylquinoline (HHQ) as signal molecules. Both activate the transcriptional regulator MvfR (Multiple Virulence Factor Regulator), also called PqsR, driving the production of QS molecules as well as toxins and biofilm formation. The aim of this work was to elucidate the effects of QS inhibitors (QSIs), such as MvfR antagonists and PqsBC inhibitors, on the biosynthesis of the MvfR-regulated small molecules 2'-aminoacetophenone (2-AA), dihydroxyquinoline (DHQ), HHQ, PQS, and 4-hydroxy-2-heptylquinoline-N-oxide (HQNO). The employed synthetic MvfR antagonist fully inhibited pqs small molecule formation showing expected sigmoidal dose-response curves for 2-AA, HQNO, HHQ and PQS. Surprisingly, DHQ levels were enhanced at lower antagonist concentrations followed by a full suppression at higher QSI amounts. This particular bi-phasic profile hinted at the accumulation of a biosynthetic intermediate resulting in the observed overproduction of the shunt product DHQ. Additionally, investigations on PqsBC inhibitors showed a reduction of MvfR natural ligands, while increased 2-AA, DHQ and HQNO levels compared to the untreated cells were detected. Moreover, PqsBC inhibitors did not show any significant effect in PA14 pqsC mutant demonstrating their target selectivity. As 2-AA is important for antibacterial tolerance, the QSIs were evaluated in their capability to attenuate persistence. Indeed, persister cells were reduced along with 2-AA inhibition resulting from MvfR antagonism, but not from PqsBC inhibition. In conclusion, antagonizing MvfR using a dosage capable of fully suppressing this QS system will lead to a favorable therapeutic outcome as DHQ overproduction is avoided and bacterial persistence is reduced.
ORIGINAL
Allegretta et al.pdf
Allegretta et al.pdf
Open Access publication
application/pdf
4910847
https://hzi.openrepository.com/bitstream/10033/620965/1/Allegretta%20et%20al.pdf
8779eba1a728a5b66f73662e8c783b37
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/620965/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620965/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/620965/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/620965/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Allegretta et al.pdf.txt
Allegretta et al.pdf.txt
Extracted Text
text/plain
50676
https://hzi.openrepository.com/bitstream/10033/620965/6/Allegretta%20et%20al.pdf.txt
2e075cacf8742baa94e91c776eea7864
MD5
6
false
THUMBNAIL
Allegretta et al.pdf.jpg
Allegretta et al.pdf.jpg
Generated Thumbnail
image/jpeg
134218
https://hzi.openrepository.com/bitstream/10033/620965/7/Allegretta%20et%20al.pdf.jpg
f36df68044b63f3868d81d2eae41333d
MD5
7
false
10033/620965
oai:hzi.openrepository.com:10033/620965
2019-08-30 11:34:22.358
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6210192019-08-30T11:26:42Zcom_10033_620656col_10033_620657
Schmitt, Christian
a5a74c2d0d6c3525d36a0b6c0e5420e4
500
Kail, Dagmar
9b4ebcf40c4275f3a471d45ef2d350ad
500
Mariano, Marica
fcfc4266e3eb665fe5531064d1832e50
500
Empting, Martin
4c7f3e8f45538c4ef6055bb98e57e2d8
500
Weber, Nadja
d883fcb4faf6b249aa84efaf10200775
500
Paul, Tamara
b3a0f31f90bee4235e3f4f06f0669c63
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Engel, Matthias
3ec141dda82defecef97cd49b8a79de5
500
Helmholtz Institute für Pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-07-25T13:56:49Z
2017-07-25T13:56:49Z
2014
Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors. 2014, 9 (3):e87851 PLoS ONE
1932-6203
24676346
10.1371/journal.pone.0087851
http://hdl.handle.net/10033/621019
PloS one
The Dyrk family of protein kinases is implicated in the pathogenesis of several diseases, including cancer and neurodegeneration. Pharmacological inhibitors were mainly described for Dyrk1A so far, but in fewer cases for Dyrk1B, Dyrk2 or other isoforms. Herein, we report the development and optimization of 2,4-bisheterocyclic substituted thiophenes as a novel class of Dyrk inhibitors. The optimized hit compounds displayed favorable pharmacokinetic properties and high ligand efficiencies, and inhibited Dyrk1B in intact cells. In a larger selectivity screen, only Clk1 and Clk4 were identified as additional targets of compound 48, but no other kinases frequently reported as off-targets. Interestingly, Dyrk1A is implicated in the regulation of alternative splicing, a function shared with Clk1/Clk4; thus, some of the dual inhibitors might be useful as efficient splicing modulators. A further compound (29) inhibited Dyrk1A and 1B with an IC50 of 130 nM, showing a moderate selectivity over Dyrk2. Since penetration of the central nervous system (CNS) seems possible based on the physicochemical properties, this compound might serve as a lead for the development of potential therapeutic agents against glioblastoma. Furthermore, an inhibitor selective for Dyrk2 (24) was also identified, which might be are suitable as a pharmacological tool to dissect Dyrk2 isoform-mediated functions.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Animals
Caspase 3
Caspase 7
Cell Line, Tumor
Cricetinae
Drug Design
Drug Evaluation, Preclinical
Drug Screening Assays, Antitumor
Gene Expression Regulation
Humans
Inhibitory Concentration 50
Models, Molecular
Molecular Conformation
Molecular Structure
Protein Kinase Inhibitors
Protein-Serine-Threonine Kinases
Protein-Tyrosine Kinases
Reactive Oxygen Species
Recombinant Fusion Proteins
Small Molecule Libraries
Structure-Activity Relationship
Thiophenes
Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors.
Article
2018-06-12T17:23:07Z
The Dyrk family of protein kinases is implicated in the pathogenesis of several diseases, including cancer and neurodegeneration. Pharmacological inhibitors were mainly described for Dyrk1A so far, but in fewer cases for Dyrk1B, Dyrk2 or other isoforms. Herein, we report the development and optimization of 2,4-bisheterocyclic substituted thiophenes as a novel class of Dyrk inhibitors. The optimized hit compounds displayed favorable pharmacokinetic properties and high ligand efficiencies, and inhibited Dyrk1B in intact cells. In a larger selectivity screen, only Clk1 and Clk4 were identified as additional targets of compound 48, but no other kinases frequently reported as off-targets. Interestingly, Dyrk1A is implicated in the regulation of alternative splicing, a function shared with Clk1/Clk4; thus, some of the dual inhibitors might be useful as efficient splicing modulators. A further compound (29) inhibited Dyrk1A and 1B with an IC50 of 130 nM, showing a moderate selectivity over Dyrk2. Since penetration of the central nervous system (CNS) seems possible based on the physicochemical properties, this compound might serve as a lead for the development of potential therapeutic agents against glioblastoma. Furthermore, an inhibitor selective for Dyrk2 (24) was also identified, which might be are suitable as a pharmacological tool to dissect Dyrk2 isoform-mediated functions.
ORIGINAL
Schmitt et al.PDF
Schmitt et al.PDF
Open Access publication
application/pdf
1065188
https://hzi.openrepository.com/bitstream/10033/621019/1/Schmitt%20et%20al.PDF
b0c69a4166a6e0ec3076ff29d83bd82b
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621019/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621019/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621019/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621019/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Schmitt et al.PDF.txt
Schmitt et al.PDF.txt
Extracted Text
text/plain
124713
https://hzi.openrepository.com/bitstream/10033/621019/6/Schmitt%20et%20al.PDF.txt
231a9a0a56235cea2e7f92b948296005
MD5
6
false
THUMBNAIL
Schmitt et al.PDF.jpg
Schmitt et al.PDF.jpg
Generated Thumbnail
image/jpeg
136752
https://hzi.openrepository.com/bitstream/10033/621019/7/Schmitt%20et%20al.PDF.jpg
252eb7eae0243048fbb2e463239f5410
MD5
7
false
10033/621019
oai:hzi.openrepository.com:10033/621019
2019-08-30 11:26:42.823
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6210892019-08-30T11:27:16Zcom_10033_620656col_10033_620657
Gobbi, Silvia
b3e9e17e2ac92f8f61d92d82f776effe
500
Hu, Qingzhong
cd531779e19f5186f085210e2d353f52
500
Zimmer, Christina
c24ecf919f6afc7468b5cba298a9c719
500
Belluti, Federica
17b2815ee8838344bff5cb49a8987c82
500
Rampa, Angela
945aa1ec7c5607698d5ac718da52dc80
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Bisi, Alessandra
bff2daa432078edee010451721c9e1d2
500
HIPS, Helmholtz Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-09-04T13:33:12Z
2017-09-04T13:33:12Z
2017-08-02
Drifting of heme-coordinating group in imidazolylmethylxanthones leading to improved selective inhibition of CYP11B1. 2017, 139:60-67 Eur J Med Chem
1768-3254
28797884
10.1016/j.ejmech.2017.07.078
http://hdl.handle.net/10033/621089
European journal of medicinal chemistry
An abnormal increase in glucocorticoid levels is responsible for pathological disorders affecting different organs and systems, and the selective inhibition of appropriate steroidogenic enzymes represents a validated strategy to restore their physiological levels. In continuing our studies on CYP11B inhibitors, in this paper a small series of 6-substituted 3-imidazolylmethylxanthones was designed and synthesized, according to the data acquired from previously reported series of derivatives and from a purposely-performed docking study. The new compounds proved to be potent inhibitors of CYP11B isoforms, being effective on CYP11B1 in the low nanomolar range and improving selectivity with respect to CYP11B2, compared to previously reported related compounds. These data further confirmed that a suitable mutual arrangement of the imidazolylmethyl pharmacophore and a properly selected substituent on the xanthone core allows a fine tuning of the activity towards the different CYPs and further corroborate the role of the xanthone scaffold as a privileged structure in this field.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Drifting of heme-coordinating group in imidazolylmethylxanthones leading to improved selective inhibition of CYP11B1.
Article
2018-10-20T00:00:00Z
An abnormal increase in glucocorticoid levels is responsible for pathological disorders affecting different organs and systems, and the selective inhibition of appropriate steroidogenic enzymes represents a validated strategy to restore their physiological levels. In continuing our studies on CYP11B inhibitors, in this paper a small series of 6-substituted 3-imidazolylmethylxanthones was designed and synthesized, according to the data acquired from previously reported series of derivatives and from a purposely-performed docking study. The new compounds proved to be potent inhibitors of CYP11B isoforms, being effective on CYP11B1 in the low nanomolar range and improving selectivity with respect to CYP11B2, compared to previously reported related compounds. These data further confirmed that a suitable mutual arrangement of the imidazolylmethyl pharmacophore and a properly selected substituent on the xanthone core allows a fine tuning of the activity towards the different CYPs and further corroborate the role of the xanthone scaffold as a privileged structure in this field.
ORIGINAL
Gobbi et al.pdf
Gobbi et al.pdf
original manuscript
application/pdf
517901
https://hzi.openrepository.com/bitstream/10033/621089/1/Gobbi%20et%20al.pdf
f316e87e5abed2fcd1cba7fb5adc3262
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621089/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621089/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621089/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621089/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Gobbi et al.pdf.txt
Gobbi et al.pdf.txt
Extracted Text
text/plain
39224
https://hzi.openrepository.com/bitstream/10033/621089/6/Gobbi%20et%20al.pdf.txt
0e996b11c9c96e27bffb6b58168d4875
MD5
6
false
THUMBNAIL
Gobbi et al.pdf.jpg
Gobbi et al.pdf.jpg
Generated Thumbnail
image/jpeg
30926
https://hzi.openrepository.com/bitstream/10033/621089/7/Gobbi%20et%20al.pdf.jpg
4334376f7dd2cef896ec33fec558c279
MD5
7
false
elsevier-thumbnail.png
application/octet-stream
56195
https://hzi.openrepository.com/bitstream/10033/621089/8/elsevier-thumbnail.png
e718cf64ef73045b05912f510d56b29b
MD5
8
false
10033/621089
oai:hzi.openrepository.com:10033/621089
2019-08-30 11:27:16.383
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6211122019-08-30T11:33:05Zcom_10033_620656col_10033_620657
Kamal, Ahmed A M
432d57b5b4747f75dd2ffdf78c56c68e
500
Petrera, Lucia
e1afb880134ae042fd01ee3d9851155f
500
Eberhard, Jens
6e47660391fa40a4bc204e4a5244339a
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Helmholtz-Institu für pharmazeutische Forschung Saarland,, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-09-18T12:58:35Z
2017-09-18T12:58:35Z
2017-05-31
Structure-functionality relationship and pharmacological profiles of Pseudomonas aeruginosa alkylquinolone quorum sensing modulators. 2017, 15 (21):4620-4630 Org. Biomol. Chem.
1477-0539
28513746
10.1039/c7ob00263g
http://hdl.handle.net/10033/621112
Organic & biomolecular chemistry
An important paradigm in anti-infective research is the antivirulence concept. Pathoblockers are compounds which disarm bacteria of their arsenal of virulence factors. PqsR is a transcriptional regulator controlling the production of such factors in Pseudomonas aeruginosa, most prominently pyocyanin. In this work, a series of tool compounds based on the structure of the natural ligand 2-heptyl-4-quinolone (HHQ) were used for probing the structure-functionality relationship. Four different profiles are identified namely agonists, antagonists, inverse agonists and biphasic modulators. Molecular docking studies revealed that each class of the PqsR modulators showed distinctive interactions in the PqsR binding domain. It was found that the substituents in position 3 of the quinolone core act as a switch between the different profiles, according to their ability to donate or accept a hydrogen bond, or form a hydrophobic interaction. Finally, it was shown that only inverse agonists were able to strongly inhibit pyocyanin production.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Structure-functionality relationship and pharmacological profiles of Pseudomonas aeruginosa alkylquinolone quorum sensing modulators.
Article
2018-05-05T00:00:00Z
An important paradigm in anti-infective research is the antivirulence concept. Pathoblockers are compounds which disarm bacteria of their arsenal of virulence factors. PqsR is a transcriptional regulator controlling the production of such factors in Pseudomonas aeruginosa, most prominently pyocyanin. In this work, a series of tool compounds based on the structure of the natural ligand 2-heptyl-4-quinolone (HHQ) were used for probing the structure-functionality relationship. Four different profiles are identified namely agonists, antagonists, inverse agonists and biphasic modulators. Molecular docking studies revealed that each class of the PqsR modulators showed distinctive interactions in the PqsR binding domain. It was found that the substituents in position 3 of the quinolone core act as a switch between the different profiles, according to their ability to donate or accept a hydrogen bond, or form a hydrophobic interaction. Finally, it was shown that only inverse agonists were able to strongly inhibit pyocyanin production.
ORIGINAL
Kamal et al.pdf
Kamal et al.pdf
original manuscript
application/pdf
5623359
https://hzi.openrepository.com/bitstream/10033/621112/1/Kamal%20et%20al.pdf
9d7b999ae1dbe5ff4975ad212d377cbb
MD5
1
true
supporting_info.pdf
supporting_info.pdf
supporting information
application/pdf
6595588
https://hzi.openrepository.com/bitstream/10033/621112/2/supporting_info.pdf
7372ac9a494b3ca681a38fccb14c1730
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621112/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621112/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621112/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621112/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Kamal et al.pdf.txt
Kamal et al.pdf.txt
Extracted Text
text/plain
39332
https://hzi.openrepository.com/bitstream/10033/621112/7/Kamal%20et%20al.pdf.txt
50b0463caff9ee7f131673dbd653b9b5
MD5
7
false
supporting_info.pdf.txt
supporting_info.pdf.txt
Extracted Text
text/plain
30823
https://hzi.openrepository.com/bitstream/10033/621112/9/supporting_info.pdf.txt
225ea702fc12e8f7d44a43ad69839976
MD5
9
false
THUMBNAIL
Kamal et al.pdf.jpg
Kamal et al.pdf.jpg
Generated Thumbnail
image/jpeg
26637
https://hzi.openrepository.com/bitstream/10033/621112/11/Kamal%20et%20al.pdf.jpg
f0837f6f085287aef831c2e2994fac79
MD5
11
false
supporting_info.pdf.jpg
supporting_info.pdf.jpg
Generated Thumbnail
image/jpeg
30755
https://hzi.openrepository.com/bitstream/10033/621112/12/supporting_info.pdf.jpg
be43b528aeaacbb92a4b18063cf81130
MD5
12
false
10033/621112
oai:hzi.openrepository.com:10033/621112
2019-08-30 11:33:05.431
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6211232019-08-30T11:31:49Zcom_10033_620656col_10033_620657
Könning, Doreen
6f537485003509929c083debb4bd4655
500
Rhiel, Laura
6340c3817533e0057b4752269009bafe
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Grzeschik, Julius
898ef13fcc0aaa56b04e030dec15e69e
500
Sellmann, Carolin
5f359ffc286c372a977b9c3f177f5bea
500
Schröter, Christian
d57b5b77843f572353fe6f682ee4beba
500
Zielonka, Stefan
147ce198439d89a72cedec64c5424535
500
Dickgießer, Stephan
a96a23a5668d5f32dd6627a9b86c7744
500
Pirzer, Thomas
28c7b5388e618f7efa1f21a1296e92e7
500
Yanakieva, Desislava
b8026263d491ac37990d0cd60e2b28f5
500
Becker, Stefan
3ce33b119656cf91f4002d7b81831889
500
Kolmar, Harald
99594f33693a836f3064a4ab58294d07
600
http://orcid.org/0000-0002-8210-1993
Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-09-26T13:22:25Z
2017-09-26T13:22:25Z
2017-08-29
Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders. 2017, 7 (1):9676 Sci Rep
2045-2322
28852148
10.1038/s41598-017-10513-9
http://hdl.handle.net/10033/621123
Scientific reports
Anti-idiotypic binders which specifically recognize the variable region of monoclonal antibodies have proven to be robust tools for pharmacokinetic studies of antibody therapeutics and for the development of cancer vaccines. In the present investigation, we focused on the identification of anti-idiotypic, shark-derived IgNAR antibody variable domains (vNARs) targeting the therapeutic antibodies matuzumab and cetuximab for the purpose of developing specific capturing ligands. Using yeast surface display and semi-synthetic, CDR3-randomized libraries, we identified several highly specific binders targeting both therapeutic antibodies in their corresponding variable region, without applying any counter selections during screening. Importantly, anti-idiotypic vNAR binders were not cross-reactive towards cetuximab or matuzumab, respectively, and comprised good target recognition in the presence of human and mouse serum. When coupled to magnetic beads, anti-idiotypic vNAR variants could be used as efficient capturing tools. Moreover, a two-step procedure involving vNAR-functionalized beads was employed for the enrichment of potentially bispecific cetuximab × matuzumab antibody constructs. In conclusion, semi-synthetic and CDR3-randomized vNAR libraries in combination with yeast display enable the fast and facile identification of anti-idiotypic vNAR domains targeting monoclonal antibodies primarily in an anti-idiotypic manner.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Semi-synthetic vNAR libraries screened against therapeutic antibodies primarily deliver anti-idiotypic binders.
Article
2018-06-13T02:43:44Z
Anti-idiotypic binders which specifically recognize the variable region of monoclonal antibodies have proven to be robust tools for pharmacokinetic studies of antibody therapeutics and for the development of cancer vaccines. In the present investigation, we focused on the identification of anti-idiotypic, shark-derived IgNAR antibody variable domains (vNARs) targeting the therapeutic antibodies matuzumab and cetuximab for the purpose of developing specific capturing ligands. Using yeast surface display and semi-synthetic, CDR3-randomized libraries, we identified several highly specific binders targeting both therapeutic antibodies in their corresponding variable region, without applying any counter selections during screening. Importantly, anti-idiotypic vNAR binders were not cross-reactive towards cetuximab or matuzumab, respectively, and comprised good target recognition in the presence of human and mouse serum. When coupled to magnetic beads, anti-idiotypic vNAR variants could be used as efficient capturing tools. Moreover, a two-step procedure involving vNAR-functionalized beads was employed for the enrichment of potentially bispecific cetuximab × matuzumab antibody constructs. In conclusion, semi-synthetic and CDR3-randomized vNAR libraries in combination with yeast display enable the fast and facile identification of anti-idiotypic vNAR domains targeting monoclonal antibodies primarily in an anti-idiotypic manner.
ORIGINAL
Könning et al.pdf
Könning et al.pdf
Open Access publication
application/pdf
3081241
https://hzi.openrepository.com/bitstream/10033/621123/1/K%c3%b6nning%20et%20al.pdf
55336ab99ed07de813b4bbe048505f18
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621123/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621123/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621123/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621123/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Könning et al.pdf.txt
Könning et al.pdf.txt
Extracted Text
text/plain
66215
https://hzi.openrepository.com/bitstream/10033/621123/6/K%c3%b6nning%20et%20al.pdf.txt
3e6d03da8cd3809b6b06500a47af00c2
MD5
6
false
THUMBNAIL
Könning et al.pdf.jpg
Könning et al.pdf.jpg
Generated Thumbnail
image/jpeg
115564
https://hzi.openrepository.com/bitstream/10033/621123/7/K%c3%b6nning%20et%20al.pdf.jpg
8d5061f081009893cc37d363bf9c4ec5
MD5
7
false
10033/621123
oai:hzi.openrepository.com:10033/621123
2019-08-30 11:31:49.522
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6211472019-08-30T11:31:23Zcom_10033_620656col_10033_620657
Liu, Yun
e148ddb574b0a675169cb05962250b43
500
Stuart, Marc C A
f26ac8e940ccec5e290ed2e7eb80677c
500
Witte, Martin D
1d38a67f156c4d6ac439ed7c55bb81d0
500
Buhler, Eric
c7a0c57d44216a87525e7a6cacaf751d
500
Hirsch, Anna K H
70f0ddf29d27965af55122735e5b86d2
500
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Universitycampus E8.1, 66123 Saarbrücken, Germany.
2017-11-01T08:31:27Z
2017-11-01T08:31:27Z
2017-10-05
Saccharide-Containing Dynamic Proteoids. 2017 Chemistry
1521-3765
28981987
10.1002/chem.201703584
http://hdl.handle.net/10033/621147
Chemistry (Weinheim an der Bergstrasse, Germany)
Dynamic proteoids are dynamic covalent analogues of proteins, which can be used as new adaptive biomaterials. We designed and synthesized a range of sugar-containing dynamic proteoid biodynamers based on the polycondensation of different types of amino acid and dipeptide hydrazides with a biological aliphatic dialdehyde and a nonbiological aromatic dialdehyde. By using the saccharide-based dialdehyde, the biocompatibility of biodynamers should be enhanced compared to previously reported biodynamers.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Saccharide-Containing Dynamic Proteoids.
Article
2018-06-13T00:01:46Z
Dynamic proteoids are dynamic covalent analogues of proteins, which can be used as new adaptive biomaterials. We designed and synthesized a range of sugar-containing dynamic proteoid biodynamers based on the polycondensation of different types of amino acid and dipeptide hydrazides with a biological aliphatic dialdehyde and a nonbiological aromatic dialdehyde. By using the saccharide-based dialdehyde, the biocompatibility of biodynamers should be enhanced compared to previously reported biodynamers.
ORIGINAL
Liu et al.pdf
Liu et al.pdf
Open Access article
application/pdf
371716
https://hzi.openrepository.com/bitstream/10033/621147/1/Liu%20et%20al.pdf
f8eb32f189b278282a55fd902d3bae53
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621147/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621147/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621147/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621147/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Liu et al.pdf.txt
Liu et al.pdf.txt
Extracted Text
text/plain
23035
https://hzi.openrepository.com/bitstream/10033/621147/6/Liu%20et%20al.pdf.txt
f874c33c83b36244f9b238268ba2803b
MD5
6
false
THUMBNAIL
Liu et al.pdf.jpg
Liu et al.pdf.jpg
Generated Thumbnail
image/jpeg
112964
https://hzi.openrepository.com/bitstream/10033/621147/7/Liu%20et%20al.pdf.jpg
2d02386740c4183495ac210d31556a00
MD5
7
false
10033/621147
oai:hzi.openrepository.com:10033/621147
2019-08-30 11:31:23.439
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6211482019-08-30T11:33:29Zcom_10033_620656col_10033_620658
Beshr, Ghamdan
bd56df65fbfa89ea13c42f39acb82f8f
500
Sikandar, Asfandyar
87ab98d890c55d6a1ab1b1fec77b3c5b
500
Jemiller, Eva-Maria
eeda2c8ef0355632c8da1abf3f653022
500
Klymiuk, Nikolai
c9f463ef2fbfffdc8c3f624750c69624
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Wagner, Stefanie
935803ea3ccfe8267a16e098ea9a33bc
500
Wolf, Eckhard
4a3ef835783339091bb13660cb902cc5
500
Koehnke, Jesko
35bf90b1c02ee8378c1ab05e7863bb15
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Universitycampus E8.1, 66123 Saarbrücken, Germany.
2017-11-01T10:37:09Z
2017-11-01T10:37:09Z
2017-09-28
Photorhabdus luminescens lectin A (PllA) - a new probe for detecting α-galactoside-terminating glycoconjugates. 2017 J. Biol. Chem.
1083-351X
28972138
10.1074/jbc.M117.812792
http://hdl.handle.net/10033/621148
The Journal of biological chemistry
Lectins play important roles in infections by pathogenic bacteria, for example, in host colonization, persistence and biofilm formation. The Gram-negative entomopathogenic bacterium Photorhabdus luminescens symbiotically lives in insect-infecting Heterorhabditis nematodes and kills the insect host upon invasion by the nematode. The P. luminescens genome harbors the gene plu2096 coding for a novel lectin that we named PllA. We analyzed the binding properties of purified PllA with a glycan array and a binding assay in solution. Both assays revealed a strict specificity of PllA for alpha-galactoside-terminating glycoconjugates. The crystal structures of apo PllA and complexes with three different ligands revealed the molecular basis for the strict specificity of this lectin. Furthermore, we found that a 90 degree twist in subunit orientation leads to a peculiar quaternary structure compared with that of its ortholog LecA from Pseudomonas aeruginosa. We also investigated the utility of PllA as a probe for detecting alpha-galactosides. The alpha-Gal epitope is present on wild-type pig cells and the main reason for hyperacute organ rejection in pig to primate xenotransplantation. We noted that PllA specifically recognizes this epitope on the glycan array and demonstrated that PllA can be used as a fluorescent probe to detect this epitope on primary porcine cells in vitro. In summary, our biochemical and structural analyses of the P. luminescens lectin PllA have disclosed the structural basis for PllAs high specificity for alpha-galactoside-containing ligands, and we show that PllA can be used to visualize alpha-Gal epitope on porcine tissues.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Photorhabdus luminescens lectin A (PllA) - a new probe for detecting α-galactoside-terminating glycoconjugates.
Article
Lectins play important roles in infections by pathogenic bacteria, for example, in host colonization, persistence and biofilm formation. The Gram-negative entomopathogenic bacterium Photorhabdus luminescens symbiotically lives in insect-infecting Heterorhabditis nematodes and kills the insect host upon invasion by the nematode. The P. luminescens genome harbors the gene plu2096 coding for a novel lectin that we named PllA. We analyzed the binding properties of purified PllA with a glycan array and a binding assay in solution. Both assays revealed a strict specificity of PllA for alpha-galactoside-terminating glycoconjugates. The crystal structures of apo PllA and complexes with three different ligands revealed the molecular basis for the strict specificity of this lectin. Furthermore, we found that a 90 degree twist in subunit orientation leads to a peculiar quaternary structure compared with that of its ortholog LecA from Pseudomonas aeruginosa. We also investigated the utility of PllA as a probe for detecting alpha-galactosides. The alpha-Gal epitope is present on wild-type pig cells and the main reason for hyperacute organ rejection in pig to primate xenotransplantation. We noted that PllA specifically recognizes this epitope on the glycan array and demonstrated that PllA can be used as a fluorescent probe to detect this epitope on primary porcine cells in vitro. In summary, our biochemical and structural analyses of the P. luminescens lectin PllA have disclosed the structural basis for PllAs high specificity for alpha-galactoside-containing ligands, and we show that PllA can be used to visualize alpha-Gal epitope on porcine tissues.
ORIGINAL
Beshr et al.pdf
Beshr et al.pdf
allowed publisher's PDF
application/pdf
17585372
https://hzi.openrepository.com/bitstream/10033/621148/1/Beshr%20et%20al.pdf
5017d1f32e129c80e133f4b6cff81800
MD5
1
true
PllA-SI-rev.pdf
PllA-SI-rev.pdf
supporting information
application/pdf
6186537
https://hzi.openrepository.com/bitstream/10033/621148/8/PllA-SI-rev.pdf
da2807dd15a0d99b7186e4f36d257b9f
MD5
8
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621148/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621148/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621148/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621148/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Beshr et al.pdf.txt
Beshr et al.pdf.txt
Extracted Text
text/plain
80327
https://hzi.openrepository.com/bitstream/10033/621148/6/Beshr%20et%20al.pdf.txt
52ab349b4611652a9bca9d7c50558cf4
MD5
6
false
PllA-SI-rev.pdf.txt
PllA-SI-rev.pdf.txt
Extracted Text
text/plain
12026
https://hzi.openrepository.com/bitstream/10033/621148/9/PllA-SI-rev.pdf.txt
ecc0abf4faea381b8408c7c30016a7e4
MD5
9
false
THUMBNAIL
Beshr et al.pdf.jpg
Beshr et al.pdf.jpg
Generated Thumbnail
image/jpeg
51071
https://hzi.openrepository.com/bitstream/10033/621148/11/Beshr%20et%20al.pdf.jpg
9190164cb4f95c2da5ec1a1216178f98
MD5
11
false
PllA-SI-rev.pdf.jpg
PllA-SI-rev.pdf.jpg
Generated Thumbnail
image/jpeg
31053
https://hzi.openrepository.com/bitstream/10033/621148/12/PllA-SI-rev.pdf.jpg
0803d8876045e3b8c79ed87c49b4548e
MD5
12
false
10033/621148
oai:hzi.openrepository.com:10033/621148
2019-08-30 11:33:29.837
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6211532019-08-30T11:31:23Zcom_10033_620656col_10033_620657
Schönauer, Esther
eec9d89662b27e1d4bdf9be0871066c8
500
Kany, Andreas M
3943517b65d530c81b68b50b2b7c90f1
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Hüsecken, Kristina
1876aa3840f04eea455734ab44933bb5
500
Hoppe, Isabel J
5205f32c294890512ca489f7990bd6cd
500
Voos, Katrin
04baef8c2d59645a6018b262144ed376
500
Yahiaoui, Samir
0cbc77c6465a4e936355fac763960cb4
500
Elsässer, Brigitta
cbdf136592d1104ee65b5bbbd0fc71e0
500
Ducho, Christian
389a152847e99ac0ee1394fdacfefb12
500
Brandstetter, Hans
227299c6d6e3fae03878dd674854779e
500
Hartmann, Rolf W.
44ed5f9bff9a26556b217cf464ef1ba1
500
Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-11-02T10:29:34Z
2017-11-02T10:29:34Z
2017-09-13
Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases. 2017, 139 (36):12696-12703 J. Am. Chem. Soc.
1520-5126
28820255
10.1021/jacs.7b06935
http://hdl.handle.net/10033/621153
Journal of the American Chemical Society
Secreted virulence factors like bacterial collagenases are conceptually attractive targets for fighting microbial infections. However, previous attempts to develop potent compounds against these metalloproteases failed to achieve selectivity against human matrix metalloproteinases (MMPs). Using a surface plasmon resonance-based screening complemented with enzyme inhibition assays, we discovered an N-aryl mercaptoacetamide-based inhibitor scaffold that showed sub-micromolar affinities toward collagenase H (ColH) from the human pathogen Clostridium histolyticum. Moreover, these inhibitors also efficiently blocked the homologous bacterial collagenases, ColG from C. histolyticum, ColT from C. tetani, and ColQ1 from the Bacillus cereus strain Q1, while showing negligible activity toward human MMPs-1, -2, -3, -7, -8, and -14. The most active compound displayed a more than 1000-fold selectivity over human MMPs. This selectivity can be rationalized by the crystal structure of ColH with this compound, revealing a distinct non-primed binding mode to the active site. The non-primed binding mode presented here paves the way for the development of selective broad-spectrum bacterial collagenase inhibitors with potential therapeutic application in humans.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases.
Article
2018-06-13T01:19:46Z
Secreted virulence factors like bacterial collagenases are conceptually attractive targets for fighting microbial infections. However, previous attempts to develop potent compounds against these metalloproteases failed to achieve selectivity against human matrix metalloproteinases (MMPs). Using a surface plasmon resonance-based screening complemented with enzyme inhibition assays, we discovered an N-aryl mercaptoacetamide-based inhibitor scaffold that showed sub-micromolar affinities toward collagenase H (ColH) from the human pathogen Clostridium histolyticum. Moreover, these inhibitors also efficiently blocked the homologous bacterial collagenases, ColG from C. histolyticum, ColT from C. tetani, and ColQ1 from the Bacillus cereus strain Q1, while showing negligible activity toward human MMPs-1, -2, -3, -7, -8, and -14. The most active compound displayed a more than 1000-fold selectivity over human MMPs. This selectivity can be rationalized by the crystal structure of ColH with this compound, revealing a distinct non-primed binding mode to the active site. The non-primed binding mode presented here paves the way for the development of selective broad-spectrum bacterial collagenase inhibitors with potential therapeutic application in humans.
ORIGINAL
Schönauer et al.pdf
Schönauer et al.pdf
Open Access article
application/pdf
2455776
https://hzi.openrepository.com/bitstream/10033/621153/1/Sch%c3%b6nauer%20et%20al.pdf
9249acf63e26af4bae51963e30ab0fd8
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621153/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621153/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621153/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621153/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Schönauer et al.pdf.txt
Schönauer et al.pdf.txt
Extracted Text
text/plain
42592
https://hzi.openrepository.com/bitstream/10033/621153/6/Sch%c3%b6nauer%20et%20al.pdf.txt
5bc07f962c75af474c693bef82c191ce
MD5
6
false
THUMBNAIL
Schönauer et al.pdf.jpg
Schönauer et al.pdf.jpg
Generated Thumbnail
image/jpeg
135842
https://hzi.openrepository.com/bitstream/10033/621153/7/Sch%c3%b6nauer%20et%20al.pdf.jpg
f5994a91f8d51ab1fd1e57d3d3a0cdc1
MD5
7
false
10033/621153
oai:hzi.openrepository.com:10033/621153
2019-08-30 11:31:23.473
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6211712019-08-30T11:33:05Zcom_10033_620656col_10033_620657
Monjas, Leticia
74bda1de19bcb74c4eb5ba960bb0147a
500
Swier, Lotteke J Y M
6b7bbea48e0a0c871458b7438957e56e
500
Setyawati, Inda
3c0051eef1bd7eb7a1691d7f902885ed
500
Slotboom, Dirk J
57b909c95c97ddef3ea699f1f8a58a3c
500
Hirsch, Anna K H
70f0ddf29d27965af55122735e5b86d2
500
Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus E9.1, 66123 Saarbrücken, Germany.
2017-11-08T13:08:39Z
2017-11-08T13:08:39Z
2017-10-20
Dynamic Combinatorial Chemistry to Identify Binders of ThiT, an S-Component of the Energy-Coupling Factor Transporter for Thiamine. 2017, 12 (20):1693-1696 ChemMedChem
1860-7187
28960943
10.1002/cmdc.201700440
http://hdl.handle.net/10033/621171
ChemMedChem
We applied dynamic combinatorial chemistry (DCC) to identify ligands of ThiT, the S-component of the energy-coupling factor (ECF) transporter for thiamine in Lactococcus lactis. We used a pre-equilibrated dynamic combinatorial library (DCL) and saturation-transfer difference (STD) NMR spectroscopy to identify ligands of ThiT. This is the first report in which DCC is used for fragment growing to an ill-defined pocket, and one of the first reports for its application with an integral membrane protein as target.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
ATP-Binding Cassette Transporters
Bacterial Proteins
Biological Transport
Carrier Proteins
Combinatorial Chemistry Techniques
Drug Design
Lactococcus lactis
Models, Molecular
Molecular Structure
Protein Subunits
Small Molecule Libraries
Thiamine
Dynamic Combinatorial Chemistry to Identify Binders of ThiT, an S-Component of the Energy-Coupling Factor Transporter for Thiamine.
Article
2018-06-13T14:07:13Z
We applied dynamic combinatorial chemistry (DCC) to identify ligands of ThiT, the S-component of the energy-coupling factor (ECF) transporter for thiamine in Lactococcus lactis. We used a pre-equilibrated dynamic combinatorial library (DCL) and saturation-transfer difference (STD) NMR spectroscopy to identify ligands of ThiT. This is the first report in which DCC is used for fragment growing to an ill-defined pocket, and one of the first reports for its application with an integral membrane protein as target.
ORIGINAL
Monjas et al.pdf
Monjas et al.pdf
Open Access article
application/pdf
527034
https://hzi.openrepository.com/bitstream/10033/621171/1/Monjas%20et%20al.pdf
313ad22fb876b14cc53a60f845dee4db
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621171/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621171/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621171/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621171/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Monjas et al.pdf.txt
Monjas et al.pdf.txt
Extracted Text
text/plain
17012
https://hzi.openrepository.com/bitstream/10033/621171/6/Monjas%20et%20al.pdf.txt
1602229df081b9bcaf40d37c37c7e4d5
MD5
6
false
THUMBNAIL
Monjas et al.pdf.jpg
Monjas et al.pdf.jpg
Generated Thumbnail
image/jpeg
159613
https://hzi.openrepository.com/bitstream/10033/621171/7/Monjas%20et%20al.pdf.jpg
fbc4f37f530ffc6571d9faaba6ec4af0
MD5
7
false
10033/621171
oai:hzi.openrepository.com:10033/621171
2019-08-30 11:33:05.259
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6212122019-08-30T11:34:22Zcom_10033_620656com_10033_620618col_10033_620658col_10033_620619
Wagner, Stefanie
935803ea3ccfe8267a16e098ea9a33bc
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Hoffmann, Michael
92e64254695f90b833f87eb64410f486
500
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Joachim, Ines
e3e184873e8376884d46e8a942d2d271
500
Müller, Rolf
09acbdcf20401224eb516fdf40681973
600
http://orcid.org/0000-0002-1042-5665
Imberty, Anne
6e3e5ebf482abdb8033b0c4c8cfa10db
500
Varrot, Annabelle
9f34f205cce62dce96f9cfa8be8d240f
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
HIPS, Helmholtz-Institut für pharmazeutische Forchung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2017-12-20T10:44:14Z
2017-12-20T10:44:14Z
2017-09-28
Covalent Lectin Inhibition and Application in Bacterial Biofilm Imaging. 2017 Angew. Chem. Int. Ed. Engl.
1521-3773
28960731
10.1002/anie.201709368
http://hdl.handle.net/10033/621212
Angewandte Chemie (International ed. in English)
Biofilm formation by pathogenic bacteria is a hallmark of chronic infections. In many cases, lectins play key roles in establishing biofilms. The pathogen Pseudomonas aeruginosa often exhibiting various drug resistances employs its lectins LecA and LecB as virulence factors and biofilm building blocks. Therefore, inhibition of the function of these proteins is thought to have potential in developing "pathoblockers" preventing biofilm formation and virulence. A covalent lectin inhibitor specific to a carbohydrate binding site is described for the first time. Its application in the LecA-specific in vitro imaging of biofilms formed by P. aeruginosa is also reported.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Covalent Lectin Inhibition and Application in Bacterial Biofilm Imaging.
Article
Biofilm formation by pathogenic bacteria is a hallmark of chronic infections. In many cases, lectins play key roles in establishing biofilms. The pathogen Pseudomonas aeruginosa often exhibiting various drug resistances employs its lectins LecA and LecB as virulence factors and biofilm building blocks. Therefore, inhibition of the function of these proteins is thought to have potential in developing "pathoblockers" preventing biofilm formation and virulence. A covalent lectin inhibitor specific to a carbohydrate binding site is described for the first time. Its application in the LecA-specific in vitro imaging of biofilms formed by P. aeruginosa is also reported.
ORIGINAL
Wagner et al_.pdf
Wagner et al_.pdf
original manuscript
application/pdf
1817069
https://hzi.openrepository.com/bitstream/10033/621212/1/Wagner%20et%20al_.pdf
86bb6e8cf5f20e38103ac1b4320a31bf
MD5
1
true
_Epoxides-SupportingInformation_final-experimental-V5.pdf
_Epoxides-SupportingInformation_final-experimental-V5.pdf
supporting information
application/pdf
1812853
https://hzi.openrepository.com/bitstream/10033/621212/2/_Epoxides-SupportingInformation_final-experimental-V5.pdf
ab7b0c2990e0958091b8291ab9985151
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621212/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621212/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621212/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621212/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Wagner et al_.pdf.txt
Wagner et al_.pdf.txt
Extracted Text
text/plain
26934
https://hzi.openrepository.com/bitstream/10033/621212/7/Wagner%20et%20al_.pdf.txt
c451eec8c15ed7c21fdb36b83a3ad040
MD5
7
false
_Epoxides-SupportingInformation_final-experimental-V5.pdf.txt
_Epoxides-SupportingInformation_final-experimental-V5.pdf.txt
Extracted Text
text/plain
39034
https://hzi.openrepository.com/bitstream/10033/621212/9/_Epoxides-SupportingInformation_final-experimental-V5.pdf.txt
b4ce31b2ab5fdab735a882415e05a398
MD5
9
false
THUMBNAIL
Wagner et al_.pdf.jpg
Wagner et al_.pdf.jpg
Generated Thumbnail
image/jpeg
26912
https://hzi.openrepository.com/bitstream/10033/621212/11/Wagner%20et%20al_.pdf.jpg
257da8ad5b898d51288ff752c620b694
MD5
11
false
_Epoxides-SupportingInformation_final-experimental-V5.pdf.jpg
_Epoxides-SupportingInformation_final-experimental-V5.pdf.jpg
Generated Thumbnail
image/jpeg
27343
https://hzi.openrepository.com/bitstream/10033/621212/12/_Epoxides-SupportingInformation_final-experimental-V5.pdf.jpg
8943b8019f6d8006a177e6385d427a63
MD5
12
false
10033/621212
oai:hzi.openrepository.com:10033/621212
2019-08-30 11:34:22.377
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6212352019-08-30T11:32:16Zcom_10033_620656col_10033_620657
Marcozzi, Alessio
d1d4b9fa62d0d8d2621c6267841a3b10
500
Masini, Tiziana
095f5b87e09d4a5f218c6e6eea350ac5
500
Zhu, Di
b520fafce6a69d7a8d68e8e1ebdaca06
500
Pesce, Diego
747217e8f1df77eabf42f3eba87aa2ba
500
Illarionov, Boris
d0f77af3052eac00246e2222b4e85902
500
Fischer, Markus
192c27e96e0675812fd8f9737db34890
500
Herrmann, Andreas
edf826a954d05c97d5533c18bbb464ca
500
Hirsch, Anna Katharina Herta
baa29cf36fb3d9bede33ff999bd24c7d
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2018-01-17T11:44:13Z
2018-01-17T11:44:13Z
2018-01-04
Phage Display on the Anti-infective Target 1-Deoxy-d-xylulose-5-phosphate Synthase Leads to an Acceptor-Substrate Competitive Peptidic Inhibitor. 2018, 19 (1):58-65 Chembiochem
1439-7633
29119720
10.1002/cbic.201700402
http://hdl.handle.net/10033/621235
Chembiochem : a European journal of chemical biology
Enzymes of the 2-C-methyl-d-erythritol-4-phosphate pathway for the biosynthesis of isoprenoid precursors are validated drug targets. By performing phage display on 1-deoxy-d-xylulose-5-phosphate synthase (DXS), which catalyzes the first step of this pathway, we discovered several peptide hits and recognized false-positive hits. The enriched peptide binder P12 emerged as a substrate (d-glyceraldehyde-3-phosphate)-competitive inhibitor of Deinococcus radiodurans DXS. The results indicate possible overlap of the cofactor- and acceptor-substrate-binding pockets and provide inspiration for the design of inhibitors of DXS with a unique and novel mechanism of inhibition.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Phage Display on the Anti-infective Target 1-Deoxy-d-xylulose-5-phosphate Synthase Leads to an Acceptor-Substrate Competitive Peptidic Inhibitor.
Article
2018-06-12T18:08:03Z
Enzymes of the 2-C-methyl-d-erythritol-4-phosphate pathway for the biosynthesis of isoprenoid precursors are validated drug targets. By performing phage display on 1-deoxy-d-xylulose-5-phosphate synthase (DXS), which catalyzes the first step of this pathway, we discovered several peptide hits and recognized false-positive hits. The enriched peptide binder P12 emerged as a substrate (d-glyceraldehyde-3-phosphate)-competitive inhibitor of Deinococcus radiodurans DXS. The results indicate possible overlap of the cofactor- and acceptor-substrate-binding pockets and provide inspiration for the design of inhibitors of DXS with a unique and novel mechanism of inhibition.
ORIGINAL
Marcozzi_et_al.pdf
Marcozzi_et_al.pdf
Open Access article
application/pdf
608743
https://hzi.openrepository.com/bitstream/10033/621235/1/Marcozzi_et_al.pdf
a75b2722ffe2fd35e0f7351fabf03f9e
MD5
1
true
cbic201700402-sup-0001-misc_information.pdf
cbic201700402-sup-0001-misc_information.pdf
supporting information
application/pdf
1603872
https://hzi.openrepository.com/bitstream/10033/621235/8/cbic201700402-sup-0001-misc_information.pdf
a726e91d8363d6462558a709dc3117cb
MD5
8
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621235/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621235/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621235/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621235/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Marcozzi_et_al.pdf.txt
Marcozzi_et_al.pdf.txt
Extracted Text
text/plain
48066
https://hzi.openrepository.com/bitstream/10033/621235/6/Marcozzi_et_al.pdf.txt
6b79758eab07c6eb2914858fae9412a8
MD5
6
false
cbic201700402-sup-0001-misc_information.pdf.txt
cbic201700402-sup-0001-misc_information.pdf.txt
Extracted Text
text/plain
2904
https://hzi.openrepository.com/bitstream/10033/621235/9/cbic201700402-sup-0001-misc_information.pdf.txt
cdd99ccf77cf2b6a3da2347ba4190ce0
MD5
9
false
THUMBNAIL
Marcozzi_et_al.pdf.jpg
Marcozzi_et_al.pdf.jpg
Generated Thumbnail
image/jpeg
147130
https://hzi.openrepository.com/bitstream/10033/621235/11/Marcozzi_et_al.pdf.jpg
c4eae9cafc7ada8bee1a378baf4dfc69
MD5
11
false
cbic201700402-sup-0001-misc_information.pdf.jpg
cbic201700402-sup-0001-misc_information.pdf.jpg
Generated Thumbnail
image/jpeg
26478
https://hzi.openrepository.com/bitstream/10033/621235/12/cbic201700402-sup-0001-misc_information.pdf.jpg
d4baff055dd3d17ad39ea152f95eca57
MD5
12
false
10033/621235
oai:hzi.openrepository.com:10033/621235
2019-08-30 11:32:16.997
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6212642019-08-30T11:31:46Zcom_10033_620656col_10033_620658
Calvert, Matthew B
621e7a4269427714cca6387f0753a791
500
Mayer, Christoph
119d9aaa31c0e0cb85da6d15e8ff1511
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
Helmholtz Institut für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2018-02-06T14:41:09Z
2018-02-06T14:41:09Z
2017-12-11
An efficient synthesis of 1,6-anhydro- N -acetylmuramic acid from N -acetylglucosamine 2017, 13:2631 Beilstein Journal of Organic Chemistry
1860-5397
30018663
10.3762/bjoc.13.261
http://hdl.handle.net/10033/621264
Beilstein Journal of Organic Chemistry
http://www.beilstein-journals.org/bjoc/content/13/1/261
http://creativecommons.org/licenses/by-nc-sa/4.0/
An efficient synthesis of 1,6-anhydro- N -acetylmuramic acid from N -acetylglucosamine
Article
2018-06-12T23:36:38Z
ORIGINAL
Calvert et al.pdf
Calvert et al.pdf
Open Access publication
application/pdf
305332
https://hzi.openrepository.com/bitstream/10033/621264/1/Calvert%20et%20al.pdf
133e40190d1cb3c5c0667ca2b59f8607
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621264/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621264/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621264/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621264/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Calvert et al.pdf.txt
Calvert et al.pdf.txt
Extracted Text
text/plain
17545
https://hzi.openrepository.com/bitstream/10033/621264/6/Calvert%20et%20al.pdf.txt
f1ce5a54d533d91903aee60d371b9a0d
MD5
6
false
THUMBNAIL
Calvert et al.pdf.jpg
Calvert et al.pdf.jpg
Generated Thumbnail
image/jpeg
61252
https://hzi.openrepository.com/bitstream/10033/621264/7/Calvert%20et%20al.pdf.jpg
37a49dcea6fd43e784831991da47142d
MD5
7
false
10033/621264
oai:hzi.openrepository.com:10033/621264
2019-08-30 11:31:46.914
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6212922019-08-30T11:36:33Zcom_10033_620656col_10033_620658
Hottmann, Isabel
0a2a9072726a829f0f8a3a6dc428f040
500
Mayer, Valentina M T
5a1b5c5ab8c738d77acf3d3365c7583b
500
Tomek, Markus B
8b12d27b924c77a9662a9b6031843177
500
Friedrich, Valentin
af0e3343e11d88e54b3b4f77bc4a2393
500
Calvert, Matthew B
621e7a4269427714cca6387f0753a791
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
Schäffer, Christina
2dfc2620871758769ff29d186bff5649
500
Mayer, Christoph
119d9aaa31c0e0cb85da6d15e8ff1511
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-02-21T14:22:42Z
2018-02-21T14:22:42Z
2018
N-Acetylmuramic Acid (MurNAc) Auxotrophy of the Oral PathogenTannerella forsythia: Characterization of a MurNAc Kinase and Analysis of Its Role in Cell Wall Metabolism. 2018, 9:19 Front Microbiol
1664-302X
29434575
10.3389/fmicb.2018.00019
http://hdl.handle.net/10033/621292
Frontiers in microbiology
Tannerella forsythia is an anaerobic, Gram-negative oral pathogen that thrives in multispecies gingival biofilms associated with periodontitis. The bacterium is auxotrophic for the commonly essential bacterial cell wall sugarN-acetylmuramic acid (MurNAc) and, thus, strictly depends on an exogenous supply of MurNAc for growth and maintenance of cell morphology. A MurNAc transporter (Tf_MurT; Tanf_08375) and an ortholog of theEscherichia colietherase MurQ (Tf_MurQ; Tanf_08385) converting MurNAc-6-phosphate to GlcNAc-6-phosphate were recently described forT. forsythia.In between the respective genes on theT. forsythiagenome, a putative kinase gene is located. In this study, the putative kinase (Tf_MurK; Tanf_08380) was produced as a recombinant protein and biochemically characterized. Kinetic studies revealed Tf_MurK to be a 6-kinase with stringent substrate specificity for MurNAc exhibiting a 6 × 104-fold higher catalytic efficiency (kcat/Km) for MurNAc than forN-acetylglucosamine (GlcNAc) withkcatvalues of 10.5 s-1and 0.1 s-1andKmvalues of 200 μM and 116 mM, respectively. The enzyme kinetic data suggest that Tf_MurK is subject to substrate inhibition (Ki[S]= 4.2 mM). To assess the role of Tf_MurK in the cell wall metabolism ofT. forsythia, a kinase deletion mutant (ΔTf_murK::erm) was constructed. This mutant accumulated MurNAc intracellularly in the exponential phase, indicating the capability to take up MurNAc, but inability to catabolize MurNAc. In the stationary phase, the MurNAc level was reduced in the mutant, while the level of the peptidoglycan precursor UDP-MurNAc-pentapeptide was highly elevated. Further, according to scanning electron microscopy evidence, theΔTf_murK::ermmutant was more tolerant toward low MurNAc concentration in the medium (below 0.5 μg/ml) before transition from healthy, rod-shaped to fusiform cells occurred, while the parent strain required > 1 μg/ml MurNAc for optimal growth. These data reveal thatT. forsythiareadily catabolizes exogenous MurNAc but simultaneously channels a proportion of the sugar into peptidoglycan biosynthesis. Deletion ofTf_murKblocks MurNAc catabolism and allows the direction of MurNAc solely to peptidoglycan biosynthesis, resulting in a growth advantage in MurNAc-depleted medium. This work increases our understanding of theT. forsythiacell wall metabolism and may pave new routes for lead finding in the treatment of periodontitis.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
N-Acetylmuramic Acid (MurNAc) Auxotrophy of the Oral PathogenTannerella forsythia: Characterization of a MurNAc Kinase and Analysis of Its Role in Cell Wall Metabolism.
Article
2018-06-13T05:40:56Z
Tannerella forsythia
is an anaerobic, Gram-negative oral pathogen that thrives in multispecies gingival biofilms associated with periodontitis. The bacterium is auxotrophic for the commonly essential bacterial cell wall sugarN-acetylmuramic acid (MurNAc) and, thus, strictly depends on an exogenous supply of MurNAc for growth and maintenance of cell morphology. A MurNAc transporter (Tf_MurT; Tanf_08375) and an ortholog of theEscherichia colietherase MurQ (Tf_MurQ; Tanf_08385) converting MurNAc-6-phosphate to GlcNAc-6-phosphate were recently described forT. forsythia.In between the respective genes on theT. forsythiagenome, a putative kinase gene is located. In this study, the putative kinase (Tf_MurK; Tanf_08380) was produced as a recombinant protein and biochemically characterized. Kinetic studies revealed Tf_MurK to be a 6-kinase with stringent substrate specificity for MurNAc exhibiting a 6 × 104-fold higher catalytic efficiency (kcat/Km) for MurNAc than forN-acetylglucosamine (GlcNAc) withkcatvalues of 10.5 s-1and 0.1 s-1andKmvalues of 200 μM and 116 mM, respectively. The enzyme kinetic data suggest that Tf_MurK is subject to substrate inhibition (Ki[S]= 4.2 mM). To assess the role of Tf_MurK in the cell wall metabolism ofT. forsythia, a kinase deletion mutant (ΔTf_murK::erm) was constructed. This mutant accumulated MurNAc intracellularly in the exponential phase, indicating the capability to take up MurNAc, but inability to catabolize MurNAc. In the stationary phase, the MurNAc level was reduced in the mutant, while the level of the peptidoglycan precursor UDP-MurNAc-pentapeptide was highly elevated. Further, according to scanning electron microscopy evidence, theΔTf_murK::ermmutant was more tolerant toward low MurNAc concentration in the medium (below 0.5 μg/ml) before transition from healthy, rod-shaped to fusiform cells occurred, while the parent strain required > 1 μg/ml MurNAc for optimal growth. These data reveal thatT. forsythiareadily catabolizes exogenous MurNAc but simultaneously channels a proportion of the sugar into peptidoglycan biosynthesis. Deletion ofTf_murKblocks MurNAc catabolism and allows the direction of MurNAc solely to peptidoglycan biosynthesis, resulting in a growth advantage in MurNAc-depleted medium. This work increases our understanding of theT. forsythiacell wall metabolism and may pave new routes for lead finding in the treatment of periodontitis.
ORIGINAL
Hottmann et al.pdf
Hottmann et al.pdf
Open Access publication
application/pdf
3944252
https://hzi.openrepository.com/bitstream/10033/621292/1/Hottmann%20et%20al.pdf
052dfb522465eae07110d15e7ced007f
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621292/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621292/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621292/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621292/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Hottmann et al.pdf.txt
Hottmann et al.pdf.txt
Extracted Text
text/plain
61992
https://hzi.openrepository.com/bitstream/10033/621292/6/Hottmann%20et%20al.pdf.txt
97be07f6be44f81dba86be5634a8e649
MD5
6
false
THUMBNAIL
Hottmann et al.pdf.jpg
Hottmann et al.pdf.jpg
Generated Thumbnail
image/jpeg
131319
https://hzi.openrepository.com/bitstream/10033/621292/7/Hottmann%20et%20al.pdf.jpg
c9ae02a181db62fea9a8d754fff748ea
MD5
7
false
10033/621292
oai:hzi.openrepository.com:10033/621292
2019-08-30 11:36:33.034
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6213382019-08-30T11:33:57Zcom_10033_338554com_10033_620656com_10033_311308col_10033_621050col_10033_620721col_10033_620657
Bussey, Kendra A
9157bd0f0e266538b08544d022348ad1
500
Lau, Ulrike
752cae0a4df01202967fd20dbb70d2f4
500
Schumann, Sophie
eb30b80e3caa6e9a9da8e854c5a94759
500
Gallo, Antonio
c022cd83ee2007d0d2e54c8820576a57
500
Osbelt, Lisa
3e6c6124f2c40a3bf52dfb6799401065
500
Stempel, Markus
7ce7db83a52627be417e6c09eba19e94
500
Arnold, Christine
233015122563c6c3ec3b98b805d5f643
500
Wissing, Josef
51e68a7924e55c999e0116dab4dc8924
500
Gad, Hans Henrik
fd0d513ddc893dd9f8ee13788be8c105
500
Hartmann, Rune
8637104e3a635021c74fea5e9f032d58
500
Brune, Wolfram
173baac82a6ec5ab90cc1e6218fab237
500
Jänsch, Lothar
14cc18542edf57a7b25c4b0c14a8c05a
600
http://orcid.org/0000-0002-5655-1181
Whitehouse, Adrian
5051c154218176610235f855924c7118
500
Brinkmann, Melanie M
b3d9e5d706e6e8628d36839ba6d8487b
500
Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7, 38124 Braunschweig, Germany.
2018-04-06T11:02:25Z
2018-04-06T11:02:25Z
2018-03
The interferon-stimulated gene product oligoadenylate synthetase-like protein enhances replication of Kaposi's sarcoma-associated herpesvirus (KSHV) and interacts with the KSHV ORF20 protein. 2018, 14 (3):e1006937 PLoS Pathog.
1553-7374
29499066
10.1371/journal.ppat.1006937
http://hdl.handle.net/10033/621338
PLoS pathogens
Kaposi's sarcoma-associated herpesvirus (KSHV) is one of the few oncogenic human viruses known to date. Its large genome encodes more than 85 proteins and includes both unique viral proteins as well as proteins conserved amongst herpesviruses. KSHV ORF20 is a member of the herpesviral core UL24 family, but the function of ORF20 and its role in the viral life cycle is not well understood. ORF20 encodes three largely uncharacterized isoforms, which we found were localized predominantly in the nuclei and nucleoli. Quantitative affinity purification coupled to mass spectrometry (q-AP-MS) identified numerous specific interacting partners of ORF20, including ribosomal proteins and the interferon-stimulated gene product (ISG) oligoadenylate synthetase-like protein (OASL). Both endogenous and transiently transfected OASL co-immunoprecipitated with ORF20, and this interaction was conserved among all ORF20 isoforms and multiple ORF20 homologs of the UL24 family in other herpesviruses. Characterization of OASL interacting partners by q-AP-MS identified a very similar interactome to that of ORF20. Both ORF20 and OASL copurified with 40S and 60S ribosomal subunits, and when they were co-expressed, they associated with polysomes. Although ORF20 did not have a global effect on translation, ORF20 enhanced RIG-I induced expression of endogenous OASL in an IRF3-dependent but IFNAR-independent manner. OASL has been characterized as an ISG with antiviral activity against some viruses, but its role for gammaherpesviruses was unknown. We show that OASL and ORF20 mRNA expression were induced early after reactivation of latently infected HuARLT-rKSHV.219 cells. Intriguingly, we found that OASL enhanced infection of KSHV. During infection with a KSHV ORF20stop mutant, however, OASL-dependent enhancement of infectivity was lost. Our data have characterized the interaction of ORF20 with OASL and suggest ORF20 usurps the function of OASL to benefit KSHV infection.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
The interferon-stimulated gene product oligoadenylate synthetase-like protein enhances replication of Kaposi's sarcoma-associated herpesvirus (KSHV) and interacts with the KSHV ORF20 protein.
Article
2018-06-12T16:56:58Z
Kaposi's sarcoma-associated herpesvirus (KSHV) is one of the few oncogenic human viruses known to date. Its large genome encodes more than 85 proteins and includes both unique viral proteins as well as proteins conserved amongst herpesviruses. KSHV ORF20 is a member of the herpesviral core UL24 family, but the function of ORF20 and its role in the viral life cycle is not well understood. ORF20 encodes three largely uncharacterized isoforms, which we found were localized predominantly in the nuclei and nucleoli. Quantitative affinity purification coupled to mass spectrometry (q-AP-MS) identified numerous specific interacting partners of ORF20, including ribosomal proteins and the interferon-stimulated gene product (ISG) oligoadenylate synthetase-like protein (OASL). Both endogenous and transiently transfected OASL co-immunoprecipitated with ORF20, and this interaction was conserved among all ORF20 isoforms and multiple ORF20 homologs of the UL24 family in other herpesviruses. Characterization of OASL interacting partners by q-AP-MS identified a very similar interactome to that of ORF20. Both ORF20 and OASL copurified with 40S and 60S ribosomal subunits, and when they were co-expressed, they associated with polysomes. Although ORF20 did not have a global effect on translation, ORF20 enhanced RIG-I induced expression of endogenous OASL in an IRF3-dependent but IFNAR-independent manner. OASL has been characterized as an ISG with antiviral activity against some viruses, but its role for gammaherpesviruses was unknown. We show that OASL and ORF20 mRNA expression were induced early after reactivation of latently infected HuARLT-rKSHV.219 cells. Intriguingly, we found that OASL enhanced infection of KSHV. During infection with a KSHV ORF20stop mutant, however, OASL-dependent enhancement of infectivity was lost. Our data have characterized the interaction of ORF20 with OASL and suggest ORF20 usurps the function of OASL to benefit KSHV infection.
ORIGINAL
Bussey et al.pdf
Bussey et al.pdf
OPen Access publication
application/pdf
35584297
https://hzi.openrepository.com/bitstream/10033/621338/1/Bussey%20et%20al.pdf
d9b0fc74eb4024874fb9e77105e47d6e
MD5
1
true
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621338/2/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
2
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621338/3/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
3
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621338/4/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621338/5/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
5
false
TEXT
Bussey et al.pdf.txt
Bussey et al.pdf.txt
Extracted Text
text/plain
121273
https://hzi.openrepository.com/bitstream/10033/621338/6/Bussey%20et%20al.pdf.txt
3d58d4d5a509f28ddd4b8911ec769257
MD5
6
false
THUMBNAIL
Bussey et al.pdf.jpg
Bussey et al.pdf.jpg
Generated Thumbnail
image/jpeg
112455
https://hzi.openrepository.com/bitstream/10033/621338/7/Bussey%20et%20al.pdf.jpg
f1ccf3062016f8e817db8277e5f2d207
MD5
7
false
10033/621338
oai:hzi.openrepository.com:10033/621338
2019-08-30 11:33:57.226
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6213662019-08-30T11:25:11Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Makshakova, Olga N
88b02abbd60a73f3008e3cfc5fe50a42
500
Wohlschlager, Therese
99fe8a12cf30b6f803e78bf0259a3504
500
Hutin, Stephanie
0b245c912c3ccfec1cca367e193a6806
500
Marsh, May
dd970185fbab249b317f8bd579cd3912
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
Künzler, Markus
3a9da4fff2b338b85cb9efa2a54263f9
500
Varrot, Annabelle
9f34f205cce62dce96f9cfa8be8d240f
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-05-07T12:38:06Z
2018-05-07T12:38:06Z
2018-03-06
Crystal Structures of Fungal Tectonin in Complex with O-Methylated Glycans Suggest Key Role in Innate Immune Defense. 2018, 26 (3):391-402.e4 Structure
1878-4186
29398527
10.1016/j.str.2018.01.003
http://hdl.handle.net/10033/621366
Structure (London, England : 1993)
Innate immunity is the first line of defense against pathogens and predators. To initiate a response, it relies on the detection of invaders, where lectin-carbohydrate interactions play a major role. O-Methylated glycans were previously identified as non-self epitopes and conserved targets for defense effector proteins belonging to the tectonin superfamily. Here, we present two crystal structures of Tectonin 2 from the mushroom Laccaria bicolor in complex with methylated ligands, unraveling the molecular basis for this original specificity. Furthermore, they revealed the formation of a ball-shaped tetramer with 24 binding sites distributed at its surface, resembling a small virus capsid. Based on the crystal structures, a methylation recognition motif was identified and found in the sequence of many tectonins from bacteria to human. Our results support a key role of tectonins in innate defense based on a distinctive and conserved type of lectin-glycan interaction.
en
http://creativecommons.org/licenses/by-nc-sa/4.0/
Crystal Structures of Fungal Tectonin in Complex with O-Methylated Glycans Suggest Key Role in Innate Immune Defense.
Article
2019-03-15T00:00:00Z
Innate immunity is the first line of defense against pathogens and predators. To initiate a response, it relies on the detection of invaders, where lectin-carbohydrate interactions play a major role. O-Methylated glycans were previously identified as non-self epitopes and conserved targets for defense effector proteins belonging to the tectonin superfamily. Here, we present two crystal structures of Tectonin 2 from the mushroom Laccaria bicolor in complex with methylated ligands, unraveling the molecular basis for this original specificity. Furthermore, they revealed the formation of a ball-shaped tetramer with 24 binding sites distributed at its surface, resembling a small virus capsid. Based on the crystal structures, a methylation recognition motif was identified and found in the sequence of many tectonins from bacteria to human. Our results support a key role of tectonins in innate defense based on a distinctive and conserved type of lectin-glycan interaction.
ORIGINAL
Sommer et al.pdf
Sommer et al.pdf
original manuscript
application/pdf
4486275
https://hzi.openrepository.com/bitstream/10033/621366/1/Sommer%20et%20al.pdf
6f27ee26e743a210228c8d882167bc08
MD5
1
true
supplemental.pdf
supplemental.pdf
supplemental material
application/pdf
4803176
https://hzi.openrepository.com/bitstream/10033/621366/2/supplemental.pdf
93e9c2068e4f07ee7da90b5031f00ace
MD5
2
false
CC-LICENSE
license_url
license_url
text/plain
49
https://hzi.openrepository.com/bitstream/10033/621366/3/license_url
924993ce0b3ba389f79f32a1b2735415
MD5
3
false
license_text
license_text
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621366/4/license_text
d41d8cd98f00b204e9800998ecf8427e
MD5
4
false
license_rdf
license_rdf
application/octet-stream
0
https://hzi.openrepository.com/bitstream/10033/621366/5/license_rdf
d41d8cd98f00b204e9800998ecf8427e
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621366/6/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
6
false
TEXT
Sommer et al.pdf.txt
Sommer et al.pdf.txt
Extracted Text
text/plain
73922
https://hzi.openrepository.com/bitstream/10033/621366/7/Sommer%20et%20al.pdf.txt
d8e8146622bf31daf46ff83aa1c868ea
MD5
7
false
supplemental.pdf.txt
supplemental.pdf.txt
Extracted Text
text/plain
8904
https://hzi.openrepository.com/bitstream/10033/621366/9/supplemental.pdf.txt
2d3515ef7bde9b68d9cd5554271084fb
MD5
9
false
THUMBNAIL
Sommer et al.pdf.jpg
Sommer et al.pdf.jpg
Generated Thumbnail
image/jpeg
42864
https://hzi.openrepository.com/bitstream/10033/621366/11/Sommer%20et%20al.pdf.jpg
f22be791588092bbe7ccebd085794f28
MD5
11
false
supplemental.pdf.jpg
supplemental.pdf.jpg
Generated Thumbnail
image/jpeg
66294
https://hzi.openrepository.com/bitstream/10033/621366/12/supplemental.pdf.jpg
66c73e4fd1c5a9a4a4ca08e9dff163b2
MD5
12
false
elsevier-thumbnail.png
application/octet-stream
56133
https://hzi.openrepository.com/bitstream/10033/621366/13/elsevier-thumbnail.png
0cbeb06fd1dd6d2069494e40207f04c0
MD5
13
false
10033/621366
oai:hzi.openrepository.com:10033/621366
2019-08-30 11:25:11.14
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214022019-08-30T11:26:38Zcom_10033_620656col_10033_620657
Liu, Yun
e148ddb574b0a675169cb05962250b43
500
Stuart, Marc C A
f26ac8e940ccec5e290ed2e7eb80677c
500
Buhler, Eric
c7a0c57d44216a87525e7a6cacaf751d
500
Hirsch, Anna K H
70f0ddf29d27965af55122735e5b86d2
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-06-18T11:57:38Z
2018-06-18T11:57:38Z
2018-05-28
1521-3927
29806088
10.1002/marc.201800099
http://hdl.handle.net/10033/621402
Dynamic proteoids are dynamic covalent analogues of proteins which are generated through the reversible polymerization of amino-acid- or peptide-derived monomers. The authors design and prepare a series of dynamic proteoids based on the reversible polycondensation of six types of dipeptide hydrazides bearing different categories of side chains. The polymerization and structures of biodynamers generated by
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
biodynamers
ae6b22df-8f30-42a0-806b-421de99f53d9
dynamic proteoids
f346a4e4-b183-4436-8370-6a3dc2e51d2b
polycondensation
23c9d7a1-b803-423f-b451-cc2d1a67b0a1
reversible polymerization
5e853d35-169e-4bcf-af7b-42974279362d
supramolecular structures
2bb46816-9def-42c3-a1c1-30010fe2032e
Dynamic Proteoids Generated From Dipeptide-Based Monomers.
Article
Macromolecular rapid communications
2018-06-18T11:57:38Z
ORIGINAL
Liu et al.pdf
Liu et al.pdf
Open Access article
application/pdf
1188074
https://hzi.openrepository.com/bitstream/10033/621402/1/Liu%20et%20al.pdf
c830422d258728cfd9a73abfaa13d904
MD5
1
true
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621402/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621402/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
TEXT
Liu et al.pdf.txt
Liu et al.pdf.txt
Extracted text
text/plain
22068
https://hzi.openrepository.com/bitstream/10033/621402/4/Liu%20et%20al.pdf.txt
3bbe689518c34768b3e6896576ee6136
MD5
4
false
THUMBNAIL
Liu et al.pdf.jpg
Liu et al.pdf.jpg
Generated Thumbnail
image/jpeg
158419
https://hzi.openrepository.com/bitstream/10033/621402/5/Liu%20et%20al.pdf.jpg
fa22a83f3e1ae05631a1b02ef72025e7
MD5
5
false
10033/621402
oai:hzi.openrepository.com:10033/621402
2019-08-30 11:26:38.192
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214232019-08-30T11:33:27Zcom_10033_620656col_10033_620658
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Hauck, Dirk
d78a0493e67fa8730a16d78132dc6953
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
HIPS, Helmholtz-Institute für pharmazeutische Forschung Saarland, Universitätscampus E8.1, 66123 Saarbrücken, Germany.
2018-07-06T08:56:40Z
2018-07-06T08:56:40Z
23656549
10.1002/slct.201700161
http://hdl.handle.net/10033/621423
β‐Linked glycosides of N‐acetyl glucosamine are widespread in nature. Their direct synthesis is hampered by the low reactivity of GlcNAc as a glycosyl donor. We report a selective and rapid copper(II) triflate‐catalyzed two‐step synthesis of β‐glycosides of GlcNAc from cheap GlcNAc as starting material without purification of intermediates. α‐Specific glycosylation can be achieved by increasing the amount of catalyst and extending reaction times.
http://doi.wiley.com/10.1002/slct.201700161
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Efficient Two Step β-Glycoside Synthesis from -Acetyl -Glucosamine: Scope and Limitations of Copper(II) Triflate-Catalyzed Glycosylation
Article
2
15
4187
4192
ChemistrySelect
2018-07-06T08:56:41Z
ORIGINAL
Sommer, Hauck and Titz.pdf
Sommer, Hauck and Titz.pdf
original manuscript
application/pdf
715593
https://hzi.openrepository.com/bitstream/10033/621423/1/Sommer%2c%20Hauck%20and%20Titz.pdf
278f218f106393b6d1aa8fb0009b5fb6
MD5
1
true
supp_info.pdf
supp_info.pdf
supporting information
application/pdf
3835744
https://hzi.openrepository.com/bitstream/10033/621423/2/supp_info.pdf
283219f9e032d69e682cc406c0705304
MD5
2
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621423/3/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
3
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621423/4/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
4
false
TEXT
Sommer, Hauck and Titz.pdf.txt
Sommer, Hauck and Titz.pdf.txt
Extracted text
text/plain
20321
https://hzi.openrepository.com/bitstream/10033/621423/5/Sommer%2c%20Hauck%20and%20Titz.pdf.txt
ad2bbff2d81a8b7e1b2e782ef1352318
MD5
5
false
supp_info.pdf.txt
supp_info.pdf.txt
Extracted text
text/plain
27647
https://hzi.openrepository.com/bitstream/10033/621423/6/supp_info.pdf.txt
eb93a85bda8806b2e164f92733d29fe9
MD5
6
false
THUMBNAIL
Sommer, Hauck and Titz.pdf.jpg
Sommer, Hauck and Titz.pdf.jpg
Generated Thumbnail
image/jpeg
37985
https://hzi.openrepository.com/bitstream/10033/621423/7/Sommer%2c%20Hauck%20and%20Titz.pdf.jpg
556a5c0c5b7cc6c227d6fdc9faabee6b
MD5
7
false
supp_info.pdf.jpg
supp_info.pdf.jpg
Generated Thumbnail
image/jpeg
75903
https://hzi.openrepository.com/bitstream/10033/621423/8/supp_info.pdf.jpg
f101bc34cf01336350cf4d861c11743c
MD5
8
false
10033/621423
oai:hzi.openrepository.com:10033/621423
2019-08-30 11:33:27.194
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214742018-09-11T01:30:01Zcom_10033_620656col_10033_620657
Liu, Yun
818ee0d2-3e0b-46a0-b03e-84bb16ff812d
500
Stuart, Marc C A
22b03d92-b7d5-462a-bc42-56128fe0b139
500
Witte, Martin D
d81d5343-ed42-402f-8d30-2214bd88d1bd
500
Buhler, Eric
17faf865-770b-4e32-84a7-47ec25083c94
500
Hirsch, Anna K H
0000-0001-8734-4663
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-09-10T14:06:00Z
2018-09-10T14:06:00Z
2017-11-16
1521-3765
28981987
10.1002/chem.201703584
http://hdl.handle.net/10033/621474
Dynamic proteoids are dynamic covalent analogues of proteins, which can be used as new adaptive biomaterials. We designed and synthesized a range of sugar-containing dynamic proteoid biodynamers based on the polycondensation of different types of amino acid and dipeptide hydrazides with a biological aliphatic dialdehyde and a nonbiological aromatic dialdehyde. By using the saccharide-based dialdehyde, the biocompatibility of biodynamers should be enhanced compared to previously reported biodynamers.
info:eu-repo/grantAgreement/EC/FP7/ 305064
openAccess
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
biodynamers
ae6b22df-8f30-42a0-806b-421de99f53d9
500
dynamic proteoids
f346a4e4-b183-4436-8370-6a3dc2e51d2b
500
equilibrium polymerization
6326ada7-281b-44e4-943e-1df185bb5a03
nanostructures
aa3227c4-9dd9-40f8-8268-989796ed68a7
supramolecular chemistry
f9f77a90-a040-4ae3-8051-e48d9c5295d8
Saccharide-Containing Dynamic Proteoids.
Article
Chemistry (Weinheim an der Bergstrasse, Germany)
2018-09-10T14:06:01Z
THUMBNAIL
Liu et al.pdf.jpg
Liu et al.pdf.jpg
Generated Thumbnail
image/jpeg
133605
https://hzi.openrepository.com/bitstream/10033/621474/5/Liu%20et%20al.pdf.jpg
1a649b7eb3929af0080cef10651630a5
MD5
5
false
TEXT
Liu et al.pdf.txt
Liu et al.pdf.txt
Extracted text
text/plain
25671
https://hzi.openrepository.com/bitstream/10033/621474/4/Liu%20et%20al.pdf.txt
3c5ef9c2b7af600c0bbee06009338824
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621474/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621474/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Liu et al.pdf
Liu et al.pdf
application/pdf
1621869
https://hzi.openrepository.com/bitstream/10033/621474/1/Liu%20et%20al.pdf
f548a08c34597aecef73f2272525583c
MD5
1
true
10033/621474
oai:hzi.openrepository.com:10033/621474
2018-09-11 01:30:01.702
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214752019-08-30T11:27:44Zcom_10033_620656col_10033_620657
Liu, Yun
e148ddb574b0a675169cb05962250b43
500
de Vries, Jan Willem
75859795dcb4a6b5cbae2a897ac19cf1
500
Liu, Qing
005a3567b609a276fb67277141f046d8
500
Hartman, Alwin M
633125073f9d46d184ea9ef2e89e6fc5
500
Wieland, Gerhard D
32370eebb2a039b06a5c1a729f849bf0
500
Wieczorek, Sebastian
12ed5886822db56a61a3d655604a86f3
500
Börner, Hans G
2a909c446b14cacc1410ebf7e78e1c89
500
Wiehe, Arno
5dbab42bccb821faa9e2f99ac8fb14b5
500
Buhler, Eric
c7a0c57d44216a87525e7a6cacaf751d
500
Stuart, Marc C A
f26ac8e940ccec5e290ed2e7eb80677c
500
Browne, Wesley R
a0ebea6056b72156bc7e578ce3f31582
500
Herrmann, Andreas
edf826a954d05c97d5533c18bbb464ca
500
Hirsch, Anna K H
ae47276b8b8d2279699ba15f468db68f
600
http://orcid.org/0000-0001-8734-4663
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-09-11T11:54:22Z
2018-09-11T11:54:22Z
2018-01-19
1521-3765
29194834
10.1002/chem.201705206
http://hdl.handle.net/10033/621475
Hydrophobic drug candidates require innovative formulation agents. We designed and synthesized lipid-DNA polymers containing varying numbers of hydrophobic alkyl chains. The hydrophobicity of these amphiphiles is easily tunable by introducing a defined number of alkyl chain-modified nucleotides during standard solid-phase synthesis of DNA using an automated DNA synthesizer. We observed that the resulting self-assembled micelles solubilize the poorly water-soluble drug, meta-tetra-hydroxyphenyl-chlorin (mTHPC) used in photodynamic therapy (PDT) with high loading concentrations and loading capacities. A cell viability study showed that mTHPC-loaded micelles exhibit good biocompatibility without irradiation, and high PDT efficacy upon irradiation. Lipid-DNAs provide a novel class of drug-delivery vehicle, and hybridization of DNA offers a potentially facile route for further functionalization of the drug-delivery system with, for instance, targeting or imaging moieties.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
amphiphiles
8d0ae5bb-da66-4eca-8e09-af6a8335f0d0
drug delivery
a322de6c-41b4-40ce-a857-437d2a1c0f7f
lipid-DNA
685ed02b-9671-4247-8c5f-9714d54605d6
micelles
bef1c192-ecb3-4295-95f9-cdd986af03a1
photodynamic therapy
b8fba0cc-b56f-4791-9282-c29780378ecd
Lipid-DNAs as Solubilizers of mTHPC.
Article
Chemistry (Weinheim an der Bergstrasse, Germany)
2018-09-11T11:54:23Z
THUMBNAIL
Liu et al.pdf.jpg
Liu et al.pdf.jpg
Generated Thumbnail
image/jpeg
133605
https://hzi.openrepository.com/bitstream/10033/621475/5/Liu%20et%20al.pdf.jpg
1a649b7eb3929af0080cef10651630a5
MD5
5
false
TEXT
Liu et al.pdf.txt
Liu et al.pdf.txt
Extracted text
text/plain
25671
https://hzi.openrepository.com/bitstream/10033/621475/4/Liu%20et%20al.pdf.txt
3c5ef9c2b7af600c0bbee06009338824
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621475/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621475/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Liu et al.pdf
Liu et al.pdf
Open Access article
application/pdf
1621869
https://hzi.openrepository.com/bitstream/10033/621475/1/Liu%20et%20al.pdf
f548a08c34597aecef73f2272525583c
MD5
1
true
10033/621475
oai:hzi.openrepository.com:10033/621475
2019-08-30 11:27:44.672
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214822019-11-20T02:02:10Zcom_10033_620613com_10033_620656col_10033_620614col_10033_620685col_10033_620657
Frank, Julia
37b05dec655f22922f40f87cfa1017ef
500
Richter, Maximilian
24141d29e949e37ecadca1deccca9b1b
500
de Rossi, Chiara
e4bbb7143cb9c1919c21166809bf508f
500
Lehr, Claus-Michael
e25b30ba80302580419199334c0f4c6b
500
Fuhrmann, Kathrin
5cc1fdabba3e27db20d6c12dc949ec90
500
Fuhrmann, Gregor
45498f31c606876157afff3f8f6fbb9d
600
http://orcid.org/0000-0002-6688-5126
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-09-17T07:54:12Z
2018-09-17T07:54:12Z
2018-08-17
2045-2322
30120298
10.1038/s41598-018-30786-y
http://hdl.handle.net/10033/621482
Extracellular vesicles (EVs) are natural nanoparticles that play important roles in intercellular communication and are increasingly studied for biosignalling, pathogenesis and therapy. Nevertheless, little is known about optimal conditions for their transfer and storage, and the potential impact on preserving EV-loaded cargoes. We present the first comprehensive stability assessment of different widely available types of EVs during various storage conditions including -80 °C, 4 °C, room temperature, and freeze-drying (lyophilisation). Lyophilisation of EVs would allow easy handling at room temperature and thus significantly enhance their expanded investigation. A model enzyme, β-glucuronidase, was loaded into different types of EVs derived from mesenchymal stem cells, endothelial cells and cancer cells. Using asymmetric flow field-flow fractionation we proved that the model enzyme is indeed stably encapsulated into EVs. When assessing enzyme activity as indicator for EV stability, and in comparison to liposomes, we show that EVs are intrinsically stable during lyophilisation, an effect further enhanced by cryoprotectants. Our findings provide new insight for exploring lyophilisation as a novel storage modality and we create an important basis for standardised and advanced EV applications in biomedical research.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Extracellular vesicles protect glucuronidase model enzymes during freeze-drying.
Article
Scientific reports
2018-09-17T07:54:13Z
THUMBNAIL
Frank et al.pdf.jpg
Frank et al.pdf.jpg
Generated Thumbnail
image/jpeg
116376
https://repository.helmholtz-hzi.de/bitstream/10033/621482/5/Frank%20et%20al.pdf.jpg
b2c1f19ce466667d88ceeec3484ac07f
MD5
5
false
Frank_supp.pdf.jpg
Frank_supp.pdf.jpg
Generated Thumbnail
image/jpeg
37157
https://repository.helmholtz-hzi.de/bitstream/10033/621482/7/Frank_supp.pdf.jpg
10908159713191635c0fe6e95b5afdbd
MD5
7
false
author's correction to Frank et al.pdf.jpg
author's correction to Frank et al.pdf.jpg
Generated Thumbnail
image/jpeg
38933
https://repository.helmholtz-hzi.de/bitstream/10033/621482/10/author%27s%20correction%20to%20Frank%20et%20al.pdf.jpg
c7aeae1ac217402cb0a67aad5b1090d0
MD5
10
false
TEXT
Frank et al.pdf.txt
Frank et al.pdf.txt
Extracted text
text/plain
37080
https://repository.helmholtz-hzi.de/bitstream/10033/621482/4/Frank%20et%20al.pdf.txt
93f327853d1b8a4fff1193cbcf34059c
MD5
4
false
author's correction to Frank et al.pdf.txt
author's correction to Frank et al.pdf.txt
Extracted text
text/plain
2926
https://repository.helmholtz-hzi.de/bitstream/10033/621482/9/author%27s%20correction%20to%20Frank%20et%20al.pdf.txt
5c37d7d9dda11805ae08669975df6543
MD5
9
false
LICENSE
license.txt
license.txt
text/plain
1685
https://repository.helmholtz-hzi.de/bitstream/10033/621482/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://repository.helmholtz-hzi.de/bitstream/10033/621482/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Frank et al.pdf
Frank et al.pdf
Open Access publication
application/pdf
2303532
https://repository.helmholtz-hzi.de/bitstream/10033/621482/1/Frank%20et%20al.pdf
9951a9408a6ee9cb6c8c1ace434dca98
MD5
1
true
author's correction to Frank et al.pdf
author's correction to Frank et al.pdf
Correction to article
application/pdf
745681
https://repository.helmholtz-hzi.de/bitstream/10033/621482/8/author%27s%20correction%20to%20Frank%20et%20al.pdf
df881c3c8deed91c1fb295f06107b631
MD5
8
false
Frank_supp.pdf
Frank_supp.pdf
supplementary material
application/pdf
3818671
https://repository.helmholtz-hzi.de/bitstream/10033/621482/6/Frank_supp.pdf
cde1aa58760eedb1aefc64427e8fd572
MD5
6
false
10033/621482
oai:repository.helmholtz-hzi.de:10033/621482
2019-11-20 02:02:10.832
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214892019-08-30T11:33:04Zcom_10033_620656col_10033_620657
Liu, Yun
e148ddb574b0a675169cb05962250b43
500
Bos, I Sophie T
8f67b71c4dc96d9de005b975e2e5e8ee
500
Oenema, Tjitske A
28dc1147f2f02b47fd2d974cfb69e438
500
Meurs, Herman
c231058457023a719ff47c5de681e2d5
500
Maarsingh, Harm
5d23f18bbdfb12a6c765f3805a533cc4
500
Hirsch, Anna K H
ae47276b8b8d2279699ba15f468db68f
600
http://orcid.org/0000-0001-8734-4663
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-09-19T08:08:09Z
2018-09-19T08:08:09Z
2018-09-01
1873-3441
29908939
10.1016/j.ejpb.2018.06.012
http://hdl.handle.net/10033/621489
Budesonide is a hydrophobic glucocorticoid with high anti-inflammatory activity for the treatment of asthma, inflammatory bowel disease and rheumatoid arthritis. A micellar drug-delivery system based on lipid-DNA may provide a strategy to maximize its drug efficacy and reduce adverse effects. In this work, we report the use of lipid-DNAA (UU11mer), featuring two hydrophobic alkyl chains and forming micelles at a comparatively low critical micelle concentration, to render budesonide water-soluble with a high loading capacity (LC). The inhibition of interleukin-8 (IL-8) release shows that the new delivery system retains the inhibitory activity in cell-based assays. In conclusion, this research provides a novel approach to formulate and administer budesonide in a non-invasive manner, which dramatically improves its water-solubility while retaining its bioavailability.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Anti-inflammatory
993577a3-4d69-475f-87b7-e0303e886e24
Budesonide
c45e8d44-fcb4-4e10-850d-8d43b2ce3b75
Drug delivery
a322de6c-41b4-40ce-a857-437d2a1c0f7f
500
Lipid-DNA
685ed02b-9671-4247-8c5f-9714d54605d6
500
Solubility
72d28ff6-f7a8-45bb-bc40-c7331277f9e1
Delivery system for budesonide based on lipid-DNA.
Article
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
THUMBNAIL
Liu et al.pdf.jpg
Liu et al.pdf.jpg
Generated Thumbnail
image/jpeg
39891
https://hzi.openrepository.com/bitstream/10033/621489/5/Liu%20et%20al.pdf.jpg
95a43fc32132d8da02d2d39d844e64f3
MD5
5
false
elsevier-thumbnail.png
application/octet-stream
56621
https://hzi.openrepository.com/bitstream/10033/621489/6/elsevier-thumbnail.png
fac9c855ed4a07ccefa0f21ff5af0bdb
MD5
6
false
TEXT
Liu et al.pdf.txt
Liu et al.pdf.txt
Extracted text
text/plain
29379
https://hzi.openrepository.com/bitstream/10033/621489/4/Liu%20et%20al.pdf.txt
a968fd25e621ced4d735784e27d972f7
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621489/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621489/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Liu et al.pdf
Liu et al.pdf
original manuscript
application/pdf
1071822
https://hzi.openrepository.com/bitstream/10033/621489/1/Liu%20et%20al.pdf
1411f7498cf0b9e8daa303ad51d33b6d
MD5
1
true
10033/621489
oai:hzi.openrepository.com:10033/621489
2019-08-30 11:33:04.645
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6214932018-09-25T06:51:10Zcom_10033_620656col_10033_620657
Liu, Yun
818ee0d2-3e0b-46a0-b03e-84bb16ff812d
500
Bos, I Sophie T
0973b5ad-6438-462f-9ab4-471b00c4bb4a
300
Oenema, Tjitske A
9839d977-f1b9-420a-88b9-b7c4724d999d
500
Meurs, Herman
83b695e2-051f-449d-9c3e-9b76c178da36
500
Maarsingh, Harm
86b1fb2b-6bf8-49fc-9ead-762b2fabf69e
500
Hirsch, Anna K H
0000-0001-8734-4663
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-09-24T14:01:09Z
2018-09-24T14:01:09Z
2018-09-01
1873-3441
29908939
10.1016/j.ejpb.2018.06.012
http://hdl.handle.net/10033/621493
Budesonide is a hydrophobic glucocorticoid with high anti-inflammatory activity for the treatment of asthma, inflammatory bowel disease and rheumatoid arthritis. A micellar drug-delivery system based on lipid-DNA may provide a strategy to maximize its drug efficacy and reduce adverse effects. In this work, we report the use of lipid-DNAA (UU11mer), featuring two hydrophobic alkyl chains and forming micelles at a comparatively low critical micelle concentration, to render budesonide water-soluble with a high loading capacity (LC). The inhibition of interleukin-8 (IL-8) release shows that the new delivery system retains the inhibitory activity in cell-based assays. In conclusion, this research provides a novel approach to formulate and administer budesonide in a non-invasive manner, which dramatically improves its water-solubility while retaining its bioavailability.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Anti-inflammatory
993577a3-4d69-475f-87b7-e0303e886e24
500
Budesonide
c45e8d44-fcb4-4e10-850d-8d43b2ce3b75
500
Drug delivery
a322de6c-41b4-40ce-a857-437d2a1c0f7f
500
Lipid-DNA
685ed02b-9671-4247-8c5f-9714d54605d6
500
Solubility
72d28ff6-f7a8-45bb-bc40-c7331277f9e1
500
Delivery system for budesonide based on lipid-DNA.
Article
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
THUMBNAIL
2019-06-14
Liu et al.pdf.jpg
Liu et al.pdf.jpg
Generated Thumbnail
image/jpeg
39891
https://hzi.openrepository.com/bitstream/10033/621493/5/Liu%20et%20al.pdf.jpg
95a43fc32132d8da02d2d39d844e64f3
MD5
5
false
TEXT
2019-06-14
Liu et al.pdf.txt
Liu et al.pdf.txt
Extracted text
text/plain
29379
https://hzi.openrepository.com/bitstream/10033/621493/4/Liu%20et%20al.pdf.txt
a968fd25e621ced4d735784e27d972f7
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621493/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621493/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Liu et al.pdf
Liu et al.pdf
original manuscript
application/pdf
1071822
https://hzi.openrepository.com/bitstream/10033/621493/1/Liu%20et%20al.pdf
1411f7498cf0b9e8daa303ad51d33b6d
MD5
1
true
10033/621493
oai:hzi.openrepository.com:10033/621493
2018-09-25 06:51:10.036
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6215052018-10-02T01:57:40Zcom_10033_620656col_10033_620658
Calvert, Matthew B
ed0f76ec-903a-4e3b-8a4f-746d871cf893
500
Mayer, Christoph
https://orcid.org/0000-0003-4731-4851
500
Titz, Alexander
0000-0001-7408-5084
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-10-01T13:29:37Z
2018-10-01T13:29:37Z
2017-01-01
1860-5397
30018663
10.3762/bjoc.13.261
http://hdl.handle.net/10033/621505
A novel synthesis of 1,6-anhydro-N-acetylmuramic acid is described, which proceeds in only five steps from the cheap starting material N-acetylglucosamine. This efficient synthesis should enable future studies into the importance of 1,6-anhydromuramic acid in bacterial cell wall recycling processes.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
N-acetylmuramic acid
05e6ae57-fa16-4da3-b91f-afe53ae77e46
anhydrosugars
5e66c292-fc5b-4463-9c44-a1917b018c75
antibiotic resistance
e0099370-5142-48e6-99dc-59282e5ac979
500
bacterial cell wall recycling
2f72a543-f317-4165-9aa0-e82b068b758a
carbohydrate synthesis
59c4cefe-5c8b-4357-8eb4-134518a775e8
An efficient synthesis of 1,6-anhydro--acetylmuramic acid from -acetylglucosamine.
Article
Beilstein journal of organic chemistry
2018-10-01T13:29:37Z
THUMBNAIL
Calvert, Mayer and Titz.pdf.jpg
Calvert, Mayer and Titz.pdf.jpg
Generated Thumbnail
image/jpeg
61234
https://hzi.openrepository.com/bitstream/10033/621505/5/Calvert%2c%20Mayer%20and%20Titz.pdf.jpg
a168fdb5ab2fd76bbafd8a70d746704f
MD5
5
false
TEXT
Calvert, Mayer and Titz.pdf.txt
Calvert, Mayer and Titz.pdf.txt
Extracted text
text/plain
17548
https://hzi.openrepository.com/bitstream/10033/621505/4/Calvert%2c%20Mayer%20and%20Titz.pdf.txt
d27683196bc293963806288cf5e7d5c7
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621505/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621505/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Calvert, Mayer and Titz.pdf
Calvert, Mayer and Titz.pdf
Open Access publication
application/pdf
305332
https://hzi.openrepository.com/bitstream/10033/621505/1/Calvert%2c%20Mayer%20and%20Titz.pdf
133e40190d1cb3c5c0667ca2b59f8607
MD5
1
true
10033/621505
oai:hzi.openrepository.com:10033/621505
2018-10-02 01:57:40.542
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6215152019-08-30T11:29:46Zcom_10033_620656col_10033_620657
Brengel, Christian
dc4fc696a5fe75d5a07912d4d04b28af
500
Thomann, Andreas
e515af4963c71ff3693be682e3be68b3
500
Schifrin, Alexander
c1840ed485e6b2bcc3e623b49fd5fbe9
500
Allegretta, Giuseppe
7c3de38445707166591b1ef19f318cea
500
Kamal, Ahmed A M
432d57b5b4747f75dd2ffdf78c56c68e
500
Haupenthal, Jörg
38a694346340f4ad927c2ee68b40a9af
500
Schnorr, Isabell
6b62385461d435657981fa66bcdd23be
500
Cho, Sang Hyun
a4dbc829861a1720ae272c2a3992808c
500
Franzblau, Scott G
cd43226cd594f0347e84430cd8e64938
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
Eberhard, Jens
6e47660391fa40a4bc204e4a5244339a
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
HIPS, Helmholtz-Institut für pharmazeutische Forschung Saarland, Universitätscampus 8.1, 66123 Saarbrücken, Germany.
2018-10-11T14:07:57Z
2018-10-11T14:07:57Z
2017-10-09
1860-7187
28815923
10.1002/cmdc.201700363
http://hdl.handle.net/10033/621515
The development of novel antimycobacterial agents against Mycobacterium tuberculosis (Mtb) is urgently required due to the appearance of multidrug resistance (MDR) combined with complicated long-term treatment. CYP121 was shown to be a promising novel target for inhibition of mycobacterial growth. In this study, we describe the rational discovery of new CYP121 inhibitors by a systematic screening based on biophysical and microbiological methods. The best hits originating from only one structural class gave initial information about molecular motifs required for binding and activity. The initial screening procedure was followed by mode-of-action studies and further biological characterizations. The results demonstrate superior antimycobacterial efficacy and a decreased toxicity profile of our frontrunner compound relative to the reference compound econazole. Due to its low molecular weight, promising biological profile, and physicochemical properties, this compound is an excellent starting point for further rational optimization.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Mycobacterium tuberculosis
302fa3a1-8373-4702-9ecb-1cf6025ed341
anti-infectives
803529e2-5c8b-42c6-a4e0-a8a998598e0c
biophysics
f9320101-1db1-4262-9437-a541ab7fe6f8
inhibitors
102ec0bc-f5c6-4325-be4d-67ddf12275e5
screening
d3e0621b-ff95-449a-8c4e-6c852dd7b97e
Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel Antimycobacterials.
Article
ChemMedChem
2018-10-11T14:07:58Z
THUMBNAIL
Brengel et al.pdf.jpg
Brengel et al.pdf.jpg
Generated Thumbnail
image/jpeg
122642
https://hzi.openrepository.com/bitstream/10033/621515/6/Brengel%20et%20al.pdf.jpg
7768797f0b39d6d3a0c0630e827ac71e
MD5
6
false
Brengel etal-supporting_information.pdf.jpg
Brengel etal-supporting_information.pdf.jpg
Generated Thumbnail
image/jpeg
38215
https://hzi.openrepository.com/bitstream/10033/621515/8/Brengel%20etal-supporting_information.pdf.jpg
03c1624c324b31cf5e2d765aa81072a3
MD5
8
false
TEXT
Brengel et al.pdf.txt
Brengel et al.pdf.txt
Extracted text
text/plain
55112
https://hzi.openrepository.com/bitstream/10033/621515/5/Brengel%20et%20al.pdf.txt
d92941840a672033eb78b10bd63d1897
MD5
5
false
Brengel etal-supporting_information.pdf.txt
Brengel etal-supporting_information.pdf.txt
Extracted text
text/plain
10866
https://hzi.openrepository.com/bitstream/10033/621515/7/Brengel%20etal-supporting_information.pdf.txt
1af873d0970df45f06a044624341b9b9
MD5
7
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621515/4/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
4
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621515/3/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
3
false
ORIGINAL
Brengel et al.pdf
Brengel et al.pdf
accepted manuscript
application/pdf
964448
https://hzi.openrepository.com/bitstream/10033/621515/1/Brengel%20et%20al.pdf
841b9d9b9ecb3b27c8db35ad2b0b062d
MD5
1
true
Brengel etal-supporting_information.pdf
Brengel etal-supporting_information.pdf
supporting information
application/pdf
1615266
https://hzi.openrepository.com/bitstream/10033/621515/2/Brengel%20etal-supporting_information.pdf
204747f0f408ca79162590892bfbc68a
MD5
2
false
10033/621515
oai:hzi.openrepository.com:10033/621515
2019-08-30 11:29:46.788
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6215322019-08-30T11:29:40Zcom_10033_620656col_10033_620658
Calvert, Matthew B
621e7a4269427714cca6387f0753a791
500
Jumde, Varsha R
30735afc9d2b52195332e496235570df
500
Titz, Alexander
bbe73a0250cae3389056476be5d00d1b
500
2018-11-02T11:37:03Z
2018-11-02T11:37:03Z
IPS, Helmholtz-Institut füt Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
1860-5397
10.3762/bjoc.14.239
http://hdl.handle.net/10033/621532
The rapid development of antimicrobial resistance is threatening mankind to such an extent that the World Health Organization expects more deaths from infections than from cancer in 2050 if current trends continue. To avoid this scenario, new classes of anti-infectives must urgently be developed. Antibiotics with new modes of action are needed, but other concepts are also currently being pursued. Targeting bacterial virulence as a means of blocking pathogenicity is a promising new strategy for disarming pathogens. Furthermore, it is believed that this new approach is less susceptible towards resistance development. In this review, recent examples of anti-infective compounds acting on several types of bacterial targets, e.g., adhesins, toxins and bacterial communication, are described.
https://www.beilstein-journals.org/bjoc/articles/14/239
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
antimicrobial resistance
bacterial adhesins
bacterial toxins
pathoblockers
quorum sensing
Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections
Article
14
2607
2617
Beilstein Journal of Organic Chemistry
2018-11-02T11:37:03Z
THUMBNAIL
Calvert et al.pdf.jpg
Calvert et al.pdf.jpg
Generated Thumbnail
image/jpeg
67038
https://hzi.openrepository.com/bitstream/10033/621532/6/Calvert%20et%20al.pdf.jpg
239e32109b495f447f8267788daec58e
MD5
6
false
TEXT
Calvert et al.pdf.txt
Calvert et al.pdf.txt
Extracted text
text/plain
71859
https://hzi.openrepository.com/bitstream/10033/621532/5/Calvert%20et%20al.pdf.txt
09e77b3e40a68872081445ac5d6c68ff
MD5
5
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621532/4/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
4
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621532/3/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
3
false
ORIGINAL
Calvert et al.pdf
Calvert et al.pdf
Open Access publication
application/pdf
15914812
https://hzi.openrepository.com/bitstream/10033/621532/2/Calvert%20et%20al.pdf
a60f3cddd1c8b1108bdddb2c31fca786
MD5
2
true
10033/621532
oai:hzi.openrepository.com:10033/621532
2019-08-30 11:29:40.826
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6215552019-08-30T11:31:44Zcom_10033_620656col_10033_620657
Vasile, Francesca
9488fdf65543376d55600d5ec16ea3b3
500
Della Volpe, Serena
ad1921c8f951a8a0b3d843fa0a1bc593
500
Ambrosio, Francesca Alessandra
dc8973f6791c662a4372d317f4546a56
500
Costa, Giosuè
27f3a880c85e1f11a80085da5ee46f6e
500
Unver, M Yagiz
076bcdcb6355a0798665d72b5ff16364
500
Zucal, Chiara
9eb5e95ede8022a44fb2e8b9ceafaff1
500
Rossi, Daniela
7e0e1e806eefde31be8a638c2282fa64
500
Martino, Emanuela
f3e21d4883ff5f3776811c3238cc3ef1
500
Provenzani, Alessandro
a4091120bde4a96005565db0b7f7a954
500
Hirsch, Anna K H
ae47276b8b8d2279699ba15f468db68f
600
http://orcid.org/0000-0001-8734-4663
Alcaro, Stefano
73c01129e89aee12ee875f7aa9330894
500
Potenza, Donatella
bb15d9d01576d8d56601634f44476c08
500
Collina, Simona
f5c90af57e02b6be637e9166ccd6d5fc
500
HIPS, Helmholtz-Institut füt Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2018-11-13T11:41:25Z
2018-11-13T11:41:25Z
2018-09-13
2045-2322
30214075
10.1038/s41598-018-32084-z
http://hdl.handle.net/10033/621555
Post-transcriptional processes have been recognised as pivotal in the control of gene expression, and impairments in RNA processing are reported in several pathologies (i.e., cancer and neurodegeneration). Focusing on RNA-binding proteins (RBPs), the involvement of Embryonic Lethal Abnormal Vision (ELAV) or Hu proteins and their complexes with target mRNAs in the aetiology of various dysfunctions, has suggested the great potential of compounds able to interfere with the complex stability as an innovative pharmacological strategy for the treatment of numerous diseases. Here, we present a rational follow-up investigation of the interaction between ELAV isoform HuR and structurally-related compounds (i.e., flavonoids and coumarins), naturally decorated with different functional groups, by means of STD-NMR and Molecular Modelling. Our results represent the foundation for the development of potent and selective ligands able to interfere with ELAV-RNA complexes.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach.
Article
Scientific reports
2018-11-13T11:41:25Z
THUMBNAIL
Vasile et al.pdf.jpg
Vasile et al.pdf.jpg
Generated Thumbnail
image/jpeg
111853
https://hzi.openrepository.com/bitstream/10033/621555/7/Vasile%20et%20al.pdf.jpg
0c8a03147ca612af1f65c71fbfe4d0c1
MD5
7
false
Vasile_supp.pdf.jpg
Vasile_supp.pdf.jpg
Generated Thumbnail
image/jpeg
52696
https://hzi.openrepository.com/bitstream/10033/621555/8/Vasile_supp.pdf.jpg
d8a840288d6fdb7c69c1f7ab07620998
MD5
8
false
TEXT
Vasile et al.pdf.txt
Vasile et al.pdf.txt
Extracted text
text/plain
46861
https://hzi.openrepository.com/bitstream/10033/621555/5/Vasile%20et%20al.pdf.txt
b13ae825c1d795df34ead7a6e171a93a
MD5
5
false
Vasile_supp.pdf.txt
Vasile_supp.pdf.txt
Extracted text
text/plain
7176
https://hzi.openrepository.com/bitstream/10033/621555/6/Vasile_supp.pdf.txt
12e09a030ee859ee66283b80d3bd2c57
MD5
6
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621555/4/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
4
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621555/3/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
3
false
ORIGINAL
Vasile et al.pdf
Vasile et al.pdf
Open Access publication
application/pdf
2241568
https://hzi.openrepository.com/bitstream/10033/621555/1/Vasile%20et%20al.pdf
c4f3da94fda48a43b002ca485c0448bb
MD5
1
true
Vasile_supp.pdf
Vasile_supp.pdf
supplementary materials
application/pdf
3515014
https://hzi.openrepository.com/bitstream/10033/621555/2/Vasile_supp.pdf
3dfec393d306d7880d5c840bdfbb64fa
MD5
2
false
10033/621555
oai:hzi.openrepository.com:10033/621555
2019-08-30 11:31:44.292
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6215692019-08-30T11:29:43Zcom_10033_620656col_10033_620657
Salah, Mohamed
19bddbb3817e61dbf347fff9d9ce695c
500
Abdelsamie, Ahmed S
b7451f5abfd51938e22a95fd4f3cec99
500
Frotscher, Martin
92285abd47d5b439933f6b3d763bd0e0
500
HIPS, Helmholtz-Institut füt Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2018-11-15T14:23:17Z
2018-11-15T14:23:17Z
2018-10-15
1872-8057
30336189
10.1016/j.mce.2018.10.001
http://hdl.handle.net/10033/621569
During the past 25 years, the modulation of estrogen action by inhibition of 17β-hydroxysteroid dehydrogenase types 1 and 2 (17β-HSD1 and 17β-HSD2), respectively, has been pursued intensively. In the search for novel treatment options for estrogen-dependent diseases (EDD) and in order to explore estrogenic signaling pathways, a large number of steroidal and nonsteroidal inhibitors of these enzymes has been described in the literature. The present review gives a survey on the development of inhibitor classes as well as the structural formulas and biological properties of their most interesting representatives. In addition, rationally designed dual inhibitors of both 17β-HSD1 and steroid sulfatase (STS) as well as the first inhibitors of 17β-HSD14 are covered.
Attribution-NonCommercial-ShareAlike 3.0 United States
http://creativecommons.org/licenses/by-nc-sa/3.0/us/
Enzyme inhibitors
159e77b3-ba76-4185-8f0a-1edd42c47bd4
Estrogen dependent diseases
2a76cea6-b521-431d-9673-24051f8a119b
Hydroxysteroid dehydrogenases
d262b5b9-b370-431f-a5f8-d9cce54228bb
Steroidogenic enzymes
d0a5b94a-c532-4d8a-b68f-95d0e26a0261
Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges.
Article
Molecular and cellular endocrinology
THUMBNAIL
2019-10-15
Salah et al.pdf.jpg
Salah et al.pdf.jpg
Generated Thumbnail
image/jpeg
24168
https://hzi.openrepository.com/bitstream/10033/621569/5/Salah%20et%20al.pdf.jpg
7ff7464effbdbcd9394a9491d8e23618
MD5
5
false
elsevier-thumbnail.png
application/octet-stream
62493
https://hzi.openrepository.com/bitstream/10033/621569/6/elsevier-thumbnail.png
2aa301697e2b86b65af32cb1b2e6e313
MD5
6
false
TEXT
2019-10-15
Salah et al.pdf.txt
Salah et al.pdf.txt
Extracted text
text/plain
94448
https://hzi.openrepository.com/bitstream/10033/621569/4/Salah%20et%20al.pdf.txt
3cbfec159aeb04113c21c498d6b49d1c
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621569/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1037
https://hzi.openrepository.com/bitstream/10033/621569/2/license_rdf
80294ba9ff4c5b4f07812ee200fbc42f
MD5
2
false
ORIGINAL
Salah et al.pdf
Salah et al.pdf
original manuscript
application/pdf
1245589
https://hzi.openrepository.com/bitstream/10033/621569/1/Salah%20et%20al.pdf
71acf6529abda0f24e4ed67d9bfc3664
MD5
1
true
10033/621569
oai:hzi.openrepository.com:10033/621569
2019-08-30 11:29:43.653
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6216632019-08-30T11:33:27Zcom_10033_620613com_10033_620656com_10033_620644com_10033_620618col_10033_620614col_10033_620657col_10033_620619col_10033_620646
Castoldi, Arianna
50cbd7f37f58d85bb053fea35c26ad2d
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
De Rossi, Chiara
f2749c9e45c875fd008eac3a166f63c5
500
Mayr, Karsten
5ce135657ef17cefd52be5c7fe3c53f8
500
Dersch, Petra
500f0a5abfe1d165918adfd28d1a4df3
600
http://orcid.org/0000-0001-8177-3280
Hartmann, Rolf
0894006c4568c1a0a48e1c9ec4eed888
500
Müller, Rolf
09acbdcf20401224eb516fdf40681973
600
http://orcid.org/0000-0002-1042-5665
Gordon, Sarah
fe8bd36286e8c4766486b67cc27df81b
500
Lehr, Claus-Michael
e25b30ba80302580419199334c0f4c6b
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-01-18T15:45:31Z
2019-01-18T15:45:31Z
2018-12-05
Pharm Res. 2018 Dec 5;36(1):22. doi: 10.1007/s11095-018-2521-3.
1573-904X
30519925
10.1007/s11095-018-2521-3
http://hdl.handle.net/10033/621663
Pharmaceutical research
The objective of this work was to evaluate the potential of polymeric spherical and aspherical invasive nanocarriers, loaded with antibiotic, to access and treat intracellular bacterial infections. Aspherical nanocarriers were prepared by stretching of spherical precursors, and both aspherical and spherical nanocarriers were surface-functionalized with the invasive protein InvA497. The relative uptake of nanocarriers into HEp-2 epithelial cells was then assessed. Nanocarriers were subsequently loaded with a preparation of the non-permeable antibiotic gentamicin, and tested for their ability to treat HEp-2 cells infected with the enteroinvasive bacterium Shigella flexneri. InvA497-functionalized nanocarriers of both spherical and aspherical shape showed a significantly improved rate and extent of uptake into HEp-2 cells in comparison to non-functionalized nanocarriers. Functionalized and antibiotic-loaded nanocarriers demonstrated a dose dependent killing of intracellular S. flexneri. A slight but significant enhancement of intracellular bacterial killing was also observed with aspherical as compared to spherical functionalized nanocarriers at the highest tested concentration. InvA497-functionalized, polymer-based nanocarriers were able to efficiently deliver a non-permeable antibiotic across host cell membranes to affect killing of intracellular bacteria. Functionalized nanocarriers with an aspherical shape showed an interesting future potential for intracellular infection therapy.
en
Springer
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
AOT-gentamicin
c6b50ccf-13e2-4f27-a6e2-c5d5a9259698
aspherical nanoparticles
d8f9a797-2966-47bf-857d-30e34ec5b75b
bacteriomimetic nanocarriers
16c644ab-5fe6-41d7-bbab-3cced2f057de
intracellular infection
9e8e8e0f-6ac2-4f8a-b3b6-21ecc70a1c33
invasin
0ac7ea70-dcbd-4a77-903b-21317f188395
Aspherical and Spherical InvA497-Functionalized Nanocarriers for Intracellular Delivery of Anti-Infective Agents.
Article
Pharmaceutical research
2019-01-18T15:45:32Z
THUMBNAIL
Castoldi et al.pdf.jpg
Castoldi et al.pdf.jpg
Generated Thumbnail
image/jpeg
93540
https://hzi.openrepository.com/bitstream/10033/621663/5/Castoldi%20et%20al.pdf.jpg
6474aa4eefdffbdad0bb2c8a09a38932
MD5
5
false
TEXT
Castoldi et al.pdf.txt
Castoldi et al.pdf.txt
Extracted text
text/plain
58328
https://hzi.openrepository.com/bitstream/10033/621663/4/Castoldi%20et%20al.pdf.txt
4b0af43f19e449c567a6843f96d7009e
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621663/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621663/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Castoldi et al.pdf
Castoldi et al.pdf
Open Access article
application/pdf
2068846
https://hzi.openrepository.com/bitstream/10033/621663/1/Castoldi%20et%20al.pdf
63c24eff36c54f6727c12a44bbe3925e
MD5
1
true
10033/621663
oai:hzi.openrepository.com:10033/621663
2019-08-30 11:33:27.918
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6216992019-02-20T01:22:06Zcom_10033_620656col_10033_620657
2019-02-19T15:09:37Z
2019-02-19T15:09:37Z
2018-09-12
2366-3987
10.1002/adtp.201800066
http://hdl.handle.net/10033/621699
Advanced Therapeutics
In an attempt to find new antibiotics, novel ways of interfering with important biological functions should be explored, especially with those which are necessary or even irreplaceable for bacterial survival, growth, and virulence. The purpose of this review is to highlight B‐type vitamin transporters from the energy‐coupling factor (ECF) family, which are not present in humans, as potential antimicrobial targets. In addition, a druggability analysis of an ECF transporter for folic acid and sequence‐conservation studies in seven prominent pathogens revealed new druggable pockets. Evaluation of the presence of de novo biosynthetic routes for the vitamins in question in the seven pathogens confirmed that this target class holds promise for the discovery of antimicrobial drugs with a new mechanism of action, possibly on a broad‐spectrum level.
Wiley-Blackwell
'info:eu-repo/grantAgreement/EC/H2020//757913
openAccess
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
Energy‐Coupling Factor Transporters as Novel Antimicrobial Targets
Article
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-02-19T15:09:38Z
TEXT
Bousis et al.pdf.txt
Bousis et al.pdf.txt
Extracted text
text/plain
79573
https://hzi.openrepository.com/bitstream/10033/621699/4/Bousis%20et%20al.pdf.txt
3c72d76a49a8caa2d3ba4427237f46a6
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621699/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621699/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Bousis et al.pdf
Bousis et al.pdf
Open Access article
application/pdf
1936239
https://hzi.openrepository.com/bitstream/10033/621699/1/Bousis%20et%20al.pdf
934ef89745732e4597f336b6eba40faf
MD5
1
true
10033/621699
oai:hzi.openrepository.com:10033/621699
2019-02-20 01:22:06.904
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/6217002021-07-23T12:59:03Zcom_10033_620656col_10033_620657
Bousis, Spyridon
f5c3227e099ddf2d1c1f23fcde9da086
500
Diamanti, Eleonora
cc492469861eae37131e5531fa2d749a
500
Slotboom, Dirk J.
2b84629eb780a8b72ecdc7ad875d7f3f
500
Hirsch, Anna K. H.
30b8be653e6270437331685516acc470
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-02-20T10:42:06Z
2019-02-20T10:42:06Z
2019-02
10.1002/adtp.201800066
https://onlinelibrary.wiley.com/doi/epdf/10.1002/adtp.201800066
http://hdl.handle.net/10033/621700
2366-3987
Advanced Therapeutics
In an attempt to find new antibiotics, novel ways of interfering with important biological functions should be explored, especially with those which are necessary or even irreplaceable for bacterial survival, growth, and virulence. The purpose of this review is to highlight B‐type vitamin transporters from the energy‐coupling factor (ECF) family, which are not present in humans, as potential antimicrobial targets. In addition, a druggability analysis of an ECF transporter for folic acid and sequence‐conservation studies in seven prominent pathogens revealed new druggable pockets. Evaluation of the presence of de novo biosynthetic routes for the vitamins in question in the seven pathogens confirmed that this target class holds promise for the discovery of antimicrobial drugs with a new mechanism of action, possibly on a broad‐spectrum level.
en
Wiley-Blackwell
info:eu-repo/grantAgreement/EC/H2020/757913
openAccess
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
antimicrobials
684b3a01-a05b-4701-9037-bc5e216b336f
600
B-type vitamins
5bd0c9aa-89b7-4720-9b92-aa0b07744f45
600
energy coupling factor transporters
a90d477b-8a01-43b8-bf73-dab51b58b1c2
600
S-components
4cb401de-19c9-46dd-962d-f4c057a50701
600
uptake
bdffa1be-4146-4dcc-8727-4da88bfde792
600
Energy‐Coupling Factor Transporters as Novel Antimicrobial Targets
Article
2019-02-20T10:42:06Z
THUMBNAIL
Bousis et al.pdf.jpg
Bousis et al.pdf.jpg
Generated Thumbnail
image/jpeg
127257
https://repository.helmholtz-hzi.de/bitstream/10033/621700/5/Bousis%20et%20al.pdf.jpg
a6a082b49ed81080123a44ea36efbe86
MD5
5
false
TEXT
Bousis et al.pdf.txt
Bousis et al.pdf.txt
Extracted text
text/plain
79573
https://repository.helmholtz-hzi.de/bitstream/10033/621700/4/Bousis%20et%20al.pdf.txt
3c72d76a49a8caa2d3ba4427237f46a6
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://repository.helmholtz-hzi.de/bitstream/10033/621700/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://repository.helmholtz-hzi.de/bitstream/10033/621700/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Bousis et al.pdf
Bousis et al.pdf
Open Access article
application/pdf
1936239
https://repository.helmholtz-hzi.de/bitstream/10033/621700/1/Bousis%20et%20al.pdf
934ef89745732e4597f336b6eba40faf
MD5
1
true
10033/621700
oai:repository.helmholtz-hzi.de:10033/621700
2021-07-23 12:59:03.675
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6217282019-08-30T11:31:49Zcom_10033_620656col_10033_620657
Bestgen, Benoît
27d59213b5b30b21843bceb12c26fcc2
500
Kufareva, Irina
75dfa2db467d8049a4d4c0be3dd764dc
500
Seetoh, Weiguang
a598955b8590b4782bb52f90518b50ca
500
Abell, Chris
623f30384648607a652b6c72ffd98f69
500
Hartmann, Rolf W
a09ea669411540c21dc150af131c326f
500
Abagyan, Ruben
2821d711184ac2eff70f01f597da41b3
500
Le Borgne, Marc
3959a3a878296b49b6291f5c85d01d22
500
Filhol, Odile
88a9941f326d7d55157a32eb05e6999b
500
Cochet, Claude
1cd8d8bee219416b25910cd6eca388ba
500
Lomberget, Thierry
5cc5c86bee08b07b7c823a7873cbd199
500
Engel, Matthias
3ec141dda82defecef97cd49b8a79de5
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-03-20T10:55:28Z
2019-03-20T10:55:28Z
2019-02-28
J Med Chem. 2019 Feb 28;62(4):1817-1836. doi: 10.1021/acs.jmedchem.8b01765. Epub 2019 Feb 13
1520-4804
30689946
10.1021/acs.jmedchem.8b01765
http://hdl.handle.net/10033/621728
Journal of Medicinal Chemistry
Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small molecule ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold. In the present work, structure optimizations guided by a binding model led to the identification of the lead compound 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (27), showing a submicromolar potency against purified CK2α (IC
en
American Chemical Society
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
CK2
71af60c4-1adc-4bb4-a511-450af62975f8
600
kinase inhibitors
57848987-37a9-4b5b-8064-424730a8068a
600
allosteric inhibition
b4cfe1e8-e24f-40b0-9b15-4e7d55543999
600
kinase selectivity
884d2a2e-a0a3-46f8-a33d-da587a28938d
600
anti-cancer
2a416956-30c7-48f4-948e-871b707d97d9
600
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action.
Article
Journal of medicinal chemistry
THUMBNAIL
2020-01-08
Bestgen_et_al.pdf.jpg
Bestgen_et_al.pdf.jpg
Generated Thumbnail
image/jpeg
44777
https://hzi.openrepository.com/bitstream/10033/621728/7/Bestgen_et_al.pdf.jpg
146d169dee6919f9459a2615e8bbea8c
MD5
7
false
2020-01-08
Supporting Information.pdf.jpg
Supporting Information.pdf.jpg
Generated Thumbnail
image/jpeg
42602
https://hzi.openrepository.com/bitstream/10033/621728/8/Supporting%20Information.pdf.jpg
8999bcbae9cbeb191025fd118d20906b
MD5
8
false
TEXT
2020-01-08
Bestgen_et_al.pdf.txt
Bestgen_et_al.pdf.txt
Extracted text
text/plain
128162
https://hzi.openrepository.com/bitstream/10033/621728/5/Bestgen_et_al.pdf.txt
7b5e651a468cc05cf02e48ff6d8f12a5
MD5
5
false
2020-01-08
Supporting Information.pdf.txt
Supporting Information.pdf.txt
Extracted text
text/plain
38899
https://hzi.openrepository.com/bitstream/10033/621728/6/Supporting%20Information.pdf.txt
0d27a32d0429798103b14b30c41ca5b4
MD5
6
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621728/4/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
4
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621728/3/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
3
false
ORIGINAL
Bestgen_et_al.pdf
Bestgen_et_al.pdf
original manuscript
application/pdf
5133104
https://hzi.openrepository.com/bitstream/10033/621728/1/Bestgen_et_al.pdf
a95f25f7938370052f475b992fe9fe62
MD5
1
true
Supporting Information.pdf
Supporting Information.pdf
supporting information
application/pdf
7117092
https://hzi.openrepository.com/bitstream/10033/621728/2/Supporting%20Information.pdf
92d669296fc8a8a62f1dbbbb75ff8ab4
MD5
2
false
10033/621728
oai:hzi.openrepository.com:10033/621728
2019-08-30 11:31:49.111
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6217442019-08-30T11:32:36Zcom_10033_620656col_10033_620657
Schmidt, Nico
7006796a908a4895e35ae6e8c268cc32
500
Li, Jun
41e690243dac37270d20b1ee47da1bfb
500
Gottardi, Stefano
8c56d05ce7c1101f0d5f1d74a025f786
500
Moreno-Lopez, Juan Carlos
4264978c27001ad53b5d044cfc557865
500
Enache, Mihaela
6af351ff4eb1cf88ad456ac0c5392e3e
500
Monjas, Leticia
74bda1de19bcb74c4eb5ba960bb0147a
500
van der Vlag, Ramon
a41b9724fb34ae0fdcd2d87a7f96768a
500
Havenith, Remco W A
92ec7471215a77fd5d62285a82c5db41
500
Hirsch, Anna K H
ae47276b8b8d2279699ba15f468db68f
600
http://orcid.org/0000-0001-8734-4663
Stöhr, Meike
f31fa16f5a98b69f4e6799a9f11ae98a
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-04-11T11:36:13Z
2019-04-11T11:36:13Z
2019-04-01
Chemistry. 2019 Apr 1;25(19):5065-5070. doi: 10.1002/chem.201806312. Epub 2019 Mar 12.
1521-3765
30657213
10.1002/chem.201806312
http://hdl.handle.net/10033/621744
Chemistry - A European Journal
A comparative study on the self-assembly of sexiphenyl-dicarbonitrile on highly oriented pyrolytic graphite and single-layer graphene on Cu(111) is presented. Despite an overall low molecule-substrate interaction, the close-packed structures exhibit a peculiar shift repeating every four to five molecules. This shift has hitherto not been reported for similar systems and is hence a unique feature induced by the graphitic substrates.
Wiley-Blackwell
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
graphene
cd74fe6a-081f-4963-b072-12d8632f0408
nanostructures
aa3227c4-9dd9-40f8-8268-989796ed68a7
500
scanning probe microscopy
6429c633-11d7-42c9-8058-cdbf40ceb940
self-assembly
a7ab1e07-3c9d-49dc-b9f7-768f84e56d5f
surface analysis
a76283fc-69fc-44d6-8768-6ca1069a0779
Comparing the Self-Assembly of Sexiphenyl-Dicarbonitrile on Graphite and Graphene on Cu(111).
Article
Chemistry (Weinheim an der Bergstrasse, Germany)
2019-04-11T11:36:14Z
THUMBNAIL
Schmidt_et_al.pdf.jpg
Schmidt_et_al.pdf.jpg
Generated Thumbnail
image/jpeg
129011
https://hzi.openrepository.com/bitstream/10033/621744/5/Schmidt_et_al.pdf.jpg
4117aec7f11cf6bf4581c1f58e9e7e79
MD5
5
false
TEXT
Schmidt_et_al.pdf.txt
Schmidt_et_al.pdf.txt
Extracted text
text/plain
36268
https://hzi.openrepository.com/bitstream/10033/621744/4/Schmidt_et_al.pdf.txt
185eab24c0ec1d56930e3886f008c5be
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621744/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621744/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Schmidt_et_al.pdf
Schmidt_et_al.pdf
Open Access article
application/pdf
1399759
https://hzi.openrepository.com/bitstream/10033/621744/1/Schmidt_et_al.pdf
ebaf786bb8fd39d4e7deab1dc82875ac
MD5
1
true
10033/621744
oai:hzi.openrepository.com:10033/621744
2019-08-30 11:32:36.141
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
Tk9OLUVYQ0xVU0lWRSBESVNUUklCVVRJT04gTElDRU5TRQoKQnkgc2lnbmluZyBhbmQgc3VibWl0dGluZyB0aGlzIGxpY2Vuc2UsIHlvdSAodGhlIGF1dGhvcihzKSBvciBjb3B5cmlnaHQKb3duZXIpIGdyYW50cyB0byBIZWxtaG9sdHogWmVudHJ1bSBm77+9ciBJbmZla3Rpb25zZm9yc2NodW5nIFJlcG9zaXRvcnkgKEhaSSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBIWkkgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgSFpJIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgSFpJIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gSFpJLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpIWkkgd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo=
oai:repository.helmholtz-hzi.de:10033/6218312019-08-30T11:32:13Zcom_10033_620656col_10033_620657
Li, Jun
41e690243dac37270d20b1ee47da1bfb
500
Solianyk, Leonid
b73fc5d0460e79bb6f5d7e959235ed5e
500
Schmidt, Nico
7006796a908a4895e35ae6e8c268cc32
500
Baker, Brian
943e0887b954d67effc7b1ee3612b237
500
Gottardi, Stefano
8c56d05ce7c1101f0d5f1d74a025f786
500
Moreno Lopez, Juan Carlos
bcdfc5970c065dd80de585c4f9472430
500
Enache, Mihaela
6af351ff4eb1cf88ad456ac0c5392e3e
500
Monjas, Leticia
74bda1de19bcb74c4eb5ba960bb0147a
500
van der Vlag, Ramon
a41b9724fb34ae0fdcd2d87a7f96768a
500
Havenith, Remco W A
92ec7471215a77fd5d62285a82c5db41
500
Hirsch, Anna K H
ae47276b8b8d2279699ba15f468db68f
600
http://orcid.org/0000-0001-8734-4663
Stöhr, Meike
f31fa16f5a98b69f4e6799a9f11ae98a
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-06-26T13:22:47Z
2019-06-26T13:22:47Z
2019-05-23
J Phys Chem C Nanomater Interfaces. 2019 May 23;123(20):12730-12735. doi: 10.1021/acs.jpcc.9b00326. Epub 2019 Apr 30.
1932-7447
31156737
10.1021/acs.jpcc.9b00326
http://hdl.handle.net/10033/621831
Journal of Physical Chemistry C
We report the formation of one- and two-dimensional metal-organic coordination structures from para-hexaphenyl-dicarbonitrile (NC-Ph6-CN) molecules and Cu atoms on graphene epitaxially grown on Ir(111). By varying the stoichiometry between the NC-Ph6-CN molecules and Cu atoms, the dimensionality of the metal-organic coordination structures could be tuned: for a 3:2 ratio, a two-dimensional hexagonal porous network based on threefold Cu coordination was observed, while for a 1:1 ratio, one-dimensional chains based on twofold Cu coordination were formed. The formation of metal-ligand bonds was supported by imaging the Cu atoms within the metal-organic coordination structures with scanning tunneling microscopy. Scanning tunneling spectroscopy measurements demonstrated that the electronic properties of NC-Ph6-CN molecules and Cu atoms were different between the two-dimensional porous network and one-dimensional molecular chains.
American Society of Chemistry
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
Low-Dimensional Metal-Organic Coordination Structures on Graphene.
Article
The journal of physical chemistry. C, Nanomaterials and interfaces
2019-06-26T13:22:48Z
THUMBNAIL
Li et al.pdf.jpg
Li et al.pdf.jpg
Generated Thumbnail
image/jpeg
143278
https://hzi.openrepository.com/bitstream/10033/621831/5/Li%20et%20al.pdf.jpg
4778c43307cd45369e4df7d74dc70985
MD5
5
false
TEXT
Li et al.pdf.txt
Li et al.pdf.txt
Extracted text
text/plain
36693
https://hzi.openrepository.com/bitstream/10033/621831/4/Li%20et%20al.pdf.txt
1a037efb8338bb072f56868d03402bda
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621831/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621831/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Li et al.pdf
Li et al.pdf
Open Access article
application/pdf
3659914
https://hzi.openrepository.com/bitstream/10033/621831/1/Li%20et%20al.pdf
0e310a13636cdf5ebf17d48dd6742934
MD5
1
true
10033/621831
oai:hzi.openrepository.com:10033/621831
2019-08-30 11:32:13.478
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6218442019-08-30T11:26:39Zcom_10033_620656col_10033_620657
Prismawan, Deka
e061a4588c2c9aa20e4e6e32bb74f329
500
van der Vlag, Ramon
a41b9724fb34ae0fdcd2d87a7f96768a
500
Guo, Hao
7a1fae7b634d5d4474e6ec7bc574e653
500
Dekker, Frank J
755eb49b1177c5b3914c26106d46b200
500
Hirsch, Anna K H
70f0ddf29d27965af55122735e5b86d2
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-07-03T14:07:18Z
2019-07-03T14:07:18Z
2019-05-01
Helv Chim Acta. 2019 May;102(5):e1900040. doi: 10.1002/hlca.201900040. Epub 2019 May 2.
0018-019X
31231138
10.1002/hlca.201900040
http://hdl.handle.net/10033/621844
Helvetica Chimica Acta
Human 15-lipoxygenase-1 (15-LOX-1) belongs to the class of lipoxygenases, which catalyze oxygenation of polyunsaturated fatty acids, such as arachidonic and linoleic acid. Recent studies have shown that 15-LOX-1 plays an important role in physiological processes linked to several diseases such as airway inflammation disease, coronary artery disease, and several types of cancer such as rectal, colon, breast and prostate cancer. In this study, we aimed to extend the structural diversity of 15-LOX-1 inhibitors, starting from the recently identified indolyl core. In order to find new scaffolds, we employed a combinatorial approach using various aromatic aldehydes and an aliphatic hydrazide tail. This scaffold-hopping study resulted in the identification of the 3-pyridylring as a suitable replacement of the indolyl core with an inhibitory activity in the micromolar range (IC50=16±6 μm) and a rapid and efficient structure-activity relationship investigation.
en
Wiley-Blackwell
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
15-lipoxygenase-1
acylhydrazone
combinatorial chemistry
enzyme inhibitors
structure–activity relationships
Replacement of an Indole Scaffold Targeting Human 15-Lipoxygenase-1 Using Combinatorial Chemistry.
Article
Helvetica chimica acta
2019-07-03T14:07:19Z
THUMBNAIL
Prismawan_et_al.pdf.jpg
Prismawan_et_al.pdf.jpg
Generated Thumbnail
image/jpeg
103961
https://hzi.openrepository.com/bitstream/10033/621844/5/Prismawan_et_al.pdf.jpg
01be23c3cca6355fa45ad9e27b37723f
MD5
5
false
TEXT
Prismawan_et_al.pdf.txt
Prismawan_et_al.pdf.txt
Extracted text
text/plain
56501
https://hzi.openrepository.com/bitstream/10033/621844/4/Prismawan_et_al.pdf.txt
d9498954d13973a76843375c5927085c
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621844/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621844/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Prismawan_et_al.pdf
Prismawan_et_al.pdf
Open Access article
application/pdf
2099064
https://hzi.openrepository.com/bitstream/10033/621844/1/Prismawan_et_al.pdf
5f9286fbb15ff9a9ebcf31a5132b42b1
MD5
1
true
10033/621844
oai:hzi.openrepository.com:10033/621844
2019-08-30 11:26:39.724
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6218462019-08-30T11:24:27Zcom_10033_620656col_10033_620657
Hartman, Alwin M.
3300f0c315be73ac484ed020cff49784
500
Gierse, Robin M.
dd3b9e956197d2b5a86f818c5ab67492
500
Hirsch, Anna K. H.
30b8be653e6270437331685516acc470
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-07-04T12:52:19Z
2019-07-04T12:52:19Z
2019-05-03
http://hdl.handle.net/10033/621846
European Journal of Organic Chemistry
Dynamic combinatorial chemistry (DCC) is a powerful tool to identify bioactive compounds. This efficient technique allows the target to select its own binders and circumvents the need for synthesis and biochemical evaluation of all individual derivatives. An ever‐increasing number of publications report the use of DCC on biologically relevant target proteins. This minireview complements previous reviews by focusing on the experimental protocol and giving detailed examples of essential steps and factors that need to be considered, such as protein stability, buffer composition and cosolvents.
en
Wiley
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
Protein-Templated Dynamic Combinatorial Chemistry: Brief Overview and Experimental Protocol
Article
2019-07-04T12:52:19Z
THUMBNAIL
Hartman_et_al.pdf.jpg
Hartman_et_al.pdf.jpg
Generated Thumbnail
image/jpeg
128772
https://hzi.openrepository.com/bitstream/10033/621846/5/Hartman_et_al.pdf.jpg
df48551d746fc7dd9db607e1b570a5ed
MD5
5
false
TEXT
Hartman_et_al.pdf.txt
Hartman_et_al.pdf.txt
Extracted text
text/plain
46303
https://hzi.openrepository.com/bitstream/10033/621846/4/Hartman_et_al.pdf.txt
37aca55bba55fe108438574582b798aa
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621846/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621846/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Hartman_et_al.pdf
Hartman_et_al.pdf
Open Access aaarticle
application/pdf
2402532
https://hzi.openrepository.com/bitstream/10033/621846/1/Hartman_et_al.pdf
728e27f326075c64dda370d4bef4d150
MD5
1
true
10033/621846
oai:hzi.openrepository.com:10033/621846
2019-08-30 11:24:27.652
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6218492019-08-30T11:26:10Zcom_10033_620656col_10033_620657
Kirsch, Philine
cadb507a4434f3d24d014f1d80e0ea54
500
Jakob, Valentin
4c8329a55aa8151b9fe411e6d98eb9f8
500
Oberhausen, Kevin
3a510d3f0dc9a4a8b053417771405807
500
Stein, Saskia C
d52dcec92214b8ea333ccb32267df43d
500
Cucarro, Ivano
60e07dd1c9d86e2e867b84c8adab5673
500
Schulz, Thomas F
0f66a8dc957772c2a89899e9eb1ff782
500
Empting, Martin
30af4662af603a71049006da15f23652
600
http://orcid.org/0000-0002-0503-5830
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-07-05T14:38:50Z
2019-07-05T14:38:50Z
2019-04-25
J Med Chem. 2019 Apr 25;62(8):3924-3939. doi: 10.1021/acs.jmedchem.8b01827. Epub 2019 Apr 12.
1520-4804
30888817
10.1021/acs.jmedchem.8b01827
http://hdl.handle.net/10033/621849
Journal of Medicinal Chemistry
The latency-associated nuclear antigen (LANA) is required for latent replication and persistence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. It acts via replicating and tethering the virus episome to the host chromatin and exerts other functions. We conceived a new approach for the discovery of antiviral drugs to inhibit the interaction between LANA and the viral genome. We applied a biophysical screening cascade and identified the first LANA binders from small, structurally diverse compound libraries. Starting from a fragment-sized scaffold, we generated optimized hits via fragment growing using a dedicated fluorescence-polarization-based assay as the structure-activity-relationship driver. We improved compound potency to the double-digit micromolar range. Importantly, we qualified the resulting hit through orthogonal methods employing EMSA, STD-NMR, and MST methodologies. This optimized hit provides an ideal starting point for subsequent hit-to-lead campaigns providing evident target-binding, suitable ligand efficiencies, and favorable physicochemical properties.
en
American Chemical Society
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.
Article
Journal of medicinal chemistry
THUMBNAIL
2020-03-19
Kirsch et al.pdf.jpg
Kirsch et al.pdf.jpg
Generated Thumbnail
image/jpeg
40049
https://hzi.openrepository.com/bitstream/10033/621849/5/Kirsch%20et%20al.pdf.jpg
f3100424ee4a80081d6c1766bbe84302
MD5
5
false
TEXT
2020-03-19
Kirsch et al.pdf.txt
Kirsch et al.pdf.txt
Extracted text
text/plain
79121
https://hzi.openrepository.com/bitstream/10033/621849/4/Kirsch%20et%20al.pdf.txt
8c2c0be9172c0cbefbe8cdba39247250
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621849/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621849/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Kirsch et al.pdf
Kirsch et al.pdf
original manuscript
application/pdf
7077640
https://hzi.openrepository.com/bitstream/10033/621849/1/Kirsch%20et%20al.pdf
469691b6b34c123b35c1d9944c67a413
MD5
1
true
10033/621849
oai:hzi.openrepository.com:10033/621849
2019-08-30 11:26:10.348
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6218502019-08-30T11:26:40Zcom_10033_620656col_10033_620658
Lepsik, Martin
386189402253c57a6d40b9c37256ac7a
500
Sommer, Roman
ab94b5af1a59bace7c8bfbc08f572b29
500
Kuhaudomlarp, Sakonwan
a5595ebfe6d79b78af98dbe032a181d1
500
Lelimousin, Mickaël
324aa30227ba56dc85a1a6c71d20c419
500
Paci, Emanuele
bacb29e357e0043b6e683f27646ab004
500
Varrot, Annabelle
9f34f205cce62dce96f9cfa8be8d240f
500
Titz, Alexander
177971b49872f92239e4e51e9bc549b7
600
http://orcid.org/0000-0001-7408-5084
Imberty, Anne
6e3e5ebf482abdb8033b0c4c8cfa10db
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-07-08T08:34:30Z
2019-07-08T08:34:30Z
2019-09-01
Eur J Med Chem. 2019 Sep 1;177:212-220. doi: 10.1016/j.ejmech.2019.05.049. Epub 2019 May 18.
1768-3254
31146126
10.1016/j.ejmech.2019.05.049
http://hdl.handle.net/10033/621850
European Journal of Medicinal Chemistry
Pathogenic micro-organisms utilize protein receptors (lectins) in adhesion to host tissues, a process that in some cases relies on the interaction between lectins and human glycoconjugates. Oligosaccharide epitopes are recognized through their three-dimensional structure and their flexibility is a key issue in specificity. In this paper, we analysed by X-ray crystallography the structures of the LecB lectin from two strains of Pseudomonas aeruginosa in complex with Lewis x oligosaccharide present on cell surfaces of human tissues. An unusual conformation of the glycan was observed in all binding sites with a non-canonical syn orientation of the N-acetyl group of N-acetyl-glucosamine. A PDB-wide search revealed that such an orientation occurs only in 4% of protein/carbohydrate complexes. Theoretical chemistry calculations showed that the observed conformation is unstable in solution but stabilised by the lectin. A reliable description of LecB/Lewis x complex by force field-based methods had proven especially challenging due to the special feature of the binding site, two closely apposed Ca2+ ions which induce strong charge delocalisation. By comparing various force-field parametrisations, we propose a general strategy which will be useful in near future for designing carbohydrate-based ligands (glycodrugs) against other calcium-dependent protein receptors.
en
Elsevier
nfo:eu-repo/grantAgreement/EC/H2020/795605
embargoedAccess
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
Calcium ion
Carbohydrate
Lectin
Molecular dynamics
N-Acetyl
Quantum effect
Induction of rare conformation of oligosaccharide by binding to calcium-dependent bacterial lectin: X-ray crystallography and modelling study.
Article
European journal of medicinal chemistry
THUMBNAIL
2020-05-18
Lepsik et al.pdf.jpg
Lepsik et al.pdf.jpg
Generated Thumbnail
image/jpeg
33261
https://hzi.openrepository.com/bitstream/10033/621850/6/Lepsik%20et%20al.pdf.jpg
4262dccfad519e82463ee97aafe12522
MD5
6
false
2020-05-18
Lepsik_supp.pdf.jpg
Lepsik_supp.pdf.jpg
Generated Thumbnail
image/jpeg
15213
https://hzi.openrepository.com/bitstream/10033/621850/8/Lepsik_supp.pdf.jpg
8987abec4b8b08ec74609e1ae4cac5ee
MD5
8
false
elsevier-thumbnail.png
application/octet-stream
54206
https://hzi.openrepository.com/bitstream/10033/621850/9/elsevier-thumbnail.png
52e914eb3075b6482d967306c1752112
MD5
9
false
TEXT
2020-05-18
Lepsik et al.pdf.txt
Lepsik et al.pdf.txt
Extracted text
text/plain
53407
https://hzi.openrepository.com/bitstream/10033/621850/5/Lepsik%20et%20al.pdf.txt
f7d0b086f02b50844c7dbd603a8ba275
MD5
5
false
2020-05-18
Lepsik_supp.pdf.txt
Lepsik_supp.pdf.txt
Extracted text
text/plain
4638
https://hzi.openrepository.com/bitstream/10033/621850/7/Lepsik_supp.pdf.txt
f3a42d2fb866664a8306ff075751747e
MD5
7
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621850/4/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
4
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621850/3/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
3
false
ORIGINAL
Lepsik et al.pdf
Lepsik et al.pdf
original manuscript
application/pdf
651415
https://hzi.openrepository.com/bitstream/10033/621850/1/Lepsik%20et%20al.pdf
6513fb11a7969d24b0fe405715e7e42a
MD5
1
true
Lepsik_supp.pdf
Lepsik_supp.pdf
supplemental information
application/pdf
275326
https://hzi.openrepository.com/bitstream/10033/621850/2/Lepsik_supp.pdf
e1201db2629881fde5f218c906b579bc
MD5
2
false
10033/621850
oai:hzi.openrepository.com:10033/621850
2019-08-30 11:26:40.329
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
oai:repository.helmholtz-hzi.de:10033/6218792019-08-30T11:26:10Zcom_10033_620656col_10033_620657
Röhrig, Teresa
ce9ab4b73bd05dbe0f6c899f264f4728
500
Kirsch, Verena
873329f31d7a5c1dde80fbd36c95c514
500
Schipp, Dorothea
f7b1508cf7dd4f311bf38172e17affa6
500
Galan, Jens
998cf305d2b860f491325897f0ed5686
500
Richling, Elke
89a22f00388fb16c2ab402ad37071f7f
500
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.
2019-07-16T13:28:20Z
2019-07-16T13:28:20Z
2019-06-19
J Agric Food Chem. 2019 Jun 19;67(24):6792-6797. doi: 10.1021/acs.jafc.9b01567. Epub 2019 Jun 10.
1520-5118
31134806
10.1021/acs.jafc.9b01567
http://hdl.handle.net/10033/621879
Journal of agricultural and food chemistry
The dominant anthocyanins in blackcurrant are delphinidin-3-O-rutinoside and cyanidin-3-O-rutinoside. Data on their absorption and distribution in the human body are limited. Therefore, we performed a human pilot study on five healthy male volunteers consuming a blackcurrant (Ribes nigrum L.) extract. The rutinosides and their degradation products gallic acid and protocatechuic acid were determined in plasma and urine. The rutinosides’ concentrations peaked in both plasma and urine samples within 2 h of extract ingestion. The recoveries of delphinidin-3-O-rutinoside and cyanidin-3-O-rutinoside from urine samples were 0.040 ± 0.011% and 0.048 ± 0.016%, respectively, over a 48 h period. Protocatechuic acid concentration increased significantly after ingestion of the blackcurrant extract. Our results show that after ingestion of a blackcurrant extract containing delphinidin-3-O-rutinoside and cyanidin-3-O-rutinoside, significant quantities of biologically active compounds circulated in the plasma and were excreted via urine. Furthermore, these results contribute to the understanding of anthocyanin metabolism in humans.
en
American Chemical Society
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/
L.
anthocyanin
bioavailability
blackcurrant
rutinoside
Absorption of Anthocyanin Rutinosides after Consumption of a Blackcurrant ( Ribes nigrum L.) Extract.
Article
Journal of agricultural and food chemistry
2019-07-16T13:28:20Z
THUMBNAIL
Röhrig et al.pdf.jpg
Röhrig et al.pdf.jpg
Generated Thumbnail
image/jpeg
146195
https://hzi.openrepository.com/bitstream/10033/621879/5/R%c3%b6hrig%20et%20al.pdf.jpg
361df749aa470a48aafacb861939cf2c
MD5
5
false
TEXT
Röhrig et al.pdf.txt
Röhrig et al.pdf.txt
Extracted text
text/plain
33811
https://hzi.openrepository.com/bitstream/10033/621879/4/R%c3%b6hrig%20et%20al.pdf.txt
e09022c30e13aa25c3360258fd51b269
MD5
4
false
LICENSE
license.txt
license.txt
text/plain
1685
https://hzi.openrepository.com/bitstream/10033/621879/3/license.txt
cb598eeb10bfed09d26fd8d285172ad4
MD5
3
false
CC-LICENSE
license_rdf
license_rdf
application/rdf+xml; charset=utf-8
1031
https://hzi.openrepository.com/bitstream/10033/621879/2/license_rdf
934f4ca17e109e0a05eaeaba504d7ce4
MD5
2
false
ORIGINAL
Röhrig et al.pdf
Röhrig et al.pdf
Open Access article
application/pdf
4428230
https://hzi.openrepository.com/bitstream/10033/621879/1/R%c3%b6hrig%20et%20al.pdf
3fa3238fb14ca6b282462a974460ef41
MD5
1
true
10033/621879
oai:hzi.openrepository.com:10033/621879
2019-08-30 11:26:10.48
Helmholtz Zentrum für Infektionsforschung Repository
hzi@openrepository.com
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
xoai///com_10033_620656/100